INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138497, 1185, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c3d8db10e403014457fe57e0049db1089cd6862b28841786168fba84af87b518df99c736f9f0b6116b40d2e09b698c71b32815fc942e511ed2a5b71652f3c0654da97f8b2ba8b4c811d0c3b0a4eecffe9e078c6c466d3e409452a45b89af874073d2cb9283a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138498, 1185, 1.0, 1.0, 'g', 'PO', NULL, 'Adult', X'789cb3523054485708f057a830b456d048cb2f5228cd4bcecf2dc8c94c4e2c494d51282d4a2dc928ca2cc92cd651484e2d2acb4c86b0f38bf20b32128b2ad353137334011c3c1863', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138499, 1185, 1.0, 1.0, 'g', 'PO', NULL, 'Adult', X'789cd3c8cccb2cc94ccc51c82f52284a4d2e2d2a4acd2bd154883654485708f057a8308c0500d2780b4f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138500, 1185, 2.0, 2.0, 'g', 'PO', NULL, 'Adult', X'789cd328482d2ace2c2e49cd2bd154883652485708f057a8308c0500685707bc', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138501, 1185, 500.0, 500.0, 'mg', 'IV', NULL, 'Adult', X'789c8b363530c84d57f00c53283432c950a830d435524849ac2cd65128c948cd53303205c906f843654d75cdc0b2b100b1550fde', X'789ced5a6d73db3612fe2b187f72a6925f94d8e929f745769cc493b851ad34936b95d1402444a1260116006dab9dfcf77b167c1365d9b4d9dedccd5c3fd914771f2cf67d57fa6327345934533c113b43b633fa5dbaa5d1c92a906aa7c7763213d3c74be7523bdcdfbf915722d9d326a2ffe4fe26b50d0c4f4538e38e98060783e3fec161fff0e0d3c1cbe18bef8783177b87cf0f5f1efec3d38ac049ad2c28ffd8792b94303cf6ff3b71ebd93fad52319caa0b1e181dcb504cd56b6d7924d81b6d123b64a9be0985610b6d98d57146603d66339b0a65f13f332200bc932e7322ecb1940757c2f598e3f358b80a6ce28c50915b6e071cb2a3838324eab1c1de51f4ea5ef4213b3c380011d1ee1f251f5e15a7e17370e5270ed9e008344744784c845375a9c16c995eb051984825ad333c3f75fcb1c7ce3f4fd5a94e121cf6c9f050b01f60230b8dfc9c2b9ddf4e71e19ffb637e853f78f45acde6eb8afd868ffcf1f4f4cb573cc5525df9875ad19586db0d5e937efb4ad8a3308bdd0caa942a6a18ef84cf05f464a565bbe78a053a994be52fc76e203e1b397dcd7fcbb412cfd82f17320ef72f3494cf9dc8350e0db0db4306f290afd821ccb6148a3498bffa6df062c96e5fc2b5e8bddd6313712d4cc97bfed913e4a67cc99c6605ddd7a93ae1811346f2989dab45a129c67e79fca12f4a24f29c948d97dcac54249db453b5ef8026e3989e581754c646b11bd62ac85f3ef72fe10d1fc7af99b8e5813073afcba9ea72c4c367c0e33225ddaacf83df3269443855a91219dc50f23f7f5e611a763b60b04da26133a22a109a32c16ef09b14b12358696a7c92198b5c70ba8c79b20a492644192b447ac576c9e699f28c32803f852c3302014336e931a8ee5a06f9ffdae894ac17091e3f9baab75a6963960288bb0846473e022c047a669023dc33b26875d2d726432a0c7cdd95648335b2f1f9eb4a6fd5f50ffb83f58b6fa8eea87f5c7ad94f95f014ed4aab7e8463031d0410af145396aebc29e2e9922b44ac84111b9f5f8c4ed96e28ad150985a5089f15eeda3f5e37018cb7abb46387d6f591380443c654ee15cbacc8c318b2f1649e394d0af4a0a9910974ca5252ee2ae6b7d2e68a1b54c03757955354a70d6ef76fae0a084ba935dc06b24dc0a74878a6421d7013e6ea5c438732c00637d8885a8f3f71dc40d6e77436d4c5e662417e0bf64084702e008f857199a56c5773d7d1b1d071ac6fe089f35561e93a3d9199d9a07f448e6284cd92d4c96bf877eda81ba69bf018b128e298d72f0a9f22b0ad91743ba81d0a65750987600bca98044135eb6a1d06f6e95a4aeee4c4f692e25966eb2c38a946bc93f3da118965d660692056d9ac1d695c9136652a73cf2364a9481b0855ea6847a849ff6204e4a5476800440dae3a1fb533afd16ee8afc84a8fd15f49da40580fe47690067503a78eb2478852d33630ea807c84b3d7b40d8c4650b6c314e4b39c3c6fc5c6025ee68c0cb6b563952323418bd022631561bf4f290aa18fb4c691b1022ac7325eb150238196198ceda2bbcc530a38dfac65b3a306c81a7fceea33db7acf05c1324b2a1cb2d325ba3ed45536cd0683e3a3633403cab7e11f310850435da5a53558ca9879a7e265924996949d852780781f9defbe1251f4060f9f0345f4497a2322990845593e3f975b2884f4188b5c19e579fe09f2f54a7d3c6f0294823f4deaa3fb40d62c7097af5159d66cb1cd10d44e1dade1e485a83cbfd1c6eed2e5e11031ac464dfb755156c94b30ff2008d0e2d2fb5898480618769cc46bfb6c481d4743dd03b612dc105c882147a37a044459597950089dbb5b4363470f69ac6b81da0c8427d48059c1d108dc756f6bc7caa967397533193fa564368aa50ffe492a02c4d76cacd32ce6f55c5dc1c3b31432e98a5de2ad8a28304ea6ea0302331fca8cb457f4e1d96d80a40d87827de1598c273a83bd68469d1bc1ad63898cafbc3913385a2c78488e65b85d62f8d689828961c69ea7c02d7ddd213085b61d0753abca0188e1572824843c57214ab99fb7bd8715de94f76f6fdf5cb27fa2f74f3eeca3f7c2bc4c0d8ecea225cb3b4df21611e33f129ae6627ab5140412c02c7008ccab3699aa77c567e589f59116a786c5ac408e976aeae3295d791cedf42de5fd5579b074c463b829ae89860bed201ed19e334b9658e09c30df2ff0f0d7ccbac45f68e398c63d6344193a4238373acacedebd61e676577a4dcb9f9cd8cea49a55084df76c3a4a3b6c453f23fa195d3ad2468ad25f4f91830d2ff471c75bdfad689ca2450b728f57bc667c6dd544639926adc3078b7d84a5cfb85af989111516c90a2e0b1a527552c4049c00339ac6608177c192b291f33ef12bcf4814b15f3a4eb8b20b0c91f5be02ce8603d6f75d34623ccd4ec5c6e49aee36bb143cb87bf32d803b13944e9d6dc6b38eb58ae0493f7ec25c3855b895e550030d89e5259480722c4dba67f062d5ff804108730aa82f5688648c09488391e1d7f96c1968a3300933414c799fbd7691dc6ab48d6a08f25927324f28bd2adc1115f350d36019c3c9a59788873c58225e7016e934405b1709bb79c6239dbcbefb237265493d0375c3a74b953da2dd2a291bfc7794f888f559c5322b581a88a532db812aca22fdfff75c64d35bfff691ff511ff98f18a64b91ea7c036a7b90f061ab68d5ac173c5ef463b9405b7efc3d5b1af8ea4555f987aca8fc539537377ec17e22635c784584741dd0f935bcbfcaf00485c9a2dd9ca0dacd35ba1a9a5cb239ad4551c3d1142f106fe8657c65482442684edd426ad038a030d815060c61e51335949707341e73a921ee6c52154029daabc47bd1d4c964aa6c86663b055e2cf6cb6a8a3926b3193a776afacfa7ca5fc7f7a30eafaed14f41b8155b6735741587a60d1c9753553db25d5444dabd8985df3e023bc06550d173f4c9771061a56844b0946bbcb602ccbeec061428d6e54d61ae9f405a4948cdd14f9fce310f40925da549a3d60928ba5e7402ffcbe154a1e10ab9c39cf76530553c17021680ce8ceeb179e6bc80a8d4e19a6ca07efe00754db8763392e92d9acb948d98f54baeb46ec2a9f790f5b7096126a86339db433b270044b9f3cb8b2e271627ad2facee4f8508312fa1df0e199eb0b1ce154a6c1f4de4bdbc5ad2ed95d7e9b1931e3bedb1b73bbe90544d17519ee7b9a782bd07a91a9144078ccfd2c890436dfeb25b00be1c3e4e0a2425a9343c97459d60ce2814fc661d10a5e5b6005d3e1547664907988bc964b4856dd2c676b995adedb4d351ff1ece761fe0e9728f9da5e8c24d22c34e3a3bdd63bf0a24ff6eaafab0474b1d1dac9c8e8412db04d8549b0f901f44e4b71b7613f0873d16e54b532d3a39350030f2499f1eb66be4cba0cd90daf05bda14328c48549bef71c7368778b747b929ce84fa7deb55daf891c650726507b3bc8fc5dc4aba82dd1690ad71941fbc5fc3b0b3c9c987efba40dd417a3f3eed04e4637beef79936edb151929ea2898efe2aa85477891eb4fff4c381ed6a6e4f9f0537866913f8fd5c2719aacdf656295ab3c852469d99c7d47821d926d2f0b9dc1e26ad6a2841aeb338421bd4450780b8461654019469d3bd2e5220eaf1e05db423c229f516b95bb18511b4d8d816bc4fc209693985cafa67713a5e698440817371f4089d3c7c144825dcc342b4dad68a2c2ca4e0c264bed7e01d804e3273b5d471485f88a01d4e7920bbc04c9c40eb48df60174261487178a2b9a603dcbfe8f70b34a68aa27ba1dfb0045d90de188e00b0de855d167343ec9d3ce7c464c10391d0da158848ea8742a9adf28d31888bcc78842483760334aa5d2ef28e8bc49b26a3e10033e86a5b44b689f359ce8dd4949f142d981f178d17d206772232ff4eda4bc4b787546b97b90a748a6c9dd4c34997dee252d2afe49c95f788d19e2e21471ed6e81c19bfdede3f6e8a31529c4aefddbe8fe67f45ebdd47f59077fcd50ba2fd367a6178744f256aaf22e21aa5c87b9d88f1b1a2ae767b30b689741a6b8c556841e97b4bb958d05777db0cd59ec5d780fc0f6e2ab4671dc47a93d935b3f92524f298e9d4fc8f45eab49f1d5d3974dd1bee5fef2e5cfede9bfc7fec4d9eb8879b08311bc556377ca35ece59b67bc1a5eafc35f476a4961f5bd73cb38227df8b5e8a8530f4ad6b734b7896ea807e504bdb50da51c25bc5137f23fcf5dbb76fff066f4f58ac', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138502, 1185, 1.0, 1.0, 'g', 'PO', NULL, 'Adult', X'789cd351c8cbcfd34dcfcfcb4fce4f4e4ecc51c8cccb2cc904d369a9c92599f9790ad1860ae90a01fe0a1586b100829e0fde', X'789ced5a6d73db3612fe2b187f72a6925f94d8e929f745769cc493b851ad34936b95d1402444a1260116006dab9dfcf77b167c1365d9b4d9dedccd5c3fd914771f2cf67d57fa6327345934533c113b43b633fa5dbaa5d1c92a906aa7c7763213d3c74be7523bdcdfbf915722d9d326a2ffe4fe26b50d0c4f4538e38e98060783e3fec161fff0e0d3c1cbe18bef8783177b87cf0f5f1efec3d38ac049ad2c28ffd8792b94303cf6ff3b71ebd93fad52319caa0b1e181dcb504cd56b6d7924d81b6d123b64a9be0985610b6d98d57146603d66339b0a65f13f332200bc932e7322ecb1940757c2f598e3f358b80a6ce28c50915b6e071cb2a3838324eab1c1de51f4ea5ef4213b3c380011d1ee1f251f5e15a7e17370e5270ed9e008344744784c845375a9c16c995eb051984825ad333c3f75fcb1c7ce3f4fd5a94e121cf6c9f050b01f60230b8dfc9c2b9ddf4e71e19ffb637e853f78f45acde6eb8afd868ffcf1f4f4cb573cc5525df9875ad19586db0d5e937efb4ad8a3308bdd0caa942a6a18ef84cf05f464a565bbe78a053a994be52fc76e203e1b397dcd7fcbb412cfd82f17320ef72f3494cf9dc8350e0db0db4306f290afd821ccb6148a3498bffa6df062c96e5fc2b5e8bddd6313712d4cc97bfed913e4a67cc99c6605ddd7a93ae1811346f2989dab45a129c67e79fca12f4a24f29c948d97dcac54249db453b5ef8026e3989e581754c646b11bd62ac85f3ef72fe10d1fc7af99b8e5813073afcba9ea72c4c367c0e33225ddaacf83df3269443855a91219dc50f23f7f5e611a763b60b04da26133a22a109a32c16ef09b14b12358696a7c92198b5c70ba8c79b20a492644192b447ac576c9e699f28c32803f852c3302014336e931a8ee5a06f9ffdae894ac17091e3f9baab75a6963960288bb0846473e022c047a669023dc33b26875d2d726432a0c7cdd95648335b2f1f9eb4a6fd5f50ffb83f58b6fa8eea87f5c7ad94f95f014ed4aab7e8463031d0410af145396aebc29e2e9922b44ac84111b9f5f8c4ed96e28ad150985a5089f15eeda3f5e37018cb7abb46387d6f591380443c654ee15cbacc8c318b2f1649e394d0af4a0a9910974ca5252ee2ae6b7d2e68a1b54c03757955354a70d6ef76fae0a084ba935dc06b24dc0a74878a6421d7013e6ea5c438732c00637d8885a8f3f71dc40d6e77436d4c5e662417e0bf64084702e008f857199a56c5773d7d1b1d071ac6fe089f35561e93a3d9199d9a07f448e6284cd92d4c96bf877eda81ba69bf018b128e298d72f0a9f22b0ad91743ba81d0a65750987600bca98044135eb6a1d06f6e95a4aeee4c4f692e25966eb2c38a946bc93f3da118965d660692056d9ac1d695c9136652a73cf2364a9481b0855ea6847a849ff6204e4a5476800440dae3a1fb533afd16ee8afc84a8fd15f49da40580fe47690067503a78eb2478852d33630ea807c84b3d7b40d8c4650b6c314e4b39c3c6fc5c6025ee68c0cb6b563952323418bd022631561bf4f290aa18fb4c691b1022ac7325eb150238196198ceda2bbcc530a38dfac65b3a306c81a7fceea33db7acf05c1324b2a1cb2d325ba3ed45536cd0683e3a3633403cab7e11f310850435da5a53558ca9879a7e265924996949d852780781f9defbe1251f4060f9f0345f4497a2322990845593e3f975b2884f4188b5c19e579fe09f2f54a7d3c6f0294823f4deaa3fb40d62c7097af5159d66cb1cd10d44e1dade1e485a83cbfd1c6eed2e5e11031ac464dfb755156c94b30ff2008d0e2d2fb5898480618769cc46bfb6c481d4743dd03b612dc105c882147a37a044459597950089dbb5b4363470f69ac6b81da0c8427d48059c1d108dc756f6bc7caa967397533193fa564368aa50ffe492a02c4d76cacd32ce6f55c5dc1c3b31432e98a5de2ad8a28304ea6ea0302331fca8cb457f4e1d96d80a40d87827de1598c273a83bd68469d1bc1ad63898cafbc3913385a2c78488e65b85d62f8d689828961c69ea7c02d7ddd213085b61d0753abca0188e1572824843c57214ab99fb7bd8715de94f76f6fdf5cb27fa2f74f3eeca3f7c2bc4c0d8ecea225cb3b4df21611e33f129ae6627ab5140412c02c7008ccab3699aa77c567e589f59116a786c5ac408e976aeae3295d791cedf42de5fd5579b074c463b829ae89860bed201ed19e334b9658e09c30df2ff0f0d7ccbac45f68e398c63d6344193a4238373acacedebd61e676577a4dcb9f9cd8cea49a55084df76c3a4a3b6c453f23fa195d3ad2468ad25f4f91830d2ff471c75bdfad689ca2450b728f57bc667c6dd544639926adc3078b7d84a5cfb85af989111516c90a2e0b1a527552c4049c00339ac6608177c192b291f33ef12bcf4814b15f3a4eb8b20b0c91f5be02ce8603d6f75d34623ccd4ec5c6e49aee36bb143cb87bf32d803b13944e9d6dc6b38eb58ae0493f7ec25c3855b895e550030d89e5259480722c4dba67f062d5ff804108730aa82f5688648c09488391e1d7f96c1968a3300933414c799fbd7691dc6ab48d6a08f25927324f28bd2adc1115f350d36019c3c9a59788873c58225e7016e934405b1709bb79c6239dbcbefb237265493d0375c3a74b953da2dd2a291bfc7794f888f559c5322b581a88a532db812aca22fdfff75c64d35bfff691ff511ff98f18a64b91ea7c036a7b90f061ab68d5ac173c5ef463b9405b7efc3d5b1af8ea4555f987aca8fc539537377ec17e22635c784584741dd0f935bcbfcaf00485c9a2dd9ca0dacd35ba1a9a5cb239ad4551c3d1142f106fe8657c65482442684edd426ad038a030d815060c61e51335949707341e73a921ee6c52154029daabc47bd1d4c964aa6c86663b055e2cf6cb6a8a3926b3193a776afacfa7ca5fc7f7a30eafaed14f41b8155b6735741587a60d1c9753553db25d5444dabd8985df3e023bc06550d173f4c9771061a56844b0946bbcb602ccbeec061428d6e54d61ae9f405a4948cdd14f9fce310f40925da549a3d60928ba5e7402ffcbe154a1e10ab9c39cf76530553c17021680ce8ceeb179e6bc80a8d4e19a6ca07efe00754db8763392e92d9acb948d98f54baeb46ec2a9f790f5b7096126a86339db433b270044b9f3cb8b2e271627ad2facee4f8508312fa1df0e199eb0b1ce154a6c1f4de4bdbc5ad2ed95d7e9b1931e3bedb1b73bbe90544d17519ee7b9a782bd07a91a9144078ccfd2c890436dfeb25b00be1c3e4e0a2425a9343c97459d60ce2814fc661d10a5e5b6005d3e1547664907988bc964b4856dd2c676b995adedb4d351ff1ece761fe0e9728f9da5e8c24d22c34e3a3bdd63bf0a24ff6eaafab0474b1d1dac9c8e8412db04d8549b0f901f44e4b71b7613f0873d16e54b532d3a39350030f2499f1eb66be4cba0cd90daf05bda14328c48549bef71c7368778b747b929ce84fa7deb55daf891c650726507b3bc8fc5dc4aba82dd1690ad71941fbc5fc3b0b3c9c987efba40dd417a3f3eed04e4637beef79936edb151929ea2898efe2aa85477891eb4fff4c381ed6a6e4f9f0537866913f8fd5c2719aacdf656295ab3c852469d99c7d47821d926d2f0b9dc1e26ad6a2841aeb338421bd4450780b8461654019469d3bd2e5220eaf1e05db423c229f516b95bb18511b4d8d816bc4fc209693985cafa67713a5e698440817371f4089d3c7c144825dcc342b4dad68a2c2ca4e0c264bed7e01d804e3273b5d471485f88a01d4e7920bbc04c9c40eb48df60174261487178a2b9a603dcbfe8f70b34a68aa27ba1dfb0045d90de188e00b0de855d167343ec9d3ce7c464c10391d0da158848ea8742a9adf28d31888bcc78842483760334aa5d2ef28e8bc49b26a3e10033e86a5b44b689f359ce8dd4949f142d981f178d17d206772232ff4eda4bc4b787546b97b90a748a6c9dd4c34997dee252d2afe49c95f788d19e2e21471ed6e81c19bfdede3f6e8a31529c4aefddbe8fe67f45ebdd47f59077fcd50ba2fd367a6178744f256aaf22e21aa5c87b9d88f1b1a2ae767b30b689741a6b8c556841e97b4bb958d05777db0cd59ec5d780fc0f6e2ab4671dc47a93d935b3f92524f298e9d4fc8f45eab49f1d5d3974dd1bee5fef2e5cfede9bfc7fec4d9eb8879b08311bc556377ca35ece59b67bc1a5eafc35f476a4961f5bd73cb38227df8b5e8a8530f4ad6b734b7896ea807e504bdb50da51c25bc5137f23fcf5dbb76fff066f4f58ac', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138503, 1185, 1.0, 1.0, 'g', 'PO', NULL, 'Adult', X'789c8b3654485708f057a8308c0500112802f9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138504, 1185, 500.0, 600.0, 'mg', 'PO', NULL, 'Adult', X'789c05c1b10a80201405d05fb9a30d8245b5344573d41e0d860f15f449f8a4dfef9c7ddda05cac9572642be43a5c93317a36267b9c07de610c371417415f45a7c804eb896541ab842f4a0049b0f9695252f703f5041a36', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138505, 1185, 1200.0, 1200.0, 'mg', 'PO', NULL, 'Adult', X'789cf3757456d02828cacc4d2caa542828ca2fc8a8cc49acc82cd6548836343230c84d5708f057282ccf8e5570cc29b1523083091955e8976703007145136a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138506, 1185, 500.0, 600.0, 'mg', 'PO', NULL, 'Adult', X'789c05c1b10e40301405d05fb9630d92122c26310bbb188a97b649b5b44ff0f7ce19ba1e22d116fcaee2873386d37c4ebd3665986b29f346ca43631a71959559207c60148973673d4169f2dce24e84c7b201b151c77a7370d90f25501de7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138507, 1185, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c2b28ca2fc8a8cc49acc82c56d04849cd2b49ccd15488363530c84d5708f057a8308c55d0082e492c2ab1523036d03533c8cdcc53484a4dcb2f4a552828ca4f4e4d292d4ad504002df31705', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138508, 1185, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c0b482d2a292d2ece2c5688363530c84d5708f057c8cf534849ac5430d45148cbcfc9c92f4f4d5148aa5430320549171a99641401c58b404a8a158c744d6301ed75156a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138509, 1185, 1.0, 1.0, 'g', 'PO', NULL, 'Adult', X'789c8b3654485708f057a8308c0500112802f9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138510, 1185, 1.0, 1.0, 'g', 'PO', NULL, 'Adult', X'789c8b3654485708f057283432c950a830544849acd45128c948cd53303530c8459232d235034916c7020062860e56', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138511, 1185, 10.0, 10.0, 'mg/kg', 'PO', NULL, 'Adult', X'789c8b3634c84dd7cf4e5708f057283432c950a8302ccf8e05004ad606b8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138512, 1185, 10.0, 10.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c3334c84dd7cf4ed74f49ac5408f057c8cc534854c8cf4b4e554849cccca95448c92f4e05f21540d2860a1ab989150aa606402d9a00fd52118a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138513, 1185, 5.0, 5.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c73cbcfc9c92f4f4d5148aa5430cd4dd7cf4ed74f49ac5408f057c8cf4b4e554849cccca90432818cca6205235d530096f21008', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138514, 1185, 10.0, 10.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c734a4c2e492dca4ccc5128cecc2b2dce2cc92cb65270cec8cc49294acd5378d4b9d44c21373faf240328ea5f949863a56068909bae9f9dae10e0af909f979caa9092989953a990965fa4600c6457162b68e4265664e696e65a29981a00d54214680200bf5b2454', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138515, 1185, 30.0, 30.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c33d44d49ac54284a4dcfcc4dcdb3523036c84dd7cf4e57482c56485428cecc4bcf495548c92f4e55d0c84dacc8cc2dcd05f3ac140c754c0d804a35019a191472', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138516, 1185, 10.0, 10.0, 'mg/kg', NULL, 1, 'Pediatric', X'789c33d64d49ac54284a4dcfcc4dcdb3523034c84dd7cf4e57c8cf4b4e554849cccca95448cb2f523006b22b8b153472132b32734b73ad144c0d800a210a3401f0e4161e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138517, 1185, 10.0, 10.0, 'mg/kg', NULL, 1, 'Pediatric', X'789c4d8ccb0e403010457fe52e59089accc6dfa0d5343a9dc423f4efb548d89e7beea14af7118bb18e4de8d0366cebd94202326f51707f3adeb90335694bd4f9586212efe5301a4304dd973afb1246f3286f6185c226a05f47d1d7b9003596292e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138518, 1185, 12.0, 12.0, 'mg/kg', NULL, 1, 'Pediatric', X'789c73cec8cc49294acd5378d4b9d448a13235b1a85821312f45c131253f27b5383935afa4d84ac1bf2831c74ac1d028375d3f3b5d3f25bf3855213f2f395521253133a752212dbf48c114c8ae2c56d0c84dacc8cc2dcdb552303530c84d8728d00400284722f6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138519, 880, 10.0, 50.0, 'mg', 'PO', 4, 'Adult', X'789ccba82c482d2a49cd2bcecccfb352303450d0553035c84d5708f05708f4740100a1e60947', X'789cc555516fdb3610fe2b073dad8015cb5e9c06ea302070bac540b379499097a9302ed45922421d5592f2a215f9ef3bcaad1167598b042bfa205024bfbbfbee3bf2f831295d57ad181b4a7248cefad2a1c1bf35533282a47326aed621b43e1f8fffd2b7d41c5857c53f3d7e04f6ca614be50a43b49966d3a3349ba493ec2a7b9dcf0ef3d9ece078369b4e8f072ca9a02d7b417e4c7e25267134fc07ba1bccaffa9672b8466f4b6d305857f0a9f55811fc625de37398642398ce4630937192656f60f9fb0816e7f25d173cb74d6319ae1c9604bf496e6270d23af2d67c26dbdd3ce4702f4b016f0cc5d99fef6526c0dbed24ee9d949d092b61a0b9dae3590b4f1788bd788aa42015464d256ce08fc569c167bbfd0d8172daeb817b3a8da0c5f978710d1fa6e961fd024e4b2a3506a7d553bcf6e2ceb7710b9e406385e1640a3da11326d9c144e6d9c1aca9c6b73b4287e9513d8206efa0b49ec0ae21d22df8e79d2558537e4a779bc9cbd3b86c496934aba56d3ba9f4ee547cce64e9a86264d5c385ecb2d0c8615ef03b546140e7b074f64602f470896b2af882180d6c352978a89c58b8b989bacfb21caaa8c98763497158fd291ea54f6be9e4a82e78a7ec33edcea8154aea716cb6014a5acbc92bf77c3f587f9e6eff2dced72fed69bcee5bb05f695eed3c24f74339e6968343cda5564f14e3c41872550fc18232e8fd38768f821b2d3606366836524307aea6ae19a4a8e5b44896da137aa9cd1cbbe814f41adc5026ddb4a85d431c5e742b37e43cad2e08d5bfb93ee130b924a76db78f3b5f14ccd405675b628d059baeed3c90eb434d9285f532fbe1f2dddb5705cba5d26d1dbb158889d341fb649fe456c3d87ef6fb046189aa1609820cbd4257c650c8956619193b5168bcb1a2e470741cfafab1e7afdea46f93dc630dbf5376ff63d8e736da1a5d83ca1a5bf5fb4d16cd3a357a2d2fd58fe96ba86de77cc1e724cee4a1f14d0e46da833c5d6fef94a36db3125d9946b026450356d5c8028d4df6446d21a576c24efad9f0f491870785d990f7649eaacb17b3b8bfff073508a59c', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138520, 880, 10.0, 20.0, 'mg', 'IM', NULL, 'Adult', X'789cf3a82c482d2a49cd2bce2c4b55482eca2cce2cb6523034d03532c84d57f0f4d5f70c532834d235c90000243b0ce2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138521, 880, 0.1, 0.5, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c3354c8cd57d055303452a84c4d2c2ab65230d03304f20df44c73d3f5b3d3153c7df53dc3140a4d74cd32741472132b1452f28b5315f2d3148c0c72d301ebfb10bc', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138522, 880, 10.0, 20.0, 'mg', 'IV', NULL, 'Pediatric', X'789cb353303452a84c4d2c2a56c8cf49b152303450d0553032c84d57f00c532834d235c90000a0ee090e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138523, 4128, 0.25, 0.25, 'mg/kg', NULL, 1, 'Adult', X'789c6d8c3b0e02310c05aff20e802059691ba8388ae57837114e226d1c3eb7c70525d52b66e6ddb9c915e1bcaca8fbe5b1c35e8505898a7ef04644edcdf20996a5b9f6cfa201eb2a0799a41bd8fdd2a660fa2ac8999182679d4a569e5ef521e81be2121c22aee1775a060e21ce92bea018324d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138524, 1485, 10.0, 10.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f55082e294a4d2fc928b65228494cca492db152303450c84dd751300251d60af9051925198939b999c90ac5f939a52599f979560a067aa6aaa852a5c505a979c5504923535500e61a1f61', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138525, 1485, 5.0, 80.0, 'mg', 'PO', 1, 'Adult', X'789c33d5b53050c84d5708f0574849cccca90400224504b1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138526, 6206, 5.0, 60.0, 'mg', 'PO', 1, 'Adult', X'789c33d53533c84d5708f05708740100134e0311', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138527, 6206, 40.0, 80.0, 'mg', 'PO', 1, 'Adult', X'789c3331d0b530c84dd74f49ac5408f05748c92ccb4c494d510874d14dca4c01007f9d0904', X'789ced586d6f1b3712fe2b037d4a01bddb4e0cb53840919358409caab153e0d04d0d6a97d2b2e2927b24d7b2aec87fef335cbdc7ad131787e28a7e10b0bb248733cfcc3c33a35f1b99abe6b74614b231a0c6c4c9cc286f8d6c34a95139cd1ff3104a3fe874966a218bb675737e529dc3bd3e75a294d9ad087ca4dfed3f6f757bad5ef7a67b3ee87607fd17ed5eb7d77d7112f7ca34286b3c76feda78238d7442c7e720efe3f19b55290789195917546a7d90ceaacc27a6497e85b742a589b9b05ecc25bdb6aef0835e93fa4d3a6b52af8b27fccef8d7392b344b290a6be8c6894cd23b18ea07740d91a28401cddd235d5c37e9bd58591f75aca6fb6a7ec2a720a65af2db4f1ff1a69559c4979dda47fa3e0ee1f1814f1ff99e6156e9700bfb94991fc0025b49684d99f5d2939d25a6dcfa80c1518194a7a9f481e6ea4e1a5aaa90d3ccdaac4d43ed2d7664120256f59e658e2df54665687845c1526a9549b1ab3e6a44a8e01b7c859ede6a72524be1659bde59321298e14880df1da919f91cdbb0b7725e1290f2147261a8474b29174db221976ea9b0960254dce1eaa3ed6347b79cf4256fb98b5b3315bd9098b3d6f36e31a7c9f7f4c345f4bfa43be114a09842a78ce0e4edf6c40c7dc80bd124915601e89c765be738ddc9c48a2564ea0e1a6490d49aaa2c3157b89c4a27e0713e2e9d8fc8d0e6c67b4288cdacd6768953d3159d6e55c1da2941aca7673376109d7711f7ddc59c043bf29bc48c67548aa0a4013a0024588d900b12c79b647640c60b37b140e31f9b34ad02032ba229ec5b2fefa49330ca4009558a923af05da8a682b5268df0d2ab66ed5e485c48596eaf7e076df95cbca690215fe94df868588c0b015ae6a481c3c7c657b3994a71305d01bcd619a0a3e2e7fe06fd9be8740e449a23b1aa1855b831533ecd854362c6e81265e96ce99460175c010d556a49d729004078fbb57748de8b54bada88c4f4bb7bd86ea227b038f6209596fe63335e296c62deb035db388740c4391c29c1476a0a88276362afcc81a15329566ca8d3ba4d8fda003c746a73ab71f052328e61ab3347d42e1827a3499386d92f954901bc932214807cb7e7e518a69cc528599bb21f3f070bfd7de37b712531d74120b5d84c64ea8b7eee38fde1cda0c085ce4e157cb677ed502f391eb779c61655de7388b08cc45cb2b379192e81140f5c14505a07a1d946218ce52c962b9c03f100d042183107316dc30a0ae5d6972a80c39fc89bd0e671aee44d353f4e6486808237ff24476ef230dbe7c9f1ff334376dbddb3561fa9ba7888e87e187f3d6df6a2b8074993aec47de4475efe5f91dccbbf8ee41ee7870738ee9d2c73500c08e37a6532670b7c0382b060b1250bc62d325987b3bb4d1f700173540ff69c902ca16b26fd9a54c431a9d0b334579a4da0ef4e5165505f7ad1e33b9ed963936efbec91c56d115b934d9b8ec886fe986de8d968a3cfbfd6fafc3eebf51f5df973aa0c33849d4ff1ecff508f2f62dfa7aaf175341829edba942964dc4e6c5969b16b8e37ac865e7b6e04c2140d6a00e52566402304dcdcba158d12f3168d4b3c36a009d4c14d2bf262262969bc858acc71ca20c68a3a85608530aa40ade464e920f6f20ac4ee29936895512921da73d63ae5179d42c5bdf1259a9d213f11b3723683899e5302c20146670a0810c485d20baeb4591511f8168450c57b7112ec96250d6abd2a6d1aaf49ccfb988d35977376a226518bf99363dfaf4bda96f43f5faa4b73fa8084008366cae0c6a3f3db85a796ac63873c5ebf2e78ceaa37fb5b656eb712d6556d640d705720e2f48100186ad0e93cd24faa85f71d1edbd017acc7219a55660e10e187da124695d320527d2ab516042f17700fecdadf365abb062171f312e5b1282a637d55720be5793eca318bb9200d770f4d1a5dbe6ed2c55593261f2e308d49f5dfca496644eb50ae9a54fa15e8a9067af795eb962d6dddf33d213d8675c4ddbe9722fd1c9b070436ae251a9aea08c335efab43de1f553ee786c66f097b7c00428469bc410c53004f09b03a52060e4cadc44f2b5f24e6a7dec7c4ec2306f197af517595984acea902ae50a142d4bf1913b6cd50042a8de63731df4790a45102dff6114b0c8465f091ab4abe182d8d9755664355c0a7382ba74eb18a29a71f527d3c9a20346adff04d5a54a92d44e310e53ae878363e40e9da66aa2a62119de90a65de417153070b52a8440b23a352b914994873a8f323cc5573cb2a785bc000ae83ee0ef81be0d7449f8e7edd2f39f2790af068ffd1f18805af26e6e584d033ddad9bffb986ae201714fcd84198942707c9a454b1ef1cd20614e9d0ae487f6cd1974de997afbf6032c72648db9dfacc835f90f1eb23b7db2375a6ff139b0fc7e6710eff139c7f4170fe0d40ffcae232412f5f8814f3c17c7560f7a5d0b396563339a0de79ebe4794ecfa68ab7a142eb6fe8a47dda3a699fe7dc90730dc637d60b57c5841bd05bcc208e46ff9e9c9e75bfa593e129b166b1b96a739bc6259ce71d4c5f779c94713e425a6f8695c4bcba47dad46ddd07a74cb41ba3073614dc880dd37aedd53db21ebedf2c556661ec92875d93aba90ab1e06b51a0fbe37e315d05bb8034f8a16ed2387036ffcd44b4d37ada84abd9e9e8fff81fdaddc775e3f704acdfcb1928011e3c64bf6d33f8b5223f7dfa0de8940060', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138528, 6206, 60.0, 60.0, 'mg', 'PO', 1, 'Adult', X'789cf3cd2f2e5128284a4c2ec92cc9cccf4b2d2a5648cf2c4b553033c84d5708f057a85030d45148cbcfc9c92f4f4d5148aa5430814a04ba00e54c1452122b8b1534d2f28b1412152c0c740d0d0cb2d31512534a734a340175b81ccf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138529, 6206, 4.0, 5.0, 'mg', 'PO', 1, 'Adult', X'789c33d135cd4dd757c88d335208f057087401002370042b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138530, 6206, 200.0, 200.0, 'mg', 'PO', 1, 'Adult', X'789c333230c84d5708f057087451a83054284f4dcdd65128c948cd53b0004914e42b14e6a7806472f3010fa30cef', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138531, 6206, 40.0, 40.0, 'mg', 'PO', 1, 'Adult', X'789c3331c84d5708f057087401000ecd02ad', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138532, 6206, 40.0, 40.0, 'mg', 'PO', 1, 'Adult', X'789c3331c84d5708f05770f27451a830554849ac2cd65128c948cd533081ca04a24b182149181a826500cbfc147a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138533, 6206, 0.05, 2.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c33d03330d535ca4dd7cf4ed74f49ac5408f05748c92ccb4c494d510874d10df4740100a1ae09dd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138534, 6206, 1.0, 2.0, 'mg', 'PO', 1, 'Pediatric', X'789c33d435ca4dd74f49ac5408f05748c92ccb4c494d510874d14dca4c51f04dac50303380480300fdc10ca8', X'789ced586d6f1b3712fe2b037d4a01bddb4e0cb53840919358409caab153e0d04d0d6a97d2b2e2927b24d7b2aec87fef335cbdc7ad131787e28a7e10b0bb248733cfcc3c33a35f1b99abe6b74614b231a0c6c4c9cc286f8d6c34a95139cd1ff3104a3fe874966a218bb675737e529dc3bd3e75a294d9ad087ca4dfed3f6f757bad5ef7a67b3ee87607fd17ed5eb7d77d7112f7ca34286b3c76feda78238d7442c7e720efe3f19b55290789195917546a7d90ceaacc27a6497e85b742a589b9b05ecc25bdb6aef0835e93fa4d3a6b52af8b27fccef8d7392b344b290a6be8c6894cd23b18ea07740d91a28401cddd235d5c37e9bd58591f75aca6fb6a7ec2a720a65af2db4f1ff1a69559c4979dda47fa3e0ee1f1814f1ff99e6156e9700bfb94991fc0025b49684d99f5d2939d25a6dcfa80c1518194a7a9f481e6ea4e1a5aaa90d3ccdaac4d43ed2d7664120256f59e658e2df54665687845c1526a9549b1ab3e6a44a8e01b7c859ede6a72524be1659bde59321298e14880df1da919f91cdbb0b7725e1290f2147261a8474b29174db221976ea9b0960254dce1eaa3ed6347b79cf4256fb98b5b3315bd9098b3d6f36e31a7c9f7f4c345f4bfa43be114a09842a78ce0e4edf6c40c7dc80bd124915601e89c765be738ddc9c48a2564ea0e1a6490d49aaa2c3157b89c4a27e0713e2e9d8fc8d0e6c67b4288cdacd6768953d3159d6e55c1da2941aca7673376109d7711f7ddc59c043bf29bc48c67548aa0a4013a0024588d900b12c79b647640c60b37b140e31f9b34ad02032ba229ec5b2fefa49330ca4009558a923af05da8a682b5268df0d2ab66ed5e485c48596eaf7e076df95cbca690215fe94df868588c0b015ae6a481c3c7c657b3994a71305d01bcd619a0a3e2e7fe06fd9be8740e449a23b1aa1855b831533ecd854362c6e81265e96ce99460175c010d556a49d729004078fbb57748de8b54bada88c4f4bb7bd86ea227b038f6209596fe63335e296c62deb035db388740c4391c29c1476a0a88276362afcc81a15329566ca8d3ba4d8fda003c746a73ab71f052328e61ab3347d42e1827a3499386d92f954901bc932214807cb7e7e518a69cc528599bb21f3f070bfd7de37b712531d74120b5d84c64ea8b7eee38fde1cda0c085ce4e157cb677ed502f391eb779c61655de7388b08cc45cb2b379192e81140f5c14505a07a1d946218ce52c962b9c03f100d042183107316dc30a0ae5d6972a80c39fc89bd0e671aee44d353f4e6486808237ff24476ef230dbe7c9f1ff334376dbddb3561fa9ba7888e87e187f3d6df6a2b8074993aec47de4475efe5f91dccbbf8ee41ee7870738ee9d2c73500c08e37a6532670b7c0382b060b1250bc62d325987b3bb4d1f700173540ff69c902ca16b26fd9a54c431a9d0b334579a4da0ef4e5165505f7ad1e33b9ed963936efbec91c56d115b934d9b8ec886fe986de8d968a3cfbfd6fafc3eebf51f5df973aa0c33849d4ff1ecff508f2f62dfa7aaf175341829edba942964dc4e6c5969b16b8e37ac865e7b6e04c2140d6a00e52566402304dcdcba158d12f3168d4b3c36a009d4c14d2bf262262969bc858acc71ca20c68a3a85608530aa40ade464e920f6f20ac4ee29936895512921da73d63ae5179d42c5bdf1259a9d213f11b3723683899e5302c20146670a0810c485d20baeb4591511f8168450c57b7112ec96250d6abd2a6d1aaf49ccfb988d35977376a226518bf99363dfaf4bda96f43f5faa4b73fa8084008366cae0c6a3f3db85a796ac63873c5ebf2e78ceaa37fb5b656eb712d6556d640d705720e2f48100186ad0e93cd24faa85f71d1edbd017acc7219a55660e10e187da124695d320527d2ab516042f17700fecdadf365abb062171f312e5b1282a637d55720be5793eca318bb9200d770f4d1a5dbe6ed2c55593261f2e308d49f5dfca496644eb50ae9a54fa15e8a9067af795eb962d6dddf33d213d8675c4ddbe9722fd1c9b070436ae251a9aea08c335efab43de1f553ee786c66f097b7c00428469bc410c53004f09b03a52060e4cadc44f2b5f24e6a7dec7c4ec2306f197af517595984acea902ae50a142d4bf1913b6cd50042a8de63731df4790a45102dff6114b0c8465f091ab4abe182d8d9755664355c0a7382ba74eb18a29a71f527d3c9a20346adff04d5a54a92d44e310e53ae878363e40e9da66aa2a62119de90a65de417153070b52a8440b23a352b914994873a8f323cc5573cb2a785bc000ae83ee0ef81be0d7449f8e7edd2f39f2790af068ffd1f18805af26e6e584d033ddad9bffb986ae201714fcd84198942707c9a454b1ef1cd20614e9d0ae487f6cd1974de997afbf6032c72648db9dfacc835f90f1eb23b7db2375a6ff139b0fc7e6710eff139c7f4170fe0d40ffcae232412f5f8814f3c17c7560f7a5d0b396563339a0de79ebe4794ecfa68ab7a142eb6fe8a47dda3a699fe7dc90730dc637d60b57c5841bd05bcc208e46ff9e9c9e75bfa593e129b166b1b96a739bc6259ce71d4c5f779c94713e425a6f8695c4bcba47dad46ddd07a74cb41ba3073614dc880dd37aedd53db21ebedf2c556661ec92875d93aba90ab1e06b51a0fbe37e315d05bb8034f8a16ed2387036ffcd44b4d37ada84abd9e9e8fff81fdaddc775e3f704acdfcb1928011e3c64bf6d33f8b5223f7dfa0de8940060', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138535, 6206, 4.0, 5.0, 'mg', 'PO', 1, 'Pediatric', X'789c33d135cd4dd757c88d335208f05708745108492c482d5248c92f4e55482f4a4c294dccc9a95428c95748c92c4ece482c4a4f5528cf48cd53482c2828ca2f28ca4c2c490500dbf5175d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138536, 6206, 2.0, 2.0, 'mg', 'PO', 1, 'Pediatric', X'789c33ca4d57d057c84e5708f057087401001c7803bc', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138537, 6206, 80.0, 80.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dac50b030c84d57d0574849acd453082d4e5548cb2f52302c2e513056482dc82cce4f492d0600de9d0c19', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138538, 6206, 1.0, 1.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c85cc310a83401005d0abfcd280185722e92c9234a9543cc118d7dd417785714073fbe809523f7826b8ebe4d0d478bc5fd8cb81be6b0af53622cfca3f784a7b008cc169193a25516cac9e23ee05bcac584650540efc91a5679aa16249838d8ae4e9791ee4f8aa5b3eb9cb0f32622d5d', X'789ced586d6f1b3712fe2b037d4a01bddb4e0cb53840919358409caab153e0d04d0d6a97d2b2e2927b24d7b2aec87fef335cbdc7ad131787e28a7e10b0bb248733cfcc3c33a35f1b99abe6b74614b231a0c6c4c9cc286f8d6c34a95139cd1ff3104a3fe874966a218bb675737e529dc3bd3e75a294d9ad087ca4dfed3f6f757bad5ef7a67b3ee87607fd17ed5eb7d77d7112f7ca34286b3c76feda78238d7442c7e720efe3f19b55290789195917546a7d90ceaacc27a6497e85b742a589b9b05ecc25bdb6aef0835e93fa4d3a6b52af8b27fccef8d7392b344b290a6be8c6894cd23b18ea07740d91a28401cddd235d5c37e9bd58591f75aca6fb6a7ec2a720a65af2db4f1ff1a69559c4979dda47fa3e0ee1f1814f1ff99e6156e9700bfb94991fc0025b49684d99f5d2939d25a6dcfa80c1518194a7a9f481e6ea4e1a5aaa90d3ccdaac4d43ed2d7664120256f59e658e2df54665687845c1526a9549b1ab3e6a44a8e01b7c859ede6a72524be1659bde59321298e14880df1da919f91cdbb0b7725e1290f2147261a8474b29174db221976ea9b0960254dce1eaa3ed6347b79cf4256fb98b5b3315bd9098b3d6f36e31a7c9f7f4c345f4bfa43be114a09842a78ce0e4edf6c40c7dc80bd124915601e89c765be738ddc9c48a2564ea0e1a6490d49aaa2c3157b89c4a27e0713e2e9d8fc8d0e6c67b4288cdacd6768953d3159d6e55c1da2941aca7673376109d7711f7ddc59c043bf29bc48c67548aa0a4013a0024588d900b12c79b647640c60b37b140e31f9b34ad02032ba229ec5b2fefa49330ca4009558a923af05da8a682b5268df0d2ab66ed5e485c48596eaf7e076df95cbca690215fe94df868588c0b015ae6a481c3c7c657b3994a71305d01bcd619a0a3e2e7fe06fd9be8740e449a23b1aa1855b831533ecd854362c6e81265e96ce99460175c010d556a49d729004078fbb57748de8b54bada88c4f4bb7bd86ea227b038f6209596fe63335e296c62deb035db388740c4391c29c1476a0a88276362afcc81a15329566ca8d3ba4d8fda003c746a73ab71f052328e61ab3347d42e1827a3499386d92f954901bc932214807cb7e7e518a69cc528599bb21f3f070bfd7de37b712531d74120b5d84c64ea8b7eee38fde1cda0c085ce4e157cb677ed502f391eb779c61655de7388b08cc45cb2b379192e81140f5c14505a07a1d946218ce52c962b9c03f100d042183107316dc30a0ae5d6972a80c39fc89bd0e671aee44d353f4e6486808237ff24476ef230dbe7c9f1ff334376dbddb3561fa9ba7888e87e187f3d6df6a2b8074993aec47de4475efe5f91dccbbf8ee41ee7870738ee9d2c73500c08e37a6532670b7c0382b060b1250bc62d325987b3bb4d1f700173540ff69c902ca16b26fd9a54c431a9d0b334579a4da0ef4e5165505f7ad1e33b9ed963936efbec91c56d115b934d9b8ec886fe986de8d968a3cfbfd6fafc3eebf51f5df973aa0c33849d4ff1ecff508f2f62dfa7aaf175341829edba942964dc4e6c5969b16b8e37ac865e7b6e04c2140d6a00e52566402304dcdcba158d12f3168d4b3c36a009d4c14d2bf262262969bc858acc71ca20c68a3a85608530aa40ade464e920f6f20ac4ee29936895512921da73d63ae5179d42c5bdf1259a9d213f11b3723683899e5302c20146670a0810c485d20baeb4591511f8168450c57b7112ec96250d6abd2a6d1aaf49ccfb988d35977376a226518bf99363dfaf4bda96f43f5faa4b73fa8084008366cae0c6a3f3db85a796ac63873c5ebf2e78ceaa37fb5b656eb712d6556d640d705720e2f48100186ad0e93cd24faa85f71d1edbd017acc7219a55660e10e187da124695d320527d2ab516042f17700fecdadf365abb062171f312e5b1282a637d55720be5793eca318bb9200d770f4d1a5dbe6ed2c55593261f2e308d49f5dfca496644eb50ae9a54fa15e8a9067af795eb962d6dddf33d213d8675c4ddbe9722fd1c9b070436ae251a9aea08c335efab43de1f553ee786c66f097b7c00428469bc410c53004f09b03a52060e4cadc44f2b5f24e6a7dec7c4ec2306f197af517595984acea902ae50a142d4bf1913b6cd50042a8de63731df4790a45102dff6114b0c8465f091ab4abe182d8d9755664355c0a7382ba74eb18a29a71f527d3c9a20346adff04d5a54a92d44e310e53ae878363e40e9da66aa2a62119de90a65de417153070b52a8440b23a352b914994873a8f323cc5573cb2a785bc000ae83ee0ef81be0d7449f8e7edd2f39f2790af068ffd1f18805af26e6e584d033ddad9bffb986ae201714fcd84198942707c9a454b1ef1cd20614e9d0ae487f6cd1974de997afbf6032c72648db9dfacc835f90f1eb23b7db2375a6ff139b0fc7e6710eff139c7f4170fe0d40ffcae232412f5f8814f3c17c7560f7a5d0b396563339a0de79ebe4794ecfa68ab7a142eb6fe8a47dda3a699fe7dc90730dc637d60b57c5841bd05bcc208e46ff9e9c9e75bfa593e129b166b1b96a739bc6259ce71d4c5f779c94713e425a6f8695c4bcba47dad46ddd07a74cb41ba3073614dc880dd37aedd53db21ebedf2c556661ec92875d93aba90ab1e06b51a0fbe37e315d05bb8034f8a16ed2387036ffcd44b4d37ada84abd9e9e8fff81fdaddc775e3f704acdfcb1928011e3c64bf6d33f8b5223f7dfa0de8940060', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138539, 6206, 40.0, 40.0, 'mg', 'PO', 1, 'Pediatric', X'789c3331c84d5708f05770f27451a830554849ac2cd65128c948cd53302228130894503034044be9290497241695289467966464e629981b296414152be4a72924e69564e6662617e5276526e6289414a52696e4a6e695286838a6e4e7a4162703d9c59a00a77e2b24', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138540, 6206, 40.0, 40.0, 'mg', 'PO', 1, 'Pediatric', X'789c5dc9410a40401406e0abfc0790cc44f6b2b1424ef030cc2b3353e3156eaf6421dff6cb33b7a26b513535ce02335d7b02b1c6237fa7ff87fe04947a2ac5201405078b658f52c3c61d61017961c7530c23d3068986c4192f3751802606', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138541, 673, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'789c9590cd0ac23010845fa5e46c6d2cd66a6edef4e0a9de544a5a170da64949b6fe2079779b6a410f0ade66663f6660ef646f9a43ae780584056469b422838034467a7b44ac2d8ba28b384135d4e6e095887aca9686d7b0cf397a38a6f124a4a37044d7346549c2c6d3219dc5499a762c9428b4b22d79274b8546770ae18afd709035752da10285dcb35bd5a56b7d15a5c0dbf6b9d914ef55ae8d901712bcdbec5a27853a3d8dbf6500f95cdacfb105f0f32d58017269ffebfcdef1fb631d9dbf68b773ce3d00ab2e7959', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138542, 151, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333530c84d5708f0572834d33534ca280200234c045a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138543, 151, 25.0, 50.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cb3b3a8ccb7523032d5353550c84dd7cf4ed74f49ac5408f05748c92ccb4c494d512834cb28b256c8cb2f5128c95748ad484e058a192b809501002a5c12f1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138544, 606, 1000.0, 1000.0, 'mg', 'PO', NULL, 'Adult', X'789c4d8c410a83401004bf520f10d9110fe22d2f48be30e2a881ec6ad655f4f7897af152d0055de29cf33daf279a10269f51fc898616393669305add69ac1ba351a19e7989bdc53de7f1491683a6f76a3572b5a691af0c6c94d9710e775f9efe0713772347', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138545, 606, 1000.0, 3000.0, 'mg', 'PO', NULL, 'Adult', X'789c33343030d0350612b9e90a05f90a8566190a150aa6ba660a298995c5006aeb07d5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138546, 606, 25.0, 25.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c1dcc510e82301045d1addc05a0489544fd7305ba85313394468b5a2a81dd4bfd79c94d5e8e6ba3af1f9edb15c934bc63855b171994a634b9375416eed6bd92714422e337794bcb96cb335b1a2487c9ce9c767fac2eef15d4300535e573e899719b7d61c61fed952427', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138547, 963, 7.0, 9.0, 'mg/kg', 'PO', 2, 'Adult', X'789c0b2e492c2ab15230d7b5cc4dd7cf4ed74f49ac5408f05748c92ccb4c494d5170f274b15648cf2c4b55302c2e5148c92f4e5530d1353452c8285228284ad52d294acc2b2ec849cc2b51c8078ae41797e4170000491e1b77', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138548, 963, 2.5, 2.5, 'mg/kg', 'PO', 2, 'Adult', X'789c0b2e492c2ab15230d233cd4dd7cf4ed74f49ac5408f05748c92ccb4c494d5170f274d151c8cc4b2e4a4d2c4e5530d033d535d03347529a9856925aa460a1509ead90989702e51a1a01f9d60abe8915560a2670b500f7ea2150', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138549, 963, 2.5, 2.5, 'mg/kg', 'PO', 2, 'Adult', X'789c0b2e492c2ab15230d233cd4dd7cf4ed74f49ac5408f05748c92ccb4c494d5170f274d151c8cc4b2e4a4d2c4e5530405655a860a4509ead909856925aa46002645a2bf82656582998c095000051ef1d30', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138550, 963, 7.0, 9.0, 'mg/kg', 'PO', 2, 'Pediatric', X'789c0b2e492c2a5130d7b5cc4dd7cf4ed74f49ac5408f05748c92ccb4c494d5170f274d15148cf2c4b55302c2e5148c92f4e5530d1353452c8285228284ad52d294acc2b2ec849cc2b51c8078ae403d5e41700004d7c1b4e', X'789ced59e96fdb3614ff571e0c0cd8003b3e96f4703ea5e9b616eb11e428364c83404bcf126b8a54492a895bf47fdf8f92e32b4e5b7745d7a1fe6288d2e33b7eef24fdae95da2a8bb528b835a4d6f13451c695c64acdad36b52aabc2ebdcfbd20dbbdd2b39e162cfd82c3cc9ee3ab54bac28398d850f9b06bdc1bd4eafdfe9f7ce7bf78707fde160b0d7ef3dd8fff9614dcb8997463b50be6b1da585d4d2792bc2bbfa95e7eb9acbf9b4e421c9a2a8b47155595a764e681fe9c7c6898ce957630b37a4c141bbdfeb1d127ebac5b3489f9acab32333a655de433a79d926a95f37e2237d6c8ac2683ab722657a0118c0ec4ce8b496d858558d96957d8f575e8c1487d55f7f63a5a49e348bf0ed28ad948fa19dd4d98a251b78b55eda4ce818ba69572a98155b9e691697d694f954896be956d8349c099fbd498c727429ec34d2675e583fa4fb9d8745d69d64dd544c612aa5f252a69cd2a3a78f0f2993974c7de729358e69bfd31f506ec1893b0b0dc8e08d71de949106b69433f8b6692253cdd376f8aac0c5d262479b44fababae13a120ee28028f4c9d893e24b56ae4d73c3c879e12b1776810f76f0788c2faeb58a6b80f234e7aa10de488494f5b9955eba76ecc0d1f20a2633e3077b0777191f7c9e588672d4db3be8f4f6ee2f918ab187450fe86a42f0fc6c0970ae2687f45c5c0f697f4e1be90bb010ca680e585c499f53c13e37def2b5f07c4829377252c464e7a0f7039d9cbe58b7b50dd55c62b497ba629263d28646ac792c3d8da6d4bf07d19b003971c835e11628205e12a11219bce163b8e34df5ef905950bda1410d480dc6fe662c1ecf6cddc654a991696f2a60859840f1d001cf5a08ac669eb8103c85b8266f142369a16508ac75343e9686bbcc5ac9acf5c2b34bad5d6a7d6e6aed62673d9b76c1f3c9c1f39d43b5e53079c2a914decae4cb0e94f1e0931bdf87fa5e7babbe47fff948f9656686ef08bc2da3f5ace4440a159f98b25262119437509d58ceb4d0c9944ef1556751388ecddf1d23513263f110e96722f13503b2d24d029d1363f653aaf4449b2bbd71a4610dd91bf2a43e910d23bd8068182a7b8352c1e13069e72d8de62dad86fea65a0d2914002b244e86499dd112ba0589389b9642da86cf3c5f3f246ec3f4f1844b98bb31cb1bedc1010e4527d29cb62911550d0e5c26e1de65b91f24dc2221eef6dac7ef051e872b8586d8c552c7730e2d085c305e75f2c7d9cee9e3401f274dbc4828ffbe994bfe4f01b01ebddf5e047cedc0dcb2d81c2fbbe356a93952e8bcd9141d9812259ceb866bae4857baf6a2c1d794f269c9d6b37641911f4f8f56fc4d95e39f10176b1ebe8bae104aceb2e40e8a938b5747dd8b578f50a959f886d73a0d944b2a6bc3b75b375e6e133974435dff184b53481f7ac91fa7e7eb049f75c155f789f89445721bf84db17dc6569a6a956e19fc3635a360a457adae2fe8a41e37bc1654a62c8df555b8d59309cd0922fde877ba94b6721d78dca0158534d55ce668dec2e7e8cab5d489505c48b1e0d79078732d318606aa10f44beb4c99822d5a9a45dc9652e10191852dc50869e122c4a01871b86f2c5829896e1a69c5d5c494aca54021684893a9bf79937361d434682f74d0653980569f1dcbb715c08834eb047ae28c33b3258c0501588b32143c22e1325a252237d52964d73656cb26ca903c090a14faf54a220474835e61e4254eb9806ecf9fc2445eb8a414f5b8ed43918cf46f4f099291e74d6b58eb6ccdfdea8aeb1f5dbc4001a819400fe88c9924b86ae69eb922b9b40e55c2154b4110aa2ab0b3700ae4c94b686f607c66cd95cf03ae221549ce37acacccd434014a6983b216087ad1bd0c19510f20f09c45ed17c16119941245e98281b0d5e7ecc21ec85615ebb7a2a3d08f0069517a53048734e8a4f2ed5b98e1f0c60a072544a2a100b4c00c86ba019d1d36dcc005c5b0c8b0a151a96e374265e119825c5eeb35b2c8dbdcb85204f397c376b6aaed5a2c2b94d8b0dcb6beef52f33b4acdf5babccbcd6f3a3777eef9eaeed9f67a2617b61038f59b6cbae2a727428d61f39887f4606f1f863d67f0310a1e19ce0eeca00cdec2691cc778246a48faf9c1fe908eff3cd93fe845fa976bb8bbf9e7722451454a2b0b6165d85485ff5de9de0f9fa1f8734e72141857c4661c1f25b7fe75e56b28839239a30affa336c3decd01fc10b53d972389b1f4bca3e0d73cd450fe9c5b83531ea3d4a338ae76212e4d12eeceb666f9fefd3fafd80fcd', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138551, 7221, 200.0, 200.0, 'mg', 'IV', 1, 'Adult', X'789ccbc84ccf5048c92f4eb552303230c84dd7cf8d3352f00c53087451a830554849ac2c0600b9f10a6a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138552, 7221, 20.0, 20.0, 'mg', 'IV', 1, 'Adult', X'789ccbc92f5748c92f4eb5523032c84dd7cf8d3352f00c53087451a830554849ac2c0600a78a09ec', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138553, 7221, 15.0, 15.0, 'mg', 'PO', NULL, 'Adult', X'789ccbcb2fca4dcc51c84d2dc9c82f294aad482c495548cdc9cccdcc4b2cc9cccfb3523034cd4d5708f0d7f7f4d5f70c532834cb50a830345048c92f4e2d0600a36214c9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138554, 7221, 15.0, 15.0, 'mg', 'PO', NULL, 'Adult', X'789c1d8b410a80201405aff20e1048412dea042da256ed051ffa419352c26e9fb59c19c6d0eb87065e672230bb982f960fe825c8a1b3c46344db078b6d55f3a2e61de7e0262cba8ce8aa572626d6d854f5c0ca4d38b18e17be90f03f2f6eb922ed', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138555, 7221, 150.0, 150.0, 'mg', 'IV', NULL, 'Adult', X'789c55cc310a02410c85e1abbc0308ee22366269e305ecc3eec3c992c960c888737bb712ac7fbeff4693c11594b081ca2c2d831f4982a6555d529b437c3db6802c7d0f411783fad6635c309fa7fac4fd81d7a9a07baafd6f8c6f1aae33aa2ed16a338903b2d077f9835f298c3000', X'789cd5577f6fdb3610fd2a07ffd502722c39755638c500d76dd60075e725e98061da029a3a4b6c28522529c75a91efbea3941f52a625718b0e1860c0167577bcf7ee1e8ffe32484c999e2b96e3600a83f75872bdd146a8410083d248bf983957d8e96874292e30dfd326f5bfc4a86b6bb9610526e7cc799771383e1886d1300acfc21fa69383e9787f2f7c39d90fc7b52d7227b4b264f965304b72a1847586f9b57ac9e1b68e7256153885997222d10e0f619e61ae5d86b453050b9d94927c540ab314953b8413b4bcc4e6099eb58d9fc7ea8db62c4538d226b753980451184493603c89d5892e1d5ad06be8a63285e35f03385ec46aaef35c2b38332c41f840545184f798a09108f75828576d7057b4e4d84aa27ffafd0f7a92425d340ffedd8c20b8734a8d5074901fc9521b5d1ac68504967c2a378c303983cce5842ea0b5cd1e702db5a1ed9884f92c5699483348b425cec66198a7a3fccf3161805fdec0760209ab6caca4bebc35e9b7b80304a62634001f78e8bd6295a3cb34e5b1658e9e14b1499bb71701a52016af198c26790acb9f47c78b116df3f920836d14d609d04e094a566102d2bbed10e310166c4b00687de443d1cb80962a48c506eb64d1347b40ed43c5bfde099991d5bf6e054c25236d80716a0802af089a509f4a53f924882e4fd5e7fd0c4aeac87ba8256e50c2ab0872c18dceb5642600ea3ed5a4df38f692db09a337689af24437e569238fd591aed9a26e60a9f6bd7aeb12ab02291605c2841abc55dd9af69775790fe1d431e37cf896c13622e7ca089f0a2336282bd73ce982be29dab05b04ea978603d21873bad002adb01e92a3864c62b5c09449bd92cc3ac1295bcc050b605d273f4c702db8a0369e12619e9ceb98e4e6eb1af9b2b26a3739dd49a7cde7e387d8a26d7d558b72898960849ff709f32175c0aee2e82bf19d406e6b357e91015b3b6aea4e2cebdff668e1e9c2eadbffc180dfa09f76bfedaea18ef37795d1ffa1d9eb363d2d900b26cf97baa8e7e0cd3cbde9d4a5c15431c52b3811f6028e18a774a7308fd56b1a2384f808a9d1553a6d8d30205c8c3237b91f8784c0e3e122f195f5ef0a02ed872b59ae9a20b990177099099e414e27f00ae9a36ac8547ca77df940e1e54a1bb5d7037270e2bba44f681fb403cf9dc264d065c2837f870541ee55e8038e8f51fad464ee83f83ed93c3dea8e9d33d78aae38422582f7f4cd4c4a3469e58bc7a9a5edc85f106325bc0f5593337f2169df9362c55959eb5faca140a3a8f8bab4d742e8bccd7b95b211ce4f1d781d8de1562e1dbf5b8b61cb847f8d6a6609e9dce2f90932fe4fec7dc53d45e3e174ec98624556492f291287b98e152b8be2afd2f8bb8dad14d705f6b46e7399ec842b0dd1c18c274bb1d2221b6d742eeaabed333a2c68e5f9aecdf3cd59dfa7e1bf49fbeb77d9b10f9619a3e9ec2fd069d5d9ee1d93eba1146b1a040799f1873b85a183d0d23548d2fd9246d24fc701cc7f5bbe9884b17abbe5069b71fa910ed03eea1e3f75d648c39263b75aafde169afe53d15f93003e1667fa0dfdfc71d7f057577f03094fb911', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138556, 7221, 10.0, 10.0, 'mg', 'PO', NULL, 'Adult', X'789cf3492d4dce2fcb2fcacc53284a2d4e2e4dd551c84d2dc9c82f294aad482c4955c82f4b2d4ac92f4eb5523034c84dd7cf8d335208f0d7f7f4d5f70c532834cb0000f1fe15f7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138557, 7221, 50.0, 50.0, 'mg', 'IV', NULL, 'Adult', X'789c2b48cd4d2d294aad484db1523035c84dd7cf8d3352f00c532834cb50a8b0504849ac2cb656082e492c2ab152303440525061080043eb125e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138558, 7221, 5.0, 15.0, 'mg', 'PO', 1, 'Adult', X'789c2ba82ccacc4d2dc948cccdcc4bd5512881f0f20b80b49582a9aea1696eba4280bfbea7afbe679842a08b42695e49668e42466a6e62497e417e666a7166b142516a71497e516a0a001ae41b58', X'789cd5577f6fdb3610fd2a07ffd502722c39755638c500d76dd60075e725e98061da029a3a4b6c28522529c75a91efbea3941f52a625718b0e1860c0167577bcf7ee1e8ffe32484c999e2b96e3600a83f75872bdd146a8410083d248bf983957d8e96874292e30dfd326f5bfc4a86b6bb9610526e7cc799771383e1886d1300acfc21fa69383e9787f2f7c39d90fc7b52d7227b4b264f965304b72a1847586f9b57ac9e1b68e7256153885997222d10e0f619e61ae5d86b453050b9d94927c540ab314953b8413b4bcc4e6099eb58d9fc7ea8db62c4538d226b753980451184493603c89d5892e1d5ad06be8a63285e35f03385ec46aaef35c2b38332c41f840545184f798a09108f75828576d7057b4e4d84aa27ffafd0f7a92425d340ffedd8c20b8734a8d5074901fc9521b5d1ac68504967c2a378c303983cce5842ea0b5cd1e702db5a1ed9884f92c5699483348b425cec66198a7a3fccf3161805fdec0760209ab6caca4bebc35e9b7b80304a62634001f78e8bd6295a3cb34e5b1658e9e14b1499bb71701a52016af198c26790acb9f47c78b116df3f920836d14d609d04e094a566102d2bbed10e310166c4b00687de443d1cb80962a48c506eb64d1347b40ed43c5bfde099991d5bf6e054c25236d80716a0802af089a509f4a53f924882e4fd5e7fd0c4aeac87ba8256e50c2ab0872c18dceb5642600ea3ed5a4df38f692db09a337689af24437e569238fd591aed9a26e60a9f6bd7aeb12ab02291605c2841abc55dd9af69775790fe1d431e37cf896c13622e7ca089f0a2336282bd73ce982be29dab05b04ea978603d21873bad002adb01e92a3864c62b5c09449bd92cc3ac1295bcc050b605d273f4c702db8a0369e12619e9ceb98e4e6eb1af9b2b26a3739dd49a7cde7e387d8a26d7d558b72898960849ff709f32175c0aee2e82bf19d406e6b357e91015b3b6aea4e2cebdff668e1e9c2eadbffc180dfa09f76bfedaea18ef37795d1ffa1d9eb363d2d900b26cf97baa8e7e0cd3cbde9d4a5c15431c52b3811f6028e18a774a7308fd56b1a2384f808a9d1553a6d8d30205c8c3237b91f8784c0e3e122f195f5ef0a02ed872b59ae9a20b990177099099e414e27f00ae9a36ac8547ca77df940e1e54a1bb5d7037270e2bba44f681fb403cf9dc264d065c2837f870541ee55e8038e8f51fad464ee83f83ed93c3dea8e9d33d78aae38422582f7f4cd4c4a3469e58bc7a9a5edc85f106325bc0f5593337f2169df9362c55959eb5faca140a3a8f8bab4d742e8bccd7b95b211ce4f1d781d8de1562e1dbf5b8b61cb847f8d6a6609e9dce2f90932fe4fec7dc53d45e3e174ec98624556492f291287b98e152b8be2afd2f8bb8dad14d705f6b46e7399ec842b0dd1c18c274bb1d2221b6d742eeaabed333a2c68e5f9aecdf3cd59dfa7e1bf49fbeb77d9b10f9619a3e9ec2fd069d5d9ee1d93eba1146b1a040799f1873b85a183d0d23548d2fd9246d24fc701cc7f5bbe9884b17abbe5069b71fa910ed03eea1e3f75d648c39263b75aafde169afe53d15f93003e1667fa0dfdfc71d7f057577f03094fb911', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138559, 7221, 1.0, 1.0, 'mg', 'IM', 1, 'Adult', X'789cf34d4d4fccc94fca492c2ec94c5648cc4bcdcd4cd45148cbcf492c49d54d494dcb4cce4ccd2bb152b031cc4d57f0f4d5f70c53087401000d691236', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138560, 7221, 1.0, 1.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb05230cc4dd74f49ac0400189803f3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138561, 7221, 10.0, 10.0, 'mg', 'PO', NULL, 'Pediatric', X'789c55cc310a84301085e1abbc1bc4885ae8092cc40561cb850147137012369922c73796d6ef7f5f8849e882b0baa8890b29832f2f3e90fa1846d8464e23bf169fd5cc8b99bff80f0ec536d863e63c61534a3aa2ed1ce8504e6f2b3feb84854a4dfa4a3daf6adde31328ea', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138562, 7221, 10.0, 10.0, 'mg', 'PO', NULL, 'Pediatric', X'789c4b49cd49ac4c4d51c8492c4955c84d2dc9c82f294aad00715273327333f3124b32f3f3ac140c0d72d3f573e38c1402fcf53d7df53dc3140acd32ac157c132bac148c4c817229f9c5a940490069241a7d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138563, 7221, 100.0, 100.0, 'mg', 'IV', NULL, 'Pediatric', X'789c55cc410ac2400c46e1abfc0710daea4ebc402fe052089de0a424190c19716e6f97ba7e7cafb0d2e002a6d001e3ac2d833f940c5631714a690ef232b5006dfd08c14e0af1bdc7b86299677b4ef63863bde375a9e89ea2ff2be5372b6e0b4cb668d694e284acec87fec55f86393206', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138564, 7221, 10.0, 10.0, 'mg', 'PO', NULL, 'Pediatric', X'789cf3492d4dce2fcb2fcacc53284a2d4e2e4dd551c84d2dc9c82f294aad482c4955c82f4b2d4ac92f4eb5523034c84dd7cf8d335208f0d7f7f4d5f70c532834cb0000f1fe15f7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138565, 7221, 5.0, 15.0, 'mg', 'PO', 1, 'Pediatric', X'789c05c1310a80300c05d0abfc0b8838747116a183a88b7ba0a106da469ae8f97d6fd542cea0e694b58939f4e39ed4784618a650338e7d8cdb182f9c0bdee652707325d747854d0c9dcdb573fa01e6451aa6', X'789cd5577f6fdb3610fd2a07ffd502722c39755638c500d76dd60075e725e98061da029a3a4b6c28522529c75a91efbea3941f52a625718b0e1860c0167577bcf7ee1e8ffe32484c999e2b96e3600a83f75872bdd146a8410083d248bf983957d8e96874292e30dfd326f5bfc4a86b6bb9610526e7cc799771383e1886d1300acfc21fa69383e9787f2f7c39d90fc7b52d7227b4b264f965304b72a1847586f9b57ac9e1b68e7256153885997222d10e0f619e61ae5d86b453050b9d94927c540ab314953b8413b4bcc4e6099eb58d9fc7ea8db62c4538d226b753980451184493603c89d5892e1d5ad06be8a63285e35f03385ec46aaef35c2b38332c41f840545184f798a09108f75828576d7057b4e4d84aa27ffafd0f7a92425d340ffedd8c20b8734a8d5074901fc9521b5d1ac68504967c2a378c303983cce5842ea0b5cd1e702db5a1ed9884f92c5699483348b425cec66198a7a3fccf3161805fdec0760209ab6caca4bebc35e9b7b80304a62634001f78e8bd6295a3cb34e5b1658e9e14b1499bb71701a52016af198c26790acb9f47c78b116df3f920836d14d609d04e094a566102d2bbed10e310166c4b00687de443d1cb80962a48c506eb64d1347b40ed43c5bfde099991d5bf6e054c25236d80716a0802af089a509f4a53f924882e4fd5e7fd0c4aeac87ba8256e50c2ab0872c18dceb5642600ea3ed5a4df38f692db09a337689af24437e569238fd591aed9a26e60a9f6bd7aeb12ab02291605c2841abc55dd9af69775790fe1d431e37cf896c13622e7ca089f0a2336282bd73ce982be29dab05b04ea978603d21873bad002adb01e92a3864c62b5c09449bd92cc3ac1295bcc050b605d273f4c702db8a0369e12619e9ceb98e4e6eb1af9b2b26a3739dd49a7cde7e387d8a26d7d558b72898960849ff709f32175c0aee2e82bf19d406e6b357e91015b3b6aea4e2cebdff668e1e9c2eadbffc180dfa09f76bfedaea18ef37795d1ffa1d9eb363d2d900b26cf97baa8e7e0cd3cbde9d4a5c15431c52b3811f6028e18a774a7308fd56b1a2384f808a9d1553a6d8d30205c8c3237b91f8784c0e3e122f195f5ef0a02ed872b59ae9a20b990177099099e414e27f00ae9a36ac8547ca77df940e1e54a1bb5d7037270e2bba44f681fb403cf9dc264d065c2837f870541ee55e8038e8f51fad464ee83f83ed93c3dea8e9d33d78aae38422582f7f4cd4c4a3469e58bc7a9a5edc85f106325bc0f5593337f2169df9362c55959eb5faca140a3a8f8bab4d742e8bccd7b95b211ce4f1d781d8de1562e1dbf5b8b61cb847f8d6a6609e9dce2f90932fe4fec7dc53d45e3e174ec98624556492f291287b98e152b8be2afd2f8bb8dad14d705f6b46e7399ec842b0dd1c18c274bb1d2221b6d742eeaabed333a2c68e5f9aecdf3cd59dfa7e1bf49fbeb77d9b10f9619a3e9ec2fd069d5d9ee1d93eba1146b1a040799f1873b85a183d0d23548d2fd9246d24fc701cc7f5bbe9884b17abbe5069b71fa910ed03eea1e3f75d648c39263b75aafde169afe53d15f93003e1667fa0dfdfc71d7f057577f03094fb911', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138566, 7221, 1.0, 1.0, 'mg', 'IM', 1, 'Pediatric', X'789cf34d4d4fccc94fca492c2ec94c5648cc4bcdcd4cd45148cbcf492c49d54d494dcb4cce4ccd2bb152b031cc4d57f0f4d5f70c53087401000d691236', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138567, 7221, 1.0, 1.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb05230cc4dd74f49ac0400189803f3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138568, 20428, 2.0, 2.0, 'g', 'PO', 2, 'Adult', X'789c734c2e2d4955482dc82cce4f49b552304a5708f05770f27451a85030544849ac0400ad8f09e4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138569, 20428, 1.0, 1.0, 'g', 'PO', NULL, 'Adult', X'789cb3b354284a4d2e2d2a4acd4b4e2dd6af4c4d2cb252304c5708f057084c49ac0400ab240a79', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138570, 20428, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789cb3b1b554284a4d2e2d2a4acd4b4e2dd6af4c4d2cb252303530c84d5708f057084c49ac0400d2e90b85', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138571, 20428, 1000.0, 1000.0, 'mg', 'PO', 2, 'Adult', X'789c05c1410a80201005d0abfc03248c11182da34dabba82a0a50b9b7026cadbf79e1545bcb37088132c119513fb86795df0c1194b08be4907515f156fd6942f0ca3713d123f157c405ab9958bfc61cf17db', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138572, 20428, 500.0, 500.0, 'mg', 'PO', 2, 'Adult', X'789c2b4a4d2e2d2a4acd4b4eb552303530c84d5708f05770f27451a85030564849ac2cd65148cc29492dca4b2cc92c03aa313480292a04ca0255998255010033a21682', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138573, 20428, 1000.0, 1000.0, 'mg', 'PO', 3, 'Adult', X'789c33343030c84d5708f05708f17451a85030574849ac2c0600402c0616', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138574, 289, 10.0, 10.0, 'mg', 'IV', NULL, 'Adult', X'789c3334c84d57f00c0300078301f5', X'789cd555db6adb4010fd9541cf912d09cb013d148c7b71a02dc13179898b98acc6f2e2bd88dd15b51afcef5dc9bd2998ba7209b46f9aeb993333ab790a0a5397b942494106c19c1c37fc0b57145c41501bd12ab7ce55361b8f3ff31dc9913665fbc5c77d5fcb0c5654e4e8da90244aa661148771b48aaeb334cae2e9e83a9d249349e74bcc71adacf77c0a6685e48a5b67b0d5752a47fb2ecbaaa928838537a2f72158c430530e4bddfa5fc11d31ad0a78478a8ec16bf55a5b2c09de6a236db6564b5d3bb2a037d047f1a6b996522b58192c083e7afa36eb4aab1f7fadeee0550e1f05b5d2c3272f09ae7647a1b5cd8a5ab8dca37255f64a3f912b9829acb68dc03db73ddf389225dcdc077dacc359ecf3e906b2b9a582a3339c5dc0284f7adeafe2181a42e39b2f8a0cbed5b456d3b06f48fd8ac0771b480d21a4477b06c92885bfedcc4b9735b0c37715318e22bfd5552df067237fd7e425291f716222ddf2f955fe31b6ec79a3bcb8a0cae39c9ce8f9f8b30b63a854a858932f3dc81f2ccc3fcce53d32d74d2437dceefe6726034b7bceec456b1b9c7ce0039b6be5fff15c159c9d785e3321c8940d380d4ca0b5e3f6f85df2a3dca291c8b4d065d30358a0d884826fc8f3f8403e8516dc4a2fbcd93343dde9b9889494a45c9fcbcd3da0bf7edaa0003404d6df3028bafb3714e270f80a91cf9541', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138575, 289, 10.0, 10.0, 'mg', 'IV', NULL, 'Pediatric', X'789cb3333454a84c4d2c2a56c8cf49b1523034c84d57f00c03004bc80692', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138576, 289, 5.0, 10.0, 'mg', 'IV', NULL, 'Pediatric', X'789c33d3353454a84c4d2c2a56c8cf49b15230d5353450c84d57f00c0300623e0739', X'789cd555db6adb4010fd9541cf912d09cb013d148c7b71a02dc13179898b98acc6f2e2bd88dd15b51afcef5dc9bd2998ba7209b46f9aeb993333ab790a0a5397b942494106c19c1c37fc0b57145c41501bd12ab7ce55361b8f3ff31dc9913665fbc5c77d5fcb0c5654e4e8da90244aa661148771b48aaeb334cae2e9e83a9d249349e74bcc71adacf77c0a6685e48a5b67b0d5752a47fb2ecbaaa928838537a2f72158c430530e4bddfa5fc11d31ad0a78478a8ec16bf55a5b2c09de6a236db6564b5d3bb2a037d047f1a6b996522b58192c083e7afa36eb4aab1f7fadeee0550e1f05b5d2c3272f09ae7647a1b5cd8a5ab8dca37255f64a3f912b9829acb68dc03db73ddf389225dcdc077dacc359ecf3e906b2b9a582a3339c5dc0284f7adeafe2181a42e39b2f8a0cbed5b456d3b06f48fd8ac0771b480d21a4477b06c92885bfedcc4b9735b0c37715318e22bfd5552df067237fd7e425291f716222ddf2f955fe31b6ec79a3bcb8a0cae39c9ce8f9f8b30b63a854a858932f3dc81f2ccc3fcce53d32d74d2437dceefe6726034b7bceec456b1b9c7ce0039b6be5fff15c159c9d785e3321c8940d380d4ca0b5e3f6f85df2a3dca291c8b4d065d30358a0d884826fc8f3f8403e8516dc4a2fbcd93343dde9b9889494a45c9fcbcd3da0bf7edaa0003404d6df3028bafb3714e270f80a91cf9541', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138577, 289, 2.5, 2.5, 'mg', 'IV', NULL, 'Pediatric', X'789c3353c8cd57d0553055a84c4d2c2ab65230d23355c84d57f00c0300563106bb', X'789cd555db6adb4010fd9541cf912d09cb013d148c7b71a02dc13179898b98acc6f2e2bd88dd15b51afcef5dc9bd2998ba7209b46f9aeb993333ab790a0a5397b942494106c19c1c37fc0b57145c41501bd12ab7ce55361b8f3ff31dc9913665fbc5c77d5fcb0c5654e4e8da90244aa661148771b48aaeb334cae2e9e83a9d249349e74bcc71adacf77c0a6685e48a5b67b0d5752a47fb2ecbaaa928838537a2f72158c430530e4bddfa5fc11d31ad0a78478a8ec16bf55a5b2c09de6a236db6564b5d3bb2a037d047f1a6b996522b58192c083e7afa36eb4aab1f7fadeee0550e1f05b5d2c3272f09ae7647a1b5cd8a5ab8dca37255f64a3f912b9829acb68dc03db73ddf389225dcdc077dacc359ecf3e906b2b9a582a3339c5dc0284f7adeafe2181a42e39b2f8a0cbed5b456d3b06f48fd8ac0771b480d21a4477b06c92885bfedcc4b9735b0c37715318e22bfd5552df067237fd7e425291f716222ddf2f955fe31b6ec79a3bcb8a0cae39c9ce8f9f8b30b63a854a858932f3dc81f2ccc3fcce53d32d74d2437dceefe6726034b7bceec456b1b9c7ce0039b6be5fff15c159c9d785e3321c8940d380d4ca0b5e3f6f85df2a3dca291c8b4d065d30358a0d884826fc8f3f8403e8516dc4a2fbcd93343dde9b9889494a45c9fcbcd3da0bf7edaa0003404d6df3028bafb3714e270f80a91cf9541', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138578, 3196, 88.0, 880.0, 'mcg', NULL, 2, 'Adult', X'789c734c2dca2fcecfb152b0b0d0b5b03050c84d4e5770f2740100565d06b3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138579, 3196, 100.0, 1000.0, 'mcg', NULL, 2, 'Adult', X'789c0bc82f4f492d52d0c8cccb48cc494dd1b452303430d005620385dce47405274f1700bc2509d7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138580, 2886, 1.2, 1.2, 'mg', 'IN', NULL, 'Adult', X'789c5d8fcd0a02310c845f658e7a595c0511af8ae063449bb581365ddaac3f6f6fd68be23133992f9353a2cab0ca6499d5f638ab9850daa3efd6f906d2008bac58755b1f455d412c53c522d353f2947d71e7ce432cbadb7fcc65e71c8c64e24c54beb2dc456f186b19e32b79b07d6fe24162184a45bf46040dc615c3a757286d8e5dd85d764e9bf23fc657b8c3b140cb7c6974e80f7aa6ba90989a618340af86c5819482f81f892e9cd24cf48a257b2278e5a2cb37ee1a62ea', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138581, 2886, 0.6, 0.6, 'mg', NULL, 1, 'Adult', X'789c3d8db10dc24010045bd9d04e0c06c9015510d0c0e97df69ff4e747f7678c4ba0101aa3123e81688359cd5c2ddfe39ee82905376372e5c52f387683cef04d026324493b1aad1f5d157d77d2f930d2de62ca8633342f1e0b9a4d3ce6d5e1d5286d1d0c7ff679bdfb1fa0c9d9505b21ca522364333b0a5b95af2601146444e207a7f205a2003903', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138582, 2886, 1.2, 1.2, 'mg', 'IN', 1, 'Adult', X'789c1d8c410e02310c03bfe2231ca8d8c253f84048bc2812dba23642dadf93e5668ded594add5e888e5aee193e1c30d9e10dcba5c2a86e34589f2c78780c09e2e44d0765127d1c937f3ee35a6e6930f1f7f14fbab1059ed9197a03d7d55574873483d897230509a931cb0fb3b92deb', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138583, 2886, 0.3, 1.8, 'mg', 'IN', 1, 'Pediatric', X'789c73cec8cc49294acd53305128c9573053a84c4d2c2ab65230d03306f10df52c72d315521233732a1532f3140c758d145232cb325352531452f28b538b015f2f13a5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138584, 2886, 0.9, 1.8, 'mg', 'IN', 1, 'Pediatric', X'789c73cec8cc49294acd53305328c957303452a84c4d2c2ab65230d0b3040be859e4a62ba42466e6542a64e62918ea1a29a4649665a6a4a628a4e417a71603006dbb13da', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138585, 2886, 0.6, 0.6, 'mg', NULL, NULL, 'Adult', X'789c25ca410a80201005d0abfc034414448b76411711fc96303ae558e0ed0b5abfb74527cda22d586131ef4278354203867e4e7b073bf4168fac1585275dfd43d24284c2eb66aed2508f4ff8b0348c13bc6bd6bfd8e52062', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138586, 2886, 0.3, 0.3, 'mg', NULL, 1, 'Adult', X'789c0dcb310e80200c46e1abfc07206ae266dc5cbd4403459b1448a068bcbd6cef0ddf510fc5be2e48e79c2477e30d594c48114a1bb34c6bba1048f47330b14ac678c56e78ea26253ba43244a9f03a847e88a3293c5c1b8363646f6dfa01372c249c', X'789ced596d6f1b3712fe2b030107d880245b92eba64a7180ce3e5f53d4a9613b071caa42a076a95d9eb9e496e4dad916f9eff70c77f5662b899da0459bf3276997dc79e333f30cc9df3aa9abb2991185ec8ca973627592ab4419d9e952a7729a5fe621947e7c7070a76e64d1b72ee37fea607bae4f9c28653a13813f191e0e8f7b8783dee0f0faf0ebf15787e3a36ffa87c3d1d1e838ce954950d678ccfcad33490b65940f4ef0bbf82ac8b751ca755dca314d4c5099ad429704fef594596851142258574fcda9f5229374665de1c774224a5f69e9bb742de65a063f3597f8527ab20bda5634a61f9dd05373628bc21aba762295f41a616031f0cc29ff92ce15540b2769efcdd57e97be1745d95bbbfd922eceaf369e69ef4418912a61f6a397d57cd3d1777815d82a7efae9673c69656e9a071e9ba4950e33f8a34cb615851db23aff82575b93ce349b199c14a190268ce99581ed428f69d01f1619429752c8a5213aec1fe39994c13bca6de568af106f55511598fa0243772ae4181dc4c1fd3e24518990412a399948750b03a974b6cc6b8d0ffd5a2bdd091568611d0d8694935804e968112d4ba35f3497189590e3abe2be184c917d3ab5642c6b2a217443344bc50b2d850f34a254d47e1d6fd2622eb5668930112b2a4d1a57797f6a2e36545cafe3d38421dca904c609a5ebcd30206207d0b01fb58e08000939d4716410780a90a8f6f143c7abb169351c1e7f35588e35be431db001ab8270990ce4a583fccaa98444a25278732b3540fad3e0e7ce363c181167a2501a6b383b97a98238278c146676868fdcd6e2374b0c7386fd23fc29a119d6f3120f7a434a2554c9b48defb5e20400569549609e9704173125fedf47584690d00424ce88c19f632c25a4895c2c5422923ae249a4300402f012d8f4fdfb2e7c0cf1cf20fe12417cbf547de928fe2bfaf7446aba80672260c11f4b4f1f8ac96cb8f5f949ae74ea90d3470d146b299c67648ff8b949e6a5a34da090bbcb400175abef8fe3fce15ac0378f1330492d1c4f10404f7f5f7f1fe9b8cdf81db5996bd73d4f3672f460a3867d48d0e760eb2f1ac75d9dccef1fc84fd7f2c454b92a91c758b00b5b565aacdd5c6b95991106b9798951934dd1889e4ccd0f22097136a1efbc892fd76d25ec4206d3dc45da00226eba94882a4ef7a8e53a257012559cfd774c8fa2ed74a5e3b2cd2449a67291bbee6c21ccae1ad0b9940676ef48f01891f1d4700c5b225cc76b6adea0b6246b638195380a6e40e34d8edbeff62b059424601a27944951a0824ca746ad88d947d206ddc00e524529946bf838b72422df2e797b431d73db06fff6016477a26974d87b7148c50f0708040c184790222effad7cc3c40d3dff522927d32ef39fc27e82128d694078e4e97b75b395fced684b2efcf1c802d72880b02a86b4bb5c988d3620ce28b87358b06658014d21c708a7734d83a3d81040d12910547bc5d943bc1c5a361f63131319fff3a4c775dc88d9f88f8e59d3d445f1e34d2aeb5268692f02a185f86335ad83d6886cbaa23b296f58f2e3649c9d9fbd371a8f90d0dd8203ef4b5780d808c586cc57bf7728c443fc8c183f9f237dd50d8ce9351091ca051231ddc191df49ceec9d4dc3b2a69c8374b8641416416383d6793fe68276cfc0a5614b43771b78c588df16757f5dd6a87eb4431fa8fcef2fef1f3f4539e5e39766b29f29335b49e840e15af036417c5cec6afe8ce7cfb8d866d62918ff2eaecd73b57faef6cfd5feb9da7f46b5bfdf40fedf94fb2f84dc9eb8b339d9ace50ff63513ada5cb6a7637d1c2fb03be56e0d3757040a182404159797cd1cb749d5814a520410870d3076751e94ffe73319a1c61c392ab790cc17be802237913fe8d38c0d5f6802fce9cdbd5743e05d935ff0afb235b79ca04eb57d86579d070233f110e714bb0c9f57ce4f249e7f971e9669752240fe3b52b815a7b667bdf0efeb6bf35fb1f16e45708e7ec1df9aa2c9df41e9f71ee7b2f515f985d112d2cd0adf009769ef0c08aacdd824ecdb57d0be78dac9c2daa7642ebdad45ce6629edaa2b6b18c4c4d84b60dfc890a359eeb923d01c8021839d4f144305ed63cecf99aeb942de3519f9ccbad1453f35a0004f8fd376322ee7e27ac39063d71a2280fc4ea19eb641afac2cae6c2d526b33afec8d5e819dccb2ac9268b5424b97c6a16ff09cc7dea591c6417023d91cdea2dbbbf137ad1d36a016a197ecd79386a0ebf3ded15a847aa6c79e125d5b63260851c8685bca65bab2b601f4bbc8f9a25a1dc6ae58b31b5258ef69abcc4e83fdf264e36b7676fdcf2e2ef69f69fcb241706f26776319b240feefc80685795c8f7a40ed6df482d039ade456592466f5b1c680e437ba19a579a8b04a05b207b7e6d5a642402aaae4a506078828c3ce650380d37aa00b168195065cd65602c11a9c493695386d913e912b87152da5311cb28b7a3de1692f83e927c5d94c1169f74a47add66d796ef97a254291840ccbd757364349b85314ebd5ba68694af2fd5bc8abdf4797bd21f72c957af152f55d35abce80dd0ccc4939f01f7814b2477b1d60d92bbb48ddc2ecdb5b5296b60f433e8df5373ba6d515da071a99c6c8eaea07992283e3443f938955a395515e85ba5fa157362a754081e1128caedd5cc8bdee8b8056822e2d9d59c2b8b2f958b77bb4b0d5c8dd9a63ae4858290499645536e6534cbbac07f93784bbbde2af43c1fc42df88ec20435b729b63e715fc16d2d8aa4d2bc381ca137fdab3ea0fd6a0171ee16d8d07cba66603c377473e40a5f715437360252f9e6160a48f1916c84b6f1c8ef53ce0aa59c4db4b7dbe7b89b9bab16234f12fd51518fbdd59fad3ec296f1ddbbff01e3084817', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138587, 2886, 0.3, 0.3, 'mg', NULL, NULL, 'Adult', X'789c73c94ccca92cce2cb65230d033ce4d572829cf4c4e55284f4dcdcea9d451c8cdcfcb2cc92f5248cec92f4ecda9544803b21353ca528b8a531552d3d252934b8af500153217fd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138588, 2886, 0.3, 0.3, 'mg', NULL, 1, 'Adult', X'789c0dcb310a80300c46e1abfc071015dcc4ad93e025429b6a206da18d8ab7b7db7bc3e7aa536ccb9c8e2949be8d57ec594c48114aeb378f4b3a1148f41b6062958cf18a5df0749b943c20952e4a85d72ef443ec4de1e1da181c237b6be30f473d24c5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138589, 2886, 0.3, 0.3, 'mg', NULL, NULL, 'Adult', X'789c0dcb410e80200c05d1abfc031063e2ceb51769a06013a009ad1a6e2fbb59bcb984ea34b11304935e2a23a9313463df8e56025c7c90333ef11b911e17ed014dbbb80ec4ba749dc8ab29bd3cd6cb397374db7eeb5b212b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138590, 2233, 1.0, 1.0, 'g', 'IV', NULL, 'Adult', X'789c33544857f00cd3f7f45528b4d03534ca000020e003fe', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138591, 2233, 6.0, 6.0, 'g', NULL, NULL, 'Adult', X'789cf34dacb052305348d74f49ac040016ed03ab', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138592, 2233, 2.0, 2.0, 'g', 'IV', NULL, 'Adult', X'789c33524857f00c5328b4c850a830574849ac2c06002cdf054a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138593, 2233, 100.0, 100.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c33343050c84dd7cf4ed74f49ac54f0f4d5f70c5348c92ccb4c494d51283434ca00009adc09cd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138594, 2233, 1200.0, 1200.0, 'g', NULL, NULL, 'Pediatric', X'789cf34bcdcf4b2c492d56b033574849ac2c56c8cf49d151b031343230480700892908b5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138595, 2233, 100.0, 100.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c333430c84dd7cf4ed74f49ac54f0f4d5f70c5348c92ccb4c494d51283434ca000096aa09ad', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138596, 2233, 1200.0, 1200.0, 'g', NULL, NULL, 'Pediatric', X'789cf34bcdcf4b2c492d56b033574849ac2c56c8cf49d151b033343230480700893508b7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138597, 2233, 150.0, 150.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c333435c84dd7cf4ed74f49ac54f0f4d5f70c5348c92ccb4c494d5128b4c800008dd20987', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138598, 2233, 90.0, 150.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789cb334d035343550c84dd7cf4ed74f49ac54f0f4d5f70c5348c92ccb4c494d5128b4c80000a54e0a3d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138599, 2233, 6.0, 6.0, 'g', NULL, NULL, 'Pediatric', X'789cf34dacb052305348d74f49ac040016ed03ab', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138600, 3839, 5.0, 5.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f55082e294acd4b2fc928b652484e2c282ecd49b55230cd4db75628494cca492db15230d0b3d05130d2038a0100c22f105c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138601, 3839, 20.0, 30.0, 'mg', 'PO', 1, 'Adult', X'789c3332d0353650c84d5708f057087401001792035b', X'789ced5adf73d33810fe57763ac3dcc32569529a16c253da1ed0195a4acbcbcde5c6a3d81b5b535932929c3630fddf6f653b8e95868bdb0186873c00b1f5ed6ab53fbe5d637fdb8b741e0792a5b83782bd13ad52156a9e592e71af037bb916ee7e626d6646fbfb77fc16d39ed2b1fbc5f71fc14da8598651c0ac933ae81f1c75fb83eea0ffb97f3c3a7c3d1a1cf65e1f1ebd3a3c2ab0185aaea421e4b7bd719472c98dd5ccdd2b6e59bc2fb47c5e6438823395318220b05839e0449e29c36284b74aa7660421cb4c2eb003964d05ae966fac4619db640519c1308ddf54b811f47baf3a70d0a37b1379ad728b06d40c7c7b4670f571224f559a2a099f358b102ec963a4f38a69a122141d385d844219b4c5d1f269f3740f74abd8ce5dfdf32f5d092e6fcb0bb7368e7261033298cbd83bfa38240763ccc462220ffadd977d486332053e9d4de48d659acc1ff40e865d32bf5af99218b87f09115b98893c97a1466610a60b0f97a17608f8022fbbc715f682dd93b27ebfb13e91eff81ce18edb04664a45c064446e2b56e9a460159ced9f4ee47b0a90ceb4122c7479907246d6f686ddc17093b94d6bddc276230f6a23dbd94331b9e5d228f98781881ba77c22070df7591e7907de7fc2612f31a79322657c0829133c964c5a300b19b9504d241dbbb14df7d3f9eaecab73d72bf5e18b3d98a16d0452cee1d2c0833ae40e7eaa24793847b83f76db38a750c227289b96aa39fd2a53a0b2fa6929b94abf0d8edcce09b5d08b8363132cc568bf95defff7e1f62d1af2412d1fd4f20f45515d61c499d504d95458114a95b20ed469db25ef68a41f44038381cbdd85aad2787bd5b99576e93338fa73a578637d3c4bf13348e726c39033115ca92c176cc5c475f0353abf860bb866a55b4670f2062e15dc4a7527417373eb987286960948984e614a918e802832c9532629032debc105d1b5551a9275960821b3060ad2140b3a9b864c59a40427751bc202364f098352301d634ac0de447e2050617b618e33f1c3f00db832d18ccb8887ae94804b526d6c461ece53104b990d4edbbb46493ed99831c4d1233abe8508677480a807a72c2ff666d19cd23c227beaa4db82dcf383e3e2f11e3366bf97ad3f73ef7654b0960ddb8bf4cccd1525d8045c06b5069f0bfc086e575be303870f5c8063a539195f96fd2f0ce07aeefc8e11fcf5a9f5441af26af511098d05b5c378e1582e14cc987d37ad5613874169b8e5736e8b75c215a6693e2745733415cc3a989213d9815c866e37454aa9bf9eb8ce6b67486773ec369e2b4eec3ad579660bba8d34bb63e2b9bdb3b9f7f6acf6d00fd5503877670cae91858f1db329ff6ee8ec2af77137c8bfe61a5d7fd1ea96fe7dcf84c8432e4b67d3fd053925c3c259aaf6d558eb6461936294ebd02872ee7280e2cf74e4e81967b37ce95472a971a9e17c3e91d912653929bf12d4a97d3c4172416334d3c4f97caa29251f45ea9a2d24cb23c812d7a5e98fbb877400a7dd2a89a47225fbee1c28165514b78d675d418ea7eb34b32a35c067cb88d3a01296d355dd1bd608ba1cff3def5eb29cc69bfdb94a79d922e978e420721e968e2b9cc3b34265b9ba301966a6f02bb572a5f19e33bacfa6112991aef55131904390452c4cb052f9f52b159c31c5d58cb4c539ad5c324378da2246536ef051db841a9d2bf6894c9a01ed806aae9dcbb912b9b42e0a290d8cae9d1a678665f7a56d54d0396927b7d85c4f89b75d41910b287ac60d24534cd89c2b4d77cf78ccdd0c306746998c9994f2e7c3e70e8c6fe82f266e298eca000a9c6f746dab72aaf2787b252d815e932993bf857089f364fd826951ca3edeb7a32cb616865440df9255405b314a0df6b4ac4a7bbb9206d6d37171be5d96309ecc26fe68f134b1920a6a294f6f93719ea0cfa17dfbd6b8aa85ae52e27b763da2b9161a9732412db39e01cf6e2a4d3d0dcadcaee6dd7950837fe9635ce7fb4cdb42f99a80a76dc9d12da6d825d2936fd2fa761da74db46fc7b21bb430a4867a1afcbed1a2a297f8a0c0fbd955f59c1699b544ae79b56a536ddcba847a1aaad6b65dfe6d05f4a4931fc28f650b6ce1c912570e6bbbd1ebc78e5eeba3ed6ef6dacd5ebbd96b377bed66afddecb59bbd76b35773f6dacd063f6e3678ceff74eee861470fbf313d5cb957932c5442c50b8f2468589cd133c90c4770c2b384196aa587ddc3de10125dbc651db85ff4048654024a70938ee00395987e03a77f5f1d0efb2378393e045732ee33112afcbfee8b7795ee7b91132e105e0f5f7420d7eeab15f7be77d81bbe78c61b920b0c132669fb40cd8271f8e8fb981bcb53f706170d44cb8f643486d4db0b163897099f726be848d63da56ac8b8cd794131f56b56a85eb33e9505aa875f0cc6c2289f82b70e28cfe29a9ffee5c0c3c37f0ee4e1d6', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138602, 3839, 1.25, 2.5, 'mg', 'PO', NULL, 'Adult', X'789c0b2e492c2ab15230d43332d535d23355c84d5708f05728cc2856a830564849ac2c06009e8d09ac', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138603, 3839, 1.25, 2.5, 'mg', NULL, NULL, 'Adult', X'789cf3cc4b2e4a4d2c4e5548aa5430d43332d535d23355c84d5728482d524849ac54285430d63507b18a0113930ca0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138604, 3839, 100.0, 100.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb05230343050c84d5728482d524849ac0400364205cb', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138605, 3839, 2.5, 15.0, 'mg', 'PO', 1, 'Adult', X'789c33d233d5353455c84d5708f057087401001aa60391', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138606, 3839, 1.5, 2.5, 'mg', 'PO', 1, 'Adult', X'789c0b2e492c2ab15230d433d535d23355c84d5708f057087401004eb10627', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138607, 3839, 1.25, 2.5, 'mg', NULL, NULL, 'Adult', X'789cf3cc4b2e4a4d2c4e5548aa5430d43332d535d23355c84d5728482d524849ac54285430d23507b18a01138b0c9f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138608, 3839, 10.0, 30.0, 'mg', 'PO', 3, 'Adult', X'789c3334d0353650c84d5708f05728c94c01001bf50406', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138609, 3839, 100.0, 100.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb05230343050c84dd74f49ac040021be0473', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138610, 3839, 5.0, 10.0, 'mg', 'PO', 3, 'Adult', X'789c33d5353450c84d5708f05728c94cd10df47401002b2004e3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138611, 3839, 2.5, 2.5, 'mg', 'PO', 3, 'Adult', X'789c0b2e492c2ab15230d23355c84d5708f05728c94cd10df47401005b5e071d', X'789ced5adf73d33810fe57763ac3dcc32569529a16c253da1ed0195a4acbcbcde5c6a3d81b5b535932929c3630fddf6f653b8e95868bdb0186873c00b1f5ed6ab53fbe5d637fdb8b741e0792a5b83782bd13ad52156a9e592e71af037bb916ee7e626d6646fbfb77fc16d39ed2b1fbc5f71fc14da8598651c0ac933ae81f1c75fb83eea0ffb97f3c3a7c3d1a1cf65e1f1ebd3a3c2ab0185aaea421e4b7bd719472c98dd5ccdd2b6e59bc2fb47c5e6438823395318220b05839e0449e29c36284b74aa7660421cb4c2eb003964d05ae966fac4619db640519c1308ddf54b811f47baf3a70d0a37b1379ad728b06d40c7c7b4670f571224f559a2a099f358b102ec963a4f38a69a122141d385d844219b4c5d1f269f3740f74abd8ce5dfdf32f5d092e6fcb0bb7368e7261033298cbd83bfa38240763ccc462220ffadd977d486332053e9d4de48d659acc1ff40e865d32bf5af99218b87f09115b98893c97a1466610a60b0f97a17608f8022fbbc715f682dd93b27ebfb13e91eff81ce18edb04664a45c064446e2b56e9a460159ced9f4ee47b0a90ceb4122c7479907246d6f686ddc17093b94d6bddc276230f6a23dbd94331b9e5d228f98781881ba77c22070df7591e7907de7fc2612f31a79322657c0829133c964c5a300b19b9504d241dbbb14df7d3f9eaecab73d72bf5e18b3d98a16d0452cee1d2c0833ae40e7eaa24793847b83f76db38a750c227289b96aa39fd2a53a0b2fa6929b94abf0d8edcce09b5d08b8363132cc568bf95defff7e1f62d1af2412d1fd4f20f45515d61c499d504d95458114a95b20ed469db25ef68a41f44038381cbdd85aad2787bd5b99576e93338fa73a578637d3c4bf13348e726c39033115ca92c176cc5c475f0353abf860bb866a55b4670f2062e15dc4a7527417373eb987286960948984e614a918e802832c9532629032debc105d1b5551a9275960821b3060ad2140b3a9b864c59a40427751bc202364f098352301d634ac0de447e2050617b618e33f1c3f00db832d18ccb8887ae94804b526d6c461ece53104b990d4edbbb46493ed99831c4d1233abe8508677480a807a72c2ff666d19cd23c227beaa4db82dcf383e3e2f11e3366bf97ad3f73ef7654b0960ddb8bf4cccd1525d8045c06b5069f0bfc086e575be303870f5c8063a539195f96fd2f0ce07aeefc8e11fcf5a9f5441af26af511098d05b5c378e1582e14cc987d37ad5613874169b8e5736e8b75c215a6693e2745733415cc3a989213d9815c866e37454aa9bf9eb8ce6b67486773ec369e2b4eec3ad579660bba8d34bb63e2b9bdb3b9f7f6acf6d00fd5503877670cae91858f1db329ff6ee8ec2af77137c8bfe61a5d7fd1ea96fe7dcf84c8432e4b67d3fd053925c3c259aaf6d558eb6461936294ebd02872ee7280e2cf74e4e81967b37ce95472a971a9e17c3e91d912653929bf12d4a97d3c4172416334d3c4f97caa29251f45ea9a2d24cb23c812d7a5e98fbb877400a7dd2a89a47225fbee1c28165514b78d675d418ea7eb34b32a35c067cb88d3a01296d355dd1bd608ba1cff3def5eb29cc69bfdb94a79d922e978e420721e968e2b9cc3b34265b9ba301966a6f02bb572a5f19e33bacfa6112991aef55131904390452c4cb052f9f52b159c31c5d58cb4c539ad5c324378da2246536ef051db841a9d2bf6894c9a01ed806aae9dcbb912b9b42e0a290d8cae9d1a678665f7a56d54d0396927b7d85c4f89b75d41910b287ac60d24534cd89c2b4d77cf78ccdd0c306746998c9994f2e7c3e70e8c6fe82f266e298eca000a9c6f746dab72aaf2787b252d815e932993bf857089f364fd826951ca3edeb7a32cb616865440df9255405b314a0df6b4ac4a7bbb9206d6d37171be5d96309ecc26fe68f134b1920a6a294f6f93719ea0cfa17dfbd6b8aa85ae52e27b763da2b9161a9732412db39e01cf6e2a4d3d0dcadcaee6dd7950837fe9635ce7fb4cdb42f99a80a76dc9d12da6d825d2936fd2fa761da74db46fc7b21bb430a4867a1afcbed1a2a297f8a0c0fbd955f59c1699b544ae79b56a536ddcba847a1aaad6b65dfe6d05f4a4931fc28f650b6ce1c912570e6bbbd1ebc78e5eeba3ed6ef6dacd5ebbd96b377bed66afddecb59bbd76b35773f6dacd063f6e3678ceff74eee861470fbf313d5cb957932c5442c50b8f2468589cd133c90c4770c2b384196aa587ddc3de10125dbc651db85ff4048654024a70938ee00395987e03a77f5f1d0efb2378393e045732ee33112afcbfee8b7795ee7b91132e105e0f5f7420d7eeab15f7be77d81bbe78c61b920b0c132669fb40cd8271f8e8fb981bcb53f706170d44cb8f643486d4db0b163897099f726be848d63da56ac8b8cd794131f56b56a85eb33e9505aa875f0cc6c2289f82b70e28cfe29a9ffee5c0c3c37f0ee4e1d6', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138612, 3839, 20.0, 20.0, 'mg', 'PO', 4, 'Adult', X'789cf34dacb052303250c84d5708f05708f47401002a5b0494', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138613, 3839, 2.5, 10.0, 'mg', 'PO', 1, 'Pediatric', X'789c33d233d5353450c84d5708f057087401001a74038c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138614, 3839, 1.25, 2.5, 'mg', 'PO', 1, 'Pediatric', X'789c0b2e492c2ab15230d43332d535d23355c84d5708f0570874010054670659', X'789ced5adf73d33810fe57763ac3dcc32569529a16c253da1ed0195a4acbcbcde5c6a3d81b5b535932929c3630fddf6f653b8e95868bdb0186873c00b1f5ed6ab53fbe5d637fdb8b741e0792a5b83782bd13ad52156a9e592e71af037bb916ee7e626d6646fbfb77fc16d39ed2b1fbc5f71fc14da8598651c0ac933ae81f1c75fb83eea0ffb97f3c3a7c3d1a1cf65e1f1ebd3a3c2ab0185aaea421e4b7bd719472c98dd5ccdd2b6e59bc2fb47c5e6438823395318220b05839e0449e29c36284b74aa7660421cb4c2eb003964d05ae966fac4619db640519c1308ddf54b811f47baf3a70d0a37b1379ad728b06d40c7c7b4670f571224f559a2a099f358b102ec963a4f38a69a122141d385d844219b4c5d1f269f3740f74abd8ce5dfdf32f5d092e6fcb0bb7368e7261033298cbd83bfa38240763ccc462220ffadd977d486332053e9d4de48d659acc1ff40e865d32bf5af99218b87f09115b98893c97a1466610a60b0f97a17608f8022fbbc715f682dd93b27ebfb13e91eff81ce18edb04664a45c064446e2b56e9a460159ced9f4ee47b0a90ceb4122c7479907246d6f686ddc17093b94d6bddc276230f6a23dbd94331b9e5d228f98781881ba77c22070df7591e7907de7fc2612f31a79322657c0829133c964c5a300b19b9504d241dbbb14df7d3f9eaecab73d72bf5e18b3d98a16d0452cee1d2c0833ae40e7eaa24793847b83f76db38a750c227289b96aa39fd2a53a0b2fa6929b94abf0d8edcce09b5d08b8363132cc568bf95defff7e1f62d1af2412d1fd4f20f45515d61c499d504d95458114a95b20ed469db25ef68a41f44038381cbdd85aad2787bd5b99576e93338fa73a578637d3c4bf13348e726c39033115ca92c176cc5c475f0353abf860bb866a55b4670f2062e15dc4a7527417373eb987286960948984e614a918e802832c9532629032debc105d1b5551a9275960821b3060ad2140b3a9b864c59a40427751bc202364f098352301d634ac0de447e2050617b618e33f1c3f00db832d18ccb8887ae94804b526d6c461ece53104b990d4edbbb46493ed99831c4d1233abe8508677480a807a72c2ff666d19cd23c227beaa4db82dcf383e3e2f11e3366bf97ad3f73ef7654b0960ddb8bf4cccd1525d8045c06b5069f0bfc086e575be303870f5c8063a539195f96fd2f0ce07aeefc8e11fcf5a9f5441af26af511098d05b5c378e1582e14cc987d37ad5613874169b8e5736e8b75c215a6693e2745733415cc3a989213d9815c866e37454aa9bf9eb8ce6b67486773ec369e2b4eec3ad579660bba8d34bb63e2b9bdb3b9f7f6acf6d00fd5503877670cae91858f1db329ff6ee8ec2af77137c8bfe61a5d7fd1ea96fe7dcf84c8432e4b67d3fd053925c3c259aaf6d558eb6461936294ebd02872ee7280e2cf74e4e81967b37ce95472a971a9e17c3e91d912653929bf12d4a97d3c4172416334d3c4f97caa29251f45ea9a2d24cb23c812d7a5e98fbb877400a7dd2a89a47225fbee1c28165514b78d675d418ea7eb34b32a35c067cb88d3a01296d355dd1bd608ba1cff3def5eb29cc69bfdb94a79d922e978e420721e968e2b9cc3b34265b9ba301966a6f02bb572a5f19e33bacfa6112991aef55131904390452c4cb052f9f52b159c31c5d58cb4c539ad5c324378da2246536ef051db841a9d2bf6894c9a01ed806aae9dcbb912b9b42e0a290d8cae9d1a678665f7a56d54d0396927b7d85c4f89b75d41910b287ac60d24534cd89c2b4d77cf78ccdd0c306746998c9994f2e7c3e70e8c6fe82f266e298eca000a9c6f746dab72aaf2787b252d815e932993bf857089f364fd826951ca3edeb7a32cb616865440df9255405b314a0df6b4ac4a7bbb9206d6d37171be5d96309ecc26fe68f134b1920a6a294f6f93719ea0cfa17dfbd6b8aa85ae52e27b763da2b9161a9732412db39e01cf6e2a4d3d0dcadcaee6dd7950837fe9635ce7fb4cdb42f99a80a76dc9d12da6d825d2936fd2fa761da74db46fc7b21bb430a4867a1afcbed1a2a297f8a0c0fbd955f59c1699b544ae79b56a536ddcba847a1aaad6b65dfe6d05f4a4931fc28f650b6ce1c912570e6bbbd1ebc78e5eeba3ed6ef6dacd5ebbd96b377bed66afddecb59bbd76b35773f6dacd063f6e3678ceff74eee861470fbf313d5cb957932c5442c50b8f2468589cd133c90c4770c2b384196aa587ddc3de10125dbc651db85ff4048654024a70938ee00395987e03a77f5f1d0efb2378393e045732ee33112afcbfee8b7795ee7b91132e105e0f5f7420d7eeab15f7be77d81bbe78c61b920b0c132669fb40cd8271f8e8fb981bcb53f706170d44cb8f643486d4db0b163897099f726be848d63da56ac8b8cd794131f56b56a85eb33e9505aa875f0cc6c2289f82b70e28cfe29a9ffee5c0c3c37f0ee4e1d6', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138615, 3839, 2.5, 15.0, 'mg', 'PO', 1, 'Pediatric', X'789c33d233d5353455c84d5708f057087401001aa60391', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138616, 3839, 1.25, 2.5, 'mg', 'PO', 1, 'Pediatric', X'789c0b2e492c2ab15230d43332d535d23355c84d5708f0570874010054670659', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138617, 6841, 25.0, 25.0, 'mcg/kg', 'IV', NULL, 'Adult', X'789c333255c84d4ed7cf4e57f00c53a830d45128c948cd5330d0338489ebe766e681e4d2f28b144a0b144af2150c2d3200aea51011', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138618, 18322, 5.0, 10.0, 'mg', 'PO', 1, 'Adult', X'789c33d53534c84d5708f0574849cccca904001f9f048a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138619, 18322, 2.5, 2.5, 'mg', NULL, 1, 'Adult', X'789c33d233cd4d574849cccca9040012d7039d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138620, 18322, 2.5, 2.5, 'mg', NULL, 1, 'Adult', X'789c33d233cd4d574849cccca9040012d7039d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138621, 2709, 0.25, 2.0, 'g/kg', NULL, NULL, 'Adult', X'789c33d03332d5355248d7cf4e5748cf2c4bcd53482d4b2daa54305328c957b050c8c82f2d2a0600be840b33', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138622, 2709, 1.0, 1.0, 'g/kg', 'IN', NULL, 'Adult', X'789c15ca310e80200c05d0abfc5127e2ea2c07a9a1c1466c132a126eafceef45f281b821998be6154b0e67c66ea539447f99fa2185419de4fe0a945b356f35731de0874aa07489bb98ce2f1b2f1bce', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138623, 2709, 0.25, 1.0, 'g/kg', 'IV', NULL, 'Adult', X'789c33d03332d5355448d7cf4e57f00c53c8cccb2cc94cccc9a9b456c84dcccc2b49cd4bcc4b4e5548c92f4e55c84f533000a936d03385ab2f34d135cb280200e31f14e6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138624, 2709, 0.25, 1.0, 'g/kg', 'IV', NULL, 'Pediatric', X'789c33d03332d5355448d7cf4e57f00c53c8cccb2cc94cccc9a9b456c84dcccc2b49cd4bcc4b4e5548c92f4e55c84f533000a936d03385ab2f34d135cb280200e31f14e6', X'789ced576d4f1b4710fe2b234b9112091bdb8969e27e42400b5242102fed078cacf1ddf86ecbbe5c77f7704e11ffbdcfde018963a294a88a5aa99f606fe7f5999967c71f7bb9af8bb96523bd29f5deb1b52a3adddba25eed75fa54c65885e9f6f64a5d8b19385fa4ffd4f6e79221f35c493ee79814c6c3f14e7f38ea8f86e7c39fa6939de9e4f56038d9793379d9ca4a1695b301921f7bbf8a15cfbafd3fca8756fdbca9644aa12ed813ebcc954e6f512e5edd484e4bef0c19b87641b62844f1e2fa2a38239edc9282f38b14d4cceebbc085d02fce9b30a553c9e032aa584718a9dc0af6886d0e055da77066f6727435b39367edd7d1f019298b3fc3a1d104d5c80a8186991d4dda9bc9c6c5b853194fd245b2f188c8bd2ebe2fb5aafad15574a358e36ecf19e32c9d7bce858e510c047d8ff016bd0f46457f8775bdf81cc25b7c8abcd0924e9757386965afbb43ba030eca166b003f62a577a0e58681cd5cd9e819e5b4886b5e7909a1f6b2a63e1c8c27fd3115dbd70515288a25b911dfd00e4547afa974754af6720c38cf70d0392de44e900331392b1495115a00fb40cf0d374942d9256aec7cb2728816f0d15995d119231f7901832f61f080434307fb94b7594d69d446d11902b4b879be2a9516e215ab0811b2527b871c8a142272d4db9c1b1502327fd15bc72ec1b587865aa023e7928be1cdbc475dde47bfc11d1cb0d6cdcfe847a026966d262932499dd84a0f079307f93f5ff5774a8f3c5e5d7de9f75b35dccd6b1dff2fe17fb98427922b8e5e65f3bf3990ffca2cce2ac952539db8aad6fc29d8fbc84ebc14c97b43a79c4a37b353da9bd9b79cc5567a3ab317f6daba9525b5a4d49a6263aafac20b874846e9eb993d45069a3a9c66b66dfe4490a9ab95cd55969a3c2985d4b442be1557a662e50deccdec03d84f533b940a51665f7a3e76c4f91f7588490acd9861a0d8376b6ebe22f334befe3a8edf7e8df7d323de090710c0fcc142efb6addc5187c046c5deba1546164376b477422b154b0aaab021350ea01168e1ae140f2e49ca84e1eef0d30ddee4d88e7beb9552e60034a0d2dd24a7a70f5e92a9aee428446d3899f89ca1085024cbf2017cd11ae21048964b80f61defdd5ac137d2ddd55a7cd12482ca34fc6ca7e5e73bbcece6c020c8fc5438dbf4f2d83c9f25a8ea75b943611f69c94a83a067f67707933641904bd9e49ebbc5044cea2cfa4c8ce2ee74cdfad321c38e944e8f3161bb54acb9dc73755182d51d262096de311a7c1fb46a5c1dcb34029c7356229863ae836c18fd2641fc882c37a8f287a7f9cf787c62cf9d94ec0d674ebba25973fdde0669c7acebc529e17518824b2d965d3ce387ac977dad9658aa77ee9ff677024f4eab6040c9071f322f9de605b840d27556623883495677efac1ed92cb13448b47dd6556cd2adb95b5209955c055a8165b189d76d3cb1c4869086912a06dd666583f14fbb31e6dfb5b72d11dc70c8f09c80592acee0fd7272f51df09c0a960f3891f5eebb5fa2e97968f073c1a8ecc594125ba66d053f0edaf61bd04575eef611fb8056abd5a0aea2cbd32973660000129d23efddca2b4de32d1a0f476f064f8df1f6f62fc733940e', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138625, 481, 50.0, 100.0, 'mg', 'PO', NULL, 'Adult', X'789c3335d0353430c84d5708f0572834d135cb500808f2030037b30557', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138626, 481, 100.0, 300.0, 'mg', 'PO', 1, 'Adult', X'789c333430d0353630c84d57700d5208f0574849cccca90400373005cf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138627, 6445, 1.0, 2.0, 'mg', 'IV', NULL, 'Adult', X'789c33d435ca4d57f00c53c82f4b2d52303450c8cdccb356c84c5328c9cf492d4a2c492d5628c948cd533004ab4bcacf292d060a151a9a82149682a44bf34a3273143c82146c0c0d0c00f4111981', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138628, 6445, 3.0, 5.0, 'mg', NULL, NULL, 'Adult', X'789cf34dac5448cbcfc9c92f5728cf2cc9504829ca2c50705048c92f4e55284a2d2ccd2c4a4d012a2852f0085248cecf2b29cacf51d0c84c5530d635cd4dd7cf28d20400fa801645', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138629, 6445, 60.0, 80.0, 'mg', 'PO', NULL, 'Adult', X'789c73cc29492dca4b2c49553033d0b530c84d5708f0572834c9000063b0077c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138630, 6445, 20.0, 20.0, 'mg', NULL, 2, 'Adult', X'789c3332c84d5770f2745128c92c294a2c494d51282d5028c957c84dac005239a910b194fce254002c9d0ec4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138631, 6445, 80.0, 80.0, 'mg', NULL, 1, 'Adult', X'789c0b2e492c2ac9cc4b5748c92f4e55b030c805b21233732a15128b1552334b32528b14227c14f28b145232cb32535253140acd742d328af4147c132b140ccd0c748d4c807af453122b01b7d5182f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138632, 6445, 40.0, 40.0, 'mg', NULL, 2, 'Adult', X'789c3331c84d5770f27451282e492c2ac9cc4b5748c92f4e05004f0b077f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138633, 6445, 80.0, 160.0, 'mg', NULL, 1, 'Adult', X'789cb330d0353433c84d574849cccca954482c5648cd2cc9482d5288f051c82f5248c92ccb4c494d512834d3b550c828020050670ead', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138634, 6445, 10.0, 10.0, 'mg', NULL, 2, 'Adult', X'789c3334c84d5748ca4cd12dc94c51282e492c2ac9cc4b5748c92f4ed553f04dac5030340229d0574849ac04003b210df2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138635, 2696, 250.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333235d0353530c84d5708f057283434ca50a85030d735344901004e1e062e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138636, 2696, 1000.0, 1000.0, 'mg', 'PO', 1, 'Adult', X'789c73cc29b15230343030c84d57700d5208f057087451a85030d735344901006a780721', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138637, 2696, 1000.0, 1000.0, 'mg', 'PO', NULL, 'Adult', X'789c33343030c84d57700d5208f05728343251a850304f51d028cf2cc95048cbcf4fd15148c957c8cb2f51482e2dd14f2e2a2dced04fce482dd70400c7531171', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138638, 2696, 250.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c73cc29b152303235d0353530c84d5708f057283434ca50a85030d73534490100780b07a9', X'789ced5c6d6fdbb616fe2b4480012966c7765edac2bd18e0ba6993b559d3b81b3acc85414bb4c4452235924aa30efdeff739b41dbf448e1335dd726ffda53125f2f0bc3ccfe12125f5efadd0e4d140f1546cb5d95637e146bad8e8b408a4daaab1addc247423762eb3ed46e3933c17e98e3611fd928debfd6d607826c20177346cb7b9fbb8de6cd55bcdf7cd27ed83667bef60a7f9f4c9e3bda7beaf089cd4caa2e7df5baf84128627feb713977ef8fb2213edbe3ae181d1890c455fbdd0964782bdd426b56db67bd0acb183e6f89fc3b367acb57b50a3ab8d8334e9abae4e53add87bc343c17e818918f25cf24ba96a93bfecc31baf483e9cd7e50b2e393e4c04b5fef8885622d5b96fcc74bb526abd97665dbf7c24d99d304fdc00a648152dd85ba2cbd6b11a4d9ab5c190074e18b9e425d85b87fd69c44edfb2bf5abb31bb644feaadfdb0af3a896bb356d3df3c3ca3fbef5e4cef6e2d5a498a7511492583c1107f82583a893979903b319b79202e7920cc90934a0b6a2c4cf3d7ee3ecd13b2ed4fc0071b691dd658a899d28e41602330b98d1b412c3e3d9a68b9d28a123d4f636e0a1591820d07cfc824192b6b9d1199d3810e82eb4e5a10dd6a96093ee97407999129c4e3afcee222014cec82a4052557c84004b50a97a4d40647c7bfad16c5b6732b98779770314f87b9d3c9a31513c04eee52a15c6d104a6b452a157722bc07e9473b83ac48b491033945de82546764960876a5409b2dcc6366e00b739e94f77bea23b00f7444f262a2d5db5464867fd690bd4ffd3c50d1a74cc74315ea809b9082bee8e110332d45fe6adacb16dbde6bd61f37e12c3614236d04c3e04084b911d7a6b92109781dbe292f9793c086981b626e88793b623e58ae2c937a43960d59fe6db2dc1f0697d1bd01e10684b7046125a894e16d8395ef022bf71be632206de2fc10e27c8f51580ef2260cb70bc383f4d372301f82a3be950eb73f9a1cd77322941c4109bee6787161d04fec314bb572b16db3d6411a35cea346c80bd23e94173214a18f748da5fc7272a441f74bf0fcd679e7a4a4e2644bb65858a6ba7e50989be719179c7df5b8deda5dd3175d0feae53ba4db95bd83dd454f3c4ef53add9eac98704589e317ad41867d2840b258f0ec36e18eb536c6cfbcdf0fc66ed756f4d54fad3d3fe8eb8aeb7b55aa3c2faf50b55a4176939ef5bde6bfacaa58931d96903671ed3843cc69789784559ebc9726da2d77ccf3e3abd3c8676b785de598f4bef2cb722edb24984d82d92498ef2cc1fc9ba4af76a2bb61fd86f51bd67f1debbf3dd36e799ebda1da866affdf547b08c0bfdb61ff06f91be4df17f2ffb75076e3b38c0dcc1e2ecc1e6a909601f5fd46e91fb2fc160faafe71d3bf950e777cb6d1cb44402f6f9dea2c4ff8cc4553254e8d88145741d1665db66da43d670157f4b2d6503093275048e70e1c78c303e7c7b799e523e10a96ab73a53fa9be3a138a276cfceca4affc8bda7d5c49180862c70c810c6624361dfc421aa60de38e7fe6bed557af5e9eb1ffb0bd669b852200a7412bcfc683e60fd4d53fe03a3e63087c4aaf97c574f170dade7f1af7d5d18bc6e98b36539ad93ccb124149a1afb008053a958eab35937b7495ccbe5ab527073fac9af5ea69d2920fbeda0564fa57994a510dc5482a11428ea0a538580c9b97cbc33f73eb968c59ba5301895dad9ce152853228c161274984890ae6340b126e6d833eb100ea60b801352cb9648ab4ab26b240a255048cbe7bdf5717d00b9a02e630db98c2c5a9e4969c104bebb429981ef5d5ec37e6329687084f8884a2a572c2f6550e471a03bb205524f88b390a27181f2ae08dd38e99ba59192939822970f8d0f0b0f0698e23123c27eb981c3148814aece478e16af7e8e55c5bb1918054c857345f284c522cdc4e0b6e5d2c94e42c3288a39dddf5cc0a65a4e9a38c40d779880c09f3ccf815cdbb87a813c2db560cce040fae87a82cd3f684913a5fec075ce2ea34e9f555b71eca115c251351476435f2113917de32261670594c50d40e6604d2c17a8a84b1744489602b91c586d60f841b798a96fc71ebdd7b36893f1fcfb314ff780280be2a8db3ff0067a883c2e98cbcdb5789c8cfa7bf95c811f849034ac29e8825dada1aa24a4e92f0225020e4672c421037143182a3cd189e2e3743284b37325b043138869f31f2411ed0fb18e4bfc9ad31bde607216f283e5d29fb4a109281119682a092921e7af41cb450b6feb38e9505147a850a610fee106f98e1369e9426446facbb3201800863b6b04ea498d15ef6d53570b1f9977cfbcac47c18eab400056041d9c72ffe6ba185f0cfe2aa3892df78d60b4a4e3ecf38cc28581073f016d679f992589d213740fdc26622b313b7873c8861139973d7f57783ccef0c99d73eff78b0d0fc6735bbebcb3031c7321700be51b1a0e2114f46f5448e449bedd5f719ea1963d9b654e372259cac46e34f0da7575137fed1fad857270253ea44dab4cde249e1b16d782643369220543d03fd587ad5eb518d757f3fddebecf7d5e125448deb4e43ab3f092347a017ade19d607ccf337324ccb4e0bcfa6c81a8e80416485b8059026061c3820da90e0171506e702c9d69a6152dd55414c45475f5505d0d7325ab143a1de5e4506ad838e8810908e1852f1ad62ea6afc5a2c77ba0716e039139e274c34e84f96d6a0ec61670eff12429f94779c0c8f6053202942bd8fc504376537188116780c6b4c9b6511d515928463e294276006350d68ca5f77e840a05881ea13f62e65d1b0894b59fa8b6e557960294bf52d2996a8864c07e7d7fccb48226db4aab19bbaff22fe47f685155ca4254a968ec02d96325102ef8cce81ac3aeda2b9813c466baa1f7de0dbd671de72c239d5e199d67acc3fc130f96cd1e88509978a519f2712e081b873b6cc4050451bafbb05f65c6c94c48dbe0bce437e78a3ffedef21a52f45f199eb2533d76280d7b6b220f7b0f0d92ba3335a7c69e833035f66acb2f7c53cc119ab68eb730c59cd815924ea70a8a0a327e9346861c6ef3c69608f8d0ba9d16c86f5813805c165512734854f0cfb120621ab9124167779523f3b48298935eaf5332acb76ed859e9b075b3753bf51523d76300abfa0e3b443e46269161259f7577d89f429e8b6aae7ab3432f34f9a227124a9429b0ec364f905f04155917e301f3027fd96111046255d5a212a821003b5de9d343b947d6c2f10455d725b22596186438a8b2028eeb0071b443b929c985fa5c6acabaf1486358d06585b0bc4ec4d04a32c19611722d8fc613376662d861eff99b1fab88ba26e9f569b79220cfed717d60b31aeba45917b57c745fa2325d853dd8aed0b6bddccdebd3e764344bb9416d1f6078151d78020e560e762f9651e5c1a754a521d9a6d2f0a12ca7c95a374c855ce4498432a88a0f20828e6115b682cc663b15598f86876845095daa2dc6b062232372d4aa65e4bd939c904ed2b0b27ead9c8a26754014808ba346a884f00e76a7c2ddacc4dad85a9187132db8c06e946a0d5e41d0f3dc9cc79a0eeb801214d93c9055c460ab8cd2919e8a4c944a79e2263be20ae27ea7cd3f6d98c5a47aa1b3caa08aa49706bb7d693d841d9d5ad0f04ac8796ef2e00626acad0a4424f54d545ab7f29dd2c639375e029d52e800856a15438eb8487d6872da1c604b5a5462e46f7268a4a604e54f8f6f47c71369836b948c139e16a1578997736a6d9959043a43ba4e67bb932ac5c5990cce857356ae50637dbe841e93ed7a9e327e515e402eabd1519cd6deeb851f9d0828fabf956e55445e03ac57444b3a941b191ead588ad62f23e2026b91879d48705951595bcec6752a75138d7d156a5078e7eabcb2521a9f13b4ed1f064da53daaa0d6cbdcce854d89c0273253a9fa3fa5d70fe7de42cced0abea368ff78fdc4657370f27d1c9cdcf5d9b710834e62f5023666a773966d9f70a9eef8c5e03a4937ffaf6673630693315f3e7ef9f2e5bf4038d03e', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138639, 2696, 250.0, 250.0, 'mg', 'PO', NULL, 'Adult', X'789c333235c84d5708f057283434ca50a850303448010031ea0504', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138640, 2696, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333530c84d5708f057283434ca000017bc0385', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138641, 2696, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333530c84d5708f057283434ca50d0282d4e5528cf2cc950482dc948cc4d2a2dc9cfd10400bc0d0b74', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138642, 2696, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333530c84d5708f057283434ca50d0282d4e5528cf2cc950482dc948cc4d2a2dc9cfd10400bc0d0b74', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138643, 2696, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c2b29ca2cc8495528294a4d2cc94dcd2bb152303530c84d5708f057283434ca2852a85030d735344901001f910cba', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138644, 2696, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c4b294dcc5128294a4d2cc94dcd2bb152303530c84d5708f05728b4c850a85030344951d048cf2c4b5528cf2cc950f0cf4d2d284aaccacf49553001a90b7481a8d1040049d21693', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138645, 2696, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333530c84d5708f057a83054d03036d03533c8cdcc53484a4dcb2f4a552828ca4f4e4d292d4ad50400d9b90c19', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138646, 2696, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333530c84d5708f057283434ca50d0282d4e5528cf2cc950482dc948cc4d2a2dc9cfd10400bc0d0b74', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138647, 2696, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c2b29ca2cc8495528294a4d2cc94dcd2bb152303530c84d5708f057283434ca2852a85030d735344901001f910cba', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138648, 2696, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c4b294dcc5128294a4d2cc94dcd2bb152303530c84d5708f05728b4c850a85030344951d048cf2c4b5528cf2cc950f0cf4d2d284aaccacf49553001a90b7481a8d1040049d21693', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138649, 2696, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333530c84d5708f057a83054d03036d03533c8cdcc53484a4dcb2f4a552828ca4f4e4d292d4ad50400d9b90c19', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138650, 2696, 15.0, 15.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cb3533053c8cdcf2bc928b6523034cd4dd7cf4ed74f49ac5408f05748c92ccb4c494d51283434cad051c84dac5030343030c805cb0300dcd91118', X'789ced5c6d6fdbb616fe2b4480012966c7765edac2bd18e0ba6993b559d3b81b3acc85414bb4c4452235924aa30efdeff739b41dbf448e1335dd726ffda53125f2f0bc3ccfe12125f5efadd0e4d140f1546cb5d95637e146bad8e8b408a4daaab1addc247423762eb3ed46e3933c17e98e3611fd928debfd6d607826c20177346cb7b9fbb8de6cd55bcdf7cd27ed83667bef60a7f9f4c9e3bda7beaf089cd4caa2e7df5baf84128627feb713977ef8fb2213edbe3ae181d1890c455fbdd0964782bdd426b56db67bd0acb183e6f89fc3b367acb57b50a3ab8d8334e9abae4e53add87bc343c17e818918f25cf24ba96a93bfecc31baf483e9cd7e50b2e393e4c04b5fef8885622d5b96fcc74bb526abd97665dbf7c24d99d304fdc00a648152dd85ba2cbd6b11a4d9ab5c190074e18b9e425d85b87fd69c44edfb2bf5abb31bb644feaadfdb0af3a896bb356d3df3c3ca3fbef5e4cef6e2d5a498a7511492583c1107f82583a893979903b319b79202e7920cc90934a0b6a2c4cf3d7ee3ecd13b2ed4fc0071b691dd658a899d28e41602330b98d1b412c3e3d9a68b9d28a123d4f636e0a1591820d07cfc824192b6b9d1199d3810e82eb4e5a10dd6a96093ee97407999129c4e3afcee222014cec82a4052557c84004b50a97a4d40647c7bfad16c5b6732b98779770314f87b9d3c9a31513c04eee52a15c6d104a6b452a157722bc07e9473b83ac48b491033945de82546764960876a5409b2dcc6366e00b739e94f77bea23b00f7444f262a2d5db5464867fd690bd4ffd3c50d1a74cc74315ea809b9082bee8e110332d45fe6adacb16dbde6bd61f37e12c3614236d04c3e04084b911d7a6b92109781dbe292f9793c086981b626e88793b623e58ae2c937a43960d59fe6db2dc1f0697d1bd01e10684b7046125a894e16d8395ef022bf71be632206de2fc10e27c8f51580ef2260cb70bc383f4d372301f82a3be950eb73f9a1cd77322941c4109bee6787161d04fec314bb572b16db3d6411a35cea346c80bd23e94173214a18f748da5fc7272a441f74bf0fcd679e7a4a4e2644bb65858a6ba7e50989be719179c7df5b8deda5dd3175d0feae53ba4db95bd83dd454f3c4ef53add9eac98704589e317ad41867d2840b258f0ec36e18eb536c6cfbcdf0fc66ed756f4d54fad3d3fe8eb8aeb7b55aa3c2faf50b55a4176939ef5bde6bfacaa58931d96903671ed3843cc69789784559ebc9726da2d77ccf3e3abd3c8676b785de598f4bef2cb722edb24984d82d92498ef2cc1fc9ba4af76a2bb61fd86f51bd67f1debbf3dd36e799ebda1da866affdf547b08c0bfdb61ff06f91be4df17f2ffb75076e3b38c0dcc1e2ecc1e6a909601f5fd46e91fb2fc160faafe71d3bf950e777cb6d1cb44402f6f9dea2c4ff8cc4553254e8d88145741d1665db66da43d670157f4b2d6503093275048e70e1c78c303e7c7b799e523e10a96ab73a53fa9be3a138a276cfceca4affc8bda7d5c49180862c70c810c6624361dfc421aa60de38e7fe6bed557af5e9eb1ffb0bd669b852200a7412bcfc683e60fd4d53fe03a3e63087c4aaf97c574f170dade7f1af7d5d18bc6e98b36539ad93ccb124149a1afb008053a958eab35937b7495ccbe5ab527073fac9af5ea69d2920fbeda0564fa57994a510dc5482a11428ea0a538580c9b97cbc33f73eb968c59ba5301895dad9ce152853228c161274984890ae6340b126e6d833eb100ea60b801352cb9648ab4ab26b240a255048cbe7bdf5717d00b9a02e630db98c2c5a9e4969c104bebb429981ef5d5ec37e6329687084f8884a2a572c2f6550e471a03bb205524f88b390a27181f2ae08dd38e99ba59192939822970f8d0f0b0f0698e23123c27eb981c3148814aece478e16af7e8e55c5bb1918054c857345f284c522cdc4e0b6e5d2c94e42c3288a39dddf5cc0a65a4e9a38c40d779880c09f3ccf815cdbb87a813c2db560cce040fae87a82cd3f684913a5fec075ce2ea34e9f555b71eca115c251351476435f2113917de32261670594c50d40e6604d2c17a8a84b1744489602b91c586d60f841b798a96fc71ebdd7b36893f1fcfb314ff780280be2a8db3ff0067a883c2e98cbcdb5789c8cfa7bf95c811f849034ac29e8825dada1aa24a4e92f0225020e4672c421037143182a3cd189e2e3743284b37325b043138869f31f2411ed0fb18e4bfc9ad31bde607216f283e5d29fb4a109281119682a092921e7af41cb450b6feb38e9505147a850a610fee106f98e1369e9426446facbb3201800863b6b04ea498d15ef6d53570b1f9977cfbcac47c18eab400056041d9c72ffe6ba185f0cfe2aa3892df78d60b4a4e3ecf38cc28581073f016d679f992589d213740fdc26622b313b7873c8861139973d7f57783ccef0c99d73eff78b0d0fc6735bbebcb3031c7321700be51b1a0e2114f46f5448e449bedd5f719ea1963d9b654e372259cac46e34f0da7575137fed1fad857270253ea44dab4cde249e1b16d782643369220543d03fd587ad5eb518d757f3fddebecf7d5e125448deb4e43ab3f092347a017ade19d607ccf337324ccb4e0bcfa6c81a8e80416485b8059026061c3820da90e0171506e702c9d69a6152dd55414c45475f5505d0d7325ab143a1de5e4506ad838e8810908e1852f1ad62ea6afc5a2c77ba0716e039139e274c34e84f96d6a0ec61670eff12429f94779c0c8f6053202942bd8fc504376537188116780c6b4c9b6511d515928463e294276006350d68ca5f77e840a05881ea13f62e65d1b0894b59fa8b6e557960294bf52d2996a8864c07e7d7fccb48226db4aab19bbaff22fe47f685155ca4254a968ec02d96325102ef8cce81ac3aeda2b9813c466baa1f7de0dbd671de72c239d5e199d67acc3fc130f96cd1e88509978a519f2712e081b873b6cc4050451bafbb05f65c6c94c48dbe0bce437e78a3ffedef21a52f45f199eb2533d76280d7b6b220f7b0f0d92ba3335a7c69e833035f66acb2f7c53cc119ab68eb730c59cd815924ea70a8a0a327e9346861c6ef3c69608f8d0ba9d16c86f5813805c165512734854f0cfb120621ab9124167779523f3b48298935eaf5332acb76ed859e9b075b3753bf51523d76300abfa0e3b443e46269161259f7577d89f429e8b6aae7ab3432f34f9a227124a9429b0ec364f905f04155917e301f3027fd96111046255d5a212a821003b5de9d343b947d6c2f10455d725b22596186438a8b2028eeb0071b443b929c985fa5c6acabaf1486358d06585b0bc4ec4d04a32c19611722d8fc613376662d861eff99b1fab88ba26e9f569b79220cfed717d60b31aeba45917b57c745fa2325d853dd8aed0b6bddccdebd3e764344bb9416d1f6078151d78020e560e762f9651e5c1a754a521d9a6d2f0a12ca7c95a374c855ce4498432a88a0f20828e6115b682cc663b15598f86876845095daa2dc6b062232372d4aa65e4bd939c904ed2b0b27ead9c8a26754014808ba346a884f00e76a7c2ddacc4dad85a9187132db8c06e946a0d5e41d0f3dc9cc79a0eeb801214d93c9055c460ab8cd2919e8a4c944a79e2263be20ae27ea7cd3f6d98c5a47aa1b3caa08aa49706bb7d693d841d9d5ad0f04ac8796ef2e00626acad0a4424f54d545ab7f29dd2c639375e029d52e800856a15438eb8487d6872da1c604b5a5462e46f7268a4a604e54f8f6f47c71369836b948c139e16a1578997736a6d9959043a43ba4e67bb932ac5c5990cce857356ae50637dbe841e93ed7a9e327e515e402eabd1519cd6deeb851f9d0828fabf956e55445e03ac57444b3a941b191ead588ad62f23e2026b91879d48705951595bcec6752a75138d7d156a5078e7eabcb2521a9f13b4ed1f064da53daaa0d6cbdcce854d89c0273253a9fa3fa5d70fe7de42cced0abea368ff78fdc4657370f27d1c9cdcf5d9b710834e62f5023666a773966d9f70a9eef8c5e03a4937ffaf6673630693315f3e7ef9f2e5bf4038d03e', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138651, 2696, 15.0, 15.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33cacdd735ad2c2ab6523034cd4dd7cf4ed74f49ac5408f05748c92ccb4c494d51283434ca50a85030344801002c500d62', X'789ced5c6d6fdbb616fe2b4480012966c7765edac2bd18e0ba6993b559d3b81b3acc85414bb4c4452235924aa30efdeff739b41dbf448e1335dd726ffda53125f2f0bc3ccfe12125f5efadd0e4d140f1546cb5d95637e146bad8e8b408a4daaab1addc247423762eb3ed46e3933c17e98e3611fd928debfd6d607826c20177346cb7b9fbb8de6cd55bcdf7cd27ed83667bef60a7f9f4c9e3bda7beaf089cd4caa2e7df5baf84128627feb713977ef8fb2213edbe3ae181d1890c455fbdd0964782bdd426b56db67bd0acb183e6f89fc3b367acb57b50a3ab8d8334e9abae4e53add87bc343c17e818918f25cf24ba96a93bfecc31baf483e9cd7e50b2e393e4c04b5fef8885622d5b96fcc74bb526abd97665dbf7c24d99d304fdc00a648152dd85ba2cbd6b11a4d9ab5c190074e18b9e425d85b87fd69c44edfb2bf5abb31bb644feaadfdb0af3a896bb356d3df3c3ca3fbef5e4cef6e2d5a498a7511492583c1107f82583a893979903b319b79202e7920cc90934a0b6a2c4cf3d7ee3ecd13b2ed4fc0071b691dd658a899d28e41602330b98d1b412c3e3d9a68b9d28a123d4f636e0a1591820d07cfc824192b6b9d1199d3810e82eb4e5a10dd6a96093ee97407999129c4e3afcee222014cec82a4052557c84004b50a97a4d40647c7bfad16c5b6732b98779770314f87b9d3c9a31513c04eee52a15c6d104a6b452a157722bc07e9473b83ac48b491033945de82546764960876a5409b2dcc6366e00b739e94f77bea23b00f7444f262a2d5db5464867fd690bd4ffd3c50d1a74cc74315ea809b9082bee8e110332d45fe6adacb16dbde6bd61f37e12c3614236d04c3e04084b911d7a6b92109781dbe292f9793c086981b626e88793b623e58ae2c937a43960d59fe6db2dc1f0697d1bd01e10684b7046125a894e16d8395ef022bf71be632206de2fc10e27c8f51580ef2260cb70bc383f4d372301f82a3be950eb73f9a1cd77322941c4109bee6787161d04fec314bb572b16db3d6411a35cea346c80bd23e94173214a18f748da5fc7272a441f74bf0fcd679e7a4a4e2644bb65858a6ba7e50989be719179c7df5b8deda5dd3175d0feae53ba4db95bd83dd454f3c4ef53add9eac98704589e317ad41867d2840b258f0ec36e18eb536c6cfbcdf0fc66ed756f4d54fad3d3fe8eb8aeb7b55aa3c2faf50b55a4176939ef5bde6bfacaa58931d96903671ed3843cc69789784559ebc9726da2d77ccf3e3abd3c8676b785de598f4bef2cb722edb24984d82d92498ef2cc1fc9ba4af76a2bb61fd86f51bd67f1debbf3dd36e799ebda1da866affdf547b08c0bfdb61ff06f91be4df17f2ffb75076e3b38c0dcc1e2ecc1e6a909601f5fd46e91fb2fc160faafe71d3bf950e777cb6d1cb44402f6f9dea2c4ff8cc4553254e8d88145741d1665db66da43d670157f4b2d6503093275048e70e1c78c303e7c7b799e523e10a96ab73a53fa9be3a138a276cfceca4affc8bda7d5c49180862c70c810c6624361dfc421aa60de38e7fe6bed557af5e9eb1ffb0bd669b852200a7412bcfc683e60fd4d53fe03a3e63087c4aaf97c574f170dade7f1af7d5d18bc6e98b36539ad93ccb124149a1afb008053a958eab35937b7495ccbe5ab527073fac9af5ea69d2920fbeda0564fa57994a510dc5482a11428ea0a538580c9b97cbc33f73eb968c59ba5301895dad9ce152853228c161274984890ae6340b126e6d833eb100ea60b801352cb9648ab4ab26b240a255048cbe7bdf5717d00b9a02e630db98c2c5a9e4969c104bebb429981ef5d5ec37e6329687084f8884a2a572c2f6550e471a03bb205524f88b390a27181f2ae08dd38e99ba59192939822970f8d0f0b0f0698e23123c27eb981c3148814aece478e16af7e8e55c5bb1918054c857345f284c522cdc4e0b6e5d2c94e42c3288a39dddf5cc0a65a4e9a38c40d779880c09f3ccf815cdbb87a813c2db560cce040fae87a82cd3f684913a5fec075ce2ea34e9f555b71eca115c251351476435f2113917de32261670594c50d40e6604d2c17a8a84b1744489602b91c586d60f841b798a96fc71ebdd7b36893f1fcfb314ff780280be2a8db3ff0067a883c2e98cbcdb5789c8cfa7bf95c811f849034ac29e8825dada1aa24a4e92f0225020e4672c421037143182a3cd189e2e3743284b37325b043138869f31f2411ed0fb18e4bfc9ad31bde607216f283e5d29fb4a109281119682a092921e7af41cb450b6feb38e9505147a850a610fee106f98e1369e9426446facbb3201800863b6b04ea498d15ef6d53570b1f9977cfbcac47c18eab400056041d9c72ffe6ba185f0cfe2aa3892df78d60b4a4e3ecf38cc28581073f016d679f992589d213740fdc26622b313b7873c8861139973d7f57783ccef0c99d73eff78b0d0fc6735bbebcb3031c7321700be51b1a0e2114f46f5448e449bedd5f719ea1963d9b654e372259cac46e34f0da7575137fed1fad857270253ea44dab4cde249e1b16d782643369220543d03fd587ad5eb518d757f3fddebecf7d5e125448deb4e43ab3f092347a017ade19d607ccf337324ccb4e0bcfa6c81a8e80416485b8059026061c3820da90e0171506e702c9d69a6152dd55414c45475f5505d0d7325ab143a1de5e4506ad838e8810908e1852f1ad62ea6afc5a2c77ba0716e039139e274c34e84f96d6a0ec61670eff12429f94779c0c8f6053202942bd8fc504376537188116780c6b4c9b6511d515928463e294276006350d68ca5f77e840a05881ea13f62e65d1b0894b59fa8b6e557960294bf52d2996a8864c07e7d7fccb48226db4aab19bbaff22fe47f685155ca4254a968ec02d96325102ef8cce81ac3aeda2b9813c466baa1f7de0dbd671de72c239d5e199d67acc3fc130f96cd1e88509978a519f2712e081b873b6cc4050451bafbb05f65c6c94c48dbe0bce437e78a3ffedef21a52f45f199eb2533d76280d7b6b220f7b0f0d92ba3335a7c69e833035f66acb2f7c53cc119ab68eb730c59cd815924ea70a8a0a327e9346861c6ef3c69608f8d0ba9d16c86f5813805c165512734854f0cfb120621ab9124167779523f3b48298935eaf5332acb76ed859e9b075b3753bf51523d76300abfa0e3b443e46269161259f7577d89f429e8b6aae7ab3432f34f9a227124a9429b0ec364f905f04155917e301f3027fd96111046255d5a212a821003b5de9d343b947d6c2f10455d725b22596186438a8b2028eeb0071b443b929c985fa5c6acabaf1486358d06585b0bc4ec4d04a32c19611722d8fc613376662d861eff99b1fab88ba26e9f569b79220cfed717d60b31aeba45917b57c745fa2325d853dd8aed0b6bddccdebd3e764344bb9416d1f6078151d78020e560e762f9651e5c1a754a521d9a6d2f0a12ca7c95a374c855ce4498432a88a0f20828e6115b682cc663b15598f86876845095daa2dc6b062232372d4aa65e4bd939c904ed2b0b27ead9c8a26754014808ba346a884f00e76a7c2ddacc4dad85a9187132db8c06e946a0d5e41d0f3dc9cc79a0eeb801214d93c9055c460ab8cd2919e8a4c944a79e2263be20ae27ea7cd3f6d98c5a47aa1b3caa08aa49706bb7d693d841d9d5ad0f04ac8796ef2e00626acad0a4424f54d545ab7f29dd2c639375e029d52e800856a15438eb8487d6872da1c604b5a5462e46f7268a4a604e54f8f6f47c71369836b948c139e16a1578997736a6d9959043a43ba4e67bb932ac5c5990cce857356ae50637dbe841e93ed7a9e327e515e402eabd1519cd6deeb851f9d0828fabf956e55445e03ac57444b3a941b191ead588ad62f23e2026b91879d48705951595bcec6752a75138d7d156a5078e7eabcb2521a9f13b4ed1f064da53daaa0d6cbdcce854d89c0273253a9fa3fa5d70fe7de42cced0abea368ff78fdc4657370f27d1c9cdcf5d9b710834e62f5023666a773966d9f70a9eef8c5e03a4937ffaf6673630693315f3e7ef9f2e5bf4038d03e', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138652, 2696, 15.0, 15.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33d33534aa2c2ab6523034cd4dd7cf4ed74f49ac5408f05748c92ccb4c494d5128343452a85030d535344801001ba40cb2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138653, 2696, 15.0, 15.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cb333cbcdb7523034cd4dd7cf4ed74f49ac5408f05748c92ccb4c494d51283434ca50a85030d73534480100075e0c48', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138654, 2696, 15.0, 15.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3332c8cdd73534aa2c2ab6523034cd4dd7cf4ed74f49ac5408f05748c92ccb4c494d51283434cab056c84dac5030353000aa48c92f4e0500da0e1147', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138655, 2696, 500.0, 500.0, 'mg', 'PO', NULL, 'Pediatric', X'789cb33334ae2c2ab652303530c84d5708f057283434ca000040e105df', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138656, 2696, 15.0, 15.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3332c8cdd73534aa2c2ab6523034cd4dd7cf4ed74f49ac5408f05748c92ccb4c494d51283434cab056c84dac5030353000aa48c92f4e55d0280512e59925190aa9251989b949a525f9399a00ad291936', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138657, 2696, 500.0, 500.0, 'mg', 'PO', NULL, 'Pediatric', X'789cb33334ae2c2ab652303530c84d5708f057283434ca50d0282d4e5528cf2cc950482dc948cc4d2a2dc9cfd1040018fd0dce', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138658, 2696, 15.0, 30.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3332c8cdd73534aa2c2ab6523034d53536c84dd7cf4ed74f49ac5408f05748c92ccb4c494d51283434cab056c84dac50303500a948c92f4e55d0280512e59925190aa9251989b949a525f9399a00dd7d19c6', X'789ced5c6d6fdbb616fe2b4480012966c7765edac2bd18e0ba6993b559d3b81b3acc85414bb4c4452235924aa30efdeff739b41dbf448e1335dd726ffda53125f2f0bc3ccfe12125f5efadd0e4d140f1546cb5d95637e146bad8e8b408a4daaab1addc247423762eb3ed46e3933c17e98e3611fd928debfd6d607826c20177346cb7b9fbb8de6cd55bcdf7cd27ed83667bef60a7f9f4c9e3bda7beaf089cd4caa2e7df5baf84128627feb713977ef8fb2213edbe3ae181d1890c455fbdd0964782bdd426b56db67bd0acb183e6f89fc3b367acb57b50a3ab8d8334e9abae4e53add87bc343c17e818918f25cf24ba96a93bfecc31baf483e9cd7e50b2e393e4c04b5fef8885622d5b96fcc74bb526abd97665dbf7c24d99d304fdc00a648152dd85ba2cbd6b11a4d9ab5c190074e18b9e425d85b87fd69c44edfb2bf5abb31bb644feaadfdb0af3a896bb356d3df3c3ca3fbef5e4cef6e2d5a498a7511492583c1107f82583a893979903b319b79202e7920cc90934a0b6a2c4cf3d7ee3ecd13b2ed4fc0071b691dd658a899d28e41602330b98d1b412c3e3d9a68b9d28a123d4f636e0a1591820d07cfc824192b6b9d1199d3810e82eb4e5a10dd6a96093ee97407999129c4e3afcee222014cec82a4052557c84004b50a97a4d40647c7bfad16c5b6732b98779770314f87b9d3c9a31513c04eee52a15c6d104a6b452a157722bc07e9473b83ac48b491033945de82546764960876a5409b2dcc6366e00b739e94f77bea23b00f7444f262a2d5db5464867fd690bd4ffd3c50d1a74cc74315ea809b9082bee8e110332d45fe6adacb16dbde6bd61f37e12c3614236d04c3e04084b911d7a6b92109781dbe292f9793c086981b626e88793b623e58ae2c937a43960d59fe6db2dc1f0697d1bd01e10684b7046125a894e16d8395ef022bf71be632206de2fc10e27c8f51580ef2260cb70bc383f4d372301f82a3be950eb73f9a1cd77322941c4109bee6787161d04fec314bb572b16db3d6411a35cea346c80bd23e94173214a18f748da5fc7272a441f74bf0fcd679e7a4a4e2644bb65858a6ba7e50989be719179c7df5b8deda5dd3175d0feae53ba4db95bd83dd454f3c4ef53add9eac98704589e317ad41867d2840b258f0ec36e18eb536c6cfbcdf0fc66ed756f4d54fad3d3fe8eb8aeb7b55aa3c2faf50b55a4176939ef5bde6bfacaa58931d96903671ed3843cc69789784559ebc9726da2d77ccf3e3abd3c8676b785de598f4bef2cb722edb24984d82d92498ef2cc1fc9ba4af76a2bb61fd86f51bd67f1debbf3dd36e799ebda1da866affdf547b08c0bfdb61ff06f91be4df17f2ffb75076e3b38c0dcc1e2ecc1e6a909601f5fd46e91fb2fc160faafe71d3bf950e777cb6d1cb44402f6f9dea2c4ff8cc4553254e8d88145741d1665db66da43d670157f4b2d6503093275048e70e1c78c303e7c7b799e523e10a96ab73a53fa9be3a138a276cfceca4affc8bda7d5c49180862c70c810c6624361dfc421aa60de38e7fe6bed557af5e9eb1ffb0bd669b852200a7412bcfc683e60fd4d53fe03a3e63087c4aaf97c574f170dade7f1af7d5d18bc6e98b36539ad93ccb124149a1afb008053a958eab35937b7495ccbe5ab527073fac9af5ea69d2920fbeda0564fa57994a510dc5482a11428ea0a538580c9b97cbc33f73eb968c59ba5301895dad9ce152853228c161274984890ae6340b126e6d833eb100ea60b801352cb9648ab4ab26b240a255048cbe7bdf5717d00b9a02e630db98c2c5a9e4969c104bebb429981ef5d5ec37e6329687084f8884a2a572c2f6550e471a03bb205524f88b390a27181f2ae08dd38e99ba59192939822970f8d0f0b0f0698e23123c27eb981c3148814aece478e16af7e8e55c5bb1918054c857345f284c522cdc4e0b6e5d2c94e42c3288a39dddf5cc0a65a4e9a38c40d779880c09f3ccf815cdbb87a813c2db560cce040fae87a82cd3f684913a5fec075ce2ea34e9f555b71eca115c251351476435f2113917de32261670594c50d40e6604d2c17a8a84b1744489602b91c586d60f841b798a96fc71ebdd7b36893f1fcfb314ff780280be2a8db3ff0067a883c2e98cbcdb5789c8cfa7bf95c811f849034ac29e8825dada1aa24a4e92f0225020e4672c421037143182a3cd189e2e3743284b37325b043138869f31f2411ed0fb18e4bfc9ad31bde607216f283e5d29fb4a109281119682a092921e7af41cb450b6feb38e9505147a850a610fee106f98e1369e9426446facbb3201800863b6b04ea498d15ef6d53570b1f9977cfbcac47c18eab400056041d9c72ffe6ba185f0cfe2aa3892df78d60b4a4e3ecf38cc28581073f016d679f992589d213740fdc26622b313b7873c8861139973d7f57783ccef0c99d73eff78b0d0fc6735bbebcb3031c7321700be51b1a0e2114f46f5448e449bedd5f719ea1963d9b654e372259cac46e34f0da7575137fed1fad857270253ea44dab4cde249e1b16d782643369220543d03fd587ad5eb518d757f3fddebecf7d5e125448deb4e43ab3f092347a017ade19d607ccf337324ccb4e0bcfa6c81a8e80416485b8059026061c3820da90e0171506e702c9d69a6152dd55414c45475f5505d0d7325ab143a1de5e4506ad838e8810908e1852f1ad62ea6afc5a2c77ba0716e039139e274c34e84f96d6a0ec61670eff12429f94779c0c8f6053202942bd8fc504376537188116780c6b4c9b6511d515928463e294276006350d68ca5f77e840a05881ea13f62e65d1b0894b59fa8b6e557960294bf52d2996a8864c07e7d7fccb48226db4aab19bbaff22fe47f685155ca4254a968ec02d96325102ef8cce81ac3aeda2b9813c466baa1f7de0dbd671de72c239d5e199d67acc3fc130f96cd1e88509978a519f2712e081b873b6cc4050451bafbb05f65c6c94c48dbe0bce437e78a3ffedef21a52f45f199eb2533d76280d7b6b220f7b0f0d92ba3335a7c69e833035f66acb2f7c53cc119ab68eb730c59cd815924ea70a8a0a327e9346861c6ef3c69608f8d0ba9d16c86f5813805c165512734854f0cfb120621ab9124167779523f3b48298935eaf5332acb76ed859e9b075b3753bf51523d76300abfa0e3b443e46269161259f7577d89f429e8b6aae7ab3432f34f9a227124a9429b0ec364f905f04155917e301f3027fd96111046255d5a212a821003b5de9d343b947d6c2f10455d725b22596186438a8b2028eeb0071b443b929c985fa5c6acabaf1486358d06585b0bc4ec4d04a32c19611722d8fc613376662d861eff99b1fab88ba26e9f569b79220cfed717d60b31aeba45917b57c745fa2325d853dd8aed0b6bddccdebd3e764344bb9416d1f6078151d78020e560e762f9651e5c1a754a521d9a6d2f0a12ca7c95a374c855ce4498432a88a0f20828e6115b682cc663b15598f86876845095daa2dc6b062232372d4aa65e4bd939c904ed2b0b27ead9c8a26754014808ba346a884f00e76a7c2ddacc4dad85a9187132db8c06e946a0d5e41d0f3dc9cc79a0eeb801214d93c9055c460ab8cd2919e8a4c944a79e2263be20ae27ea7cd3f6d98c5a47aa1b3caa08aa49706bb7d693d841d9d5ad0f04ac8796ef2e00626acad0a4424f54d545ab7f29dd2c639375e029d52e800856a15438eb8487d6872da1c604b5a5462e46f7268a4a604e54f8f6f47c71369836b948c139e16a1578997736a6d9959043a43ba4e67bb932ac5c5990cce857356ae50637dbe841e93ed7a9e327e515e402eabd1519cd6deeb851f9d0828fabf956e55445e03ac57444b3a941b191ead588ad62f23e2026b91879d48705951595bcec6752a75138d7d156a5078e7eabcb2521a9f13b4ed1f064da53daaa0d6cbdcce854d89c0273253a9fa3fa5d70fe7de42cced0abea368ff78fdc4657370f27d1c9cdcf5d9b710834e62f5023666a773966d9f70a9eef8c5e03a4937ffaf6673630693315f3e7ef9f2e5bf4038d03e', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138659, 2696, 500.0, 500.0, 'mg', 'PO', NULL, 'Pediatric', X'789cb33334ae2c2ab652303530c84d5708f057283434ca50d0282d4e5528cf2cc950482dc948cc4d2a2dc9cfd1040018fd0dce', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138660, 2696, 15.0, 15.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3334cd4dd7cf4e5708f057a830b456c84dac50303530c84d57d03036d03533c8cdcc53484a4dcb2f4a552828ca4f4e4d292d4ad504008e7c1015', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138661, 2696, 20.0, 20.0, 'mg/kg', 'PO', 2, 'Pediatric', X'789c3332c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5170f27451a85030d7353449b156c84dac5030343000a9042a030082b90ef4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138662, 2696, 15.0, 30.0, 'mg/kg', 'PO', NULL, 'Adult', X'789c3332c8cdd73534aa2c2ab6523034d53536c84dd7cf4ed74f49ac5408f05748c92ccb4c494d51283434cab056c84dac50303500a948c92f4e55d0280512e59925190aa9251989b949a525f9399a00dd7d19c6', X'789ced5c6d6fdbb616fe2b4480012966c7765edac2bd18e0ba6993b559d3b81b3acc85414bb4c4452235924aa30efdeff739b41dbf448e1335dd726ffda53125f2f0bc3ccfe12125f5efadd0e4d140f1546cb5d95637e146bad8e8b408a4daaab1addc247423762eb3ed46e3933c17e98e3611fd928debfd6d607826c20177346cb7b9fbb8de6cd55bcdf7cd27ed83667bef60a7f9f4c9e3bda7beaf089cd4caa2e7df5baf84128627feb713977ef8fb2213edbe3ae181d1890c455fbdd0964782bdd426b56db67bd0acb183e6f89fc3b367acb57b50a3ab8d8334e9abae4e53add87bc343c17e818918f25cf24ba96a93bfecc31baf483e9cd7e50b2e393e4c04b5fef8885622d5b96fcc74bb526abd97665dbf7c24d99d304fdc00a648152dd85ba2cbd6b11a4d9ab5c190074e18b9e425d85b87fd69c44edfb2bf5abb31bb644feaadfdb0af3a896bb356d3df3c3ca3fbef5e4cef6e2d5a498a7511492583c1107f82583a893979903b319b79202e7920cc90934a0b6a2c4cf3d7ee3ecd13b2ed4fc0071b691dd658a899d28e41602330b98d1b412c3e3d9a68b9d28a123d4f636e0a1591820d07cfc824192b6b9d1199d3810e82eb4e5a10dd6a96093ee97407999129c4e3afcee222014cec82a4052557c84004b50a97a4d40647c7bfad16c5b6732b98779770314f87b9d3c9a31513c04eee52a15c6d104a6b452a157722bc07e9473b83ac48b491033945de82546764960876a5409b2dcc6366e00b739e94f77bea23b00f7444f262a2d5db5464867fd690bd4ffd3c50d1a74cc74315ea809b9082bee8e110332d45fe6adacb16dbde6bd61f37e12c3614236d04c3e04084b911d7a6b92109781dbe292f9793c086981b626e88793b623e58ae2c937a43960d59fe6db2dc1f0697d1bd01e10684b7046125a894e16d8395ef022bf71be632206de2fc10e27c8f51580ef2260cb70bc383f4d372301f82a3be950eb73f9a1cd77322941c4109bee6787161d04fec314bb572b16db3d6411a35cea346c80bd23e94173214a18f748da5fc7272a441f74bf0fcd679e7a4a4e2644bb65858a6ba7e50989be719179c7df5b8deda5dd3175d0feae53ba4db95bd83dd454f3c4ef53add9eac98704589e317ad41867d2840b258f0ec36e18eb536c6cfbcdf0fc66ed756f4d54fad3d3fe8eb8aeb7b55aa3c2faf50b55a4176939ef5bde6bfacaa58931d96903671ed3843cc69789784559ebc9726da2d77ccf3e3abd3c8676b785de598f4bef2cb722edb24984d82d92498ef2cc1fc9ba4af76a2bb61fd86f51bd67f1debbf3dd36e799ebda1da866affdf547b08c0bfdb61ff06f91be4df17f2ffb75076e3b38c0dcc1e2ecc1e6a909601f5fd46e91fb2fc160faafe71d3bf950e777cb6d1cb44402f6f9dea2c4ff8cc4553254e8d88145741d1665db66da43d670157f4b2d6503093275048e70e1c78c303e7c7b799e523e10a96ab73a53fa9be3a138a276cfceca4affc8bda7d5c49180862c70c810c6624361dfc421aa60de38e7fe6bed557af5e9eb1ffb0bd669b852200a7412bcfc683e60fd4d53fe03a3e63087c4aaf97c574f170dade7f1af7d5d18bc6e98b36539ad93ccb124149a1afb008053a958eab35937b7495ccbe5ab527073fac9af5ea69d2920fbeda0564fa57994a510dc5482a11428ea0a538580c9b97cbc33f73eb968c59ba5301895dad9ce152853228c161274984890ae6340b126e6d833eb100ea60b801352cb9648ab4ab26b240a255048cbe7bdf5717d00b9a02e630db98c2c5a9e4969c104bebb429981ef5d5ec37e6329687084f8884a2a572c2f6550e471a03bb205524f88b390a27181f2ae08dd38e99ba59192939822970f8d0f0b0f0698e23123c27eb981c3148814aece478e16af7e8e55c5bb1918054c857345f284c522cdc4e0b6e5d2c94e42c3288a39dddf5cc0a65a4e9a38c40d779880c09f3ccf815cdbb87a813c2db560cce040fae87a82cd3f684913a5fec075ce2ea34e9f555b71eca115c251351476435f2113917de32261670594c50d40e6604d2c17a8a84b1744489602b91c586d60f841b798a96fc71ebdd7b36893f1fcfb314ff780280be2a8db3ff0067a883c2e98cbcdb5789c8cfa7bf95c811f849034ac29e8825dada1aa24a4e92f0225020e4672c421037143182a3cd189e2e3743284b37325b043138869f31f2411ed0fb18e4bfc9ad31bde607216f283e5d29fb4a109281119682a092921e7af41cb450b6feb38e9505147a850a610fee106f98e1369e9426446facbb3201800863b6b04ea498d15ef6d53570b1f9977cfbcac47c18eab400056041d9c72ffe6ba185f0cfe2aa3892df78d60b4a4e3ecf38cc28581073f016d679f992589d213740fdc26622b313b7873c8861139973d7f57783ccef0c99d73eff78b0d0fc6735bbebcb3031c7321700be51b1a0e2114f46f5448e449bedd5f719ea1963d9b654e372259cac46e34f0da7575137fed1fad857270253ea44dab4cde249e1b16d782643369220543d03fd587ad5eb518d757f3fddebecf7d5e125448deb4e43ab3f092347a017ade19d607ccf337324ccb4e0bcfa6c81a8e80416485b8059026061c3820da90e0171506e702c9d69a6152dd55414c45475f5505d0d7325ab143a1de5e4506ad838e8810908e1852f1ad62ea6afc5a2c77ba0716e039139e274c34e84f96d6a0ec61670eff12429f94779c0c8f6053202942bd8fc504376537188116780c6b4c9b6511d515928463e294276006350d68ca5f77e840a05881ea13f62e65d1b0894b59fa8b6e557960294bf52d2996a8864c07e7d7fccb48226db4aab19bbaff22fe47f685155ca4254a968ec02d96325102ef8cce81ac3aeda2b9813c466baa1f7de0dbd671de72c239d5e199d67acc3fc130f96cd1e88509978a519f2712e081b873b6cc4050451bafbb05f65c6c94c48dbe0bce437e78a3ffedef21a52f45f199eb2533d76280d7b6b220f7b0f0d92ba3335a7c69e833035f66acb2f7c53cc119ab68eb730c59cd815924ea70a8a0a327e9346861c6ef3c69608f8d0ba9d16c86f5813805c165512734854f0cfb120621ab9124167779523f3b48298935eaf5332acb76ed859e9b075b3753bf51523d76300abfa0e3b443e46269161259f7577d89f429e8b6aae7ab3432f34f9a227124a9429b0ec364f905f04155917e301f3027fd96111046255d5a212a821003b5de9d343b947d6c2f10455d725b22596186438a8b2028eeb0071b443b929c985fa5c6acabaf1486358d06585b0bc4ec4d04a32c19611722d8fc613376662d861eff99b1fab88ba26e9f569b79220cfed717d60b31aeba45917b57c745fa2325d853dd8aed0b6bddccdebd3e764344bb9416d1f6078151d78020e560e762f9651e5c1a754a521d9a6d2f0a12ca7c95a374c855ce4498432a88a0f20828e6115b682cc663b15598f86876845095daa2dc6b062232372d4aa65e4bd939c904ed2b0b27ead9c8a26754014808ba346a884f00e76a7c2ddacc4dad85a9187132db8c06e946a0d5e41d0f3dc9cc79a0eeb801214d93c9055c460ab8cd2919e8a4c944a79e2263be20ae27ea7cd3f6d98c5a47aa1b3caa08aa49706bb7d693d841d9d5ad0f04ac8796ef2e00626acad0a4424f54d545ab7f29dd2c639375e029d52e800856a15438eb8487d6872da1c604b5a5462e46f7268a4a604e54f8f6f47c71369836b948c139e16a1578997736a6d9959043a43ba4e67bb932ac5c5990cce857356ae50637dbe841e93ed7a9e327e515e402eabd1519cd6deeb851f9d0828fabf956e55445e03ac57444b3a941b191ead588ad62f23e2026b91879d48705951595bcec6752a75138d7d156a5078e7eabcb2521a9f13b4ed1f064da53daaa0d6cbdcce854d89c0273253a9fa3fa5d70fe7de42cced0abea368ff78fdc4657370f27d1c9cdcf5d9b710834e62f5023666a773966d9f70a9eef8c5e03a4937ffaf6673630693315f3e7ef9f2e5bf4038d03e', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138663, 2696, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789cb33334ae2c2ab652303530c84d5708f057283434ca50d0282d4e5528cf2cc950482dc948cc4d2a2dc9cfd1040018fd0dce', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138664, 2696, 15.0, 15.0, 'mg/kg', 'PO', NULL, 'Adult', X'789c3334cd4dd7cf4e5708f057a830b456c84dac50303530c84d57d03036d03533c8cdcc53484a4dcb2f4a552828ca4f4e4d292d4ad504008e7c1015', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138665, 2696, 20.0, 20.0, 'mg/kg', 'PO', 2, 'Adult', X'789c3332c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5170f27451a85030d7353449b156c84dac5030343000a9042a030082b90ef4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138666, 257, 12.5, 50.0, 'MG', 'PO', NULL, 'Adult', X'789cb3523034d23355d055303550f0755708f0570874718c040030c704b5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138667, 257, 2.0, 4.0, 'mg/kg', 'PO', 2, 'Pediatric', X'789cb3513053c8cdcf2bc928b65230d235c94dd7cf4ed74f49ac5408f05770f274010093270929', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138668, 257, 1.0, 2.0, 'mg/kg', 'PO', 2, 'Pediatric', X'789c3353c8cd57d0553052a8ccb75230d435ca4dd7cf4ed74f49ac5408f05770f274d151c84dac503036d733cd050b03003acd0d74', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138669, 257, 1.0, 2.0, 'mg/kg', 'PO', 2, 'Pediatric', X'789c3352d055303452a8d4cfb75230d435ca4dd7cf4ed74f49ac5408f0572804d2ba4999293a0ab989150a860606b960290064150ed4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138670, 24417, 5.0, 15.0, 'mg', 'PO', NULL, 'Adult', X'789c0b2e492c2ab15230d53534cd4d5708f0572834d135cb500808f2030068a20764', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138671, 24417, 0.05, 0.15, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33d03330d535d03334cd4dd7cf4e5708f0572834d135cb500808f203005b1206e9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138672, 24417, 5.0, 5.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb05230cd4dd74fc92f4e05001d2e0464', X'789ced57516fdb3610fe2b070f0536204e94ac7651612f9ed3ae03d2c470bca7a910ced4592222912a4925568bfcf71e253bb1dc04768275e8b0be49d4c7bbe377df1d4f9f7b89a9d2586141bd107a17cb5ae8442bea1d40af32b95fcb9c2b6d78747423afa838d426f54ff2a803b5c26049498cceef38094e86fde0b87f1ccc8257e1e075180c0e8727af8683d70d9684935a59467eeefd418a0ce6cdb3a365b37d56971446eaa2945a26913ad5165382b7da143684c945a4c6ba28b48299c184e09c43e7f5a95eca369e036842534eaa3534af41e8622e152570235d162914e4b0904a9719310c2d4cc808cdab4d88d57c33ca5b5e7238cfc9bffdfd81df72a9ae9a97fba8db70f7e0adc5b1cdfbbd9d68769b1875e0b71f7c7ca3a4ca5dcc5c499576d87ce03cab58fbe728af299ea093a49cedecba74685c0883fef1a0489974f8f8b23fcc60323d8fd45f9620d737641dd062e1ed5e13249a57512560336ddcd6b7caa0770e3f9f5fcc0061218d757de690c0194257b0fb5f5abb02ab062915e83c2103e53aba6e0efc9157a778b32cc93046b0fe1e3ccb9f2a91d732a930979f08e6685905ec4254c630167463863d3abca2ed733e1a4fa42e89d6228596771867cc5aa416dab47cb00aafc9d8d600af160d0d919a71b1ac20f31a4e06fd41f0023e9ef45f4282b505a72191b695704520174cb74afb8e4c0195a56d2a9e20cf4ea0fb6ad5fe74c1251ab72f2b89c5ad85dbcd44fcd7e4f44855fcd0d377a2a7ff65229e7ff57c9b5c4c2891e88c14fbde2dab1b9d332655071c1c06837e70e83bc0d1d57613788f4b6e0ffcc573f704413631fe432ef7a7bef17a599290deab2eab1cef09583b9f184a152a51c394bfaa3452218c237586c2b5ed6b2aed158cd151aa59e6d67f2fb5b572cee34aa52c2e5886535298af321ba9e692672b669cc36f300c42484870cb63b959df617dfafd69227597b615fa3860293e0667a1be38f0b833b67abc096bbeb28623f58e7c8188ed5094768c5ef8c9aae37463fdb9aadee66fb7a44ffd28db826d2c557c67a13b6d3d9a81dd1eeeb6c67e6bbcb1b5ad963197b6611526523ca088519e93496bdf06448ed61ef9d9fb19ca1b25bef9503c25145f7b79a8282fb991eaaa8b9b922d25dfa4dad4704aa5216b9b1e362a152177c15a095db2947ee731bb166838b7be37ca4f95f1621d292cb33ac7a57c68366be7ee8ebf73e416c726a66833af274c50646cff2d339556fcb024a3add385f7c33dd23a59aedbaaa1429bc873cb75c193af745f7bdd4b54ab53edcef41ad851ce0615bb2d6c823b56d61cee11c41ad9d9bfc5fc8e7f850d70abd16faf856df5fd10c3772b867f29354f6c70131e400a143ad769dd89ed1de60b9ef41714c2af87031eab325db1bff7fc3f3cd7b9b4450867fc8bc04b6f967c857987215486af210f12192ac6805ec0a809269c73ab6ec6b26b6c8a623d331a125472353c39f8dbdb2f908af880', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138673, 25569, 100.0, 100.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db65230343050c84d0700475f065a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138674, 25569, 100.0, 400.0, 'mg', NULL, 1, 'Adult', X'789c333430d035313050c84dd74f49ac540874d175f2740100377d0565', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138675, 25569, 600.0, 600.0, 'mg', 'PO', 2, 'Adult', X'789c33333050c84d5708f05770f274010015cf0339', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138676, 25569, 300.0, 300.0, 'mg', 'PO', 2, 'Adult', X'789c0b2e492c2a5128cf2cc95030363050c84d5708f05770f274d151c8cc4b2e4a4d2c4e4d5148aa543002cbe9a724562aa496a5160105748d1580bc62008c751416', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138677, 25569, 100.0, 100.0, 'mg', 'PO', 4, 'Adult', X'789c33343050c84d5708f05708f474010015bb0343', X'789ced595b4fe33814fe2b164fbb12a52dccb50f2b15d8d96117860e4523ada6a3c84d4e132f8e5dd94e2133e2bfef67875e52cab4a0d9b92d2fd024e77ef5f1f9b49598228d14cf69abc3b6ce84d38a4f84d9da665b8591fe5de6dcd8769acd4b7141f98e36a9ff259a35501b1b3ea624e2ce63ecb6769f355aed46bb75de7ad169b53b7bcf77f69e3e7dde7a19602976422b0bc84f5bfb3cbe488d2e54121e1d5db99a1c4c5856d8824b59b2544c4831a158acf3a150dc536197c2650325f55804f8811a69c386da65cc19e22e27e5981e0dd4eba37703c555127eb1b1b6ae4157f857186263a3c75929f995b003b5c38e9ce71a17c600197c872454caac2b124189e7ef32825014e81e9cbe3b3a6cb45f82b8659724e54ed0b1182eaa798d578e0f25f9a7f71ff02485ba080f739d673aacb7fdf10c1494e714a0d97a5c0fb48c75b73d36a217d5d0a345f41aa7a9add6139d415e7ff0b6eb26b950c23a137c5e8b94f3724c9d81ea2a27600f2e07ea505b9e127ba54d6e3bacdd6ab13c1da8335d38b27019ab13ebb0de29bca8f31cc1746e7842ec0d9201986fb49946f703bc391368bdb273d0a9b6857411d440d8d574f59e3a9f46f540f58c76c41187426562888cf1810f4f006da0a077e349d0bd99f092bd3d6cec1f1d0e545fcbe0df25c4817a1660610c56c1396e5c482eb6b7f8651b38b1f1c8091b966c77ce812664f0a2b1c7f064d7a6597b46f5ade7d7f3ece09c1caa8b86af49cc502aa0e8431df0df867570548f12c19d11f106ce3ae00a85645ec37e6b33441cccab65b2cd9280cf26dc0804e9309817f188324606e54ea1e221e151ca66456dbd856f71dc632571632b8e0f61f91dbba23fa6587019f5f4b8907cde5fa622ac107dab8708838671199d71b7c27d1db64f8a46c2c16485bb2491668e19612f5852186fbbf194c00eeb4eb480fd90c4cc6a5984d69414c49c665cc63ad3d2dbd4c18aa13f2c98cc4b7fcc6317848e3cf99a1c15e1a14f393722041ce4bc4de08c14945f1185a196f85ac678f24f61a795631ab8fe8b6309945484a018168e49181f4d4f2d6230f4364410f7c4ec0af6af690cf157a64125c0409d089934729d10ca2e0a4f3ee6c278d29d3a27541e5f48962166322ecafec5882e6bf499a0aef2fedb05ce720c3f46ce0f1539f777d7b2c31ffdf535fdf5b5adbdecedff99b97f0275373f1f058d0f50db0d172a11f18a534b574a3269e99b412cb9b54d7f307e00976e02b12d4567c4e3cdce467d32421775b8e01dedf49588852bfd993d8c024e387fdcfce38841006fd9d718c9c04d59e1e71a57e2245fb1f5631a9f1f50cf3d25466301bbe7e87f8a62a36569fdb7be83a5956dfca93365d1126da912a37302d7337f7a945aa5c160cdee3bf0d5f1c50ddf181d93ac2380502e7833f32fe1e6549631744afc4bcc88820fc9cf83392676e10a70ac2003580039caf342116447fbc54ce5aad63c97a35b382d2a9844586da084bd91c179ddbdbafd12c7e831804f8dcb7082f5c1cdc047cf204e4a0da366b0e67906ba431d970e184af015c5b79a526b3e79c30b4bbc39c161bd9afba0993119f13052c1101959afcd2bb04e0b4872c66d06e1874938de4b8640567efe2d52bc3e2c6d4a454038f5476c6e4a95d20cea507cfc8838b7d0b3db3fdf66dd63fc39f88b91a409af1cfc3b0c0cec6eacc0eb588c755262d2f6a7f57bd482b97a8b21b67e50a841d76e1e16e26e93799cafbebfb83b60d7130db8d10c375ac0adf1b82bf0d77358c28c669835fab7227f3de1294a3443a951fc7ca2ac275fe14775fc3ba45f4caf0d06c745e8ba95abc4dcc0a83780f5385891aa6bbcbf8c7133b53e56d9efa0ca2ef7bec732fb58661fcbec4f54667ff884bee771bf0701721ea37ca765bdb770396a4831a20edb6b3c65992e7c353d2110d352d8bcc38e052605f6cbc1dfbd274f5bbf42ae2ba47ab527794571b5cdb8a7342714675c817aa4475137beb5c1d9c7f463c37d17be4d88a1a1f9d51a0bb7c6379b8a6d7f6586b4f3be62397745b5bcf1607e193711a6b8e7edf42c30c2c5766de8626864f09ddfee2dec159b0365a65bc9815ab1204cb40ad7767e515886fd608890d97e7087f5351b71b37db34ab42ce350d7cf8f36d397c865912a31c220a81c48860bc4b06d14395513a050f828fdf469f484bce43bec441bc7a5efffdcb1dd1761f9e2d797525fc291fee22130f04d11591f8745ea02a39d817adffef0ed56960f5e09f689a2aeb4bae6bae3b9bbc2be77dd86449bca9ffe64b228c9436c71fcf3af6fe7e6dac05d0bc05fc0e3d7d7ff0200e28654', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138678, 1065, 250.0, 750.0, 'mg', 'PO', NULL, 'Adult', X'789c333235d0353735c84d5708f057283434ca000023fe0450', X'789ced5c6d73d34812fe2b53f97249ad1dbf8400e7adba2ac704f041882f0e29b6d6946b228de5d9483362460af16ef1dfefe9f14b2c5b46417077c0e90b607bbaa7a7bb9f7e1b89bff67c930663c523b1d7617b3d191b3d09f51df7a4daabb1bdd484f4fd344962db69343eca1b111d6a13d0bf64636bb9f50c8f853fe60951b59bedc7f566abde6a5e369f748e9b9da3d6e1d3bf3f7d747cecd60a2f915a59acfc6bef8550c2f0d0fd3b11778efc72168b0e6b2b9f05ee575a3d52cfc3541bfd21954a875a093b52cfb4e58160cfb5896c87f5af7e658373b63f4cb8f2b9f13bacd56cd658fb187f1c379bbfb2d30bfabb465f370f46aaa7a3482b7669b82fd81be8013cdcb96af88b8ea6d8be8ea7c9948791f440f042de0ac592a960511a26320e05e3fead3056303199e0509685d226c267d722d41f6bb4d40836e5165f809233233ca11216e95b907ee43336313a62b111509fbc962a0089b40cf2334dc46cb27166065e13696c829d1478a804643a911ebed686455ccd9854bef49cce2cdbb7a93725a2b7977d8605b112290e2df9c1a1b3447abd6e8c4ff82ae1d7a1a04fbfbfc727ec72e33edc1b67d30cc5ceb245f1e93dedd4f5a1c5316c887367cc9f23d9d24dc6edcccac1f948c1bef527c7cd2820e37f68b5a7f014a72170262f5afff9ae3552fd2bd0349bf5474dfab27f45345992d52f770cebbb61b2f6d587a7d3bdac96e828d06e46aeb7cad3511c9219843f52c78e1aee4712b61f4dc1f888f97c6617dcdbebe2affdd85b67d2bfea8cd4bad0b4f249bdf568b178708edfc9b537b75a5be3769b4b73bfdbeaf79c8375553235fc2e73b8be02229c7ff1b0c65ef46becdc0027dccc542078b829e4f94566476cf8b8b91067ae743fabf45f58abde06b07c39df62ddc9a19214e8163ab5c5dbe05ccb8dfa6aa23b8cf07bbf3d93939122bec2186da48d46caa63686d391b607da26f5d3bb58db14101ed0016721bf937669cd7bfd2df9ed035f624921eebc30f5857f90a354449c5b110af3373b7e26b93153c1330a5eb9eb49ff19f960fd6897791028a75afae3e7026128c36353c836fb28c44d1e8fde942bcf80cb67e9778a30447404a8c3307b86ae9726c2e92a0b4e62557fb230cbe95d2210ea122378125160c4619d9cb00d9351942a4d38428c94968cd29b1ac42e8ff5a03429cc486db26e21b4c26373c43c4fe04e760ce9845159515dcc672f7b8c5cac432785b5e11e08d82eaa239e0b6e16c678b282a64ab844849dceb0dcd306dca186917aa3130af3c82d381a48292cc7c2e02f07198668e709a6b4aa235318891c82f01ff3659273c2f8e20e8078901c4319c910df269aadce719d26cc5bc837821077c86dc86273f9867c22d847994cd7a51aa933ed9c3616ca124a2803294d6ce05894d066cbdc02efe67402320c57526cf9c48392c83aee8a13c8c9fa6af0bfe793395c31a36799e5f334f49d6596cdc457a5962ab554a9a54a2d556af9f152cbcf13bb37b35215bcabe05d05ef2a78ffc4c1bb0a71df22c46d268e2ac65531ae8a71df4b8cfb0a346e01bb826305c71f118edf0246657c7f134095f357ceff233aff97faeda6df578e5b39eeffc471bf57c7db0448e5793f9be75516fd4f5ab4cc434ddfc0a803e14b9e18e97de9234d479995eee2b9593f427868dc040d2896a2842f6f251970fb16bad5acb78edd5a770d4df7ca671c167301a6410326462ce96eba759c61dbbfba67fbb4bec5f878c577795fedf8bad1d39c6fff6af7b5eec6753a48d97e370c0f3618d03369c7cdaca44533b60dedf4af1a1b0ada9eb36da96a7e24b61f907f3907dc3d793bc88cde1eb2fbdaf86de7fe8da5b5bee980eef39e5338b12b70adfc27df6ae3b50ba9f17eabde7a32fe0dc1c18ecf43ff20e306148fd61e5f0cdc03951bcf50ce7df53154b832d587a759dfcc7345bae9a28bae7abbb912790b2d79d8f8afcf70324f9dfce0e0df712f58a1bf427f85fedde8af60f273c324e721be0a27257032843525b2e440c7e9dcdd6d4653cf4c1a30ea1a54e07a13742f814247301ba90eebb17d6a3e16af43ccbb9f117e75d01b29d8f135f7927923843d6f18ad0ab03dbd5ad22197b9c60167cca24919a90b411e3f2fed47cabdbbd0416f455f4a341fd2b83100f46119fa02c53c1a0d484506f442d8d9f529474d16bd6e4452d5dc5338868446e7c57da627ce0e869ed859361223f512cd18d0b5d896d5d106b93b6378c31fa9759307cb941070cbb29dcf4e153ea00ba2178816a463a9c6f7a4997baa85c68bf92d6fdc33d43b6d54cc6f453a26d2f11ae9627289b6d4f0b5d765b273a0301426985133eb85dcda06bd2f459687f9a44d161db40b8b97f24f749fbe9cb78e0fb7c2e2351807ecf185e0deb614b91353b4ea08b3d9cad1d0bb3501bcfc5f9730238074eb02b4cf8633e5e958342eb5b1dc1796f9e8f2352d215f9bea04fe843e3b41084c809b6122106e6cfd9f7aaa2c8d08660aad7f44f477f0441123509a08bc95f0b0e7cc5244ed8588b6061a4823c4d2c9447a344bf017578a3536b022f5c124ba060e203a1324a1f67448839091ba14cad78afe4db92e719f9849e38402effe75c8bd1b76adefd8476e80a8e00048908a10667160e71734980804fbc7e3666d317fb3694c2f5661458db99188a769c8a1a5cf520b40c7d0623ca5221c4749911f7832c5f92ddde108369dc53a08679e88241fa9dfdbef478ad086c53850089b2fe270de2da67baf2c639d0b6e11629757ac23d578c321036f5ce948127c4a45d7d58d6d3150972b1751b5f29fefca7fb66e02bf77072a2960a9f45456c6018ae188c3437430cb48fa9287937a2827f4e0159bea9452ee99802070261b75d86b945b8626fcf00f92b5c3de1a44f61a7b2e3ce1d67ac8ef584a39bbebcd979c2076c31f3ce9f3f090a13a475d8cd4fcec4d97053303372b931856d5f578b8429814c5f9e195c89e78e80a634fc4e0178ac612ae40466a531e86339442fd9172a88f5cf1819f6eb991f3f2678d147840ea434207c5c548ad3eba4a9946b473af26de1e0e83bc3ae73efc0522cc14f229d6230ab8ace989300422c38dc7dcde12869612d2c0dabdbaaa20c9be72f104288cc043aac9fcd0e0ff0e2d0295463c81ebbd6ba3ca9b0b01544367f4462f558224604a88bf970dab8f3eb3fa7ee1dac948a61746a731eb32442d11b345e3b58c3f2bc9102b534105c4e9219b70014614acde3d2ab3e362a7e5fbbb9f073c00e42424ebbf303c62e8869c4289ecdc04ce7f9d6b10d7c3e5716aeca4c67ae827f75c965845755ad99f97652bb63b380d96028a123cae24720087dadc6173185c3c4c080e5b5000b72c28c3e574915c3c0f1c9676cbe1f3f64bf920bd9510e76c38ece6900d8bc82e72c98a76eb75eb3b288b3d80c7d343763acff048e6793a2b92ba77c8fe1008ece554f5fa90ae51b5374b34fdcf010f11c0c1e38d0838c1c36e327c73c802304462d1a2944b8301f2be74c1a19c46ce347a22baa5a6de8752dc0e6f2ce2f3f2900253980af567ee498ae811c3a8de2a41f92a14d756d2116c1e1c1fb871e39e0d3b1d9ebcfea50cab2d4eaf06bd3c460f0b11d72eebdbb8c6ba51dc4319189491298f55accb9818853db5a5e5d4bc2466113728743c50e77079d72a62b37aaaa29c145319942646139308c4da481a7e2dcbc164c9e3360d0394402559d038517950a68d0fcb611e1f9c839663d0a3aa62ee536c6244aa7c5906b9eb6c7caa8b9153bf924db9f3740111b815476950c631ba1e2af8e4f3221445f2450fea84e0c2a4aec4e025843949cdcd54874892f00f94d6dc93796c8a6b1d818291e6da0ba1d05427f804bf2fc3ee371817a527cfb4d65e99f33da759a7b4ce7b9334e486c84bc59213937a9f014121fd6b1148fd35301a70341ba9711ce8fffcd1d4e095c9bd5c44ce3429b504682c6779682c3ccf95bc36525368527222bd5c2c6e313993d6db02e434e4d1cc7722f172903a9b793a469c8eee7b923255c585f46e449258b9438c429d901c735cd3f088dfe6178e5b6cba8a53d6ddaef8a8a3573a9a79b9d563118ae673002d694e36313cd891848ad80c8cb8451a726e27427cada89ecd876361419f375bfb4a3efbd4aaae981d9488a6cf53bb6636370b4420330f33de96ba449c68d73326cb766b678c7fbf3d68a9e625ff1ff3922f9cbf0d85187743ab33bed15dfb1fd7f6cfb854796f393e68b299cfa9f0866c49335ed07c7affe9d3a77f03c4d8a0d4', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138679, 1065, 250.0, 750.0, 'mg', 'PO', NULL, 'Adult', X'789c73cb2c2a2e5170c92f4eb552303235d0353735c84d5708f057a830040074bf07ca', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138680, 1065, 200.0, 400.0, 'mg', 'IV', NULL, 'Adult', X'789c333230d0353130c84d57f00c5328343402001f0103db', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138681, 1065, 400.0, 400.0, 'mg', 'IV', NULL, 'Adult', X'789c73cb2c2a2e5170c92f4eb552303130c84d57f00c53a85030040060da071e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138682, 1065, 400.0, 400.0, 'mg', 'IV', NULL, 'Adult', X'789c73cc29b152303130c84d57f00c5328b4c800002b1604d4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138683, 1065, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333530c84d57700d5208f057283432c950a85030564849ac2c060054d606fb', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138684, 1065, 250.0, 250.0, 'mg', 'PO', NULL, 'Adult', X'789c73cc29b152303235c84d5708f057283434ca50a85030564849ac2c060068b607be', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138685, 1065, 400.0, 400.0, 'mg', 'IV', NULL, 'Adult', X'789c333130c84d57f00c53283434ca50a85030d73534514849ac2c0600545e06d6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138686, 1065, 1000.0, 1000.0, 'mg', 'PO', NULL, 'Adult', X'789c33343030c84d57700d5208f057283432c950a85030d73534514849ac2c06006d7107bd', X'789ced5c6d73d34812fe2b53f97249ad1dbf8400e7adba2ac704f041882f0e29b6d6946b228de5d9483362460af16ef1dfefe9f14b2c5b46417077c0e90b607bbaa7a7bb9f7e1b89bff67c930663c523b1d7617b3d191b3d09f51df7a4daabb1bdd484f4fd344962db69343eca1b111d6a13d0bf64636bb9f50c8f853fe60951b59bedc7f566abde6a5e369f748e9b9da3d6e1d3bf3f7d747cecd60a2f915a59acfc6bef8550c2f0d0fd3b11778efc72168b0e6b2b9f05ee575a3d52cfc3541bfd21954a875a093b52cfb4e58160cfb5896c87f5af7e658373b63f4cb8f2b9f13bacd56cd658fb187f1c379bbfb2d30bfabb465f370f46aaa7a3482b7669b82fd81be8013cdcb96af88b8ea6d8be8ea7c9948791f440f042de0ac592a960511a26320e05e3fead3056303199e0509685d226c267d722d41f6bb4d40836e5165f809233233ca11216e95b907ee43336313a62b111509fbc962a0089b40cf2334dc46cb27166065e13696c829d1478a804643a911ebed686455ccd9854bef49cce2cdbb7a93725a2b7977d8605b112290e2df9c1a1b3447abd6e8c4ff82ae1d7a1a04fbfbfc727ec72e33edc1b67d30cc5ceb245f1e93dedd4f5a1c5316c887367cc9f23d9d24dc6edcccac1f948c1bef527c7cd2820e37f68b5a7f014a72170262f5afff9ae3552fd2bd0349bf5474dfab27f45345992d52f770cebbb61b2f6d587a7d3bdac96e828d06e46aeb7cad3511c9219843f52c78e1aee4712b61f4dc1f888f97c6617dcdbebe2affdd85b67d2bfea8cd4bad0b4f249bdf568b178708edfc9b537b75a5be3769b4b73bfdbeaf79c8375553235fc2e73b8be02229c7ff1b0c65ef46becdc0027dccc542078b829e4f94566476cf8b8b91067ae743fabf45f58abde06b07c39df62ddc9a19214e8163ab5c5dbe05ccb8dfa6aa23b8cf07bbf3d93939122bec2186da48d46caa63686d391b607da26f5d3bb58db14101ed0016721bf937669cd7bfd2df9ed035f624921eebc30f5857f90a354449c5b110af3373b7e26b93153c1330a5eb9eb49ff19f960fd6897791028a75afae3e7026128c36353c836fb28c44d1e8fde942bcf80cb67e9778a30447404a8c3307b86ae9726c2e92a0b4e62557fb230cbe95d2210ea122378125160c4619d9cb00d9351942a4d38428c94968cd29b1ac42e8ff5a03429cc486db26e21b4c26373c43c4fe04e760ce9845159515dcc672f7b8c5cac432785b5e11e08d82eaa239e0b6e16c678b282a64ab844849dceb0dcd306dca186917aa3130af3c82d381a48292cc7c2e02f07198668e709a6b4aa235318891c82f01ff3659273c2f8e20e8078901c4319c910df269aadce719d26cc5bc837821077c86dc86273f9867c22d847994cd7a51aa933ed9c3616ca124a2803294d6ce05894d066cbdc02efe67402320c57526cf9c48392c83aee8a13c8c9fa6af0bfe793395c31a36799e5f334f49d6596cdc457a5962ab554a9a54a2d556af9f152cbcf13bb37b35215bcabe05d05ef2a78ffc4c1bb0a71df22c46d268e2ac65531ae8a71df4b8cfb0a346e01bb826305c71f118edf0246657c7f134095f357ceff233aff97faeda6df578e5b39eeffc471bf57c7db0448e5793f9be75516fd4f5ab4cc434ddfc0a803e14b9e18e97de9234d479995eee2b9593f427868dc040d2896a2842f6f251970fb16bad5acb78edd5a770d4df7ca671c167301a6410326462ce96eba759c61dbbfba67fbb4bec5f878c577795fedf8bad1d39c6fff6af7b5eec6753a48d97e370c0f3618d03369c7cdaca44533b60dedf4af1a1b0ada9eb36da96a7e24b61f907f3907dc3d793bc88cde1eb2fbdaf86de7fe8da5b5bee980eef39e5338b12b70adfc27df6ae3b50ba9f17eabde7a32fe0dc1c18ecf43ff20e306148fd61e5f0cdc03951bcf50ce7df53154b832d587a759dfcc7345bae9a28bae7abbb912790b2d79d8f8afcf70324f9dfce0e0df712f58a1bf427f85fedde8af60f273c324e721be0a27257032843525b2e440c7e9dcdd6d4653cf4c1a30ea1a54e07a13742f814247301ba90eebb17d6a3e16af43ccbb9f117e75d01b29d8f135f7927923843d6f18ad0ab03dbd5ad22197b9c60167cca24919a90b411e3f2fed47cabdbbd0416f455f4a341fd2b83100f46119fa02c53c1a0d484506f442d8d9f529474d16bd6e4452d5dc5338868446e7c57da627ce0e869ed859361223f512cd18d0b5d896d5d106b93b6378c31fa9759307cb941070cbb29dcf4e153ea00ba2178816a463a9c6f7a4997baa85c68bf92d6fdc33d43b6d54cc6f453a26d2f11ae9627289b6d4f0b5d765b273a0301426985133eb85dcda06bd2f459687f9a44d161db40b8b97f24f749fbe9cb78e0fb7c2e2351807ecf185e0deb614b91353b4ea08b3d9cad1d0bb3501bcfc5f9730238074eb02b4cf8633e5e958342eb5b1dc1796f9e8f2352d215f9bea04fe843e3b41084c809b6122106e6cfd9f7aaa2c8d08660aad7f44f477f0441123509a08bc95f0b0e7cc5244ed8588b6061a4823c4d2c9447a344bf017578a3536b022f5c124ba060e203a1324a1f67448839091ba14cad78afe4db92e719f9849e38402effe75c8bd1b76adefd8476e80a8e00048908a10667160e71734980804fbc7e3666d317fb3694c2f5661458db99188a769c8a1a5cf520b40c7d0623ca5221c4749911f7832c5f92ddde108369dc53a08679e88241fa9dfdbef478ad086c53850089b2fe270de2da67baf2c639d0b6e11629757ac23d578c321036f5ce948127c4a45d7d58d6d3150972b1751b5f29fefca7fb66e02bf77072a2960a9f45456c6018ae188c3437430cb48fa9287937a2827f4e0159bea9452ee99802070261b75d86b945b8626fcf00f92b5c3de1a44f61a7b2e3ce1d67ac8ef584a39bbebcd979c2076c31f3ce9f3f090a13a475d8cd4fcec4d97053303372b931856d5f578b8429814c5f9e195c89e78e80a634fc4e0178ac612ae40466a531e86339442fd9172a88f5cf1819f6eb991f3f2678d147840ea434207c5c548ad3eba4a9946b473af26de1e0e83bc3ae73efc0522cc14f229d6230ab8ace989300422c38dc7dcde12869612d2c0dabdbaaa20c9be72f104288cc043aac9fcd0e0ff0e2d0295463c81ebbd6ba3ca9b0b01544367f4462f558224604a88bf970dab8f3eb3fa7ee1dac948a61746a731eb32442d11b345e3b58c3f2bc9102b534105c4e9219b70014614acde3d2ab3e362a7e5fbbb9f073c00e42424ebbf303c62e8869c4289ecdc04ce7f9d6b10d7c3e5716aeca4c67ae827f75c965845755ad99f97652bb63b380d96028a123cae24720087dadc6173185c3c4c080e5b5000b72c28c3e574915c3c0f1c9676cbe1f3f64bf920bd9510e76c38ece6900d8bc82e72c98a76eb75eb3b288b3d80c7d343763acff048e6793a2b92ba77c8fe1008ece554f5fa90ae51b5374b34fdcf010f11c0c1e38d0838c1c36e327c73c802304462d1a2944b8301f2be74c1a19c46ce347a22baa5a6de8752dc0e6f2ce2f3f2900253980af567ee498ae811c3a8de2a41f92a14d756d2116c1e1c1fb871e39e0d3b1d9ebcfea50cab2d4eaf06bd3c460f0b11d72eebdbb8c6ba51dc4319189491298f55accb9818853db5a5e5d4bc2466113728743c50e77079d72a62b37aaaa29c145319942646139308c4da481a7e2dcbc164c9e3360d0394402559d038517950a68d0fcb611e1f9c839663d0a3aa62ee536c6244aa7c5906b9eb6c7caa8b9153bf924db9f3740111b815476950c631ba1e2af8e4f3221445f2450fea84e0c2a4aec4e025843949cdcd54874892f00f94d6dc93796c8a6b1d818291e6da0ba1d05427f804bf2fc3ee371817a527cfb4d65e99f33da759a7b4ce7b9334e486c84bc59213937a9f014121fd6b1148fd35301a70341ba9711ce8fffcd1d4e095c9bd5c44ce3429b504682c6779682c3ccf95bc36525368527222bd5c2c6e313993d6db02e434e4d1cc7722f172903a9b793a469c8eee7b923255c585f46e449258b9438c429d901c735cd3f088dfe6178e5b6cba8a53d6ddaef8a8a3573a9a79b9d563118ae673002d694e36313cd891848ad80c8cb8451a726e27427cada89ecd876361419f375bfb4a3efbd4aaae981d9488a6cf53bb6636370b4420330f33de96ba449c68d73326cb766b678c7fbf3d68a9e625ff1ff3922f9cbf0d85187743ab33bed15dfb1fd7f6cfb854796f393e68b299cfa9f0866c49335ed07c7affe9d3a77f03c4d8a0d4', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138687, 1065, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c73cc29b152303530c84d5708f057283434ca50a85030d73534514849ac2c06007e6b0852', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138688, 1065, 400.0, 400.0, 'mg', 'IV', NULL, 'Adult', X'789c333130c84d57f00c53283434ca50f00f5230050b04f88304142a14cc0c1452122b8b01c9a40a70', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138689, 1065, 400.0, 400.0, 'mg', 'IV', NULL, 'Adult', X'789c73cb2c2a2e5148c92f4eb552303130c84d57f00c53d05630d43552484c49c92cc9cccf4bcc5148cc2bc94ccacc2fc94c2e060080181042', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138690, 1065, 400.0, 400.0, 'mg', 'IV', NULL, 'Adult', X'789c333130c84d57f00c53283434ca50f00f5230050b04f88304142a14cc750d0d1452122b8b01dd4a0acf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138691, 1065, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333530c84d5708f057283434ca50a8503033504849ac2c56d0c82f5248ad28c82f2e2d4a053292734a53525334013e260ecf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138692, 1065, 750.0, 750.0, 'mg', 'PO', 2, 'Adult', X'789c333735c84d5708f05770f27451a85030d435564849ac2c0600466d0639', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138693, 1065, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333530c84d5708f057283434ca50a8503052284f4dcd2e060049e306ae', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138694, 1065, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333530c84d5708f057283434ca50a85030564849ac2c060043130641', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138695, 1065, 500.0, 750.0, 'mg', 'PO', NULL, 'Adult', X'789c333530d0353735c84d5708f057283434ca50a85030d635574849ac2c06006340076e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138696, 1065, 750.0, 750.0, 'mg', 'PO', NULL, 'Adult', X'789c333735c84d5708f057283434ca50a8503054c8cdcf2bc900004a9006bb', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138697, 1065, 20.0, 30.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3332d03536c84dd7cf4ed74f49ac5408f05748c92ccb4c494d51283434ca000088d50949', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138698, 1065, 10.0, 15.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523034d03534cd4dd7cf4e5708f057a8503004008857087f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138699, 1065, 750.0, 750.0, 'mg', 'PO', NULL, 'Pediatric', X'789cf34dacb052303735c84dd74fc92f4e5508f0070033bb058a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138700, 1065, 15.0, 30.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c3334d53536c84dd7cf4ed74f49ac54f00c5348c92ccb4c494d5128b4d03534ca00009c1109b2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138701, 1065, 5.0, 15.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb55230d53534cd4dd7cf4e57f00c53a85030040081510853', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138702, 1065, 400.0, 400.0, 'mg', 'IV', NULL, 'Pediatric', X'789cf34dacb052303130c84dd74fc92f4e55f00c030033510582', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138703, 1065, 400.0, 400.0, 'mg', 'IV', NULL, 'Pediatric', X'789cf34dac50d070ccc9d1b452303130c84dd74fc92f4e55f00c53c82f5230450804f80300fa3e0c2f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138704, 1065, 20.0, 30.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c3332d03536c84dd7cf4ed74f49ac54f00cd30ff05748c92ccb4c494d51283434ca50a85030335000ca150300165b0d06', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138705, 1065, 10.0, 15.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523034d03534cd4dd7cf4e57f00c53a8503054d048cf2c4b5528cf2cc95030d43552484c49c92cc9cccf4bcc5148cc2bc94ccacc2fc94c2ed60400d5531619', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138706, 1065, 20.0, 30.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c3332d03536c84dd7cf4ed74f49ac54f00cd30ff05748c92ccb4c494d51283434ca50a85030d735345000ca1603002f2d0d65', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138707, 1065, 10.0, 15.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523034d03534cd4dd7cf4e57f00cd30ff057a850300400a3c6094d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138708, 1065, 20.0, 30.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3332d03536c84dd7cf4ed74f49ac5408f05748c92ccb4c494d51283434ca50a850303350004a142b68e41729a45614e4179716a50219c939a540459a006d921493', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138709, 1065, 10.0, 15.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523034d03534cd4dd7cf4e5708f057a8503004008857087f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138710, 1065, 6.0, 10.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d33534c84dd7cf4e57f00c5328b4c80000247a048a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138711, 1065, 400.0, 400.0, 'mg', 'IV', NULL, 'Pediatric', X'789cf34dacb052303130c84dd74fc92f4e55f00c030033510582', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138712, 1065, 10.0, 20.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3334d03532c84dd7cf4e5708f057283434ca00002c0e04e1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138713, 1065, 750.0, 750.0, 'mg', 'PO', NULL, 'Pediatric', X'789cf34dacb052303735c84dd74fc92f4e5508f0070033bb058a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138714, 721, 25.0, 50.0, 'mg', 'PO', 1, 'Adult', X'789cf32fc8cccf4c5148492d48cd4b49cd4b4e55d028284a2d4bcd2bc9cccf53c84f53284acd492c284e55484c2b492d52c8072bd74d2b4a4d55a85030d7353448d1d451700df1f74032c24ac1c854d7d420375d21c05f21253133a752c13f48c1d80224e2e9ab5068520e00983226d4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138715, 55, 10.0, 10.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c3334c84dd7cf4e57f00c5328b4c850a85030345048010041ce05c4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138716, 55, 400.0, 400.0, 'mg', 'PO', 3, 'Adult', X'789c332c2e51482dc82cce4f49d551f0cdcc49d1cdcd4fb152303130c84d5708f05708f17451a85030d73534504801003cab0ce4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138717, 55, 5.0, 10.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c332c2e51482dc82cce4f49d551084e2d4b2d4ab55230d53534c84dd7cf4e57f00c5328b4c850a85030d235574801004e950d8c', X'789ced596d6f1b3712fe2b0303073480d77ab194184a11c089d3da412dab9662f4ae0a047a77b4cb3397dc925cc77291ffdee1be48a2245b9b1c0ee81df2c55eae669e19cecb438ef4e741a4f37826598a070338380d17a150f75c1f1cc241ae857b97589b9941abf599df617aa474ec9e78cb1335a166194633669d46b7dd7d19b43b41a73d69bf1af45e0d3aeda35ebfdf3dee15b2185aaea421c93f0f7e46899a89e2d9e243a13e59643898ca536939c1333195b492792850191e2130c9848a712acf946131c24f4aa7660017378730ba821fbaed36a4f121f4aaff4c4670523cbf98ca772a4d958489660434a45d93e2bfdc2ed843e15b7ebbeede177a65d9ad40b7fafd13ad049777c562e5eed2cf06315b8a12f20a617b6ffba1864b9d59adf3e593f3f734ca859d5168b88cbdb09e8f6fa6f2bd0c314b98e0969ba9ecb4d3b8751753e8e08f93041ea0d386682a2929dc32d1bacc4315e6964954b98142ff224d73a942956668515a82301630e346457808975c4441aaa2810b7e1abb744c2ece08f75550227bd263bc478d03e8075b7e7483574efc1ac35c6b249fb710fbeef3719e651a8da17cad09bcbd385b7754ab941bf48d6fc3550e3e67b112d9341a9cac190e26cef80dd33c4421d88e802da57fad508b9dee7277332885e039ea0c0dd5acb1a89f83ef3fb422b6a8d5fe6ef88f053ea82cb1548d290f73f32436151e106c962c047be006b804be6d6e77269cee1d318c2d0bbee75bf8d69627d4fd1dea84bc365fefbdfdea9eb487f3647b36f0a988fe6cccd34ce0c3ec86ebdc045d1f7e59bcfbe156a21e8257438d9daac47721eda896c6b0a5eeccd3f56dac9748a3b4ce56e225e78e30e2cc522c76f1ee10956494af92407bede065d918458953734474244418c11f9d6e41c1bda0dba9cb1e3dba3e865441009d0e2c5a8a96eda0d7df0d75e221bde9746b8d26e2757da55f4bffdda076ade77a71658b1a6e69eb6570024949e0879032b25bc86c402d5dee6c21acc8a122e41ddc33ba1ac09b026100db08c7c13a46afc0b821854ea9f06c946a85e728beb00e95f927e390d4a758611b1a1a7f6ac78df4bc767ad2f14ee579efe9d0d7a7d6cd7fdbe1f14dd0692d1d17ec965333b89b4b1fcad3c5ddf85c1545ca20a83994b7bf171459cbe9760719f1c67fc2f4bee1c6acb3542809629c6148ebd94865b960abeb6f6d66a431964c860bb8a64f654c575e783b95bfb0d016d270cdcd1dbc631663a5391af7f998cdd15d58e8f60725edd09dd95dfe5c5ee8a6abdf09e8f6837e1b627e8f05bd546f3beda0dbabde767bf5db1f5dc831d4c828924538fbed7f1cae8b9d9f95abdce464b31061060cdd8704a665019d8154fe9bab1abedb1f8041848c8577eedacea5416d1dea603fec600bb7a65cc757ba7ebcc639e5db2a602e100e8bc272045774e5a60181688d5716083f51b988e01663ba4f300b364110ea33516ee4eac82da372bed04cba69e31c33ca45b88cf55091019c7389d1b756d766daf797d7999bd64a6133e372b644f0cfb4270b67bf85a5eacca9ced654cb527ea7a4d58ccb88873b0af95408d4f1c2a52014cc98961b2fbf2e3cd51443b381c1d935b270dbca0ec0833155019d53fec8c384c8432e4b47a7929824338b30a10cd26a8cfc31d7580c856c351a294a7342e7d12421aeba55e1c2aa8c4e4492f805f3bbfaf954b2fa42ea163157186101a317543b29834baa403ea7d9942c8c3f8c0beb93f743fa3319d5d5541ceb650bcf1917e4cd811f9832e26e66f5ef142c37c85af744a6ae145ad40b5a27c81c2e8b5898b8e9983f3e52711a6781196adf536d136a84d8b94f599ce76e84811608a49b11258d7c17787f046f3f0e5b8e060899f4a9d51265a965a4e16e7ab58b4d179b11a9978a063ceacb7bd5bdcce17e98d152d443a852bf5fbf16f4b45dbdec572da4760e006585351f012a790f6bb33af7a36d69f88cb1aced0614b192f530d67aa2c977212be10d94ba999a802c65fd486f37618370574ab33525bf6a3e8c1b540c09f9997a3f6c901c12f2b526a3065a24b4312f658de798a5a887b04546cfa314e2b35abcbaecfcff30f1e621f39d8abf53f1772afe4ec5ff2b54fc77e4abaf9c0446642065a1122a5e6c1e29f340f0390ea07bd487008e8f8e21d1e4f32512a0a2e93b1d40f1738b58d0b43927a31881fbd2c6c00fdc4d31ee99e6712d162f5e83a01954d3461e6803b6f872ffa32e36718961c224a1b9b9f0342c3fbb9009bfe5d6c0d9f014322516296a1a9cbf6183c5cceabee8f34fccf7990a350d5f06baed4e9f5210d2ae1e9560a9fb9d88cb7f9726e077f76344a8c91919bb5d52af1444fd89b2c163f849306b0e61f8cf01fc16fc8c12aa78624eb32c13f4d1850c5fc35568d52d8dceced6d1a6b1c27bdaea33a6ced9679b282db13435615a6d5a7a0d63cc2ca69599e3a3af8dd5972f7f01c031c01c', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138718, 55, 400.0, 400.0, 'mg', 'PO', 3, 'Adult', X'789c0b4a4d2e2d2a4acd4b4eb552303130c84d5708f05708f17451a850305548010099ee0902', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138719, 55, 400.0, 400.0, 'mg', 'PO', 2, 'Adult', X'789c0b2e2d28284a2d2ececccfb352303130c84d5708f05770f274010075b4081c', X'789ced596d6f1b3712fe2b0303073480d77ab194184a11c089d3da412dab9662f4ae0a047a77b4cb3397dc925cc77291ffdee1be48a2245b9b1c0ee81df2c55eae669e19cecb438ef4e741a4f37826598a070338380d17a150f75c1f1cc241ae857b97589b9941abf599df617aa474ec9e78cb1335a166194633669d46b7dd7d19b43b41a73d69bf1af45e0d3aeda35ebfdf3dee15b2185aaea421c93f0f7e46899a89e2d9e243a13e59643898ca536939c1333195b492792850191e2130c9848a712acf946131c24f4aa7660017378730ba821fbaed36a4f121f4aaff4c4670523cbf98ca772a4d958489660434a45d93e2bfdc2ed843e15b7ebbeede177a65d9ad40b7fafd13ad049777c562e5eed2cf06315b8a12f20a617b6ffba1864b9d59adf3e593f3f734ca859d5168b88cbdb09e8f6fa6f2bd0c314b98e0969ba9ecb4d3b8751753e8e08f93041ea0d386682a2929dc32d1bacc4315e6964954b98142ff224d73a942956668515a82301630e346457808975c4441aaa2810b7e1abb744c2ece08f75550227bd263bc478d03e8075b7e7483574efc1ac35c6b249fb710fbeef3719e651a8da17cad09bcbd385b7754ab941bf48d6fc3550e3e67b112d9341a9cac190e26cef80dd33c4421d88e802da57fad508b9dee7277332885e039ea0c0dd5acb1a89f83ef3fb422b6a8d5fe6ef88f053ea82cb1548d290f73f32436151e106c962c047be006b804be6d6e77269cee1d318c2d0bbee75bf8d69627d4fd1dea84bc365fefbdfdea9eb487f3647b36f0a988fe6cccd34ce0c3ec86ebdc045d1f7e59bcfbe156a21e8257438d9daac47721eda896c6b0a5eeccd3f56dac9748a3b4ce56e225e78e30e2cc522c76f1ee10956494af92407bede065d918458953734474244418c11f9d6e41c1bda0dba9cb1e3dba3e865441009d0e2c5a8a96eda0d7df0d75e221bde9746b8d26e2757da55f4bffdda076ade77a71658b1a6e69eb6570024949e0879032b25bc86c402d5dee6c21acc8a122e41ddc33ba1ac09b026100db08c7c13a46afc0b821854ea9f06c946a85e728beb00e95f927e390d4a758611b1a1a7f6ac78df4bc767ad2f14ee579efe9d0d7a7d6cd7fdbe1f14dd0692d1d17ec965333b89b4b1fcad3c5ddf85c1545ca20a83994b7bf171459cbe9760719f1c67fc2f4bee1c6acb3542809629c6148ebd94865b960abeb6f6d66a431964c860bb8a64f654c575e783b95bfb0d016d270cdcd1dbc631663a5391af7f998cdd15d58e8f60725edd09dd95dfe5c5ee8a6abdf09e8f6837e1b627e8f05bd546f3beda0dbabde767bf5db1f5dc831d4c828924538fbed7f1cae8b9d9f95abdce464b31061060cdd8704a665019d8154fe9bab1abedb1f8041848c8577eedacea5416d1dea603fec600bb7a65cc757ba7ebcc639e5db2a602e100e8bc272045774e5a60181688d5716083f51b988e01663ba4f300b364110ea33516ee4eac82da372bed04cba69e31c33ca45b88cf55091019c7389d1b756d766daf797d7999bd64a6133e372b644f0cfb4270b67bf85a5eacca9ced654cb527ea7a4d58ccb88873b0af95408d4f1c2a52014cc98961b2fbf2e3cd51443b381c1d935b270dbca0ec0833155019d53fec8c384c8432e4b47a7929824338b30a10cd26a8cfc31d7580c856c351a294a7342e7d12421aeba55e1c2aa8c4e4492f805f3bbfaf954b2fa42ea163157186101a317543b29834baa403ea7d9942c8c3f8c0beb93f743fa3319d5d5541ceb650bcf1917e4cd811f9832e26e66f5ef142c37c85af744a6ae145ad40b5a27c81c2e8b5898b8e9983f3e52711a6781196adf536d136a84d8b94f599ce76e84811608a49b11258d7c17787f046f3f0e5b8e060899f4a9d51265a965a4e16e7ab58b4d179b11a9978a063ceacb7bd5bdcce17e98d152d443a852bf5fbf16f4b45dbdec572da4760e006585351f012a790f6bb33af7a36d69f88cb1aced0614b192f530d67aa2c977212be10d94ba999a802c65fd486f37618370574ab33525bf6a3e8c1b540c09f9997a3f6c901c12f2b526a3065a24b4312f658de798a5a887b04546cfa314e2b35abcbaecfcff30f1e621f39d8abf53f1772afe4ec5ff2b54fc77e4abaf9c0446642065a1122a5e6c1e29f340f0390ea07bd487008e8f8e21d1e4f32512a0a2e93b1d40f1738b58d0b43927a31881fbd2c6c00fdc4d31ee99e6712d162f5e83a01954d3461e6803b6f872ffa32e36718961c224a1b9b9f0342c3fbb9009bfe5d6c0d9f014322516296a1a9cbf6183c5cceabee8f34fccf7990a350d5f06baed4e9f5210d2ae1e9560a9fb9d88cb7f9726e077f76344a8c91919bb5d52af1444fd89b2c163f849306b0e61f8cf01fc16fc8c12aa78624eb32c13f4d1850c5fc35568d52d8dceced6d1a6b1c27bdaea33a6ced9679b282db13435615a6d5a7a0d63cc2ca69599e3a3af8dd5972f7f01c031c01c', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138720, 55, 400.0, 400.0, 'mg', 'PO', 3, 'Adult', X'789c332c2e51482dc82cce4f49b552303130c84d5708f05708f17451a85030d5353450480100b8bb09a3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138721, 55, 400.0, 400.0, 'mg', 'PO', 3, 'Adult', X'789c0b4a4d2e2d2a4acd4b4eb552303130c84d5708f05708f17451a85030d5353450480100b59d0990', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138722, 55, 400.0, 800.0, 'mg', 'PO', 2, 'Adult', X'789c0b2e2d28284a2d2ececccfb352303130d0b53030c84d5708f05770f274d10df1740100baff09ef', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138723, 55, 800.0, 800.0, 'mg', 'PO', 4, 'Adult', X'789cb33030c84d5708f05708f47451a85030d53557480100359b04ff', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138724, 55, 10.0, 10.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c3334c84dd7cf4e57f00c5328b4c850a85030574801003c40059a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138725, 55, 800.0, 800.0, 'mg', 'PO', NULL, 'Adult', X'789cb33030c84d5708f05730add04f49ac54a85030574801003f5605d9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138726, 55, 10.0, 10.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c3334c84dd7cf4e57f00c5328b4c850a85030574801003c40059a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138727, 55, 800.0, 800.0, 'mg', 'PO', NULL, 'Adult', X'789cb33030c84d5708f05730add04f49ac54a85030574801003f5605d9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138728, 55, 10.0, 10.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c3334c84dd7cf4e57f00c5328b4c850a85030574801003c40059a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138729, 55, 800.0, 800.0, 'mg', 'PO', NULL, 'Adult', X'789cb33030c84d5708f05730add04f49ac54a85030574801003f5605d9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138730, 55, 400.0, 800.0, 'mg', 'PO', 2, 'Adult', X'789c333130d0b53030c84d5708f05770f274d10df1740100310304ea', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138731, 55, 400.0, 400.0, 'mg', 'PO', NULL, 'Adult', X'789c333130c84d5708f05730add04f49ac04001fd50462', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138732, 55, 40.0, 60.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c3331d03533c84dd7cf4ed74f49ac54f00c5348c92ccb4c494d51283434ca50a8503034d1353254480100f24e0b7f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138733, 55, 30.0, 45.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c3336d03531cd4dd7cf4ed74f49ac54f00c5348c92ccb4c494d5128b4c850a8503034d1353254480100e7d60b56', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138734, 55, 30.0, 30.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c3336c84dd7cf4ed74f49ac54f00c5348c92ccb4c494d5128b4c850a8503034d1353254480100d19a0ac0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138735, 55, 40.0, 80.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3331d0b530c84dd7cf4ed74f49ac5408f05748c92ccb4c494d512834d3b550c850a850305548d151c84dac503004ab010076620ed0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138736, 55, 1.0, 1.0, 'g', 'PO', NULL, 'Pediatric', X'789c334cd74f49ac5408f05748c92ccb4c494d5130ad008b542898eb1a1a28a40000b1bf09f9', X'789ced596d6f1b3712fe2b0303073480d77ab194184a11c089d3da412dab9662f4ae0a047a77b4cb3397dc925cc77291ffdee1be48a2245b9b1c0ee81df2c55eae669e19cecb438ef4e741a4f37826598a070338380d17a150f75c1f1cc241ae857b97589b9941abf599df617aa474ec9e78cb1335a166194633669d46b7dd7d19b43b41a73d69bf1af45e0d3aeda35ebfdf3dee15b2185aaea421c93f0f7e46899a89e2d9e243a13e59643898ca536939c1333195b492792850191e2130c9848a712acf946131c24f4aa7660017378730ba821fbaed36a4f121f4aaff4c4670523cbf98ca772a4d958489660434a45d93e2bfdc2ed843e15b7ebbeede177a65d9ad40b7fafd13ad049777c562e5eed2cf06315b8a12f20a617b6ffba1864b9d59adf3e593f3f734ca859d5168b88cbdb09e8f6fa6f2bd0c314b98e0969ba9ecb4d3b8751753e8e08f93041ea0d386682a2929dc32d1bacc4315e6964954b98142ff224d73a942956668515a82301630e346457808975c4441aaa2810b7e1abb744c2ece08f75550227bd263bc478d03e8075b7e7483574efc1ac35c6b249fb710fbeef3719e651a8da17cad09bcbd385b7754ab941bf48d6fc3550e3e67b112d9341a9cac190e26cef80dd33c4421d88e802da57fad508b9dee7277332885e039ea0c0dd5acb1a89f83ef3fb422b6a8d5fe6ef88f053ea82cb1548d290f73f32436151e106c962c047be006b804be6d6e77269cee1d318c2d0bbee75bf8d69627d4fd1dea84bc365fefbdfdea9eb487f3647b36f0a988fe6cccd34ce0c3ec86ebdc045d1f7e59bcfbe156a21e8257438d9daac47721eda896c6b0a5eeccd3f56dac9748a3b4ce56e225e78e30e2cc522c76f1ee10956494af92407bede065d918458953734474244418c11f9d6e41c1bda0dba9cb1e3dba3e865441009d0e2c5a8a96eda0d7df0d75e221bde9746b8d26e2757da55f4bffdda076ade77a71658b1a6e69eb6570024949e0879032b25bc86c402d5dee6c21acc8a122e41ddc33ba1ac09b026100db08c7c13a46afc0b821854ea9f06c946a85e728beb00e95f927e390d4a758611b1a1a7f6ac78df4bc767ad2f14ee579efe9d0d7a7d6cd7fdbe1f14dd0692d1d17ec965333b89b4b1fcad3c5ddf85c1545ca20a83994b7bf171459cbe9760719f1c67fc2f4bee1c6acb3542809629c6148ebd94865b960abeb6f6d66a431964c860bb8a64f654c575e783b95bfb0d016d270cdcd1dbc631663a5391af7f998cdd15d58e8f60725edd09dd95dfe5c5ee8a6abdf09e8f6837e1b627e8f05bd546f3beda0dbabde767bf5db1f5dc831d4c828924538fbed7f1cae8b9d9f95abdce464b31061060cdd8704a665019d8154fe9bab1abedb1f8041848c8577eedacea5416d1dea603fec600bb7a65cc757ba7ebcc639e5db2a602e100e8bc272045774e5a60181688d5716083f51b988e01663ba4f300b364110ea33516ee4eac82da372bed04cba69e31c33ca45b88cf55091019c7389d1b756d766daf797d7999bd64a6133e372b644f0cfb4270b67bf85a5eacca9ced654cb527ea7a4d58ccb88873b0af95408d4f1c2a52014cc98961b2fbf2e3cd51443b381c1d935b270dbca0ec0833155019d53fec8c384c8432e4b47a7929824338b30a10cd26a8cfc31d7580c856c351a294a7342e7d12421aeba55e1c2aa8c4e4492f805f3bbfaf954b2fa42ea163157186101a317543b29834baa403ea7d9942c8c3f8c0beb93f743fa3319d5d5541ceb650bcf1917e4cd811f9832e26e66f5ef142c37c85af744a6ae145ad40b5a27c81c2e8b5898b8e9983f3e52711a6781196adf536d136a84d8b94f599ce76e84811608a49b11258d7c17787f046f3f0e5b8e060899f4a9d51265a965a4e16e7ab58b4d179b11a9978a063ceacb7bd5bdcce17e98d152d443a852bf5fbf16f4b45dbdec572da4760e006585351f012a790f6bb33af7a36d69f88cb1aced0614b192f530d67aa2c977212be10d94ba999a802c65fd486f37618370574ab33525bf6a3e8c1b540c09f9997a3f6c901c12f2b526a3065a24b4312f658de798a5a887b04546cfa314e2b35abcbaecfcff30f1e621f39d8abf53f1772afe4ec5ff2b54fc77e4abaf9c0446642065a1122a5e6c1e29f340f0390ea07bd487008e8f8e21d1e4f32512a0a2e93b1d40f1738b58d0b43927a31881fbd2c6c00fdc4d31ee99e6712d162f5e83a01954d3461e6803b6f872ffa32e36718961c224a1b9b9f0342c3fbb9009bfe5d6c0d9f014322516296a1a9cbf6183c5cceabee8f34fccf7990a350d5f06baed4e9f5210d2ae1e9560a9fb9d88cb7f9726e077f76344a8c91919bb5d52af1444fd89b2c163f849306b0e61f8cf01fc16fc8c12aa78624eb32c13f4d1850c5fc35568d52d8dceced6d1a6b1c27bdaea33a6ced9679b282db13435615a6d5a7a0d63cc2ca69599e3a3af8dd5972f7f01c031c01c', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138737, 55, 1.0, 1.0, 'g', 'PO', NULL, 'Pediatric', X'789c0bf0b752b03352a8d4cfb752304cd74f49ac5408f05748c92ccb4c494d5130d635ad008b552898eb1a9a28a400003f940d57', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138738, 55, 30.0, 30.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cf30cb352b03354a8d4cfb7523036c84dd7cf4ed74f49ac54f00c5348c92ccb4c494d5128b4c850a85030d735345148010042bc0d8d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138739, 55, 80.0, 80.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c0bf0b752b0533052a8d4cfb752b030c84dd7cf4ed74f49ac5408f05748c92ccb4c494d512834cb50a8503055480100220d0d1d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138740, 55, 30.0, 30.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cf30cb352b0533054a8d4cfb7523036c84dd7cf4ed74f49ac54f00c5348c92ccb4c494d5128b4c850a85030d735345048010049480da9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138741, 55, 30.0, 30.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c3336c84dd7cf4ed74f49ac54f00c5348c92ccb4c494d5128b4c850a85030d7353450480100c7070a90', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138742, 55, 4.0, 4.0, 'g', 'PO', NULL, 'Pediatric', X'789c0bf0b752b053303452a8d4cfb7523049d74f49ac5408f05748c92ccb4c494d5130ad008b542898ea9a2ba400002a760d1b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138743, 55, 30.0, 30.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cf30cb3523036c84dd7cf4ed74f49ac54f00c5348c92ccb4c494d5128b4c850a85030d7353450480100ebd00b89', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138744, 55, 30.0, 30.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c3336c84dd7cf4ed74f49ac54f00c5348c92ccb4c494d5128b4c850a85030d7353450480100c7070a90', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138745, 55, 15.0, 15.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c333455c84dd7cf4e5708f057d0c84dac5048c92f4e55c84f5330323000ca682a982a9464e6a6162b14a41629a42456020055f30e94', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138746, 164, 1000.0, 1000.0, 'mcg', 'PO', NULL, 'Adult', X'789cf3cb2fca4dcc51484c2ace2f2a28c9cccfb3523034303050c84d4ed74f49ac5408f00700d3d20b69', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138747, 164, 100.0, 1000.0, 'mcg', 'IV', 1, 'Adult', X'789cf34dcc494c2ace2f2a28c9cccfb352303430d005620385dce47405cf307d4f5f85fc228594d4d40285606785ccbcacd46490428594c4cc9c4a8534a09c1948813950a0b21800aae31881', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138748, 164, 500.0, 500.0, 'mcg', 'IN', NULL, 'Adult', X'789cf34b2c4ecc51282e284aacb45230353050c84d4e57c8cc2b294acc03c9e45402390af979a90a79f9c5254599390ae5a9a9d93995001a4513ec', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138749, 164, 30.0, 50.0, 'mcg', 'IM', 1, 'Pediatric', X'789c3336d03535c84d4e57f0f4554849cccca954d028284a4d4b2d2a4a4dd154f00f523034303050002ad04f49ac5408f007005e090e6b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138750, 1572, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138751, 6543, 1.0, 1.0, 'g', 'IM', 1, 'Adult', X'789c334c57f0f4d5f70c534849cccca954a85030d5353401722a8b0162dd07a0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138752, 6543, 1.0, 1.0, 'g', 'IM', NULL, 'Adult', X'789c73cb2c2a2e5170c92f4eb552304c57f0f4d5f70c53a85030040060c80713', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138753, 6543, 1.0, 1.0, 'g', 'IM', 1, 'Adult', X'789c334c57f0f4d5f70c534849cccca95448cb2f5248ccc901004aae0710', X'789ced5a6d6fdb3812fe2b44803da4d8c471deda3b63f700c74d5ba34dce88d3a0c5b930686a2cf342913a524aa32ef2df6f48bd58b2e5c81116b8bb5d7f8ba39987f3f2cc7048e9b73d4fc7fe54d200f67a64ef5247340409c1de01d98bb5b0ff5b4451687a4747dff93d041da57dfb173faa881aa6f18737a591d538e99ebc3eec1e1f1e776fbb6f7ae727bdb3379dd7a7ddb3f3bf3959601157d2a0e46f7bef114153e1fe8ee0d1a9df2621f4267240f52c5dc14ce45b65a80fe49dd281e991e1d50119dea1880a0225c9ada61e906bf4c13e930f54fe98c80fd4108a2b3df02821d4a75c9a885c8e2f3e1174814a6e2c6cdf101586ca80472235910168e5569cc80302b983c4536088541161ea01f4448e0cc49ec295ed1280f1e312cd73bec5b3b27b4ff8af88ce04d85ffffc86bf0497f7eec7d2dd929fcd512f0b23fa12a530bd19e3aa10ad206cf6ea79b892deb4a4f7f4cd7adff762114d317b5cfa9524d7442b27c3f4a42279ec63be8f8677c4a35c24e4919c1f1e9fe18f04f3f78e6bcc2ac2438f14728fe478af1a786bc93804c6e79c4d87d2e38c2e57ddb0ce5c69428598c8a18c349da1875c5241b89c6726572d19df7389dccb1f4ee4aff8fccdf2f948428c31e2d4528b216f63e988f9ef986b641fdadc5d0a7fbe1d6662a1b0b6a2c0af2b22ef13094c09e573e69e9d62b5e54b617a1789a08fdc580ca1341a85a69b58fba093140a496d60354c5bf175c5d3668258856949a1caba3c2e5b10ad10ad2060b09a75ad50cac8df9764ab14deb16cc7b25db7d9cc83361be4ff391546e0711a69e4c20bb7c1fdd3401d1e9f4c13a0dabcaaa89d7603ffe8de3fc214e434c241c7c3cc5d0cdf3ed3bdce9ddab2854de4157dc4ff130785c248432fd68eaf07c400106a377062323a2321733adb945a6fd677dac2febf1f9f4ebfae1b3f2e60eb219e21c5b2b6107fa4c258d494d648832fa96409b9c1a7d29fc81eb998c84f380d3ae91e19d3396039c4f25eaaef72226fc0165b9a1e1c0aad6d385cea8120bf9c767be4bc8be14e0b15e74a08949750c10dc769d3e70f8061b5cf4d1c8602029011e17312e0c0198135031cf9c92faf1724d45cd9f931674479110f98066a32e9f3ee4fbfcb521f20449f59e61bd977be91bf90c284571379add0b7a8f5fcba1aeee6da786b8f1ca9b09962a9160859c50c946d827c43e7ec0b01da4f7060274c50638eec09063dc5538336200dcf667e7c4e03ac094225986801180643f68757444991bcaa2bbc018dd797abc19dc80b88e8a123141e15c6c07fc41a2672c14da4347264703dc682344a7bf6b890b28b0721e5dae6ccfe87d9dc5119f11957363fe8874252dbde8b3d149732ad76cd925dcd69280b571a5ce6d0168d3613ccd2f6bf16be366cfeaf46b0ef3dd8604d6f80b2f550d6ce9b80751e37843c87c3d62669be5963dd43ac55a41e3943a1220ff860d0c1f0cfe7f8af18918a1964222f1fb12e1fa8493780ef3c5a100cb589b1efd000cfe7f6d42d44cc7076c9e612674b646db1fab7942d1246b5670713db0588a666e18026126c8bc259828b746f5ed955d2b37ec5d1b79c6abd006aa7a6796c9720e833105df87b4d63031499e2913b1ca9d2dde0565369b03548cb13db22a98776a1f1efc01deffb22023b255d21c9907963dc35621b157428e221cd2259cc6823ec54181a0f02678851819bbb6e175a0533c59208fdb237188909a5b5f5065dc69ffcc70f8e8dc94e50b1ce2c494255c4ea8efaa985ad1ac1460e34537255b5606395e2252a35639685eb0a659ba12e97ace86754dde2e2a433758215ed55ca35dc7895a52b383911b7d8fa72c98a7e0d4d9ba152a5292a4d0ba50a6a4eec2d529e4b56f45d39342ba762556ed455d0162c49d5a6a9da3453abe6bb54845b24bd2c5db5b052be5b9896cb4f9d7c35fb69656f91fc4cb0a26ddb41b3aa935ae15cd640b6215d2e5ae5c7b2dd6cd5150ae10a4aa54f3d8fb114cd0ec97fdccd6b6db4dced5ebbdd6bb77bed76afddeef547d9bdfed42dbdcdd17ad767767d66d7675edc67460baa03eadebe24d551998af9a1e073e891332ce02bc00a54829ba047065f4767e75d3bf3320de99df7679c8581ecffb5fbd32b2bcb16ee1b08a2e6a4cf52890b6c52383133ee51f1b21a4f2faf8aebb8e9b898bf3834df617d84aa5fe38934b16110229e80a37c9843e36313e3889ea003c389b497de3a70f7d8f8e8816a8ec625a4ac8a0317371195116adc4c64f193ec2bed3ee880b93b1e2036436738cbd0c73fa3098904eda33c67e961818110e43b4a942e1eeddb33142d2cb4aff13edf0edd1533d997b6ff272682c0bd39c94e2288ffe57822657aeb8e3f4e2692a646704930665a1d90591c390363fb69cad236943e7d467a2958f2ccdaf45eab38247d62220d2109915189f42dc7083e2cbd64f4f034142972d921730accbe79c015cfdaac98ad547ed9b6f918809b84b3d066ffbda60119a934a056ed1fd9e73a8e1a16b593bb73402e0ec8e080bcdf7387c962e6779269fd15b01b908a577cd002e38e6bac150c9b73b6bd1154ba6f666243fc362897b61014538c21429eb71a9c9b97e2f038680173351ef75b78717553abd6b4daa07fd8521337ce70d1219721f7b08f70af36664d56e309ee5f80fdbb5da83e750892cf8d643e48a83360b802e1cae31a7c6acbc3ac025e77888f80383c29a8a5f497930693102100ecadb63bb40bc995d2f4117b25250cfb1b9ab2818e4d381f3ab6338918e48f56d5894dccbe0b6aa1f951c0cc70eb8269558fe9c2474b18f7dde1cf6da0d6903e8e067540dbd5f6ccedf0263c20fd201c10097eeb76b30215aa36291e83b6df1ab40b73ae4c02aa19e0a62feb4cf872dc044305d660eb648f17dc6fad3cd2382d62b30db8a633deae4c728c8758f83803b584b01f8f4886c13461a75dcde30f47d07600033b56a49c22730db1f4789bca2dc378dcbe4c8d5b75f5124c3b7ffa5822e9a7b4ad88d16738ac47cf9bd054f29bbfe77d21d045acef174ae02e89fcc0d99a32de06668c072315d9afc532a3022aa2d2f5e50be1be627271f6a404b2b1c5bef66775488d2de09da6c87de3e81bc5826aabdfaa995ce8983d53058dfa9fc0e7eab93a6a4c3ac5e346ac1d4210637ced69aecde64b2170b989eda1000f91495d3936fa73c7679a2bdb9ba4fd7cacb618d740aeb8616b15b91034483c6712adafa9c6b934612ac4461d2c4f2575634513cc0d67f71045866f30a33126d68eb4b0716824f4a17e745c83e94b6ab7ddf599cf1edfa50a12563b3f36253a3df42b6cff38f36beab7de85e001f721473b10f86f6927dafa7a6cecbe42e1810aa74f0c8f7debc11917ad66d932d0be3dad1668af5a98f52e36a5bc4960ae95e9daec35860bc248b95363941fb836ee33dfd6af5a7637267f8e1b9317dec08d01a67d6154851bcb6bb9d617f72b104d2f4b97c24fdf9e9e9efe03623958a2', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138754, 6543, 30.0, 30.0, 'mg/kg', 'IM', 2, 'Pediatric', X'789c3336c84dd7cf4ed74f49ac54f0f4d5f70c5348c92ccb4c494d5170f27451a85030d5353451004a16030006a50c62', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138755, 6543, 15.0, 15.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523034cd4dd7cf4e57f0f4d5f70c53a8503004008cbf08b6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138756, 6543, 1.0, 1.0, 'g', NULL, NULL, 'Pediatric', X'789cf34dacb052305448d74f49ac040016ca03a6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138757, 12548, 100.0, 100.0, 'mg', NULL, NULL, 'Adult', X'789c85ce310bc2301086e1bf72a342855a1b2a752a8893931d14b7849e31905e25b98afaeb4d88735c6e7a1fbedb4f5e6a849e1d92e6bb6f81a5b2c82d34a28075598e7a077ef62c0de1b07268517afc45b038a3b56a666708fad3b28d2028114e9528be1869c8cbcb31ca88367f50f7b0481f43b16fead0d7db02445565d1617237f39cd24c2df20bd7b79294de19f51731175ce9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138758, 12548, 100.0, 150.0, 'mg', 'PO', 1, 'Adult', X'789cf3cccd4d4dc94c2c4955284acd494d2c4eb552303430d0353435c84d5708f05730d2355128c9cc4d2d564849cccca904006ee20efa', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138759, 12548, 150.0, 150.0, 'mg', 'PO', 1, 'Adult', X'789c0b2e2d2e49cccc4b4d51284acd494d2c4eb552303435c84d5708f05730d4355228c9cc4d2d564849cccca9040044d50e5a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138760, 1738, 50.0, 100.0, 'mg', 'PO', NULL, 'Adult', X'789c0bf0b7523035d0353430c84d572834cb500808f20300336e0530', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138761, 1738, 50.0, 100.0, 'mg', 'IM', NULL, 'Adult', X'789cf3f4b5523035d0353430c84d572834d135cb500808f203003c890588', X'789ce5566d6fdb3610fe2b0703fb66c72f8bd355280a18ceb6f4431c2ff60a1453615ca48b44842255924aad14f9ef3b4a96637941ec65188a61df6cea9e7b79f8dc1dbf756253242b85197502e85c94b1d1ebf24128ea74a15318e94f53e7721bf4fb5fc51d6527da24fe97e8ef19dbc8604ef10a9dc78c06a3b3de60d81b0e968337c1781c0c4e4fdebe1d9e9e0e2b5b8a9cd0cab2e5b7ceafa4c8a0ac7e3b5a57f065995310aa89722215d661c6416ca8fa7031841ba9a33b32a13ad71613825fb4c96c0057eca30b1f2e4335d559a6152c0dc604332e8dbf4e1c1a5c57b18b9bddf08f7ce4f04692fff7c767fe2785baabfe3ca5d3cee330357bf68f9f7d94495c48b7e2a4854a5ac54ed45a902b4335bf0a603c60ce0659025fce52985fcf42f5e172f7f4b4d79c4fa4249388080c61554fa834b332378511aeb0b5bbd1b872d5fb290dd50c0b4bc82c86eaa3ce84e33c6aefa3f136261b6ea22aab3325702fabf9157c496d939487a4f6f5ac56751f43676dc85e77d0fbe51fe16703596d212d8f0d73871d6d2d5bf89adfc3e88d5d0bdb5cc861f4d6b2856faeeb307e6b59ab724eb1406798949794d916d6bb332875238c2ce9c758422cee454c3108e5f4ae8ece7ac3d18e752da31711ef37800511a0ef1988abcc5e10f0f064c84eefd8afb6f47de4f85f134f75f98b9c22817235d77921f169243f154589421595708d35db01cc34a445860a627408788f427a6643754d0a25d42a0a606aa612de8d0701c41471bf5982c2166ce0af086e4ad6c20fa1baa09c1d475b94eae36baf6f3fd7c3649cfbd59737b055848e126dc476604fb57206858a45f40c37f5302981c51b49b4b6ef3769a87e9631195982af8b94e36ef96d09b9d152ab049b31757c7d9bcd714fc6d2ea7a33b6da893ce3b0b3202374b197302fa528d5ecba9e9b4eaf45247c774f670bbe2566c2da6a8d2c483c14c62fdca53696b7a8e5cf906beed47afbed245b13e5176e2bd88262ac77d2b978f04f046bfd6d638c514afb2e8edec1cfa57fdc36de41aeb6c8561335451ff6b7b5dc34d1bfcbf5fed5febfc97e4df57fb3dbe6299a0c23eed8a46c05ba4079db93e29678baa542c68614bc815417c676a17add59f8b1371a3447cd2878df1c85ea9238329363b30036b3af0bd34ff3d3f18047c79a07a54f3380df0dd7e1cda314155b83be8549547f9b711d247d41f7bc2095c344372611f98925fb394b324ffdabda3f980d45943b56d72bc8e025bc9a48abffa2eedd67f94b6af91ecfedee119df84f94cc4df4f827c4be7de9', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138762, 1738, 25.0, 25.0, 'mg', 'PO', NULL, 'Adult', X'789c0bf0b7523032cd4d572834d3b5c800001bbf03c9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138763, 1738, 25.0, 100.0, 'mg', 'IM', NULL, 'Adult', X'789cf3f4b5523032d5353430c84d572834d3b5c8500808f203003cc4058e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138764, 1738, 50.0, 100.0, 'mg', 'PO', NULL, 'Adult', X'789c0bf0b7523035d0353430c84d5708f05728cc2806002e19051c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138765, 1738, 50.0, 50.0, 'mg', 'IM', NULL, 'Adult', X'789cf3f4b5523035c84d5728cc28060014ca0396', X'789ce5566d6fdb3610fe2b0703fb66c72f8bd355280a18ceb6f4431c2ff60a1453615ca48b44842255924aad14f9ef3b4a96637941ec65188a61df6cea9e7b79f8dc1dbf756253242b85197502e85c94b1d1ebf24128ea74a15318e94f53e7721bf4fb5fc51d6527da24fe97e8ef19dbc8604ef10a9dc78c06a3b3de60d81b0e968337c1781c0c4e4fdebe1d9e9e0e2b5b8a9cd0cab2e5b7ceafa4c8a0ac7e3b5a57f065995310aa89722215d661c6416ca8fa7031841ba9a33b32a13ad71613825fb4c96c0057eca30b1f2e4335d559a6152c0dc604332e8dbf4e1c1a5c57b18b9bddf08f7ce4f04692fff7c767fe2785baabfe3ca5d3cee330357bf68f9f7d94495c48b7e2a4854a5ac54ed45a902b4335bf0a603c60ce0659025fce52985fcf42f5e172f7f4b4d79c4fa4249388080c61554fa834b332378511aeb0b5bbd1b872d5fb290dd50c0b4bc82c86eaa3ce84e33c6aefa3f136261b6ea22aab3325702fabf9157c496d939487a4f6f5ac56751f43676dc85e77d0fbe51fe16703596d212d8f0d73871d6d2d5bf89adfc3e88d5d0bdb5cc861f4d6b2856faeeb307e6b59ab724eb1406798949794d916d6bb332875238c2ce9c758422cee454c3108e5f4ae8ece7ac3d18e752da31711ef37800511a0ef1988abcc5e10f0f064c84eefd8afb6f47de4f85f134f75f98b9c22817235d77921f169243f154589421595708d35db01cc34a445860a627408788f427a6643754d0a25d42a0a606aa612de8d0701c41471bf5982c2166ce0af086e4ad6c20fa1baa09c1d475b94eae36baf6f3fd7c3649cfbd59737b055848e126dc476604fb57206858a45f40c37f5302981c51b49b4b6ef3769a87e9631195982af8b94e36ef96d09b9d152ab049b31757c7d9bcd714fc6d2ea7a33b6da893ce3b0b3202374b197302fa528d5ecba9e9b4eaf45247c774f670bbe2566c2da6a8d2c483c14c62fdca53696b7a8e5cf906beed47afbed245b13e5176e2bd88262ac77d2b978f04f046bfd6d638c514afb2e8edec1cfa57fdc36de41aeb6c8561335451ff6b7b5dc34d1bfcbf5fed5febfc97e4df57fb3dbe6299a0c23eed8a46c05ba4079db93e29678baa542c68614bc815417c676a17add59f8b1371a3447cd2878df1c85ea9238329363b30036b3af0bd34ff3d3f18047c79a07a54f3380df0dd7e1cda314155b83be8549547f9b711d247d41f7bc2095c344372611f98925fb394b324ffdabda3f980d45943b56d72bc8e025bc9a48abffa2eedd67f94b6af91ecfedee119df84f94cc4df4f827c4be7de9', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138766, 1738, 50.0, 50.0, 'mg', 'PO', NULL, 'Pediatric', X'789c0bf0b7523035c84dd74f49ac5448c92ccb4c494d51c8cc2bc9572834d3b5c8500808f20300c6fd0b17', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138767, 1738, 50.0, 100.0, 'mg', 'PO', NULL, 'Pediatric', X'789c0bf0b7523035d0353430c84dd74f49ac5448c92ccb4c494d51c8cc2bc9572834d3b5c8500808f20300e3d60bd5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138768, 1738, 1.1, 1.1, 'mg/kg', 'IM', NULL, 'Pediatric', X'789cf3f4b55230d433cc4dd7cf4ed74fc92f4e050029630530', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138769, 3840, 1.0, 50.0, 'mcg/kg', 'IV', NULL, 'Adult', X'789c33d4353550c84d4ed7cf4ed7cfcdcc53f00c03002eb0054e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138770, 3840, 20.0, 50.0, 'mcg/kg', NULL, NULL, 'Adult', X'789cf34dac503032d0353550c84d4ed7cf4ed7cfcdcc03003a980606', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138771, 3840, 1.0, 4.0, 'mcg/kg', NULL, NULL, 'Adult', X'789cf3cc4b2e4a4d2c4e5530d43551c84d4ed7cf4ed7cfcdcc53283434d0353650003275144a324b8a124b52154af21552d3d252934b00c9d71167', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138772, 3840, 1.0, 3.0, 'mcg/kg', 'IV', NULL, 'Adult', X'789c33d43556c84d4ed7cf4ed7cfcdcc53f00c03002b2e051c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138773, 3840, 2.0, 10.0, 'mcg/kg', 'IV', NULL, 'Adult', X'789c33d2353450c84d4ed7cf4ed7cfcdcc53f00c03002e82054b', X'789ced58df6fdb380cfe57843cb540b3fce875c5f230206bb7b5c0d60549d797f310303263eb6a4b3e49eeea0dfddf8f9293d44a33242deed01dd0972092488ae4f78912fdb315eb32994ac8b13560ad5355402e24b60e58abd4999b4aad2dcca0d3f92eae317fa574e2fe894e53d2700d05c653b04ea1dfedbf6e777bed5ef7b27b3c38ea0fbaaf5ff58e0e8f8fdf7859e456286948f267eb234ad490f9ff166fbdfa6555e02092576054a1d118a54d244f958104d907a5733360e757913c5179ae24bbd41023bb20f7ddbcb45a1542fa7dca5973ab3b9ab230cbd08dfefc46a34cc86b3fb8dfbab9e7f60c04d277dfdc0ee732161ceee35b1a3eab0a65511a5a882487d260cc66154539c1c20ace4caaf87524df513015071d0b88e4e7f3485274650e1d433141b6943a43d096cd4164a5c6a786daf0687ba44de13ad0615c66764aa8089904914e9c8f6c0fe2bf4ac9ed3e85d86b1f7559ce93ce75d221c278f03ec32deb77c385489e4bae110cb25efb8fa6c6dfbd6efb9044853c6056580d1699550ce7738a3a92639c6be056e98ad5a9f950a7c6ef7db8be7590e33d9a2c082f94d6b0521298052551dc78fb5093095d107d62f3baa59132b64d2aa5e1c27ad099a1bc8b4cfcf023523b7aa0f654bc1a6e6fc7ab295ce33542fa6fb5e0bb61f6d06fb6971366b12274d49cb06bacee3f19b91d32d86ff7d73ce99c7f795c127d0226057201d974a48a32db7042471a130992576c4cab3289e4809d64600c3b89e427a257ed10fb4a41d201f6beee652217968e720c16f61d11dd29ad131c497f44064c129128b1c6e644320a7909c4839533744ce4ebfa179d61a045e3a772683dc61d8abcbb1b6a61331572bab2b0a0d589a28a0be217556f9865a893ca21ce5d2a3beeaaa1a2063cad40ebb4b2692e80aafb2845c553ad72c52bab727802bec3f806b5c1e918813ff46483c1d604b550e59ac7128ab4cae056905741d1be228c28ffc41dcd02dfdf692579aa4c012627d04888383017332db29a67917c7f4b49ba0153335c22d70431a97e049968acafd0466c7562dded16de8b2e6dcbc245852ea63146f2c2dd26d0b95144c59a37f256a0adbcffa857010c65429708e51ab26271d8dcbd5a9942224d0f7f50ac795d5c9abeec44ac46dab673aa294cd6ff8d2ba9696503023bf8e495a6815260b591fcedd69ac261840bd476086f29b99ea115a23ba5e85e3acc91e7c22e5079b940b7c99fed1602e9c0ce82793bd4a085605d717eaf53bb5e535e8eedcbb17d39b61b8eedb31e8ca7bc955e98f39b30679482ce81ab4c2555d85343366f6762eefabcbe6b314a8bc480cf48d8aa4c987cb078911fb0c5d3fa808de8199a83abedd4af2c3a8caf9a7a3c0686e50bcd85199e82242baedd197af20c3655fc911639e88ade9d9c5a79a503173fa9efbe651ab0d3e1018bcaeee1ac4f4d29515924e9fa4acfafbc7d7b2fb7e15d384657e66e70fadeb750e617db5db866815a60bab09cf57eef4daffe3d1b87e3c955e0cc7272cc40c6abd1232e971ab2ff3827eb18fc2f92f26c4e3eb651469c0e33a302ffd63fc6cd4aeb3ffe45f2c4553d95a0bcff8ae53f273cc727b8a0daac7cdce553e64a36b0f120b6eda61a2ad35a25b038d9cd4a2d46f5efeeee1f8416606d', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138774, 3840, 5.0, 10.0, 'mcg/kg', 'IV', NULL, 'Adult', X'789c33d5353450c84d4ed7cf4ed7cfcdcc53f00c03002eb8054e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138775, 3840, 5.0, 10.0, 'mcg/kg', 'IV', NULL, 'Pediatric', X'789c33d5353450c84d4ed7cf4ed7cfcdcc53f00c53d0c84dac5048c92f4e55c84f53304296d5040040450e12', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138776, 3840, 1.0, 4.0, 'mcg/kg', NULL, NULL, 'Pediatric', X'789cf3cc4b2e4a4d2c4e5530d43551c84d4ed7cf4ed7cfcdcc53283434d0353650003275144a324b8a124b52154af21552d3d252934b00c9d71167', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138777, 3840, 2.0, 20.0, 'mcg/kg', 'IV', NULL, 'Pediatric', X'789c33d2353250c84d4ed7cf4ed7cfcdcc53f00cd3f7f407003fe40613', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138778, 3886, 50.0, 50.0, 'mg', 'PO', NULL, 'Adult', X'789c3335c84d5708f0d7f70cd3f7f4552834d135cb0000332f051c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138779, 3886, 400.0, 400.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacc8cc2dcd5570c92f4eb55230313050c84d5728cf2cc9c8cc53303251c8c82f2d2a0600dd8e0bf6', X'789cd556df6fdb3610fe570e7e8e625b8d9c427d729b0d2d50774192eda50a04863a4b84295225a92642e1ff7d477a762cc7586cef0736c00f2675f7f1bb3bdec7fb31284c5be68ad538486170256a54555718a198c3c1190c5a23fd87cab9c6a6c3e1a358607dae4de9ff89e14b7bcb0d6bb0c899f36ef1289e44a371341edd8d2ed3649c26c979fce6e23279136c913ba19525cb1f8369510b25ac33ccef852d874f01e5ae6b30cdd4543981353ac16da6deadd61579307244dabad29695083f6b535b32bfd1ad430b7a0e7de814b461f20c3efd36fc34cbd4075dd75ac19d6105c217ca834de1cab03aa00696edc336d1256d39f620d1afbeded34a0ab5088b67c65b545f4fe2b631a1f7519e033c0c68cb7e79efb94e8b56ba9c722354d9cbea9ed80633edffe7b7822f08c1f6ec93515dc2f52fc39037f876114daa4ccdd893a8db1a081f53b8188d808c1e85ab8482f8022add9a407c2b63cb3fc96060fc8f9138bc9281c73516823923f889d9cbe39e471c4d3a9dc2383e4fa2380961c0b749f4162a637763b84cf68490a949348e3d06c449f447260204e5609cec8b9af6cf638f355c94e01336a9fe6235febb411d59dddb06b96032bfd64d2bd97311d7915d1b2c1553bc831bfaaaca8c84e37da63e33ee82351861177e7326e402703ea7b32d3083d0d06da173498150310945b83c24481fb1214fbede004e478a028ddf403058b481fda99ab34bf800f5f6d2bf32b6b950f906a12f43fd905f87ddd8e7de3ee7f43294da888d227dd08aa458a842f03d799f4a89a6ecc069e092593bf40fd409f59d16dfd158cc6f90f197a7ec6bdf5b3442b73b6c485279a5099a4851ed9c7e125cb86eb78b4258fe21e9797f61ad457606df752d5677e8160bb62ef2815d781899d75f862dcf7ce3b9aac8b191ef66ee7f1cfad1d48f7d442a666ac6b5d465d73be52393f3488a390963e2f572a56c332430226beb143e0bbac199fae9891b5c0d2e41504e2031435e319a80ea5ccff3297f316051e373411ac42857910ae143bdf681562d947e546750310b0536869e01b284555f01fd2a1ad08c75a4f5a4a45880640f1d8d845eb511e6ad3a41d736c541e5fa17b33f738220d12529ad1ffcd2f3f17a41535f46fad2542bcb301065246d05bc8d7825b5d1ae42dd549d94e1cbaf965853120c060c266507cc0317288511146da6be8eef4f95e61d2687ccd57d87759b623e9556bfe8d3cd547c44d3fecb73ecdfdfbccbe5ef29594982', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138780, 3886, 12.5, 25.0, 'mg', 'PO', NULL, 'Pediatric', X'789c33d235abccb7523034d233d53532cd4d5708f0572834d3b550c8282a060064d5075e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138781, 3886, 75.0, 75.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacc8cc2dcd5570c92f4eb552303755c84d5728cf2cc9c8cc53303251c8c82f2d2a0600d5290bce', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138782, 3886, 25.0, 50.0, 'mg', 'PO', NULL, 'Pediatric', X'789c33d33534aaccb7523032d53535c84d5708f0572834d3b5c800004ab40629', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138783, 3886, 150.0, 150.0, 'mg', NULL, NULL, 'Pediatric', X'789c33343550c84d5728cf2cc9c8cc53303251c8c82f2d2a06004ae60715', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138784, 3886, 1.25, 1.25, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c33d4333255c84dd7cf4e57f0f4552834cb000026be04a1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138785, 862, 5.0, 7.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c33d535cf4dd7cf4e57f00c53283432c900002601048d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138786, 862, 5.0, 7.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c73cb2c2a2e5170c92f4eb55230d535cf4dd7cf4e57f00c03005b08073b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138787, 862, 1.0, 1.7, 'mg/kg', 'IM', NULL, 'Adult', X'789c33d435d433cf4dd7cf4e57f0f4d5f70c5328b4c800003699057f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138788, 862, 240.0, 240.0, 'mg', 'IM', NULL, 'Adult', X'789c333231c84d57f0f455a85030040013fd030a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138789, 862, 1.5, 1.5, 'mg/kg', 'IM', NULL, 'Adult', X'789c33d433cd4dd7cf4e57f0f4d5f70c5328b4c800002f4c051f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138790, 862, 2.0, 2.0, 'mg/kg', 'IM', NULL, 'Adult', X'789c0b2e492c2a5130ca4dd7cf4e57f0f4d5f70c53a850300400534606a3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138791, 862, 3.0, 5.0, 'mg/kg', 'IM', NULL, 'Adult', X'789c73cc29b15230d635cd4dd7cf4e57f0f4d5f70c53283432c90000557806c9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138792, 862, 2.5, 2.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4e5570ccc9b15230d233cd4dd7cf4e57f00cd3f7f455a8300400b3f709fe', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138793, 862, 2.5, 2.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d233cd4dd7cf4e57f00cd3f7f455283432c900003487054e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138794, 862, 5.0, 5.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc29b15230cd4dd7cf4e57f00cd3f7f4552834b1c800004bb6066f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138795, 862, 2.5, 2.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d233cd4dd7cf4e57f00cd3f7f4552834b4c80000348c0551', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138796, 862, 5.0, 5.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc29b15230cd4dd7cf4e57f00cd3f7f4552834b1c800004bb6066f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138797, 862, 2.5, 2.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d233cd4dd7cf4e57f00cd3f7f4552834b4c80000348c0551', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138798, 862, 3.5, 3.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc295130b45230d633cd4dd7cf4e57f00cd3f7f455283432c9280200668c078d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138799, 862, 4.5, 4.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc295130b25230d133cd4dd7cf4e57f00cd3f7f455283436d335b1c80000751707b9', X'789ced5a5b53db4816fe2ba778d825157c07c278b35365c88d4a202e9c64b21553aeb6d4963b48dddaee9613ed14ff7dbf966c631b19196576f330f39002a9fb7ce77e13f97dcfd74930922ce27b5dda7bcda56591f084dc3ba0bd4487eee5d4dad8741b8d6fe2864775a503f79b68acdf359e6631f747cc3a9276b37d5c6bb66aade687e6b3ee51a77bf4acde69b73b479dec2ef7ac50d2e0e6ef8e25d72ccc7eb7fc7b46fe218d7977287b91902a08534f19e1f3a17ca10c0b38bd523a325d3abff8079d7f1aca3315454ad207cd7c4e975004674e36e1a5f2805e33cda214421e642fd94d2640325e95e116af2c1b87dc3d7db9c65328e44df67027d3ba30e5e6d9b87f7bedb8f4fc24b423e82164b0a6712f0ca1d184d4981b7e4089e1d4f3bf26c6729f7ee322985afa279d9ffe464fa9593fa4efb4dfc343cdbd7a024339eafc3e691e7366c9cf78d0981920c03c219ff1d01428bf70c0a8bd26d0cbef964b1fb4e7d2723d63e1501ed59e4541e32680d5e9dfedc3e950be121a1ca10eefd2caa9f3899c391728e9081107f5c5e145c3519f4cf7d66dee8cf3517a2a8a43e131683d7aada4f294e76d8446fbb019391898a0558031809a9a8ffae72fd6a85af5a30dfe4339b04c5b6aafbe07a633a6ed52a7b64e90a97b2e270ab125669cbe098b171ee2c4cfc36b53969d626a83fee1803a5bb99c47d3cff3dc660cfde5ba47baae92c136adfea7b2d84f55b64ac3f8417dfbdc17cc6ae16d6d17ec070bfefef393d10b969ad1fbd07fb2067f571d28e3d45e1af953c385236cf9bc7d42df38bf3114706399431fca8d7bb96d33abafbf3f745e6a9fd4dabf9463b44e1ec0e8346b9dceee18d482ffefcba8f3c376970e370e3bc7b59ccfe11fc964e3a8d639762c8ef0b39c0bb5da0fb12961f22a0943fac07554207e7b61e74dd2a25ebd8ca17908d546add1859276faf840ea341f13045b8cb7631c6cd57147176fa1cfc4dbd1815b34c9a033f7d842f76c35c083de993b65543bce7f31ebeed9cae4f87efc3ec4e6d75de0efa06bcf8aeac44704899b70c5847e6da7ea113d26ef0f31f70484e9ab3809d95db55b08d3d73c904c7a295de1540643d9a51743f98e79b9a7bad4d76a0c06291936c1b671c53102515e7c21bb9bdcd7c72312f3016b5e7b71aacf426a356b47cd2e05ae99c0ad7901c94e9eb796ef0f4f6acf9cc7dff048a1ce87a911667eb63273b10918d0e27c2897a35d316764c1313808e9698e36b06809cbcb1bbd61215507346ca684efd68ea15c369e9db4ed6cd3b6eb0cd1fe65de559122b5cccbbb18a211732dac92dc315b374efb271ae60d8f1129de3c24b081b990a0bfd1d260d8c42e153a319f08c9fdaa73c366a0960f0f2fdc0a9f5f362321474b84f92801375acd3060b871f35e62a030731da46415792133a6e1be083c4ef8f96e8b01cdf0d11567de7d2ec5f3ab162a59bff7de2aabbe0b4fd87428bfb4ae61521e4ff5ca4ba469a8649069426a4292275a4589f190f69ac6a1f26e204741b9ca3f14ac71bb64f02c6bcc5424f29a70ae11793934662a21bfe6f29211963fba22fd8fd5db34e7ff5bbf3f82df2363ac3f653a621e2c14a46b8cdfb070520bc58477dbb50e4d55a291c5171c582a1426eaba1281e4cf0bfd478dfc24be78e12e7a532671cf19bce7e5b74e9130c66545a73920267d3ac24f2dc6caa8083503922752587380326474123b7d29babaec11724d9a70aeb49cd7a409820117dc768172e3e10d8a17c5f03c1730478aeec9b352f6a57d5d25f950a5c742a13c8d065cc2ba62867fbc3c07dff275430e86d220d838f401b786998371da4f4cc2c23045913b1fca4ca7282b7c389a31689375ce1552edf4b14c5a505c0de5f291f69526893ac927132709b0ddaa84da94a30f9e428414934580fb28b799c93c8ec9e81b6ec0a20b4d61ac8fb8ba947002dc8f1fce51c721c9be7451961acb23600839c99506fe670c9d5291cf2cc3437b28592e04dc009b697540e3c4660226ae2bdcc986db9d076edf5d5cd1ccc9f45aab24a61e198b558d6284702a03886c08874bc90cf90977e1f6b24e13c601e4a2e1f361158e734e281d4850c11e4e6cb49e4cc2ecfbaf6611f5556e5047f65e07596264a1e150eb0b750ee8f480ce0ee8f55e56ea1631e7a269ef6a0f2c5660b720f51702f20a189f84163e122d57b600e0736b3729189c21152297824a302f5d2a649f6f00b1f05c01d0e0b13822892ac05c0c06bd2a64578564655e38ebd5b650ee607e164febf432163e4a89f00b8d765ec6bf4e5f39a6a1625b9549ffae4e91fbf4965a156097d9c56b59865c72d79f6739c12ae0659d02006a3d55bc52540320e2a8aeae3e145ba40ce14269f61dd59211863d06492a86e39bbaab4d61c2e57f0a35290de73aa14f8b0a946f433e36c2a9608a127247c68d3b187a39387df7b40ad43da4b7fdb322a032a7e4b99df77d131f502f8acf30d90595cbc40654acaab81803aa461c179bb93c7fe7d41431ed71f47d594906162205b73abb5c8aa9082a874adf8d5fa8b691d06c2c8af3a4548205c82c0903cc41558c008819aaa0f4604d13d7ab4881b4c74316a31511cedc7091c7154d344fb02e1665efa3707ce176c2a4925d57712aaad443a620ba1886844ac1d5f3b028d88785284bfdbee1893f978271acd66ed8601582e434d1375315fa6e73c03c1c334f14c194cf5e1cb3a356f1742e1496198b27847f15b87fc1bf984219f1f9f81282d8aba2df2bac4d9e3059085bb7ec3af22ad974aa13ef8144183cfd7bd958c003a17e2897fa0c8b47a2338828817d3dccaa5580de301e65ce49dc7e808535ad94939fc4580be54a941413e11526e4e6a875218c772f27a7218b523f9388152755e97c927a2a46bd8eeef6932a83d295f06eb8b546fc8018f33d3c8988cd8a07c87b86ed49e6baeffdc9cf7d35902a4abdc229b24c9ad34c12851e80d15fb3604b2f2aad359acfd08cb2a8e3215e4b37d716a763e9641f2a6c561842611e5f4c103522ace2a8559c7db7b52ec19e5489e4578959f19be45e56c974a5f1bfcf63abb2f5d12ef6aead35fefafe3797bf3e9dfc393e9d3cf253dc80f3512f346a2d36eebecf19dabf60423ea9fae78162a492ff8b7647339ad3dc5edfdedefe17ccfa0f41', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138800, 862, 2.5, 2.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d233cd4dd7cf4e57f00cd3f7f4552834b4c80000348c0551', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138801, 862, 3.5, 3.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc295130b45230d633cd4dd7cf4e57f00cd3f7f455283432c9280200668c078d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138802, 862, 4.0, 4.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc295130b25230c94dd7cf4e57f00cd3f7f455283432d13536cb000069120750', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138803, 862, 2.5, 2.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d233cd4dd7cf4e57f00cd3f7f45528543034ca00003980056b', X'789ced5a5b53db4816fe2ba778d825157c07c278b35365c88d4a202e9c64b21553aeb6d4963b48dddaee9613ed14ff7dbf966c631b19196576f330f39002a9fb7ce77e13f97dcfd74930922ce27b5dda7bcda56591f084dc3ba0bd4487eee5d4dad8741b8d6fe2864775a503f79b68acdf359e6631f747cc3a9276b37d5c6bb66aade687e6b3ee51a77bf4acde69b73b479dec2ef7ac50d2e0e6ef8e25d72ccc7eb7fc7b46fe218d7977287b91902a08534f19e1f3a17ca10c0b38bd523a325d3abff8079d7f1aca3315454ad207cd7c4e975004674e36e1a5f2805e33cda214421e642fd94d2640325e95e116af2c1b87dc3d7db9c65328e44df67027d3ba30e5e6d9b87f7bedb8f4fc24b423e82164b0a6712f0ca1d184d4981b7e4089e1d4f3bf26c6729f7ee322985afa279d9ffe464fa9593fa4efb4dfc343cdbd7a024339eafc3e691e7366c9cf78d0981920c03c219ff1d01428bf70c0a8bd26d0cbef964b1fb4e7d2723d63e1501ed59e4541e32680d5e9dfedc3e950be121a1ca10eefd2caa9f3899c391728e9081107f5c5e145c3519f4cf7d66dee8cf3517a2a8a43e131683d7aada4f294e76d8446fbb019391898a0558031809a9a8ffae72fd6a85af5a30dfe4339b04c5b6aafbe07a633a6ed52a7b64e90a97b2e270ab125669cbe098b171ee2c4cfc36b53969d626a83fee1803a5bb99c47d3cff3dc660cfde5ba47baae92c136adfea7b2d84f55b64ac3f8417dfbdc17cc6ae16d6d17ec070bfefef393d10b969ad1fbd07fb2067f571d28e3d45e1af953c385236cf9bc7d42df38bf3114706399431fca8d7bb96d33abafbf3f745e6a9fd4dabf9463b44e1ec0e8346b9dceee18d482ffefcba8f3c376970e370e3bc7b59ccfe11fc964e3a8d639762c8ef0b39c0bb5da0fb12961f22a0943fac07554207e7b61e74dd2a25ebd8ca17908d546add1859276faf840ea341f13045b8cb7631c6cd57147176fa1cfc4dbd1815b34c9a033f7d842f76c35c083de993b65543bce7f31ebeed9cae4f87efc3ec4e6d75de0efa06bcf8aeac44704899b70c5847e6da7ea113d26ef0f31f70484e9ab3809d95db55b08d3d73c904c7a295de1540643d9a51743f98e79b9a7bad4d76a0c06291936c1b671c53102515e7c21bb9bdcd7c72312f3016b5e7b71aacf426a356b47cd2e05ae99c0ad7901c94e9eb796ef0f4f6acf9cc7dff048a1ce87a911667eb63273b10918d0e27c2897a35d316764c1313808e9698e36b06809cbcb1bbd61215507346ca684efd68ea15c369e9db4ed6cd3b6eb0cd1fe65de559122b5cccbbb18a211732dac92dc315b374efb271ae60d8f1129de3c24b081b990a0bfd1d260d8c42e153a319f08c9fdaa73c366a0960f0f2fdc0a9f5f362321474b84f92801375acd3060b871f35e62a030731da46415792133a6e1be083c4ef8f96e8b01cdf0d11567de7d2ec5f3ab162a59bff7de2aabbe0b4fd87428bfb4ae61521e4ff5ca4ba469a8649069426a4292275a4589f190f69ac6a1f26e204741b9ca3f14ac71bb64f02c6bcc5424f29a70ae11793934662a21bfe6f29211963fba22fd8fd5db34e7ff5bbf3f82df2363ac3f653a621e2c14a46b8cdfb070520bc58477dbb50e4d55a291c5171c582a1426eaba1281e4cf0bfd478dfc24be78e12e7a532671cf19bce7e5b74e9130c66545a73920267d3ac24f2dc6caa8083503922752587380326474123b7d29babaec11724d9a70aeb49cd7a409820117dc768172e3e10d8a17c5f03c1730478aeec9b352f6a57d5d25f950a5c742a13c8d065cc2ba62867fbc3c07dff275430e86d220d838f401b786998371da4f4cc2c23045913b1fca4ca7282b7c389a31689375ce1552edf4b14c5a505c0de5f291f69526893ac927132709b0ddaa84da94a30f9e428414934580fb28b799c93c8ec9e81b6ec0a20b4d61ac8fb8ba947002dc8f1fce51c721c9be7451961acb23600839c99506fe670c9d5291cf2cc3437b28592e04dc009b697540e3c4660226ae2bdcc986db9d076edf5d5cd1ccc9f45aab24a61e198b558d6284702a03886c08874bc90cf90977e1f6b24e13c601e4a2e1f361158e734e281d4850c11e4e6cb49e4cc2ecfbaf6611f5556e5047f65e07596264a1e150eb0b750ee8f480ce0ee8f55e56ea1631e7a269ef6a0f2c5660b720f51702f20a189f84163e122d57b600e0736b3729189c21152297824a302f5d2a649f6f00b1f05c01d0e0b13822892ac05c0c06bd2a64578564655e38ebd5b650ee607e164febf432163e4a89f00b8d765ec6bf4e5f39a6a1625b9549ffae4e91fbf4965a156097d9c56b59865c72d79f6739c12ae0659d02006a3d55bc52540320e2a8aeae3e145ba40ce14269f61dd59211863d06492a86e39bbaab4d61c2e57f0a35290de73aa14f8b0a946f433e36c2a9608a127247c68d3b187a39387df7b40ad43da4b7fdb322a032a7e4b99df77d131f502f8acf30d90595cbc40654acaab81803aa461c179bb93c7fe7d41431ed71f47d594906162205b73abb5c8aa9082a874adf8d5fa8b691d06c2c8af3a4548205c82c0903cc41558c008819aaa0f4604d13d7ab4881b4c74316a31511cedc7091c7154d344fb02e1665efa3707ce176c2a4925d57712aaad443a620ba1886844ac1d5f3b028d88785284bfdbee1893f978271acd66ed8601582e434d1375315fa6e73c03c1c334f14c194cf5e1cb3a356f1742e1496198b27847f15b87fc1bf984219f1f9f81282d8aba2df2bac4d9e3059085bb7ec3af22ad974aa13ef8144183cfd7bd958c003a17e2897fa0c8b47a2338828817d3dccaa5580de301e65ce49dc7e808535ad94939fc4580be54a941413e11526e4e6a875218c772f27a7218b523f9388152755e97c927a2a46bd8eeef6932a83d295f06eb8b546fc8018f33d3c8988cd8a07c87b86ed49e6baeffdc9cf7d35902a4abdc229b24c9ad34c12851e80d15fb3604b2f2aad359acfd08cb2a8e3215e4b37d716a763e9641f2a6c561842611e5f4c103522ace2a8559c7db7b52ec19e5489e4578959f19be45e56c974a5f1bfcf63abb2f5d12ef6aead35fefafe3797bf3e9dfc393e9d3cf253dc80f3512f346a2d36eebecf19dabf60423ea9fae78162a492ff8b7647339ad3dc5edfdedefe17ccfa0f41', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138804, 862, 3.5, 3.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc295130b45230d633cd4dd7cf4e57f00cd3f7f455283432010057e406b3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138805, 862, 4.0, 4.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc295130b25230c94dd7cf4e57f00cd3f7f455283432d13536cb000069120750', X'789ced5a5b53db4816fe2ba778d825157c07c278b35365c88d4a202e9c64b21553aeb6d4963b48dddaee9613ed14ff7dbf966c631b19196576f330f39002a9fb7ce77e13f97dcfd74930922ce27b5dda7bcda56591f084dc3ba0bd4487eee5d4dad8741b8d6fe2864775a503f79b68acdf359e6631f747cc3a9276b37d5c6bb66aade687e6b3ee51a77bf4acde69b73b479dec2ef7ac50d2e0e6ef8e25d72ccc7eb7fc7b46fe218d7977287b91902a08534f19e1f3a17ca10c0b38bd523a325d3abff8079d7f1aca3315454ad207cd7c4e975004674e36e1a5f2805e33cda214421e642fd94d2640325e95e116af2c1b87dc3d7db9c65328e44df67027d3ba30e5e6d9b87f7bedb8f4fc24b423e82164b0a6712f0ca1d184d4981b7e4089e1d4f3bf26c6729f7ee322985afa279d9ffe464fa9593fa4efb4dfc343cdbd7a024339eafc3e691e7366c9cf78d0981920c03c219ff1d01428bf70c0a8bd26d0cbef964b1fb4e7d2723d63e1501ed59e4541e32680d5e9dfedc3e950be121a1ca10eefd2caa9f3899c391728e9081107f5c5e145c3519f4cf7d66dee8cf3517a2a8a43e131683d7aada4f294e76d8446fbb019391898a0558031809a9a8ffae72fd6a85af5a30dfe4339b04c5b6aafbe07a633a6ed52a7b64e90a97b2e270ab125669cbe098b171ee2c4cfc36b53969d626a83fee1803a5bb99c47d3cff3dc660cfde5ba47baae92c136adfea7b2d84f55b64ac3f8417dfbdc17cc6ae16d6d17ec070bfefef393d10b969ad1fbd07fb2067f571d28e3d45e1af953c385236cf9bc7d42df38bf3114706399431fca8d7bb96d33abafbf3f745e6a9fd4dabf9463b44e1ec0e8346b9dceee18d482ffefcba8f3c376970e370e3bc7b59ccfe11fc964e3a8d639762c8ef0b39c0bb5da0fb12961f22a0943fac07554207e7b61e74dd2a25ebd8ca17908d546add1859276faf840ea341f13045b8cb7631c6cd57147176fa1cfc4dbd1815b34c9a033f7d842f76c35c083de993b65543bce7f31ebeed9cae4f87efc3ec4e6d75de0efa06bcf8aeac44704899b70c5847e6da7ea113d26ef0f31f70484e9ab3809d95db55b08d3d73c904c7a295de1540643d9a51743f98e79b9a7bad4d76a0c06291936c1b671c53102515e7c21bb9bdcd7c72312f3016b5e7b71aacf426a356b47cd2e05ae99c0ad7901c94e9eb796ef0f4f6acf9cc7dff048a1ce87a911667eb63273b10918d0e27c2897a35d316764c1313808e9698e36b06809cbcb1bbd61215507346ca684efd68ea15c369e9db4ed6cd3b6eb0cd1fe65de559122b5cccbbb18a211732dac92dc315b374efb271ae60d8f1129de3c24b081b990a0bfd1d260d8c42e153a319f08c9fdaa73c366a0960f0f2fdc0a9f5f362321474b84f92801375acd3060b871f35e62a030731da46415792133a6e1be083c4ef8f96e8b01cdf0d11567de7d2ec5f3ab162a59bff7de2aabbe0b4fd87428bfb4ae61521e4ff5ca4ba469a8649069426a4292275a4589f190f69ac6a1f26e204741b9ca3f14ac71bb64f02c6bcc5424f29a70ae11793934662a21bfe6f29211963fba22fd8fd5db34e7ff5bbf3f82df2363ac3f653a621e2c14a46b8cdfb070520bc58477dbb50e4d55a291c5171c582a1426eaba1281e4cf0bfd478dfc24be78e12e7a532671cf19bce7e5b74e9130c66545a73920267d3ac24f2dc6caa8083503922752587380326474123b7d29babaec11724d9a70aeb49cd7a409820117dc768172e3e10d8a17c5f03c1730478aeec9b352f6a57d5d25f950a5c742a13c8d065cc2ba62867fbc3c07dff275430e86d220d838f401b786998371da4f4cc2c23045913b1fca4ca7282b7c389a31689375ce1552edf4b14c5a505c0de5f291f69526893ac927132709b0ddaa84da94a30f9e428414934580fb28b799c93c8ec9e81b6ec0a20b4d61ac8fb8ba947002dc8f1fce51c721c9be7451961acb23600839c99506fe670c9d5291cf2cc3437b28592e04dc009b697540e3c4660226ae2bdcc986db9d076edf5d5cd1ccc9f45aab24a61e198b558d6284702a03886c08874bc90cf90977e1f6b24e13c601e4a2e1f361158e734e281d4850c11e4e6cb49e4cc2ecfbaf6611f5556e5047f65e07596264a1e150eb0b750ee8f480ce0ee8f55e56ea1631e7a269ef6a0f2c5660b720f51702f20a189f84163e122d57b600e0736b3729189c21152297824a302f5d2a649f6f00b1f05c01d0e0b13822892ac05c0c06bd2a64578564655e38ebd5b650ee607e164febf432163e4a89f00b8d765ec6bf4e5f39a6a1625b9549ffae4e91fbf4965a156097d9c56b59865c72d79f6739c12ae0659d02006a3d55bc52540320e2a8aeae3e145ba40ce14269f61dd59211863d06492a86e39bbaab4d61c2e57f0a35290de73aa14f8b0a946f433e36c2a9608a127247c68d3b187a39387df7b40ad43da4b7fdb322a032a7e4b99df77d131f502f8acf30d90595cbc40654acaab81803aa461c179bb93c7fe7d41431ed71f47d594906162205b73abb5c8aa9082a874adf8d5fa8b691d06c2c8af3a4548205c82c0903cc41558c008819aaa0f4604d13d7ab4881b4c74316a31511cedc7091c7154d344fb02e1665efa3707ce176c2a4925d57712aaad443a620ba1886844ac1d5f3b028d88785284bfdbee1893f978271acd66ed8601582e434d1375315fa6e73c03c1c334f14c194cf5e1cb3a356f1742e1496198b27847f15b87fc1bf984219f1f9f81282d8aba2df2bac4d9e3059085bb7ec3af22ad974aa13ef8144183cfd7bd958c003a17e2897fa0c8b47a2338828817d3dccaa5580de301e65ce49dc7e808535ad94939fc4580be54a941413e11526e4e6a875218c772f27a7218b523f9388152755e97c927a2a46bd8eeef6932a83d295f06eb8b546fc8018f33d3c8988cd8a07c87b86ed49e6baeffdc9cf7d35902a4abdc229b24c9ad34c12851e80d15fb3604b2f2aad359acfd08cb2a8e3215e4b37d716a763e9641f2a6c561842611e5f4c103522ace2a8559c7db7b52ec19e5489e4578959f19be45e56c974a5f1bfcf63abb2f5d12ef6aead35fefafe3797bf3e9dfc393e9d3cf253dc80f3512f346a2d36eebecf19dabf60423ea9fae78162a492ff8b7647339ad3dc5edfdedefe17ccfa0f41', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138806, 862, 2.5, 2.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d233cd4dd7cf4e57f00cd3f7f455283434ca00003480054b', X'789ced5a5b53db4816fe2ba778d825157c07c278b35365c88d4a202e9c64b21553aeb6d4963b48dddaee9613ed14ff7dbf966c631b19196576f330f39002a9fb7ce77e13f97dcfd74930922ce27b5dda7bcda56591f084dc3ba0bd4487eee5d4dad8741b8d6fe2864775a503f79b68acdf359e6631f747cc3a9276b37d5c6bb66aade687e6b3ee51a77bf4acde69b73b479dec2ef7ac50d2e0e6ef8e25d72ccc7eb7fc7b46fe218d7977287b91902a08534f19e1f3a17ca10c0b38bd523a325d3abff8079d7f1aca3315454ad207cd7c4e975004674e36e1a5f2805e33cda214421e642fd94d2640325e95e116af2c1b87dc3d7db9c65328e44df67027d3ba30e5e6d9b87f7bedb8f4fc24b423e82164b0a6712f0ca1d184d4981b7e4089e1d4f3bf26c6729f7ee322985afa279d9ffe464fa9593fa4efb4dfc343cdbd7a024339eafc3e691e7366c9cf78d0981920c03c219ff1d01428bf70c0a8bd26d0cbef964b1fb4e7d2723d63e1501ed59e4541e32680d5e9dfedc3e950be121a1ca10eefd2caa9f3899c391728e9081107f5c5e145c3519f4cf7d66dee8cf3517a2a8a43e131683d7aada4f294e76d8446fbb019391898a0558031809a9a8ffae72fd6a85af5a30dfe4339b04c5b6aafbe07a633a6ed52a7b64e90a97b2e270ab125669cbe098b171ee2c4cfc36b53969d626a83fee1803a5bb99c47d3cff3dc660cfde5ba47baae92c136adfea7b2d84f55b64ac3f8417dfbdc17cc6ae16d6d17ec070bfefef393d10b969ad1fbd07fb2067f571d28e3d45e1af953c385236cf9bc7d42df38bf3114706399431fca8d7bb96d33abafbf3f745e6a9fd4dabf9463b44e1ec0e8346b9dceee18d482ffefcba8f3c376970e370e3bc7b59ccfe11fc964e3a8d639762c8ef0b39c0bb5da0fb12961f22a0943fac07554207e7b61e74dd2a25ebd8ca17908d546add1859276faf840ea341f13045b8cb7631c6cd57147176fa1cfc4dbd1815b34c9a033f7d842f76c35c083de993b65543bce7f31ebeed9cae4f87efc3ec4e6d75de0efa06bcf8aeac44704899b70c5847e6da7ea113d26ef0f31f70484e9ab3809d95db55b08d3d73c904c7a295de1540643d9a51743f98e79b9a7bad4d76a0c06291936c1b671c53102515e7c21bb9bdcd7c72312f3016b5e7b71aacf426a356b47cd2e05ae99c0ad7901c94e9eb796ef0f4f6acf9cc7dff048a1ce87a911667eb63273b10918d0e27c2897a35d316764c1313808e9698e36b06809cbcb1bbd61215507346ca684efd68ea15c369e9db4ed6cd3b6eb0cd1fe65de559122b5cccbbb18a211732dac92dc315b374efb271ae60d8f1129de3c24b081b990a0bfd1d260d8c42e153a319f08c9fdaa73c366a0960f0f2fdc0a9f5f362321474b84f92801375acd3060b871f35e62a030731da46415792133a6e1be083c4ef8f96e8b01cdf0d11567de7d2ec5f3ab162a59bff7de2aabbe0b4fd87428bfb4ae61521e4ff5ca4ba469a8649069426a4292275a4589f190f69ac6a1f26e204741b9ca3f14ac71bb64f02c6bcc5424f29a70ae11793934662a21bfe6f29211963fba22fd8fd5db34e7ff5bbf3f82df2363ac3f653a621e2c14a46b8cdfb070520bc58477dbb50e4d55a291c5171c582a1426eaba1281e4cf0bfd478dfc24be78e12e7a532671cf19bce7e5b74e9130c66545a73920267d3ac24f2dc6caa8083503922752587380326474123b7d29babaec11724d9a70aeb49cd7a409820117dc768172e3e10d8a17c5f03c1730478aeec9b352f6a57d5d25f950a5c742a13c8d065cc2ba62867fbc3c07dff275430e86d220d838f401b786998371da4f4cc2c23045913b1fca4ca7282b7c389a31689375ce1552edf4b14c5a505c0de5f291f69526893ac927132709b0ddaa84da94a30f9e428414934580fb28b799c93c8ec9e81b6ec0a20b4d61ac8fb8ba947002dc8f1fce51c721c9be7451961acb23600839c99506fe670c9d5291cf2cc3437b28592e04dc009b697540e3c4660226ae2bdcc986db9d076edf5d5cd1ccc9f45aab24a61e198b558d6284702a03886c08874bc90cf90977e1f6b24e13c601e4a2e1f361158e734e281d4850c11e4e6cb49e4cc2ecfbaf6611f5556e5047f65e07596264a1e150eb0b750ee8f480ce0ee8f55e56ea1631e7a269ef6a0f2c5660b720f51702f20a189f84163e122d57b600e0736b3729189c21152297824a302f5d2a649f6f00b1f05c01d0e0b13822892ac05c0c06bd2a64578564655e38ebd5b650ee607e164febf432163e4a89f00b8d765ec6bf4e5f39a6a1625b9549ffae4e91fbf4965a156097d9c56b59865c72d79f6739c12ae0659d02006a3d55bc52540320e2a8aeae3e145ba40ce14269f61dd59211863d06492a86e39bbaab4d61c2e57f0a35290de73aa14f8b0a946f433e36c2a9608a127247c68d3b187a39387df7b40ad43da4b7fdb322a032a7e4b99df77d131f502f8acf30d90595cbc40654acaab81803aa461c179bb93c7fe7d41431ed71f47d594906162205b73abb5c8aa9082a874adf8d5fa8b691d06c2c8af3a4548205c82c0903cc41558c008819aaa0f4604d13d7ab4881b4c74316a31511cedc7091c7154d344fb02e1665efa3707ce176c2a4925d57712aaad443a620ba1886844ac1d5f3b028d88785284bfdbee1893f978271acd66ed8601582e434d1375315fa6e73c03c1c334f14c194cf5e1cb3a356f1742e1496198b27847f15b87fc1bf984219f1f9f81282d8aba2df2bac4d9e3059085bb7ec3af22ad974aa13ef8144183cfd7bd958c003a17e2897fa0c8b47a2338828817d3dccaa5580de301e65ce49dc7e808535ad94939fc4580be54a941413e11526e4e6a875218c772f27a7218b523f9388152755e97c927a2a46bd8eeef6932a83d295f06eb8b546fc8018f33d3c8988cd8a07c87b86ed49e6baeffdc9cf7d35902a4abdc229b24c9ad34c12851e80d15fb3604b2f2aad359acfd08cb2a8e3215e4b37d716a763e9641f2a6c561842611e5f4c103522ace2a8559c7db7b52ec19e5489e4578959f19be45e56c974a5f1bfcf63abb2f5d12ef6aead35fefafe3797bf3e9dfc393e9d3cf253dc80f3512f346a2d36eebecf19dabf60423ea9fae78162a492ff8b7647339ad3dc5edfdedefe17ccfa0f41', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138807, 862, 4.0, 4.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc29b15230c94dd7cf4e57f00cd3f7f455283432c900004b970668', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138808, 862, 2.5, 2.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4e5570ccc9b15230d233cd4dd7cf4e57f00cd3f7f455a8300400b3f709fe', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138809, 862, 2.5, 2.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d233cd4dd7cf4e57f00cd3f7f4552834b4c80000348c0551', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138810, 862, 4.0, 4.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc29b15230c94dd7cf4e57f00cd3f7f455283432d13536cb00005f5006fe', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138811, 862, 2.5, 2.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d233cd4dd7cf4e57f00cd3f7f455283434ca00003480054b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138812, 862, 4.0, 4.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc29b15230c94dd7cf4e57f00cd3f7f4552834320100452f0600', X'789ced5a5b53db4816fe2ba778d825157c07c278b35365c88d4a202e9c64b21553aeb6d4963b48dddaee9613ed14ff7dbf966c631b19196576f330f39002a9fb7ce77e13f97dcfd74930922ce27b5dda7bcda56591f084dc3ba0bd4487eee5d4dad8741b8d6fe2864775a503f79b68acdf359e6631f747cc3a9276b37d5c6bb66aade687e6b3ee51a77bf4acde69b73b479dec2ef7ac50d2e0e6ef8e25d72ccc7eb7fc7b46fe218d7977287b91902a08534f19e1f3a17ca10c0b38bd523a325d3abff8079d7f1aca3315454ad207cd7c4e975004674e36e1a5f2805e33cda214421e642fd94d2640325e95e116af2c1b87dc3d7db9c65328e44df67027d3ba30e5e6d9b87f7bedb8f4fc24b423e82164b0a6712f0ca1d184d4981b7e4089e1d4f3bf26c6729f7ee322985afa279d9ffe464fa9593fa4efb4dfc343cdbd7a024339eafc3e691e7366c9cf78d0981920c03c219ff1d01428bf70c0a8bd26d0cbef964b1fb4e7d2723d63e1501ed59e4541e32680d5e9dfedc3e950be121a1ca10eefd2caa9f3899c391728e9081107f5c5e145c3519f4cf7d66dee8cf3517a2a8a43e131683d7aada4f294e76d8446fbb019391898a0558031809a9a8ffae72fd6a85af5a30dfe4339b04c5b6aafbe07a633a6ed52a7b64e90a97b2e270ab125669cbe098b171ee2c4cfc36b53969d626a83fee1803a5bb99c47d3cff3dc660cfde5ba47baae92c136adfea7b2d84f55b64ac3f8417dfbdc17cc6ae16d6d17ec070bfefef393d10b969ad1fbd07fb2067f571d28e3d45e1af953c385236cf9bc7d42df38bf3114706399431fca8d7bb96d33abafbf3f745e6a9fd4dabf9463b44e1ec0e8346b9dceee18d482ffefcba8f3c376970e370e3bc7b59ccfe11fc964e3a8d639762c8ef0b39c0bb5da0fb12961f22a0943fac07554207e7b61e74dd2a25ebd8ca17908d546add1859276faf840ea341f13045b8cb7631c6cd57147176fa1cfc4dbd1815b34c9a033f7d842f76c35c083de993b65543bce7f31ebeed9cae4f87efc3ec4e6d75de0efa06bcf8aeac44704899b70c5847e6da7ea113d26ef0f31f70484e9ab3809d95db55b08d3d73c904c7a295de1540643d9a51743f98e79b9a7bad4d76a0c06291936c1b671c53102515e7c21bb9bdcd7c72312f3016b5e7b71aacf426a356b47cd2e05ae99c0ad7901c94e9eb796ef0f4f6acf9cc7dff048a1ce87a911667eb63273b10918d0e27c2897a35d316764c1313808e9698e36b06809cbcb1bbd61215507346ca684efd68ea15c369e9db4ed6cd3b6eb0cd1fe65de559122b5cccbbb18a211732dac92dc315b374efb271ae60d8f1129de3c24b081b990a0bfd1d260d8c42e153a319f08c9fdaa73c366a0960f0f2fdc0a9f5f362321474b84f92801375acd3060b871f35e62a030731da46415792133a6e1be083c4ef8f96e8b01cdf0d11567de7d2ec5f3ab162a59bff7de2aabbe0b4fd87428bfb4ae61521e4ff5ca4ba469a8649069426a4292275a4589f190f69ac6a1f26e204741b9ca3f14ac71bb64f02c6bcc5424f29a70ae11793934662a21bfe6f29211963fba22fd8fd5db34e7ff5bbf3f82df2363ac3f653a621e2c14a46b8cdfb070520bc58477dbb50e4d55a291c5171c582a1426eaba1281e4cf0bfd478dfc24be78e12e7a532671cf19bce7e5b74e9130c66545a73920267d3ac24f2dc6caa8083503922752587380326474123b7d29babaec11724d9a70aeb49cd7a409820117dc768172e3e10d8a17c5f03c1730478aeec9b352f6a57d5d25f950a5c742a13c8d065cc2ba62867fbc3c07dff275430e86d220d838f401b786998371da4f4cc2c23045913b1fca4ca7282b7c389a31689375ce1552edf4b14c5a505c0de5f291f69526893ac927132709b0ddaa84da94a30f9e428414934580fb28b799c93c8ec9e81b6ec0a20b4d61ac8fb8ba947002dc8f1fce51c721c9be7451961acb23600839c99506fe670c9d5291cf2cc3437b28592e04dc009b697540e3c4660226ae2bdcc986db9d076edf5d5cd1ccc9f45aab24a61e198b558d6284702a03886c08874bc90cf90977e1f6b24e13c601e4a2e1f361158e734e281d4850c11e4e6cb49e4cc2ecfbaf6611f5556e5047f65e07596264a1e150eb0b750ee8f480ce0ee8f55e56ea1631e7a269ef6a0f2c5660b720f51702f20a189f84163e122d57b600e0736b3729189c21152297824a302f5d2a649f6f00b1f05c01d0e0b13822892ac05c0c06bd2a64578564655e38ebd5b650ee607e164febf432163e4a89f00b8d765ec6bf4e5f39a6a1625b9549ffae4e91fbf4965a156097d9c56b59865c72d79f6739c12ae0659d02006a3d55bc52540320e2a8aeae3e145ba40ce14269f61dd59211863d06492a86e39bbaab4d61c2e57f0a35290de73aa14f8b0a946f433e36c2a9608a127247c68d3b187a39387df7b40ad43da4b7fdb322a032a7e4b99df77d131f502f8acf30d90595cbc40654acaab81803aa461c179bb93c7fe7d41431ed71f47d594906162205b73abb5c8aa9082a874adf8d5fa8b691d06c2c8af3a4548205c82c0903cc41558c008819aaa0f4604d13d7ab4881b4c74316a31511cedc7091c7154d344fb02e1665efa3707ce176c2a4925d57712aaad443a620ba1886844ac1d5f3b028d88785284bfdbee1893f978271acd66ed8601582e434d1375315fa6e73c03c1c334f14c194cf5e1cb3a356f1742e1496198b27847f15b87fc1bf984219f1f9f81282d8aba2df2bac4d9e3059085bb7ec3af22ad974aa13ef8144183cfd7bd958c003a17e2897fa0c8b47a2338828817d3dccaa5580de301e65ce49dc7e808535ad94939fc4580be54a941413e11526e4e6a875218c772f27a7218b523f9388152755e97c927a2a46bd8eeef6932a83d295f06eb8b546fc8018f33d3c8988cd8a07c87b86ed49e6baeffdc9cf7d35902a4abdc229b24c9ad34c12851e80d15fb3604b2f2aad359acfd08cb2a8e3215e4b37d716a763e9641f2a6c561842611e5f4c103522ace2a8559c7db7b52ec19e5489e4578959f19be45e56c974a5f1bfcf63abb2f5d12ef6aead35fefafe3797bf3e9dfc393e9d3cf253dc80f3512f346a2d36eebecf19dabf60423ea9fae78162a492ff8b7647339ad3dc5edfdedefe17ccfa0f41', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138813, 862, 2.5, 2.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d233cd4dd7cf4e57f00cd3f7f455283434ca00003480054b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138814, 862, 4.0, 4.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc29b15230c94dd7cf4e57f00cd3f7f4552834b4c800004b9c066b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138815, 862, 2.5, 2.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d233cd4dd7cf4e57f00cd3f7f45528b4c800002f790520', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138816, 862, 4.0, 4.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc29b15230c94dd7cf4e57f00cd3f7f455283434ca00004b900665', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138817, 862, 2.5, 2.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d233cd4dd7cf4e57f00cd3f7f45528b4c800002f790520', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138818, 862, 4.0, 4.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc29b15230c94dd7cf4e57f00cd3f7f455283432c900004b970668', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138819, 862, 2.5, 2.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d233cd4dd7cf4e57f00cd3f7f45528b4c800002f790520', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138820, 862, 6.5, 6.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc29b15230d333cd4dd7cf4e57f00cd3f7f455283432c9000055de06cd', X'789ced5a5b53db4816fe2ba778d825157c07c278b35365c88d4a202e9c64b21553aeb6d4963b48dddaee9613ed14ff7dbf966c631b19196576f330f39002a9fb7ce77e13f97dcfd74930922ce27b5dda7bcda56591f084dc3ba0bd4487eee5d4dad8741b8d6fe2864775a503f79b68acdf359e6631f747cc3a9276b37d5c6bb66aade687e6b3ee51a77bf4acde69b73b479dec2ef7ac50d2e0e6ef8e25d72ccc7eb7fc7b46fe218d7977287b91902a08534f19e1f3a17ca10c0b38bd523a325d3abff8079d7f1aca3315454ad207cd7c4e975004674e36e1a5f2805e33cda214421e642fd94d2640325e95e116af2c1b87dc3d7db9c65328e44df67027d3ba30e5e6d9b87f7bedb8f4fc24b423e82164b0a6712f0ca1d184d4981b7e4089e1d4f3bf26c6729f7ee322985afa279d9ffe464fa9593fa4efb4dfc343cdbd7a024339eafc3e691e7366c9cf78d0981920c03c219ff1d01428bf70c0a8bd26d0cbef964b1fb4e7d2723d63e1501ed59e4541e32680d5e9dfedc3e950be121a1ca10eefd2caa9f3899c391728e9081107f5c5e145c3519f4cf7d66dee8cf3517a2a8a43e131683d7aada4f294e76d8446fbb019391898a0558031809a9a8ffae72fd6a85af5a30dfe4339b04c5b6aafbe07a633a6ed52a7b64e90a97b2e270ab125669cbe098b171ee2c4cfc36b53969d626a83fee1803a5bb99c47d3cff3dc660cfde5ba47baae92c136adfea7b2d84f55b64ac3f8417dfbdc17cc6ae16d6d17ec070bfefef393d10b969ad1fbd07fb2067f571d28e3d45e1af953c385236cf9bc7d42df38bf3114706399431fca8d7bb96d33abafbf3f745e6a9fd4dabf9463b44e1ec0e8346b9dceee18d482ffefcba8f3c376970e370e3bc7b59ccfe11fc964e3a8d639762c8ef0b39c0bb5da0fb12961f22a0943fac07554207e7b61e74dd2a25ebd8ca17908d546add1859276faf840ea341f13045b8cb7631c6cd57147176fa1cfc4dbd1815b34c9a033f7d842f76c35c083de993b65543bce7f31ebeed9cae4f87efc3ec4e6d75de0efa06bcf8aeac44704899b70c5847e6da7ea113d26ef0f31f70484e9ab3809d95db55b08d3d73c904c7a295de1540643d9a51743f98e79b9a7bad4d76a0c06291936c1b671c53102515e7c21bb9bdcd7c72312f3016b5e7b71aacf426a356b47cd2e05ae99c0ad7901c94e9eb796ef0f4f6acf9cc7dff048a1ce87a911667eb63273b10918d0e27c2897a35d316764c1313808e9698e36b06809cbcb1bbd61215507346ca684efd68ea15c369e9db4ed6cd3b6eb0cd1fe65de559122b5cccbbb18a211732dac92dc315b374efb271ae60d8f1129de3c24b081b990a0bfd1d260d8c42e153a319f08c9fdaa73c366a0960f0f2fdc0a9f5f362321474b84f92801375acd3060b871f35e62a030731da46415792133a6e1be083c4ef8f96e8b01cdf0d11567de7d2ec5f3ab162a59bff7de2aabbe0b4fd87428bfb4ae61521e4ff5ca4ba469a8649069426a4292275a4589f190f69ac6a1f26e204741b9ca3f14ac71bb64f02c6bcc5424f29a70ae11793934662a21bfe6f29211963fba22fd8fd5db34e7ff5bbf3f82df2363ac3f653a621e2c14a46b8cdfb070520bc58477dbb50e4d55a291c5171c582a1426eaba1281e4cf0bfd478dfc24be78e12e7a532671cf19bce7e5b74e9130c66545a73920267d3ac24f2dc6caa8083503922752587380326474123b7d29babaec11724d9a70aeb49cd7a409820117dc768172e3e10d8a17c5f03c1730478aeec9b352f6a57d5d25f950a5c742a13c8d065cc2ba62867fbc3c07dff275430e86d220d838f401b786998371da4f4cc2c23045913b1fca4ca7282b7c389a31689375ce1552edf4b14c5a505c0de5f291f69526893ac927132709b0ddaa84da94a30f9e428414934580fb28b799c93c8ec9e81b6ec0a20b4d61ac8fb8ba947002dc8f1fce51c721c9be7451961acb23600839c99506fe670c9d5291cf2cc3437b28592e04dc009b697540e3c4660226ae2bdcc986db9d076edf5d5cd1ccc9f45aab24a61e198b558d6284702a03886c08874bc90cf90977e1f6b24e13c601e4a2e1f361158e734e281d4850c11e4e6cb49e4cc2ecfbaf6611f5556e5047f65e07596264a1e150eb0b750ee8f480ce0ee8f55e56ea1631e7a269ef6a0f2c5660b720f51702f20a189f84163e122d57b600e0736b3729189c21152297824a302f5d2a649f6f00b1f05c01d0e0b13822892ac05c0c06bd2a64578564655e38ebd5b650ee607e164febf432163e4a89f00b8d765ec6bf4e5f39a6a1625b9549ffae4e91fbf4965a156097d9c56b59865c72d79f6739c12ae0659d02006a3d55bc52540320e2a8aeae3e145ba40ce14269f61dd59211863d06492a86e39bbaab4d61c2e57f0a35290de73aa14f8b0a946f433e36c2a9608a127247c68d3b187a39387df7b40ad43da4b7fdb322a032a7e4b99df77d131f502f8acf30d90595cbc40654acaab81803aa461c179bb93c7fe7d41431ed71f47d594906162205b73abb5c8aa9082a874adf8d5fa8b691d06c2c8af3a4548205c82c0903cc41558c008819aaa0f4604d13d7ab4881b4c74316a31511cedc7091c7154d344fb02e1665efa3707ce176c2a4925d57712aaad443a620ba1886844ac1d5f3b028d88785284bfdbee1893f978271acd66ed8601582e434d1375315fa6e73c03c1c334f14c194cf5e1cb3a356f1742e1496198b27847f15b87fc1bf984219f1f9f81282d8aba2df2bac4d9e3059085bb7ec3af22ad974aa13ef8144183cfd7bd958c003a17e2897fa0c8b47a2338828817d3dccaa5580de301e65ce49dc7e808535ad94939fc4580be54a941413e11526e4e6a875218c772f27a7218b523f9388152755e97c927a2a46bd8eeef6932a83d295f06eb8b546fc8018f33d3c8988cd8a07c87b86ed49e6baeffdc9cf7d35902a4abdc229b24c9ad34c12851e80d15fb3604b2f2aad359acfd08cb2a8e3215e4b37d716a763e9641f2a6c561842611e5f4c103522ace2a8559c7db7b52ec19e5489e4578959f19be45e56c974a5f1bfcf63abb2f5d12ef6aead35fefafe3797bf3e9dfc393e9d3cf253dc80f3512f346a2d36eebecf19dabf60423ea9fae78162a492ff8b7647339ad3dc5edfdedefe17ccfa0f41', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138821, 862, 2.5, 2.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d233cd4dd7cf4e57f00cd3f7f405001d1203ef', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138822, 862, 6.5, 7.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc29b15230d333d535d733cd4dd7cf4e57f00cd3f7f455283432c900006c8c0794', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138823, 2323, 200.0, 400.0, 'mg', 'PO', NULL, 'Adult', X'789c333230d0353130c84d5708f057283434ca0000234b0443', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138824, 2323, 300.0, 300.0, 'mg', 'PO', NULL, 'Adult', X'789c333630c84d5708f057283434ca50a850304f01002ce304d6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138825, 2323, 300.0, 300.0, 'mg', 'PO', NULL, 'Adult', X'789c333630c84d5708f057283434ca50a850304f01002ce304d6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138826, 2323, 300.0, 300.0, 'mg', 'PO', NULL, 'Adult', X'789c333630c84d5708f057283434ca50a850303448010031a30500', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138827, 2323, 400.0, 400.0, 'mg', 'PO', NULL, 'Adult', X'789c333130c84d5708f057283434ca50a85030d735344901003bfd0569', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138828, 2323, 400.0, 400.0, 'mg', 'PO', 2, 'Pediatric', X'789cb33334aa2c2ab652303130c84d5708f05770f27451a8503034490100603006f1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138829, 2323, 20.0, 20.0, 'mg/kg', NULL, 2, 'Pediatric', X'789c3332c84dd7cf4e5770f27451a850303448d151c84dac5030310089a7e417a702009b540998', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138830, 353, 5.0, 10.0, 'mg', 'PO', NULL, 'Adult', X'789c33d53534c84d5708f057287449cccca90400241c04db', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138831, 353, 5.0, 5.0, 'mg', 'PO', NULL, 'Adult', X'789c0dca310a80300c05d0abfc038843a18bb3bb82270834d5406c3546a1b7b7d35bdee6643e219e3bd605f74ca20db91aa4b890823a47bbd89c9f221f0f4815618c900cd6c4d67bdfa124a81446b277ff01da6d1d42', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138832, 353, 2.5, 5.0, 'mg', 'PO', NULL, 'Pediatric', X'789c33d233d535cd4d5708f057287449cccca904002780050f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138833, 260, 50.0, 50.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db652704e2c503035c84dd7513037cd4db756700d020b191900c5001c130c7a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138834, 260, 50.0, 50.0, 'mg', 'PO', NULL, 'Adult', X'789c3335c84d5708f0572834d3b5c8000018a8038d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138835, 260, 300.0, 300.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb052303630c84dd74f49ac04001ede0455', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138836, 260, 75.0, 75.0, 'mg', 'PO', 1, 'Adult', X'789c3337cd4d5708f05708f17451c82f52303580700b3353405c230310df350824949298995309003c6b0da8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138837, 260, 300.0, 300.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb052303630c84dd74f49ac04001ede0455', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138838, 260, 75.0, 75.0, 'mg', 'PO', 1, 'Adult', X'789c3337cd4d5708f05708f17451c82f52303580700b3353405c230310df350824949298995309003c6b0da8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138839, 260, 300.0, 300.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb052303630c84dd74f49ac04001ede0455', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138840, 260, 50.0, 50.0, 'mg', 'PO', NULL, 'Adult', X'789c3335c84d5708f0572834d3b5c8000018a8038d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138841, 260, 300.0, 300.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb052303630c84dd74f49ac04001ede0455', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138842, 260, 50.0, 100.0, 'mg', 'PO', 3, 'Adult', X'789c3335d0353430c84d5708f05708f17451a830d73534514849ac2c0600558f06ea', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138843, 260, 300.0, 300.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb052303630c84dd74f49ac04001ede0455', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138844, 260, 150.0, 150.0, 'mg', NULL, NULL, 'Adult', X'789cf3cdcc4951f0cc2d48cc2cca4dcd2bb152f04dac5030343550c84dd74f49ac0400aae30a54', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138845, 260, 100.0, 100.0, 'mg', NULL, NULL, 'Adult', X'789c732e72ce51b03132b552f04dac5030343050c84dd74f49ac0400508a06ba', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138846, 260, 100.0, 100.0, 'mg', NULL, NULL, 'Adult', X'789c734c29cd29b152f04dac5030343050c84dd74f49ac5428cf2cc950c8482d482cc94c56c8cc2d48cc2cca4dcd2b010053e60fbd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138847, 260, 100.0, 100.0, 'mg', NULL, NULL, 'Adult', X'789c734c29cd29b152f04dac5030343050c84dd74f49ac5428cf2cc950c8482d482cc94c56c8cc2d48cc2cca4dcd2b010053e60fbd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138848, 1667, 50.0, 100.0, 'mg', NULL, NULL, 'Adult', X'789c3335d0353430c84d57c8c94f4cc9cc4b5748c92f4ed5513032050a159ae89a296414152ba4e5172998588098004ea80e3d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138849, 1667, 25.0, 25.0, 'mg', 'PO', 2, 'Adult', X'789c3332cd4d5708f05770f274d10df174d151c84dac50303230c84dd74f49acd45148cf2c4b5528cf2cc95048cbcf4f010030f30e18', X'789ced58616f1b3712fd2b0303057a80144b8a95b46a7180625f121549aa464281c3a958d0cb9196672eb921b98eb785ff7b1f7765492b2b559ce6c31de00f867797f386c3376fc8a1fe3891ae5c2546e47c32a293899136e790895499930e9d944ec7cf5908851f9d9e7e54579c3fb16e159fd4e9beb54f9d2858262244d0a03778d6edf5bbfddebcf77c341c8e06c327cf7acf07fdef6b5b4e83b2c6c3f28f93576cd8095d3f07bea9e1f3aae0d1c2bc9b8d27170b7361bd5831bdb42ef7239afe4cdfd618959232341892309286bd7c45415cfa7f2cccb9cd736b68ee84647a87d50115c3bd8bb4bcdc0de0169f00d41cdffef31bdeb43257f5cb36a03a92e3a43466b7bf459f6359ea9020766556adc51d88e164ea38b0cb132d2ead3b9ddbd4eaca2bdfc20d7ba0332e535b21e194a4f5dc0101f8f4e1acfb8c32e769691d9d7d171f17e6671fd80a1732a782c23b18ad8dc1e08bc945773eb9e8502e6e6810bd9e4a517568a5ae993eaa90c191950bf3ca96a1e677eab9947685d7da4f4d37fcd43e0212efea68081a5052570b33365795aed74eb3c21a59e97b315c2ad90d4aeec5b030ef332e7311ac92343e18fc61e0493b8fb79f95d73645c713bc678f39b6be0e7075dc61042500253ba096d7c3441e77bcc525bbb896ef434c1ff7bc45255b54a3f947197f15197fc90ef5a8e4afab64964a049c318776f0a9086c02c9320da5279088c3c8fab249ef8f51b7b67464b51c910f18a6de9301b27bb5a2c9af74437d682d6383affde6eb87fea03b38cb3034803cbacf093af00d7ef697f8c101fc3fe901f8e101078785dbef362ea246a37aa5ba5692655d82bfdc95e0d9d6a42c2858eaa3daffb6b43f45f7f10437c8a441263bc8af2b1eb1279e59c1a9123a99daa2d4627bca6f16e4786584492b7a8f51b3826ee8c5c2bc1169a8ad4754387b095a2af262c948091ba1a9512236a5d8598cc85812f2bfa50f39d6b8301bc5de1b79cd05dca6f7f1e09497ca30f6a054947166e0ae95475ad592b2354ce58550eec0240f857f71fef7e83a9e9b8bd8d736c63e5126d9785827e8dc9ae0843252a507d233d69addaa8afa4db5f0fe34b6c9a06d36261c4b758fd705b64cb150e1b3908bf8bd7458ad704a80a54dc04f9d24d0851614d25b988959368bef50890818f294f4ad616bf0145bd7314671748110aecfc6ddb179e66c7e69d32ad8828d12adc1732b566badd185f2d6499c65bb06ef387536a8dfa357e4825d3c9ca3665b56ae16da36651df26a65d4122b4305ee5a4e4b8d265bb88aa007f67be1cc19fc6a0b12ed925e0aad6d74c5d7ecb8bd5e1b59a31427d15afb07cdcec72f5e912fdd8a315f118b5852e9511877ba83dec0bd54f65af8143ce01c870ec59e49866b05f600e3f1de1a387ffdb2f5bed4253683d8cc98b06ffb6ab24d4f4cbb4ec174a67cb0aeda3134c41a394009c732801fdff22239aba413f7bc7b2ebc6a9b0a1fb25cb43e617bd0d6acb866e16165b5be9b8062cfc97b16e97dfd1fbaa0cc22e965dbaed84820e3dc3a97c55bda6eda76a8aa5fc03e1abb7ad1a7356f0bf376b230b3e0ec156f04cef8d3cae70bd3ce579da466279ca23fd33ace5ccbba666c9c9681a9197f29942e1dafb73e1bec8d4a55a8e2541097e9fe6433e341a5af8cc49c1c1b3dce63e9ee175987eed65387131f5db46cadb38ef34ae8bd81fd1b49bdf1c4ab698b4559f922261d931b8174e2bfb8c4dd5ac585a00ea33e9085a08ab55a321652a4198296ea77d4337bc4e6b01161156fe69df16c0ee9f1f5dafa9e94b1291a1562b3925a671893482e4061146891812b1f09c73604c2bee84eb593f5cfe81a27c9c6b87528bf9d1c07c3a68581428e83a251bb2fbd2f9ccf684a2328a941c91da8e5f5134a3beeb901266b60b201b6bc7f5aa6c727d8c7de352d8f15fe4515bebf533e96f86389ff8f96f8ffa1341fd8d84c33e17281ce16ad676b9daf855e76b55af288ce9e0ceb0bbaef50bcf6f69b97d8b16d3782b78c59ea3d6a44f4062db9fb81ceff3d3d1bf63a3438ff9e6258e8700368f8d74d8af5d5b7b6d2810f7ad6fba643e8f3d9d3d3a7df445f69260c5cc55e789c36a67c83ce8bf2cd5069ae8cfd88ee57994c5d820e4aab545b7b53ad20c0f8039963dc3862d389e6cf07b1d2021930f5cf34a149f78dc0ec10132ef7beb9c13e90bd197332d6deb698abef3b74b7c1fead1fd05b5e3ee397f464630ffddedefe096c65a59b', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138850, 1667, 50.0, 50.0, 'mg', 'PO', 3, 'Adult', X'789c3335c84d5708f05708f174d15128492c482d5248c92f4e55284a2cc84cc9a9040094c90a42', X'789ced58616f1b3712fd2b0303057a80144b8a95b46a7180625f121549aa464281c3a958d0cb9196672eb921b98eb785ff7b1f7765492b2b559ce6c31de00f867797f386c3376fc8a1fe3891ae5c2546e47c32a293899136e790895499930e9d944ec7cf5908851f9d9e7e54579c3fb16e159fd4e9beb54f9d2858262244d0a03778d6edf5bbfddebcf77c341c8e06c327cf7acf07fdef6b5b4e83b2c6c3f28f93576cd8095d3f07bea9e1f3aae0d1c2bc9b8d27170b7361bd5831bdb42ef7239afe4cdfd618959232341892309286bd7c45415cfa7f2cccb9cd736b68ee84647a87d50115c3bd8bb4bcdc0de0169f00d41cdffef31bdeb43257f5cb36a03a92e3a43466b7bf459f6359ea9020766556adc51d88e164ea38b0cb132d2ead3b9ddbd4eaca2bdfc20d7ba0332e535b21e194a4f5dc0101f8f4e1acfb8c32e769691d9d7d171f17e6671fd80a1732a782c23b18ad8dc1e08bc945773eb9e8502e6e6810bd9e4a517568a5ae993eaa90c191950bf3ca96a1e677eab9947685d7da4f4d37fcd43e0212efea68081a5052570b33365795aed74eb3c21a59e97b315c2ad90d4aeec5b030ef332e7311ac92343e18fc61e0493b8fb79f95d73645c713bc678f39b6be0e7075dc61042500253ba096d7c3441e77bcc525bbb896ef434c1ff7bc45255b54a3f947197f15197fc90ef5a8e4afab64964a049c318776f0a9086c02c9320da5279088c3c8fab249ef8f51b7b67464b51c910f18a6de9301b27bb5a2c9af74437d682d6383affde6eb87fea03b38cb3034803cbacf093af00d7ef697f8c101fc3fe901f8e101078785dbef362ea246a37aa5ba5692655d82bfdc95e0d9d6a42c2858eaa3daffb6b43f45f7f10437c8a441263bc8af2b1eb1279e59c1a9123a99daa2d4627bca6f16e4786584492b7a8f51b3826ee8c5c2bc1169a8ad4754387b095a2af262c948091ba1a9512236a5d8598cc85812f2bfa50f39d6b8301bc5de1b79cd05dca6f7f1e09497ca30f6a054947166e0ae95475ad592b2354ce58550eec0240f857f71fef7e83a9e9b8bd8d736c63e5126d9785827e8dc9ae0843252a507d233d69addaa8afa4db5f0fe34b6c9a06d36261c4b758fd705b64cb150e1b3908bf8bd7458ad704a80a54dc04f9d24d0851614d25b988959368bef50890818f294f4ad616bf0145bd7314671748110aecfc6ddb179e66c7e69d32ad8828d12adc1732b566badd185f2d6499c65bb06ef387536a8dfa357e4825d3c9ca3665b56ae16da36651df26a65d4122b4305ee5a4e4b8d265bb88aa007f67be1cc19fc6a0b12ed925e0aad6d74c5d7ecb8bd5e1b59a31427d15afb07cdcec72f5e912fdd8a315f118b5852e9511877ba83dec0bd54f65af8143ce01c870ec59e49866b05f600e3f1de1a387ffdb2f5bed4253683d8cc98b06ffb6ab24d4f4cbb4ec174a67cb0aeda3134c41a394009c732801fdff22239aba413f7bc7b2ebc6a9b0a1fb25cb43e617bd0d6acb866e16165b5be9b8062cfc97b16e97dfd1fbaa0cc22e965dbaed84820e3dc3a97c55bda6eda76a8aa5fc03e1abb7ad1a7356f0bf376b230b3e0ec156f04cef8d3cae70bd3ce579da466279ca23fd33ace5ccbba666c9c9681a9197f29942e1dafb73e1bec8d4a55a8e2541097e9fe6433e341a5af8cc49c1c1b3dce63e9ee175987eed65387131f5db46cadb38ef34ae8bd81fd1b49bdf1c4ab698b4559f922261d931b8174e2bfb8c4dd5ac585a00ea33e9085a08ab55a321652a4198296ea77d4337bc4e6b01161156fe69df16c0ee9f1f5dafa9e94b1291a1562b3925a671893482e4061146891812b1f09c73604c2bee84eb593f5cfe81a27c9c6b87528bf9d1c07c3a68581428e83a251bb2fbd2f9ccf684a2328a941c91da8e5f5134a3beeb901266b60b201b6bc7f5aa6c727d8c7de352d8f15fe4515bebf533e96f86389ff8f96f8ffa1341fd8d84c33e17281ce16ad676b9daf855e76b55af288ce9e0ceb0bbaef50bcf6f69b97d8b16d3782b78c59ea3d6a44f4062db9fb81ceff3d3d1bf63a3438ff9e6258e8700368f8d74d8af5d5b7b6d2810f7ad6fba643e8f3d9d3d3a7df445f69260c5cc55e789c36a67c83ce8bf2cd5069ae8cfd88ee57994c5d820e4aab545b7b53ad20c0f8039963dc3862d389e6cf07b1d2021930f5cf34a149f78dc0ec10132ef7beb9c13e90bd197332d6deb698abef3b74b7c1fead1fd05b5e3ee397f464630ffddedefe096c65a59b', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138851, 1667, 25.0, 25.0, 'mg', 'PO', 2, 'Adult', X'789c3332cd4d5708f05748ca4cd12dc94cd151c84dac50303230c84dd74f49ac04008ac4093d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138852, 1667, 25.0, 25.0, 'mg', 'PO', 2, 'Adult', X'789c3332cd4d5708f05748ca4cd12dc94cd151c84dac50303230c84dd74f49ac04008ac4093d', X'789ced58616f1b3712fd2b0303057a80144b8a95b46a7180625f121549aa464281c3a958d0cb9196672eb921b98eb785ff7b1f7765492b2b559ce6c31de00f867797f386c3376fc8a1fe3891ae5c2546e47c32a293899136e790895499930e9d944ec7cf5908851f9d9e7e54579c3fb16e159fd4e9beb54f9d2858262244d0a03778d6edf5bbfddebcf77c341c8e06c327cf7acf07fdef6b5b4e83b2c6c3f28f93576cd8095d3f07bea9e1f3aae0d1c2bc9b8d27170b7361bd5831bdb42ef7239afe4cdfd618959232341892309286bd7c45415cfa7f2cccb9cd736b68ee84647a87d50115c3bd8bb4bcdc0de0169f00d41cdffef31bdeb43257f5cb36a03a92e3a43466b7bf459f6359ea9020766556adc51d88e164ea38b0cb132d2ead3b9ddbd4eaca2bdfc20d7ba0332e535b21e194a4f5dc0101f8f4e1acfb8c32e769691d9d7d171f17e6671fd80a1732a782c23b18ad8dc1e08bc945773eb9e8502e6e6810bd9e4a517568a5ae993eaa90c191950bf3ca96a1e677eab9947685d7da4f4d37fcd43e0212efea68081a5052570b33365795aed74eb3c21a59e97b315c2ad90d4aeec5b030ef332e7311ac92343e18fc61e0493b8fb79f95d73645c713bc678f39b6be0e7075dc61042500253ba096d7c3441e77bcc525bbb896ef434c1ff7bc45255b54a3f947197f15197fc90ef5a8e4afab64964a049c318776f0a9086c02c9320da5279088c3c8fab249ef8f51b7b67464b51c910f18a6de9301b27bb5a2c9af74437d682d6383affde6eb87fea03b38cb3034803cbacf093af00d7ef697f8c101fc3fe901f8e101078785dbef362ea246a37aa5ba5692655d82bfdc95e0d9d6a42c2858eaa3daffb6b43f45f7f10437c8a441263bc8af2b1eb1279e59c1a9123a99daa2d4627bca6f16e4786584492b7a8f51b3826ee8c5c2bc1169a8ad4754387b095a2af262c948091ba1a9512236a5d8598cc85812f2bfa50f39d6b8301bc5de1b79cd05dca6f7f1e09497ca30f6a054947166e0ae95475ad592b2354ce58550eec0240f857f71fef7e83a9e9b8bd8d736c63e5126d9785827e8dc9ae0843252a507d233d69addaa8afa4db5f0fe34b6c9a06d36261c4b758fd705b64cb150e1b3908bf8bd7458ad704a80a54dc04f9d24d0851614d25b988959368bef50890818f294f4ad616bf0145bd7314671748110aecfc6ddb179e66c7e69d32ad8828d12adc1732b566badd185f2d6499c65bb06ef387536a8dfa357e4825d3c9ca3665b56ae16da36651df26a65d4122b4305ee5a4e4b8d265bb88aa007f67be1cc19fc6a0b12ed925e0aad6d74c5d7ecb8bd5e1b59a31427d15afb07cdcec72f5e912fdd8a315f118b5852e9511877ba83dec0bd54f65af8143ce01c870ec59e49866b05f600e3f1de1a387ffdb2f5bed4253683d8cc98b06ffb6ab24d4f4cbb4ec174a67cb0aeda3134c41a394009c732801fdff22239aba413f7bc7b2ebc6a9b0a1fb25cb43e617bd0d6acb866e16165b5be9b8062cfc97b16e97dfd1fbaa0cc22e965dbaed84820e3dc3a97c55bda6eda76a8aa5fc03e1abb7ad1a7356f0bf376b230b3e0ec156f04cef8d3cae70bd3ce579da466279ca23fd33ace5ccbba666c9c9681a9197f29942e1dafb73e1bec8d4a55a8e2541097e9fe6433e341a5af8cc49c1c1b3dce63e9ee175987eed65387131f5db46cadb38ef34ae8bd81fd1b49bdf1c4ab698b4559f922261d931b8174e2bfb8c4dd5ac585a00ea33e9085a08ab55a321652a4198296ea77d4337bc4e6b01161156fe69df16c0ee9f1f5dafa9e94b1291a1562b3925a671893482e4061146891812b1f09c73604c2bee84eb593f5cfe81a27c9c6b87528bf9d1c07c3a68581428e83a251bb2fbd2f9ccf684a2328a941c91da8e5f5134a3beeb901266b60b201b6bc7f5aa6c727d8c7de352d8f15fe4515bebf533e96f86389ff8f96f8ffa1341fd8d84c33e17281ce16ad676b9daf855e76b55af288ce9e0ceb0bbaef50bcf6f69b97d8b16d3782b78c59ea3d6a44f4062db9fb81ceff3d3d1bf63a3438ff9e6258e8700368f8d74d8af5d5b7b6d2810f7ad6fba643e8f3d9d3d3a7df445f69260c5cc55e789c36a67c83ce8bf2cd5069ae8cfd88ee57994c5d820e4aab545b7b53ad20c0f8039963dc3862d389e6cf07b1d2021930f5cf34a149f78dc0ec10132ef7beb9c13e90bd197332d6deb698abef3b74b7c1fead1fd05b5e3ee397f464630ffddedefe096c65a59b', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138853, 1667, 0.2, 0.2, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cb331b150c8c82f2d52c8cf49b152282e492c2a5130d033ca4dd7cf4e57f00c53a85030d45128c948cd038a1a42440b0d8d748d4c32805246004dad11f3', X'789ced58616f1b3712fd2b0303057a80144b8a95b46a7180625f121549aa464281c3a958d0cb9196672eb921b98eb785ff7b1f7765492b2b559ce6c31de00f867797f386c3376fc8a1fe3891ae5c2546e47c32a293899136e790895499930e9d944ec7cf5908851f9d9e7e54579c3fb16e159fd4e9beb54f9d2858262244d0a03778d6edf5bbfddebcf77c341c8e06c327cf7acf07fdef6b5b4e83b2c6c3f28f93576cd8095d3f07bea9e1f3aae0d1c2bc9b8d27170b7361bd5831bdb42ef7239afe4cdfd618959232341892309286bd7c45415cfa7f2cccb9cd736b68ee84647a87d50115c3bd8bb4bcdc0de0169f00d41cdffef31bdeb43257f5cb36a03a92e3a43466b7bf459f6359ea9020766556adc51d88e164ea38b0cb132d2ead3b9ddbd4eaca2bdfc20d7ba0332e535b21e194a4f5dc0101f8f4e1acfb8c32e769691d9d7d171f17e6671fd80a1732a782c23b18ad8dc1e08bc945773eb9e8502e6e6810bd9e4a517568a5ae993eaa90c191950bf3ca96a1e677eab9947685d7da4f4d37fcd43e0212efea68081a5052570b33365795aed74eb3c21a59e97b315c2ad90d4aeec5b030ef332e7311ac92343e18fc61e0493b8fb79f95d73645c713bc678f39b6be0e7075dc61042500253ba096d7c3441e77bcc525bbb896ef434c1ff7bc45255b54a3f947197f15197fc90ef5a8e4afab64964a049c318776f0a9086c02c9320da5279088c3c8fab249ef8f51b7b67464b51c910f18a6de9301b27bb5a2c9af74437d682d6383affde6eb87fea03b38cb3034803cbacf093af00d7ef697f8c101fc3fe901f8e101078785dbef362ea246a37aa5ba5692655d82bfdc95e0d9d6a42c2858eaa3daffb6b43f45f7f10437c8a441263bc8af2b1eb1279e59c1a9123a99daa2d4627bca6f16e4786584492b7a8f51b3826ee8c5c2bc1169a8ad4754387b095a2af262c948091ba1a9512236a5d8598cc85812f2bfa50f39d6b8301bc5de1b79cd05dca6f7f1e09497ca30f6a054947166e0ae95475ad592b2354ce58550eec0240f857f71fef7e83a9e9b8bd8d736c63e5126d9785827e8dc9ae0843252a507d233d69addaa8afa4db5f0fe34b6c9a06d36261c4b758fd705b64cb150e1b3908bf8bd7458ad704a80a54dc04f9d24d0851614d25b988959368bef50890818f294f4ad616bf0145bd7314671748110aecfc6ddb179e66c7e69d32ad8828d12adc1732b566badd185f2d6499c65bb06ef387536a8dfa357e4825d3c9ca3665b56ae16da36651df26a65d4122b4305ee5a4e4b8d265bb88aa007f67be1cc19fc6a0b12ed925e0aad6d74c5d7ecb8bd5e1b59a31427d15afb07cdcec72f5e912fdd8a315f118b5852e9511877ba83dec0bd54f65af8143ce01c870ec59e49866b05f600e3f1de1a387ffdb2f5bed4253683d8cc98b06ffb6ab24d4f4cbb4ec174a67cb0aeda3134c41a394009c732801fdff22239aba413f7bc7b2ebc6a9b0a1fb25cb43e617bd0d6acb866e16165b5be9b8062cfc97b16e97dfd1fbaa0cc22e965dbaed84820e3dc3a97c55bda6eda76a8aa5fc03e1abb7ad1a7356f0bf376b230b3e0ec156f04cef8d3cae70bd3ce579da466279ca23fd33ace5ccbba666c9c9681a9197f29942e1dafb73e1bec8d4a55a8e2541097e9fe6433e341a5af8cc49c1c1b3dce63e9ee175987eed65387131f5db46cadb38ef34ae8bd81fd1b49bdf1c4ab698b4559f922261d931b8174e2bfb8c4dd5ac585a00ea33e9085a08ab55a321652a4198296ea77d4337bc4e6b01161156fe69df16c0ee9f1f5dafa9e94b1291a1562b3925a671893482e4061146891812b1f09c73604c2bee84eb593f5cfe81a27c9c6b87528bf9d1c07c3a68581428e83a251bb2fbd2f9ccf684a2328a941c91da8e5f5134a3beeb901266b60b201b6bc7f5aa6c727d8c7de352d8f15fe4515bebf533e96f86389ff8f96f8ffa1341fd8d84c33e17281ce16ad676b9daf855e76b55af288ce9e0ceb0bbaef50bcf6f69b97d8b16d3782b78c59ea3d6a44f4062db9fb81ceff3d3d1bf63a3438ff9e6258e8700368f8d74d8af5d5b7b6d2810f7ad6fba643e8f3d9d3d3a7df445f69260c5cc55e789c36a67c83ce8bf2cd5069ae8cfd88ee57994c5d820e4aab545b7b53ad20c0f8039963dc3862d389e6cf07b1d2021930f5cf34a149f78dc0ec10132ef7beb9c13e90bd197332d6deb698abef3b74b7c1fead1fd05b5e3ee397f464630ffddedefe096c65a59b', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138854, 1667, 0.2, 0.2, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d235574849ac2c56c8cf49b152082e492c2a5130d033ca4dd7cf4e57f00c53a85030d45128c948cd4388161a1ae91a996400a58c00407d11b5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138855, 1667, 0.2, 0.2, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cb35330574849ac2c56c8cf49b152082e492c2a5130d033ca4dd7cf4e57f00c53a85030d45128c948cd03899a42840b0d8d748d4c3280724600510c11e9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138856, 1667, 1.0, 2.0, 'mg/kg', 'PO', 2, 'Pediatric', X'789c33d435ca4dd7cf4ed74f49ac5408f05748c92ccb4c494d5170f274d10df474d151c84dac50304128292d5028c957303435d0353230c8058b0100b8f8146b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138857, 10188, 50.0, 50.0, 'mcg', 'IV', NULL, 'Adult', X'789cf3cccb2cc94ccc5170cacf292db6523035c84d4e57f00c53d0284acc4b4f553032d5353400896902001a550c9f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138858, 10188, 25.0, 50.0, 'mcg', 'IV', NULL, 'Adult', X'789c7329ca2c50284a2c49b5523032d5353550c84d4ed7cf2852f00c03006d2307ce', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138859, 1088, 10.0, 20.0, 'mg', 'PO', 1, 'Adult', X'789cf3cd4f492d4a2c4955f0cc2b49cd2bce2ca9b4523034d0353250c84d5708f0574849cccca90400f38a0c49', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138860, 1088, 40.0, 80.0, 'mg', 'PO', 1, 'Adult', X'789cf3c84ccf50f0cc2b49cd2bce2ca9b4523031d0b53050c84d5708f0574849cccca90400b8970aa1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138861, 1088, 80.0, 80.0, 'mg', 'PO', NULL, 'Adult', X'789cb33050c84d5708f057d008cecc4bcf495548c92f4e552828cacc2f5228c9570870f6d40400c0660b05', X'789ced57df6fdb3610fe570e7e6a813ab15377edf466785b13a0690d2703364481409367890bc5d3482a895ae47fdf51761ccb49eb262bb697bc1816f5ddef3beabb2f3de5ea3cb3a2c45e02bd712077297c1041dbde2be8d5cec4e32284ca27fbfb57fa02cb3d7279fca7f7b7d15e3a51a1ca4488420783839ffa83617f38381dbc4d46ef92e168efcd9bb7af7f1eb458944193f58cfcd21bab525bed8313f1ac3d0a78dd6a396d2a4ce0a4b5e1e1c5e1f1fbfe84c6304355cb203cc2912df45cb3272f53fb0b799123fc46aef4496a675407f4400be81a4860fa29b5132a4bb270ea8442f8c809f0097cd05554d53a58cf377dbce1a320e606e3d3d9393f196d2f960ff1dd58d52664ec80b67927800774f50e392867d896c2528b0efc9814b29731ae80d6ebd024301cf40f0650e6ec3628a14d93da439d179b90d1a0ffae03e975fd6d5d949c8e4c92232b5c93f9c62a476dddefccaf95bc38e1400c8222ce71e534390804d3c9d1cb6dcdbb32f31f05bb9de3ff29da1f68f6911d7852a1d4c26453aa6a23ee12716b75ea30b7c2ca06667198f294e7e08fd47e1032b46870da5f24f01e2dd7c498062c057028794cd02a54705568f675ee90477e81a85a1d33b4c2c0b2ef53fb9140a8bf6a1f582470e1b062d572fd7a429647505ba525575d81b610018cf570a54301ec8bbe4430fce34069cfa6f071a9f87abcbbefb3b544b692b86913dbf1fa5e5ac7c6a0cb9b58386984f7fbf1427dd205c2317bcc6628e47d2b0f75f80972c7d45d5c9b710a74ad258f0a97a71073456543a6f1da3f70292c6fc16e442e14dc01b9169eafd4c65758792db8b8a2e682a4f6f7d3a3d41e594fa5e579fefef9f89a97bb0bb385671b77baee47f86d5d5bf88eae8dc8bfe3ebb701ee6859a76cb78e3b6847c332d3bbc557b88e2c5767b7600475a436cbf96dd13572391c4f6bc2ed567eeec2e72efc375df823fae729df98e7523dba54d342b85248329437dd5b439845dfe805d3fd7155391eb3924902f390e1080aaa1d97f16c789eda63e4b290d1be4ce0f6ff672613f30664134816916fc1e4cfe9ebf128b5bf5e4b874bd27f0b8e3b81700868346f052d11b9d402e6cc6ef69ef0e13e4659085e2eca8c16d958dedb60560b8a87c874fbd166e416e003569100c98258754047865d20268ca140be13623c7a291ae1ede2f369cc846cb5f8eca576ac948ee65ab67661e9ca46165208665069af32a82938aa987fe162c101f994a36312270b562c4dcd6b4f65c4df35b22f82a3d79f5b7af30a74c9e9bfe4b430ef23f6c630ad84456de5f2b542193920bfe71a29d132365eadd0735a6d24750b23ca72a52b9e84589239e568d917c6559c595c07479643393b387f6cea6f6efe01bd0c019d', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138862, 728, 100.0, 100.0, 'mg', 'PO', 2, 'Adult', X'789c458e3b0ec2301044af320708c28e948a0e81441a4281e8d7f102168e1d6c03f2ed59d2d0cebcf968a5a61b4ec3babfe0a9db7b820bae38f2be36381ff6c70686325bc480c4798e2133285894e8399171de15215d18130b071b7f7ec187f9e1abe885d39b7c86a9e8fe53db7eb7c16b961690f48e719a38589959f2f10adda955bb7c13f40bfbd536b7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138863, 728, 200.0, 200.0, 'mg', 'PO', 2, 'Adult', X'789c4d8e3b0ec2301044af320708228e94062a1048a4010a44bfc49b8fd8d8c8760869383b4ed2d0eecc7b3b3b09ec0c058658d2ada9a1ad67f8b261dd0b6f90a56957e37a5917779007c1c792f05c4b5059113bb0c65765681c249a1c1e237c2017269dfae3f7c5011f280ccccf04b7d3f18cd6948ec92f3e50983319e33d8ade247e92e59322c25bf42f041b47382e6dd7b1d1f1f54cda0a2a4f57cbda58fd01c6aa470e', X'789ced580d4f1b3910fd2b2324a454829204282554955268af9c80224048a74b1539bb93c4c56befd9de90a5e27efbbdd94d68c2d10f904e27dd558228ebb5c7f3debc198ff37925f5c5a86f55c62b1d5a3952890b2ad329afacd14ae18d0c8e63cc436763e35a5f71f6dcf9917cd31bcb7343e255ce695f4559d26eb65fac375bebade64573a7b3fda2d3dc7ddeda7cb9b5bb5dcde5246a6703667e5ef9852d7b65aaef91a7d5f28b32e74ecf766dd489b393c2046563cf1e60bf11d33be7b3d0a1ede61ab59af221dfdacd269d7ed838bcdcc3e0467644c1193abcecd97d9765ced2855729d3097062e9a5ce72382aae1483456f6e3114d5c0b03cfdfe114f46dbabeae18b77cb6e7d9fa87bf36f3fca2eddb430b10f44da8e96b01f3bebe21894e465cf025f36aa71d11fadf6d893b63a6a654cb94617efdf9eacd140054e09083d871c3098944d293a0313036d74c44c6d13cf9847a993f791ae99af4c89f1c87ea24ca041093eefb67a7378b047450e2ba4603701856c536c53ad7743a17cbd5df986a90894811dab2293712a05a27a6248c60c98dca1f6020e156054609bda9f351a3a63dc35ccffd96a13301a58f2e25288ca4731b7c80376a429b52a0c35098fc0f758648796a014cd36c26b834dd292a2ba129f94c51f5ee5da708e0893641235ba6f0f9ead51a6b037fe81659e25e2d7e28ed514b6ca26fcc0eea71f2aa043e7659d01ba489b94aa125818a33c534245cfb58ee3d4ab6b65c408d443b9e789764520b883f8a49f0a0b954f98eea475580ba9b318f74a623dfbe65f91547389f86335a52d79dc00e6c7656a955fa79c821caf938772ec5c0d39968444230e62450728950a3804ba51625a3b3dfbbab543a55ba3c0c027d9fa042fce734e4072ffd4e505547d57f4e68e9c7a1e89024a3aab22d9b31ddaef5994d658cdee5050c3c8255cbbb2eedaf6ec191463a8c6d4b3e73c6148a1b1eff70dbdda6c5276b49169fbac4327c006ae799a30906dce99ecd9f79c395063caa05109cf8b3c378c50c44a44b3086d37572524756887928cf315b25e1222b973e1581bd106c12ae411f91b5bd7ded6131624f0d43a7c9fbcef57e20339ebeac9a1af6dffcec2ac28ef3b1b3dd232d5c903c1ea1a24c0a8146c8951216c48c2e3805185cc85f27164b1010b06587d15273967b4177a7b763c236e712cd4f14b9407c1a8203a484ef5ec7c00c7465a54b450ca43108400e0c580c590e5c23bd81c63bb9491f12160e21354da4de145e0fe19abe4efb01f30b872ce5eaacbb296cf50759c7176547187aa734903e3922b7c7ba707f2698a08314108a54d5c0e9ce7854e74aaa4a4e07897fa79a6c2b896228bc05c3e46c15155010a65889c0178986265047536acffeac636c86e176e8a57a8c6084006ea2d27f0a6d6ec427d0cac6f0a50457a486ae08b3c0aebc958f911fc01a5119cb2d5aa67d5c82b5b004119e14a585966b1d68bf4164b2cbc6e35570145dfdc688b805063b3b5fa4cb246a50ac721355a9bf27ca073e372006bb4aaf727aa40e8e74fd238c1caa5cb7455df1bbb32da8d6a2a2b5ecac31b53788ff49a6809fa6cf0c223b93d35762a93a04b8d329c018ded6a8532f559a383f352e81a5bb527cafb31036ffd7c683fd591c6191dabd948541c38911aede795a1833bad6148068e65d77241d8b3f1535f781dc581766db93e3252ea1e5d00aa8c1db944d2c4635ea59a6af83ed33f540de6387ea00acc67d649ff7fd5f2fd9cfe29e6ff80987f06f11f0be2535a9427c7f114499ce1ea60dca85c8ae67b6586eb460fd146b536c782144e3834b059870c1a7cbf47fbbf9d6e6d3771e9dadfc5bd78bf85cfcdee1689ff513ab49e7d3b05eebabf041f9669777b15e4a3ebc33561acec8853dc61d06fa0b6bc6a8263d9475e601b690cbb49bd98a7681828bb7b35eb52f788ed58221b28e06287ce48fa8a494d27964f9c810e783da0e8e9ea5672a2486ca07d0a6b72eb935bc68de8acea71a493ca381ba0847190abc7580f6a197ace81a33231d47ed6033eb64767ee774d70cb3784bab4deff0d22dc1fc0cd6c02a7ab9aee7976fb7daa5a669b7e5f2cf389b0fab59f25c2637f9708dfb2f655988fd9a15f1be9c348ff8b915aef67e86ed13227bc7c0e73ee12912ca29e711a1295f363237c7bfb17bd246e2f', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138864, 728, 150.0, 200.0, 'mg', 'IN', 2, 'Adult', X'789c258ec10ec2300c437fc54790401a203e00340e3bc12f8435db22dab46a33a6fd3d9d90ec8bed44af53243261b502f299c9ad30fa888e20adaa5512cfc9a487cbf388ddedd1ee0f08246ad5f0d4c742411c830c99fb1802ab63f79fb092f60c170b230e385d9be3b969c288d713f7aec510f376e7998ae102476bc19b6bca101593ca565116b1c9655ac86f4f6c62a4cc5f897341c5f901bf0a44f8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138865, 728, 50.0, 50.0, 'mg', 'PO', NULL, 'Adult', X'789cf3cccb2cc94cccb1523035c84d5708f0d7f70c53283434ca280200688b07b9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138866, 728, 50.0, 50.0, 'mg', 'PO', 2, 'Adult', X'789c1d8d310ec2301004bfb20f00619052d145695241457f898fc8c2be8b6c87c8bfe742bbbb33db53610f15642eab4a619078548d9c690a31d476429039b3ede0f5e82b76e64f6c9657ce5f8a055343e7d282e7e332bed08fc31ddb6a169079674d89c5dbcd9fd737aece9d6fee006cfa03e1a22c1c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138867, 728, 400.0, 400.0, 'mg', NULL, NULL, 'Adult', X'789cf34dac50303130c84dd74f49ac04001b42041c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138868, 1801, 10.0, 60.0, 'mg', NULL, NULL, 'Adult', X'789c3334d03533c84dd74f49ac5448c92ccb4c494d5128b4d03534ca0000687707f0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138869, 1801, 2.5, 5.0, 'mg', 'PO', 1, 'Pediatric', X'789c0b284a4d4cc9cf492d4e4ecd2bb15230d233d53555c84d5708f0574849cccca90400b4700a81', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138870, 3826, 20.0, 20.0, 'mg/kg', NULL, NULL, 'Adult', X'789c3332c84dd7cf4ed751c8cc4b2b2d4e55482c513035d035340009e766e60100981c098d', X'789cd5576d6f223710fe2b23a47e63617761a1b7aa2a9190bb9c94f61049da0f4784ccee003ebcf6d6f62621a7fcf78ebd9040121d4d4ebdaa5f00dbf3e6e799190f5f1bb9ae1653c90a6ca4d0182d51aa19d3336e996834a15169e1f697d696266db76ff80a8b96d20bf78bb79f899b4cb312f329b34e2b0ee35e104641145e84fd34799776fbad7e2fecf7fa5e1633cb953424f9b5f101256a26fc6f8bb75efd625d623a91036979a6e475250c9376229b1359bbac984533914365d802e1bdd205ad7a49b1681767c0e597dafe44c6216d25409b8a5c8051a2aa0f22926d42d46bc5eebb13facfb8d575df3dbfea755b3fbbef77fd5a260a691b2c9bf90b54b3dd3bdcd3169d0874abcf57b4125caefce2f14efb97398cf01379f2f1686b0785c3868e7684efaf5cac83bc12764ae871b9d8c3fddc325b19c0920b2cc97d653618ae08012ee7954160169230f070b40b4e58fec6d6a0b1443a50322381b9454d78019d56e4146eb85d02cb73ee00231a12d2f636896191a9a5125e24d7ec8689896cc31005d7bc2ae0426381928238532ca760215714819a7bebce0264aa987189f9c60918cb64ce74ceef684f10eb7758b2229831436bf6cc1b945a5995d15e8e99469232f0f1f892a22db8318edf89fc1c5d51c274c2207699011fff80bfa22488fdfd26f21cf95da5d134a1605c5a94cc61e0e29cc82d4e30e3796079fed6d4794ecb61d66b9de9aece5e0a3d47fe1fa464ad33ddd1a9136a84396756f3ec954905ea7a2f555ab0934cf34a889a702e214ab632df867c52c571af9bc05aa5d00912efa59d935167238821e7d73ca75470d264ea78c945ae51c2af403adaa410079d434a835c115f194a4bf2d121f9ff9a744fd079891967623a526525d863f3dd3a1b695c3818d730a653499599c290ca8e65d64ba77042406b0333572496b810ab26b87690b14d4b1da3abed9a7f8711b59889fcf07e0cbf10c14d58f06b0424bad710c541d483a5aa3481793a4ce1039d4998e15c6984d3215009538ff9a926bf6e27a714cd439691c683dd6dddd6c2b3b5577406761cc6dd076fd40d08974d98298c31afb20d539477d44da8df10754d985516a422f373df5eb67de2cd743e45f8309943f73cd7c266cae5f4c1c286d36325ada602c879f602a30321502fd66015648219d376afbd6bd67a45d7596e70e045c9b8a63b135723a5cbe55a73f6ba2b6e5e1402dae0748c2c7b1ecb0b061be7a8b9aaf6e54ed7a5a272369b7c3225d7cc2a2230c792eadded37819512193501be907c4e579796def5b9054b0dbb72bde24b451afe39209f59450f0292239a00e88c000b98a684a262f04d5e72437b75060f169ac94aa86c6d293d3cd33b77ae212f0a25f7bb1be65ebd49e9f352c04fad1c42f2ff81cb53367f00306f74f1ca441e2d992e1815ba5aacf77c7d92066d0a9fdc1c198741cfbf594d370d24f5203042b64addbab3990c4e99980782cf3185df91061f370a7593200943586ad29473e2c8386351a7e3b71e5ea34e3fe8d75bbe8f1a483a41d4757a54c148f12bc14d91c2a69d4de4c92d75c1ba515f6a6a584e2c5b3262b170e3d2c0034013f5d1fee0f8964676f47db3e739e274208cda03f76877aa7f69267cf931fcb1e1ff1bd353f39b73d2773cf827b754ccf4204fcf3610ecc47e7c324a61ef0f1cd0cb0bdb3bfdb977a757d6cf18e748199ce1becf33bca53f3345d984cbf2420d09d0d7dabebfff1b6a9405ad', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138871, 3826, 5.0, 10.0, 'mg/kg', NULL, NULL, 'Adult', X'789cf34dac54284a2d484d2c51c8cf4b4e55484c2b492d52303450c8cdcc2b2d492d5628cf2cc950484c49c92cc9cccf4bcc5130d53534c84dd7cf4e07005dfc1433', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138872, 3826, 10.0, 10.0, 'mg/kg', NULL, NULL, 'Adult', X'789c1dca410ac3300c44d1abcc054a93337455e8b6079858ae236a5b41320472fa9a2effe3bf8ca2bd402c32ec8375412bf76f41b2b669cf8253c70e2206bbd045af69d59c573ed86e1b63366bb2ddeaff15e7c98ac36d589a2639799e57e0f97883d23442adc70f91112cfc', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138873, 3826, 130.0, 260.0, 'mg', 'IV', NULL, 'Adult', X'789c333436d0353233c84d57f00c53283434d5353250c8cdcc030040e505d7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138874, 3826, 50.0, 100.0, 'mg', NULL, 2, 'Adult', X'789c3335d0353430c84d5748ca4cd12dc94c010022b204b5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138875, 3826, 20.0, 20.0, 'mg/kg', 'IN', NULL, 'Pediatric', X'789c3332c84dd7cf4e57c82f4b2d52303450c8cdcc2b2d492dd653f04dac54284a2d484d2c51482bcdc95148c92f4e55c8cc53303485a901004a811410', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138876, 3826, 3.0, 5.0, 'mg/kg', 'IN', NULL, 'Pediatric', X'789c7bd4b9c454a132df4ac158d734375d3f3b5d3f25b15221334fc150d7482125b32c332535452125bf38b5180039950e5c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138877, 3826, 2.0, 3.0, 'mg/kg', 'IN', NULL, 'Pediatric', X'789c73cec8cc49294acd53b0533055a82c2ab65230d235ce4dd7cf4ed74f49ac54c8cc5330d4355248c92ccb4c494d5148c92f4e2d0600a0a11067', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138878, 3826, 1.0, 3.0, 'mg/kg', 'IN', NULL, 'Pediatric', X'789c734cc9cf492d4e4ecd2b29b65230d435ce4dd7cf4ed74f49ac54c8cc03f28d145232cb325352531452f28b538b016c1e0f81', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138879, 121, 15.0, 15.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db652303455c84dd7513036005326201e00ae45097b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138880, 121, 15.0, 45.0, 'mg', 'PO', 1, 'Adult', X'789c3334d5353155c84d5708f057284c0100186203a5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138881, 121, 45.0, 45.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb052303155c84dd74f49ac04001e9f044b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138882, 121, 15.0, 30.0, 'mg', 'PO', 1, 'Pediatric', X'789cb33334d5353650c84d5708f057284c01001bc803dd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138883, 121, 15.0, 15.0, 'mg', 'PO', 1, 'Pediatric', X'789c0b2e492c2a5128cf2cc950303455c84d5708f057284c0100567d0719', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138884, 121, 45.0, 45.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb052303155c84dd74f49ac04001e9f044b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138885, 2971, 20.0, 60.0, 'mg', 'IN', 1, 'Adult', X'789c3332d0353350c84d574849cccca954c8cc5330d2355648c92ccb4c494d5148c92f4e2d0600b3bd0afd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138886, 2971, 5.0, 60.0, 'mg', 'IN', 1, 'Pediatric', X'789cb333abccb75230d53533c84d574849cccca954c8cc5348c92ccb4c494d5148c92f4e2d0600c2770bb4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138887, 810, 40.0, 40.0, 'mg', 'PO', NULL, 'Adult', X'789c3331c84d5708f05728cc2856a830d13553284f4dcd2e060049c606d2', X'789ced576d6fdb3610fe2b0703fb16c5f26b0bb728e0386993a1c9bc380db04d83414b678933452a24955829f2df7ba462c78ebd0d09866d18f6c190793cdecb73c7bbe3d746a2cb742a598e8d01343eb25c599e70898d0368945a3862666d6106cde61d5f607ea874eafef1e636af89352b309932eb8eb4c3763f085b412bbc0adf0c7a9d41ab73d80ddff4c2d0f3626cb9928638bf368649ce2537563347f3248b4b2fe5aa2a7000a7b4c988072379da869950f10275248f956129c247a57333805678006dfa3199403784f10fefe8d3ec41fe194c690a94868447f25295160da8396cab1dd0890338bb8ee448e5b99270a559827041b090f03116314f0e1ebf301c7927cad9a61f0f44b26c26d0ad7ef9955682cb45bd707bc3a414764a4673996e39392419b70849a912944c402962e75e37cc53320a6e3203cb6ed0873bc48589e4505848bc9401395cf31c9d1d83d2f5f2ec1a6e5a6dc848c439e3d2924c19ef8a6f3f898fe4274638f0788fea3dfa36147c3ab93c76a282ee86214bdafc3d5b37cefeac040194a20e4ee88f21c84d2513ad72f412fb2b1bfa9efb8f249db325c5ffd901f25cb3d80764cbe58d73a787505442690e5cceeb483ee1e23da1ac0ada6f21611539f3c5203142acf219973e69e08edb0c94cd50438e098f3dd5c09c6281943f8f845724cb98a43117927d0933fe42a0d3d5ea43854c53328b2492e1612f68e569739134c95ce741c2b8a88219a7cd8965da02b3405c8e27f53c1b0c9bf0ae25d55c0498672194c185d91157917fdf815c79dd4ffc2bcd91ec0404b4db6f6ded7a69b5f96e2f68efeed6f66e1c7b8d91af807d5260cc99988e55510af654a2d6c86b4cdd75aae09276651a51dd388ae46797683e2134370b471c6b35233d151836c73d86342edd5ddc5b0d5c9918c0488fc4fb5e388004638d8c528f3c479855d00bbf73773d7535e3063afda0fb96b2f91d9ccd810ca0b41195e1a6de67734ba9b9a245729d56b50297debb3ab614b4bb24fca036a745ac3575a5b5b18da783f0140b82626fde3eba76a1288c38a77a9e6c5ab4417e2ef6cfc2f6df01f3799afc1368fe553a5f78f746ca556c2ed765745bb310a8d30aac825830639a6e6aa166cd4a7fefa82e6bdfdd785e30ae7394f6552dfa16b5c1e925b278d7847df199a0e6aa7c66aa64455609b67449329429579860ce22797572e14a1bded230127caf32e99ade64ddf458aa992c69baa9acf20926b05c289a5c389db51931cdfcde23a5707568bd32c8ef4b8d4ee3753d229140adb3ca663967441e5d4c08bc258fb9a5d21c678a5070452b86df58e940270b321f79eb74bbc1411bb720500b8925cd444ecf8f57506825944cd7aded5901a8e7a72d443264098b33d290f0fb7bca0f431a62c2d0f282d56d977288ac45e729cd220871c6683620b65bee673f38a25ee2922be6487ebf34a7ff8fd36eeefe2b03f5b719f5d2812c633a6731219a565bd69d32310f049fd33ba54d3349e7b0e71bc8877648df7a407cacf7349d20a95034ece603708f8f9c091a11047501dd1cfd34eef688e76449eda37e91947af5b47a99ade7e8fc272d53359f0ee39d57d50405d66f8e6cf5b282a787d54b153e3c7c033a8ad900', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138888, 810, 20.0, 20.0, 'mg', 'PO', 2, 'Adult', X'789c73cc295148c92fcecc4bb7523032c84d5708f05770f27451c82f82703dc3140a0d8d14328a0007b80c08', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138889, 810, 20.0, 20.0, 'mg', 'PO', NULL, 'Adult', X'789c3332c84d5708f05728cc280600127f0362', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138890, 810, 40.0, 40.0, 'mg', 'PO', NULL, 'Adult', X'789c3331c84d5708f05728cc28060012950364', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138891, 810, 20.0, 20.0, 'mg', 'IV', NULL, 'Adult', X'789c73cc295148c92fcecc4bb7523032c84d57f00c5328343452c828020071a80803', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138892, 810, 20.0, 40.0, 'mg', 'PO', 2, 'Adult', X'789c3332d03531c84d5708f05770f27451a8303452284f4dcd2e06004aff06b0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138893, 810, 20.0, 20.0, 'mg', 'IV', NULL, 'Adult', X'789c73cc295148c92fcecc4bb7523032c84d57f00c5328343452c828020071a80803', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138894, 810, 20.0, 60.0, 'mg', 'PO', NULL, 'Adult', X'789c3332d03533c84d5708f057283453c82802002161044a', X'789ced576d6fdb3610fe2b0703fb16c5f26b0bb728e0386993a1c9bc380db04d83414b678933452a24955829f2df7ba462c78ebd0d09866d18f6c190793cdecb73c7bbe3d746a2cb742a598e8d01343eb25c599e70898d0368945a3862666d6106cde61d5f607ea874eafef1e636af89352b309932eb8eb4c3763f085b412bbc0adf0c7a9d41ab73d80ddff4c2d0f3626cb9928638bf368649ce2537563347f3248b4b2fe5aa2a7000a7b4c988072379da869950f10275248f956129c247a57333805678006dfa3199403784f10fefe8d3ec41fe194c690a94868447f25295160da8396cab1dd0890338bb8ee448e5b99270a559827041b090f03116314f0e1ebf301c7927cad9a61f0f44b26c26d0ad7ef9955682cb45bd707bc3a414764a4673996e39392419b70849a912944c402962e75e37cc53320a6e3203cb6ed0873bc48589e4505848bc9401395cf31c9d1d83d2f5f2ec1a6e5a6dc848c439e3d2924c19ef8a6f3f898fe4274638f0788fea3dfa36147c3ab93c76a282ee86214bdafc3d5b37cefeac040194a20e4ee88f21c84d2513ad72f412fb2b1bfa9efb8f249db325c5ffd901f25cb3d80764cbe58d73a787505442690e5cceeb483ee1e23da1ac0ada6f21611539f3c5203142acf219973e69e08edb0c94cd50438e098f3dd5c09c6281943f8f845724cb98a43117927d0933fe42a0d3d5ea43854c53328b2492e1612f68e569739134c95ce741c2b8a88219a7cd8965da02b3405c8e27f53c1b0c9bf0ae25d55c0498672194c185d91157917fdf815c79dd4ffc2bcd91ec0404b4db6f6ded7a69b5f96e2f68efeed6f66e1c7b8d91af807d5260cc99988e55510af654a2d6c86b4cdd75aae09276651a51dd388ae46797683e2134370b471c6b35233d151836c73d86342edd5ddc5b0d5c9918c0488fc4fb5e388004638d8c528f3c479855d00bbf73773d7535e3063afda0fb96b2f91d9ccd810ca0b41195e1a6de67734ba9b9a245729d56b50297debb3ab614b4bb24fca036a745ac3575a5b5b18da783f0140b82626fde3eba76a1288c38a77a9e6c5ab4417e2ef6cfc2f6df01f3799afc1368fe553a5f78f746ca556c2ed765745bb310a8d30aac825830639a6e6aa166cd4a7fefa82e6bdfdd785e30ae7394f6552dfa16b5c1e925b278d7847df199a0e6aa7c66aa64455609b67449329429579860ce22797572e14a1bded230127caf32e99ade64ddf458aa992c69baa9acf20926b05c289a5c389db51931cdfcde23a5707568bd32c8ef4b8d4ee3753d229140adb3ca663967441e5d4c08bc258fb9a5d21c678a5070452b86df58e940270b321f79eb74bbc1411bb720500b8925cd444ecf8f57506825944cd7aded5901a8e7a72d443264098b33d290f0fb7bca0f431a62c2d0f282d56d977288ac45e729cd220871c6683620b65bee673f38a25ee2922be6487ebf34a7ff8fd36eeefe2b03f5b719f5d2812c633a6731219a565bd69d32310f049fd33ba54d3349e7b0e71bc8877648df7a407cacf7349d20a95034ece603708f8f9c091a11047501dd1cfd34eef688e76449eda37e91947af5b47a99ade7e8fc272d53359f0ee39d57d50405d66f8e6cf5b282a787d54b153e3c7c033a8ad900', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138895, 810, 20.0, 20.0, 'mg', 'IV', NULL, 'Adult', X'789c73cc295148c92fcecc4bb7523032c84d57f00c5328343452c828020071a80803', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138896, 810, 160.0, 160.0, 'mg', 'PO', NULL, 'Adult', X'789cf34dacb052303433c84d5708f057283453c828020035ad056c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138897, 810, 20.0, 20.0, 'mg', 'IV', NULL, 'Adult', X'789c3332c84d57f00c5328343452c82802001c2903e4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138898, 810, 20.0, 20.0, 'mg', 'PO', 2, 'Adult', X'789c3332c84d5708f05770f27451a8503034d035b2504849ac2c06004c2e0666', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138899, 810, 0.5, 1.0, 'mg', 'PO', 1, 'Pediatric', X'789c33d033d535cc4dd7cf4ed14f49ac5408f0574849cccca9d44dca4c01006d2a087f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138900, 810, 0.5, 0.5, 'mg/kg', NULL, 1, 'Pediatric', X'789c0b2e492c2a51482c5130d033cd4dd7cf4ed74f49ac544849cccca9d44dca4c0100a52a0a88', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138901, 810, 0.5, 1.0, 'mg/kg', 'IV', 2, 'Pediatric', X'789c73cc295148c92fcecc4bb75230d033d535cc4dd7cf4ed74f49ac54f00c5348ca4c0100b23b0a61', X'789ced576d6fdb3610fe2b0703fb16c5f26b0bb728e0386993a1c9bc380db04d83414b678933452a24955829f2df7ba462c78ebd0d09866d18f6c190793cdecb73c7bbe3d746a2cb742a598e8d01343eb25c599e70898d0368945a3862666d6106cde61d5f607ea874eafef1e636af89352b309932eb8eb4c3763f085b412bbc0adf0c7a9d41ab73d80ddff4c2d0f3626cb9928638bf368649ce2537563347f3248b4b2fe5aa2a7000a7b4c988072379da869950f10275248f956129c247a57333805678006dfa3199403784f10fefe8d3ec41fe194c690a94868447f25295160da8396cab1dd0890338bb8ee448e5b99270a559827041b090f03116314f0e1ebf301c7927cad9a61f0f44b26c26d0ad7ef9955682cb45bd707bc3a414764a4673996e39392419b70849a912944c402962e75e37cc53320a6e3203cb6ed0873bc48589e4505848bc9401395cf31c9d1d83d2f5f2ec1a6e5a6dc848c439e3d2924c19ef8a6f3f898fe4274638f0788fea3dfa36147c3ab93c76a282ee86214bdafc3d5b37cefeac040194a20e4ee88f21c84d2513ad72f412fb2b1bfa9efb8f249db325c5ffd901f25cb3d80764cbe58d73a787505442690e5cceeb483ee1e23da1ac0ada6f21611539f3c5203142acf219973e69e08edb0c94cd50438e098f3dd5c09c6281943f8f845724cb98a43117927d0933fe42a0d3d5ea43854c53328b2492e1612f68e569739134c95ce741c2b8a88219a7cd8965da02b3405c8e27f53c1b0c9bf0ae25d55c0498672194c185d91157917fdf815c79dd4ffc2bcd91ec0404b4db6f6ded7a69b5f96e2f68efeed6f66e1c7b8d91af807d5260cc99988e55510af654a2d6c86b4cdd75aae09276651a51dd388ae46797683e2134370b471c6b35233d151836c73d86342edd5ddc5b0d5c9918c0488fc4fb5e388004638d8c528f3c479855d00bbf73773d7535e3063afda0fb96b2f91d9ccd810ca0b41195e1a6de67734ba9b9a245729d56b50297debb3ab614b4bb24fca036a745ac3575a5b5b18da783f0140b82626fde3eba76a1288c38a77a9e6c5ab4417e2ef6cfc2f6df01f3799afc1368fe553a5f78f746ca556c2ed765745bb310a8d30aac825830639a6e6aa166cd4a7fefa82e6bdfdd785e30ae7394f6552dfa16b5c1e925b278d7847df199a0e6aa7c66aa64455609b67449329429579860ce22797572e14a1bded230127caf32e99ade64ddf458aa992c69baa9acf20926b05c289a5c389db51931cdfcde23a5707568bd32c8ef4b8d4ee3753d229140adb3ca663967441e5d4c08bc258fb9a5d21c678a5070452b86df58e940270b321f79eb74bbc1411bb720500b8925cd444ecf8f57506825944cd7aded5901a8e7a72d443264098b33d290f0fb7bca0f431a62c2d0f282d56d977288ac45e729cd220871c6683620b65bee673f38a25ee2922be6487ebf34a7ff8fd36eeefe2b03f5b719f5d2812c633a6731219a565bd69d32310f049fd33ba54d3349e7b0e71bc8877648df7a407cacf7349d20a95034ece603708f8f9c091a11047501dd1cfd34eef688e76449eda37e91947af5b47a99ade7e8fc272d53359f0ee39d57d50405d66f8e6cf5b282a787d54b153e3c7c033a8ad900', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138902, 810, 40.0, 40.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dac503031c84dd74f49ac0400184703ec', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138903, 810, 0.5, 0.5, 'mg/kg', 'PO', 1, 'Pediatric', X'789c33d033cd4dd7cf4ed74f49ac5408f0574849cccca90400456906c8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138904, 810, 1.0, 1.0, 'mg/kg', 'PO', 2, 'Pediatric', X'789c33cc4dd7cf4ed74f49ac5408f05748ca4c010031450582', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138905, 810, 1.0, 2.0, 'mg/kg', 'PO', 2, 'Pediatric', X'789c33d435ca4dd7cf4ed74f49ac5408f05748ca4c0100382505e1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138906, 810, 1.0, 1.0, 'mg/kg', NULL, 2, 'Pediatric', X'789c0b2e492c2a5130cc4dd7cf4ed74f49ac5448ca4c0100494006f1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138907, 810, 0.5, 1.0, 'mg/kg', 'IV', 2, 'Pediatric', X'789c73cc295148c92fcecc4bb75230d033d535cc4dd7cf4ed74f49ac54f00c5348ca4c0100b23b0a61', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138908, 810, 40.0, 40.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dac503031c84dd74f49ac0400184703ec', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138909, 8074, 20.0, 20.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db652303250c84dd7513001510a2589490094300926', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138910, 8074, 40.0, 40.0, 'mg', 'PO', NULL, 'Adult', X'789c3331d035b7d4b354c84eb752303150c84d5708f057a83004003efb0595', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138911, 8074, 80.0, 80.0, 'mg', 'PO', NULL, 'Adult', X'789cb3b33050c84db75200530a01fe0a1586002ef204d9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138912, 8074, 40.0, 40.0, 'mg', 'PO', NULL, 'Pediatric', X'789c3331d035b7d4b354c84eb752303150c84d5708f057a83004003efb0595', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138913, 8074, 80.0, 80.0, 'mg', 'PO', NULL, 'Pediatric', X'789cb3b33050c84db75200530a01fe0a1586002ef204d9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138914, 3229, 20.0, 120.0, 'mg', 'PO', 1, 'Adult', X'789c3332d0353432c84d5708f0574849cccca9040025c004e9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138915, 3229, 20.0, 120.0, 'mg', 'PO', 1, 'Pediatric', X'789cb3533057a84c4d2c2a56c8cf49b1523032d0353432c84d5708f0574849cccca9040096cc097b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138916, 17996, 150.0, 1000.0, 'mg', 'PO', 2, 'Adult', X'789c333435d035343030c84d5708f05770f274010022090407', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138917, 17996, 500.0, 500.0, 'mg', NULL, 3, 'Adult', X'789c333530c84d5708f17451a85030574849ac2c06002d1e052b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138918, 17996, 500.0, 500.0, 'mg', 'PO', 3, 'Adult', X'789c333530c84d5708f05708f17401001422032a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138919, 487, 100.0, 100.0, 'mg', 'PO', 1, 'Adult', X'789c33343050c84d5770f27451c82f523082f0521233732a1502fc016fff080e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138920, 487, 100.0, 200.0, 'mg', NULL, 2, 'Adult', X'789c333430d035323050c84d5770f2740100160c0334', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138921, 487, 100.0, 100.0, 'mg', 'PO', NULL, 'Adult', X'789c333430c84d5708f057c8cccb2cc94cccc9a90400329c0614', X'789ced576d4f233710fe2ba37c4ec84ba127d2aa520aa5201d1001dfbaa7d5604f76ad78edad5f80e5c47fbff18600091c85a8ad2ad14f89bde367669e19cf8cbf76a48b456eb0a2ce183a930a4d40a90c75bad0894ea7cd3284da8ffbfd6b35a76acbba22fd53fd55592f1cd624730ce9c86830fab13718f686838bc1a7f1f6a7f168676b777b38dade6e654904658d67c9af9d89ac94513e384c7bed56a09b16e5a2a9699c998909ea4a39d499e96686952a515acd7a5da184cfccbef558101c5857f93108ac7dd404d641c04b4da10bbe71b1cecc998d813cd819acea1cc3690bbe67abca1ab87028094e981146fbdd0a7be5546b75bc7c6af81d6fb50ad2ea8f2fbc6293e6ede2d18307d3df40e78328233f22acbbfb36a09513775f92ad131975c8992b658a15965ff0ad7364663a92b9c57cb2223b1c0ca02ae0d7a3fdc4ef68b192a87403d3d3ce2a2349e914dd5c196f99ecaa9b33082749e3b05212752e9527f4b4aea0377a50f202e209456735d5ec635ea156454a88dc37463a5b3dc36298e92970ac8342ad9bcc5ca814748258037a30449224040b15de80b49e924f7ce8cfe1a874ebda5f89786bdac6a4adb3ffa158fb1b9c5de7ef3fecedbf6cdadb6bd62216241506c7b6bdb74e74f3616f376f089dcfad962b07475ba3def6d63607ac3f6f1d7a39479f60fdf23da8fbabf432c69befe726c6bee2f93f6eeddb15bc33dee73509ceac7c6aeba8f1d1b925fed4514a50d1c0197f3545c6bd722f339f5184561a9cf2f331b0a99cc5ed82dbaf3136c02581e32e2c817b2e775e32a85382320637f43db7a7e187416f87adffdce7563c5e5645f6845167caf9c015b2e94228c9c0c2cd3e6fdc9f1deef446bbef390b7445ae01cb5b0e1e717e1eeedca3a4cacca70ff7c7f757e89a689e6edc21d5ecaa581a0fc93949336eae72d3a1609dd5bf6ee9fb6946ab97c772c125a0b04ed1b2b7ef59c3754119a9c40b519c68cd934093ea84d0e87d3f8d7c1b64cb4432899ef23342f15ccb4b97e49c9cb271556eeff0a00b6553db40c6b3641764e35dd984b252c841435136029d4c8bc5af00748e3ce7d1346a9ed09023c985af6201143cd2017fac79720a963fccb8af464799395e5657a848a3b11572e2529cdb9a4cc2c6c2a189da8a2670687d97ab690c6ef135334fea343cd46958d6e9cc9c4725528702256931b83e2f688b7972c5f9138cdcd0d865c52e95e99f60ae82aa5b8c2e6814f334a0625d53508152fea1644af8df01cb1491d2e1db5bce3fefdbd3b3b8601103de24cb27e64651e0f44f4db56a5d95c4b9e31762ca39c5762aad924cc96d250a651659c3928eb06205de3a492e33a72e94d687f6063c89194782235bf3656206da50bcb7ba7db0cc58bf18ffa7c6f753e3a371f3de19ad4457a1b0da16cd0a4987a8673dad6634e6a6d71bed949ce9c448fc12f4d5184eb871313f2e75fc4b7e7a54f7df6e49fe049e33590356369ad0be90513019fa4188af12a7333f2c678a64667ebb118e164fe7b6b56fe0c6318912d3cc9fdb593e11cfdefe4726909b110700ae55285333875934ad6032b07d2ac3f1086ac7f42a0e11bb76954c34055f7b9d9e0d8f72260a4d1c0ce4abe939c4dc0a53804090dec4f873a27ca2bd5db3f87e60db742e5801787d207814e501e0eeee1b9d520e53', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138922, 487, 200.0, 200.0, 'mg', NULL, NULL, 'Adult', X'789c0bc92c294a2c4955282d50482c56c84b4d4d494d5128c957c84dac5048c92f4e55303230c84d57283434ca2802005dcb0ee4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138923, 487, 2.2, 4.4, 'mg/kg', 'PO', 2, 'Pediatric', X'789c33d233d235d13351c84dd7cf4e5708f05770f2740100311204f9', X'789ced576d4f233710fe2ba37c4ec84ba127d2aa520aa5201d1001dfbaa7d5604f76ad78edad5f80e5c47fbff18600091c85a8ad2ad14f89bde367669e19cf8cbf76a48b456eb0a2ce183a930a4d40a90c75bad0894ea7cd3284da8ffbfd6b35a76acbba22fd53fd55592f1cd624730ce9c86830fab13718f686838bc1a7f1f6a7f168676b777b38dade6e654904658d67c9af9d89ac94513e384c7bed56a09b16e5a2a9699c998909ea4a39d499e96686952a515acd7a5da184cfccbef558101c5857f93108ac7dd404d641c04b4da10bbe71b1cecc998d813cd819acea1cc3690bbe67abca1ab87028094e981146fbdd0a7be5546b75bc7c6af81d6fb50ad2ea8f2fbc6293e6ede2d18307d3df40e78328233f22acbbfb36a09513775f92ad131975c8992b658a15965ff0ad7364663a92b9c57cb2223b1c0ca02ae0d7a3fdc4ef68b192a87403d3d3ce2a2349e914dd5c196f99ecaa9b33082749e3b05212752e9527f4b4aea0377a50f202e209456735d5ec635ea156454a88dc37463a5b3dc36298e92970ac8342ad9bcc5ca814748258037a30449224040b15de80b49e924f7ce8cfe1a874ebda5f89786bdac6a4adb3ffa158fb1b9c5de7ef3fecedbf6cdadb6bd62216241506c7b6bdb74e74f3616f376f089dcfad962b07475ba3def6d63607ac3f6f1d7a39479f60fdf23da8fbabf432c69befe726c6bee2f93f6eeddb15bc33dee73509ceac7c6aeba8f1d1b925fed4514a50d1c0197f3545c6bd722f339f5184561a9cf2f331b0a99cc5ed82dbaf3136c02581e32e2c817b2e775e32a85382320637f43db7a7e187416f87adffdce7563c5e5645f6845167caf9c015b2e94228c9c0c2cd3e6fdc9f1deef446bbef390b7445ae01cb5b0e1e717e1eeedca3a4cacca70ff7c7f757e89a689e6edc21d5ecaa581a0fc93949336eae72d3a1609dd5bf6ee9fb6946ab97c772c125a0b04ed1b2b7ef59c3754119a9c40b519c68cd934093ea84d0e87d3f8d7c1b64cb4432899ef23342f15ccb4b97e49c9cb271556eeff0a00b6553db40c6b3641764e35dd984b252c841435136029d4c8bc5af00748e3ce7d1346a9ed09023c985af6201143cd2017fac79720a963fccb8af464799395e5657a848a3b11572e2529cdb9a4cc2c6c2a189da8a2670687d97ab690c6ef135334fea343cd46958d6e9cc9c4725528702256931b83e2f688b7972c5f9138cdcd0d865c52e95e99f60ae82aa5b8c2e6814f334a0625d53508152fea1644af8df01cb1491d2e1db5bce3fefdbd3b3b8601103de24cb27e64651e0f44f4db56a5d95c4b9e31762ca39c5762aad924cc96d250a651659c3928eb06205de3a492e33a72e94d687f6063c89194782235bf3656206da50bcb7ba7db0cc58bf18ffa7c6f753e3a371f3de19ad4457a1b0da16cd0a4987a8673dad6634e6a6d71bed949ce9c448fc12f4d5184eb871313f2e75fc4b7e7a54f7df6e49fe049e33590356369ad0be90513019fa4188af12a7333f2c678a64667ebb118e164fe7b6b56fe0c6318912d3cc9fdb593e11cfdefe4726909b110700ae55285333875934ad6032b07d2ac3f1086ac7f42a0e11bb76954c34055f7b9d9e0d8f72260a4d1c0ce4abe939c4dc0a53804090dec4f873a27ca2bd5db3f87e60db742e5801787d207814e501e0eeee1b9d520e53', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138924, 487, 100.0, 100.0, 'mg', 'PO', 2, 'Pediatric', X'789c33343050c84d5708f05770f2740100158e0334', X'789ced576d4f233710fe2ba37c4ec84ba127d2aa520aa5201d1001dfbaa7d5604f76ad78edad5f80e5c47fbff18600091c85a8ad2ad14f89bde367669e19cf8cbf76a48b456eb0a2ce183a930a4d40a90c75bad0894ea7cd3284da8ffbfd6b35a76acbba22fd53fd55592f1cd624730ce9c86830fab13718f686838bc1a7f1f6a7f168676b777b38dade6e654904658d67c9af9d89ac94513e384c7bed56a09b16e5a2a9699c998909ea4a39d499e96686952a515acd7a5da184cfccbef558101c5857f93108ac7dd404d641c04b4da10bbe71b1cecc998d813cd819acea1cc3690bbe67abca1ab87028094e981146fbdd0a7be5546b75bc7c6af81d6fb50ad2ea8f2fbc6293e6ede2d18307d3df40e78328233f22acbbfb36a09513775f92ad131975c8992b658a15965ff0ad7364663a92b9c57cb2223b1c0ca02ae0d7a3fdc4ef68b192a87403d3d3ce2a2349e914dd5c196f99ecaa9b33082749e3b05212752e9527f4b4aea0377a50f202e209456735d5ec635ea156454a88dc37463a5b3dc36298e92970ac8342ad9bcc5ca814748258037a30449224040b15de80b49e924f7ce8cfe1a874ebda5f89786bdac6a4adb3ffa158fb1b9c5de7ef3fecedbf6cdadb6bd62216241506c7b6bdb74e74f3616f376f089dcfad962b07475ba3def6d63607ac3f6f1d7a39479f60fdf23da8fbabf432c69befe726c6bee2f93f6eeddb15bc33dee73509ceac7c6aeba8f1d1b925fed4514a50d1c0197f3545c6bd722f339f5184561a9cf2f331b0a99cc5ed82dbaf3136c02581e32e2c817b2e775e32a85382320637f43db7a7e187416f87adffdce7563c5e5645f6845167caf9c015b2e94228c9c0c2cd3e6fdc9f1deef446bbef390b7445ae01cb5b0e1e717e1eeedca3a4cacca70ff7c7f757e89a689e6edc21d5ecaa581a0fc93949336eae72d3a1609dd5bf6ee9fb6946ab97c772c125a0b04ed1b2b7ef59c3754119a9c40b519c68cd934093ea84d0e87d3f8d7c1b64cb4432899ef23342f15ccb4b97e49c9cb271556eeff0a00b6553db40c6b3641764e35dd984b252c841435136029d4c8bc5af00748e3ce7d1346a9ed09023c985af6201143cd2017fac79720a963fccb8af464799395e5657a848a3b11572e2529cdb9a4cc2c6c2a189da8a2670687d97ab690c6ef135334fea343cd46958d6e9cc9c4725528702256931b83e2f688b7972c5f9138cdcd0d865c52e95e99f60ae82aa5b8c2e6814f334a0625d53508152fea1644af8df01cb1491d2e1db5bce3fefdbd3b3b8601103de24cb27e64651e0f44f4db56a5d95c4b9e31762ca39c5762aad924cc96d250a651659c3928eb06205de3a492e33a72e94d687f6063c89194782235bf3656206da50bcb7ba7db0cc58bf18ffa7c6f753e3a371f3de19ad4457a1b0da16cd0a4987a8673dad6634e6a6d71bed949ce9c448fc12f4d5184eb871313f2e75fc4b7e7a54f7df6e49fe049e33590356369ad0be90513019fa4188af12a7333f2c678a64667ebb118e164fe7b6b56fe0c6318912d3cc9fdb593e11cfdefe4726909b110700ae55285333875934ad6032b07d2ac3f1086ac7f42a0e11bb76954c34055f7b9d9e0d8f72260a4d1c0ce4abe939c4dc0a53804090dec4f873a27ca2bd5db3f87e60db742e5801787d207814e501e0eeee1b9d520e53', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138925, 4696, 20.0, 20.0, 'mg', 'IV', NULL, 'Adult', X'789c3332c84d57f00c5348cbcfc9c92f4f4d5148aa543031d0b50009171a1ae466e62994162894e4035149628e427e9a82b101500e00e2641158', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138926, 4696, 0.5, 2.0, 'mg', NULL, NULL, 'Adult', X'789c33d033d535ca4dd7cfcdcc0300105e033a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138927, 4696, 20.0, 20.0, 'mg', NULL, NULL, 'Adult', X'789c0b2e492c2a5128cf2cc950c8494c4a2d49ccc9cf513032c84d57c82f4b2d5230d43552c8cdcc2b2d492d060043620ec2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138928, 4696, 20.0, 20.0, 'mg', NULL, NULL, 'Adult', X'789c05c1810d80200c04c0557e004d8cc64d5800e5034da0282dceef5d28d405fbd632de633dd1440d535d2a3c8e4cc7557b4f7806cde620c410ef22fc987e62521520', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138929, 4696, 1.0, 8.0, 'mg', NULL, NULL, 'Adult', X'789c0bc948cdd351282e492c2a5148cc53c8cc4b2b2dcecccf53c84f5330d4b5c84dd7cfcdcc0300e9b20c76', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138930, 103, 10.0, 25.0, 'mg', NULL, NULL, 'Adult', X'789c3334d03532cd4d572834d3b5c8282a06001e020443', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138931, 103, 5.0, 5.0, 'g', 'IV', NULL, 'Adult', X'789c3dca310e80200c05d0abfc03b830b8700163dcdd4968b0032d4211b9bd9b6f7e87e810dc3d88b14db0246a46d163e387b09f28b372d49785e0bcc360bb10b276b13f2fe805a658916ac8ed03f9571db1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138932, 103, 5.0, 5.0, 'g', NULL, NULL, 'Adult', X'789c0bcdcbcecb2fcf53282c4dcc2bc92ca954c8cc4b4f2d2e494db1523055482f4acc2d0600e7580ccc', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138933, 103, 0.5, 0.5, 'g', 'IV', NULL, 'Adult', X'789c2d8d3b0ec2400c05aff24e10520077484b917ec53aac256c237f10e2f440443ba3d12c2b16dd2ad814de92c081793ae17610569426df918310c4ef720a44da03e63b94f6622941b7d843a7761dd4275c481a6b27876d7ffb9b50873dbff088349c31ac3c3e7c7b2d6d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138934, 103, 5.0, 5.0, 'g', 'IV', NULL, 'Pediatric', X'789c3dca310e80200c05d0abfc03b830b8700163dcdd4968b0032d4211b9bd9b6f7e87e810dc3d88b14db0246a46d163e387b09f28b372d49785e0bcc360bb10b276b13f2fe805a658916ac8ed03f9571db1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138935, 103, 70.0, 70.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c0bcdcbcecb2fcf53282c4dcc2bc92ca954c8cc4b4f2d2e494db1523037c84dd7cf4e57282d5028c957305548cf55d0484c29cd295148c92f4ed5040071541440', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138936, 103, 1.0, 1.0, 'g', 'IM', NULL, 'Pediatric', X'789c0bc948cd5348cf2c4b553054482f4acc55f0f455283436c8cdcc5328cd2bc9cc5128c92f49cc5148c92f4e55284a2d2ccd2c4a4d01321293335253006d181529', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138937, 103, 70.0, 70.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c3337c84dd7cf4e57c8cccb2cc94ccc5148c92f4e050045fb0712', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138938, 30888, 1.0, 1.0, 'mcg/kg', NULL, NULL, 'Adult', X'789c3354c84d4ed7cf4e57c82f4b2d52303450c8cdcc2b2d492d06005e5f080c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138939, 30888, 0.2, 0.7, 'mcg/kg', NULL, NULL, 'Adult', X'789c73cbcfc9c92f4f4d5148aa5430d0335228c90752e60ab9c9e9fad9e9fa194500a99e0a01', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138940, 30888, 1.0, 1.0, 'mcg/kg', NULL, NULL, 'Adult', X'789c3354c84d4ed7cf4e57c82f4b2d52303450c8cdcc2b2d492d06005e5f080c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138941, 30888, 0.6, 0.6, 'mcg', NULL, NULL, 'Adult', X'789c73cbcfc9c92f4f4d5148aa5430d03353c84d4ed7cf285228c92c294a2c010a97e42ba4a6a5a526972868a4a7e6a51625e6e480141a81240cc1aab3411a34017fde17f6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138942, 30888, 0.2, 0.4, 'mcg/kg', NULL, NULL, 'Pediatric', X'789c0b2e492c2a51482c5130d033d235d03351c84d4ed7cf4ed7cfc82f2d5248cc4b5128c92c294a2c495528c9574854c84dac50c84f533044550700e84515ff', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138943, 30888, 0.4, 0.4, 'mcg/kg', NULL, NULL, 'Pediatric', X'789c0dcac11180200c04c056ae02f16125769081181927840967ffbaef3db586bb8ea60d0c2c4a1242ecdb01af561e2b77bc892b12629dc23f4e61d7c1f5019e5215f3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138944, 3269, 0.0, 0.0, 'mcg', NULL, NULL, 'Adult', X'789c33d431303050c84d4e57484cc9cdcccb2c2e492d4a4d51284a4d2e49ccc9a904009b2f0ade', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138945, 3269, 800.0, 800.0, 'mcg', 'PO', NULL, 'Adult', X'789cb3303050c84d4e5708f007000db202af', X'789cd5556d4f143110fe2b93fda4c9010b8ae87e23802f09e805303171c966ae3bb7dbd04e376d17d990fbef4ef7503cc49033d1e887cb6d3b6fcf3ced3cbdc96adf3715a3a5ac80ec4407d77917a233d904b2de9bb4dbc6d885626beb8bbe24bbe97c93bef4d63de7a03c7654571853cc4ebef36223dfded8cecff3bd6277af78b6b3f97cf7d5dedeeee84b2a6ac7413c6fb237c4e4d18cdf91aec7f0f3a1a302a6293b3606b9d65cf2a10bd810bc76de86a2e453d7470ae0e6b05f5bcd3a448f29ab980e9cb58ee1dc634df05e9a0b051c0cd1455263f97ef62382856c459c194aabcf17b2329a2f978b64dbaf7b132ba9aeb95941f940ae6c2a903bf4b1b7554bd679df0ae695a833528e6b38d64c105b69bd1b403a04850c3302bc6d863cd520d9054bd3a331c3049c5ffe5f61a379f99902bdd44fabcd923f6f5f94bc3dc9f31cac6a56737d732bf9e5ad79fa215b6d7df11815ff5f776b9ef559474aa3a9a6aeeb0dde1debb7f6a69e1a4656039c8a959b920bf854f2314af5e40d5e87cbb47974ad3c4501a6a56f4f18a2d5462ca724bdc1f23215c02e424d7321ab2ef92d7592433d645caf935fc37d7caa0f931e2c9d43a5b9fa9e2193827789571b7e3ced77ff2af9570a2335ce6b01bf18793f702ce3ab65d0d503acef1b43be19203a500643d84aaa55f25d774fbeb4c4d007e15b7ca2f01da1378a7c78fa5b037f2591549d12aa9fc13c34f567e4b5ebef8166ecdac1e0b50ea25d43f0ed105bab710227ef4a7ef30e04403af68f7281d3b4f8be8bbda792cf5befeccc91fc8c5c875a74d6d7e4efcfeac85ad2b995aa871a652a49aae0ac76364d127442ec04e6729f7b43ac68028cc215a62b8735aa568aee33093691ce96421c23d6d586bfc5c17deeff2912fe389835aff2b4456f5139e39a6105d55b34f30da3e7f2cceee41bcf739b5ed813925c4278b005dcaa51c94b255b3eac27a45a14cdb5e3b33bc228e06c6051faa45cdd8f0f361c897ea314ee695de08bc5577a0ff445', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138946, 4436, 3.0, 4.0, 'g', 'IV', NULL, 'Adult', X'789cf30cb35230d6355148d74fc92f4e552834d135cb28b256c8cb2f5128c95748ad484e4d4d513002c91b9964140100387a0daa', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138947, 4436, 2.0, 3.0, 'g', 'IM', NULL, 'Adult', X'789cf3f4b55230d2355648d74fc92f4e552834d33534ca28b256c8cb2f5128c95748ad484e4d4d513032012a00121945004e180dee', X'789ced5a6d6fdb3812fe2b443e75b1f14b5ed02bbcf7c571d336b7492e88b3450fe7c2a0a5b1c48b44aa2495465df4bfdf434ab625c7a9bcba030e8bcb9736b2661ececb33c321eddf0f429d4773c9533a18b1831b9191e6814812210f0ed941ae13f7716c6d664683c157714f695fe9c8fd2506dbd226d03ca370cead533a1e1ebfee0d8f7a47c3bbe19bd170381a1ef54f4e4f4fff72ea6529b0424903c9df0fde930450e2ffb6f4e8d5ef8a8c4633794696b34b1e589ecee45b657844ec9dd2a919b18b8f33395169aa24bbd33c24760d2fccc8a3e78bfa02dff191e58b84dcd33f3fe30916dffb87cd82b595da5d77c2f34af8fb67873f0ef3c4ce61a19051c3918b8f2376d23b65d1205486d897d3deeb58ffc2a4b2cc2a468f0151c88eddfbe3d358cfe4c5d5881df74ed6f2af7b47c7cf2ab058ff317fbdad37140a6eb50876d97b4d4a728b40b2a3e190a5d1e03e42a8071757ec0b0c817d72c9a5358ccb904d6291849a242c1e0e7b272bf941c88b4a27140f2284bda5db1d6c9d6614089ecc6f5496277cc39995b9379a22c96550b05bbc95d10cc69ccda4cf8d9306876e49f28495aecea44f143e9de84902b37ba730fa72900a59a5897d79e3d2e05ffff5f8c94b978c995c4770263f50868582267e4da22b1fb71d6b27e55b57caa5b0990b395f2354149d286935173214c18e408e93847454388e05093766e03a03e2c073273b93d74af6b8e4595c24882d1c8e51a1da9034c222c9d66b2e5017bdc4d78541288c8d537ec882c23885a5586804c9b88c04242d2864c54228bceb6141853c5b5025500910213525f12dd7040e19a543d2ab4c8a34e342530a0808a950e429d3645cb04b533f1499bae709a582a38324a81784846961ee3b10701c3e3837e7b7c483a751db017830252d54be15dd2a728fa5631a261b11dc4b32a697208d708057d6bfbd3d9f4e992964a8554a8862905b6251d923c53744881e11b998526eb10ccb7263f3a40cecb92efc0b968284628946098043acf8b7a9ffffeefcda55b08547164146302565b1aee29d23a1422ea93264d247e8974b810e4f6c93a01908c4b58e893bf2a72a295c72b92cc38d4512caef5546b27a94945b5d7bce1c25edfa03c623cd251c701fc20948d8189e2f544d6a95c4addc560c3968a6b0e4badb181a2978bbb61a4b04489615192f3d7556f2dc101f3ca854946de4908585c92833c2fbc9431ec4e4826754ea6dbae5262e1dd23922982382efe8c1d1741c095b219f2788a676314208171209410e6d8106f5ee8e51420f5e6edb81bd1a448d52edbda12e0cf45a541a6cdba3c938f9f95abe81b5837ded802ba5794da9810aeeb6a338a1861698deaee5841a5a2b66ef11879564437fbb1eda71d61af34aa381b729a576a4cb8d6c03a3567fed20d735e1064abd6af7180debd20d9ceddade2349db1acd886ffac11ec1ae093739b669242d3cab049b35f41fb2a6de8cda312675e966a69b3d6c8f6c6f296c71b9ec79fb70b8926ce8bbfed8aeeba59a4cabdae91e2c5b4936f47d136e572ec5cac9e865c7fe1fecd8db63d3cb96fdb265bf6cd92f5bf6cb96fdb265b76fd97fbedda2cb25d00b4dffe434bd89391811a844454583ac1f78b2c41cb9a4113b19f6de0c5301325d1118a11261d211abee15c1b0c74093bfca64304a725d38c120e612724c2dd93828df5ec8582c84356c2114767b6cd118ce9c404049c2be72fc93e6013a72664548e50daeb1ee461d326e967da0720cc892ea86f0171673e3afe9324379a850711840bd2838dee5326d7de3379fae6f0e05b5dfa9fd4acdf0613836b9099c2b586db0ba8624f62a37393c2d7e4225cfa4708373eaaf62f1ea816b01e30a5657d52e4a163e42e37626d78fec95d2fed29d967ebe067600671099127dfa334c2830e247c2df6e7e1536ae457a73b789b6f11b44d716625e62bfdd5d302561c92ba924463963b1c1056c3dca03ffd3117a966221b768459f8e67b2ca90900c31d3ea902d72eb0d44a58535db207df203e98d60cd3367d37badf28c8d41094d19cb40dc4246ee9cc1f0726d9961614eeeaaf7bccf969c00e40e229f4ebbac58ad846907c42a8781e7476a74456fa1cbfe7bcd5376a3ca803ab5bfebc89783a78643edafdc396467876c72c8de1ff873defab6da4b96e5bd867d06e966652075c0f828b40839c2e69ddd0170b19f111cb9900ac465d12e943633ce5d21a8400501105679fb6fe0883cede0d4d5743adea176dba676db496d32ee75d49c5a9cc1faec3c43c3d4a90877c6ac75f93efb17618bd81daa36edcb3e03f9fc2ced6e14f6499a2f8f6b8ab82b0fb30d78dd671100312d28da49e94fc72d260121c558efbbc3ee90b4d1e84a69fe885ec919361a37b83c43c7361e7de8bbce94e424bfed74a54d1f4dcc7dddd4c1835f135a18e15c309deab15c78b08161e7d3b3cb9f3b10e4fc09d2af37934e40beb617e8e3a44d76c8c669366192a2ce6d620b2a535da83225ad41e46e615e29b394eb80b0e9cb5d267c3a6a83e1096ab073b2a7b1883a2bdf686509cd36159a2f44b7aebdc278c8930833504708f74dbe0c104c93f5bbd53c1e3c41bb014cdc5851728a2d35e532145d2ab70e130af7e56ede252075986efe8c51226ea2c66cd08518e34048b23f36a1ade46fd6633dc67cd2b99f31780763ce727d1fab04bb24f881d99a0762174c7ba559c2c8a855165756e1386df104e2efc26bebefff4076317c7246d5dce27e5a107471f09de6e0bef1f4b579c2b553efd44cce741efca00a5af52f2912ea4775d49a748ee346ae3d823befa900136a87907ce094fad4e4ee5080436ab1ab1c5bfdf928165a28d79ba4588a6067313e01b9122678529171c2d322f426f1dd35d53a6016381fa351a79b53c9aeb1a20de65604f764ad11cf98d11a13674759d8eec72dfc61f7e8f804662cb9db769fce7cee8a40aab408f69a1f9f30d65ba2fca5c152f3e8995da895779a1eb00f79da51828fa59b68bb95e32451ee073ffeb73febafbcbaccb275a057eeb4ba46fba94b97c84d2d6f9202dfc9f47ed97b122fcaacf2c746bb3a713dbbd17c7e7ad7f27265f2ff7165f247aee0be7fff37b44dd0c7', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138948, 4436, 100.0, 100.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cf34bcdcf4b2c492db65230343050c84dd7cf4e57f00cd3f7f455283434ca000093e208fe', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138949, 4436, 200.0, 300.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cf3cc4b4bcc2b295648cc4b5170cec8cc49294acdb352303230d035363050c84dd7cf4ed74f49ac54f00cd3f7f45548c92ccb4c494d512834d135cb2802004f3e12fd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138950, 140, 10.0, 10.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db6523034c84dd751303405914640360095fc0912', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138951, 140, 20.0, 20.0, 'mg', 'PO', 1, 'Adult', X'789c3332c84d5708f057087401000eb902ab', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138952, 140, 10.0, 10.0, 'mg', 'PO', 1, 'Adult', X'789c3334c84d5708f057087451a83036554849ac2cb656082e492c2ab15230d33534c85028c82f2ed1cd2f50c8cf4b4e55c848cd0572138b338b15528174524e6671466a0a00e7b31729', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138953, 140, 20.0, 20.0, 'mg', 'PO', 1, 'Adult', X'789c3332c84d5708f057c8cf4b4e554849cccca90400335605ee', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138954, 140, 15.0, 15.0, 'mg', NULL, 1, 'Adult', X'789c3334cd4d572829cf4c4e554849cccca954a850303204322b8b1532d3149c8b9c73141e752e353405000e360d9f', X'789ced5a6d6fdb3610fe2b0703053ac04e6ca7ce5a775f5c27453bac9b97b85b87aa10188a96d850a446524e8422fbed3b527212d94aed26595f567f686ad177cf1d8fcf1d8fb43eb4229dc7a124296b0da175c4e744ab73724264ab0dad5c0b379a589b99e1eeee193f65e98ed2b1fbc47797840dd524635148acd3e977fbfb9d6eafd3eb4ebb8f87ddde70efd1cea0ff78ffc99e9765d472250d4a7e688da2944b6eac266ecc0f5976ee51a645c686811c49cba922712e88b4816cc37342add2f086c04b99f0138e0f813c5086c40c9e2b9d9a21f4ba69dc86dec0fdede3e7401ea9dc32036a06758b6860acd25449986a1231f8158381006f8866c22aef6e7e72dde30b1cb2e44430f7f4f61d3e092e4ffdc395eb359fd707b32e7ef1ced91845b9b0214e8bcbb81696069f5ad344abf44431fc27b849777176ea9485995659520872ce4d0dc2850426bfc1ef07adfa6c9ce1833fa6e1e406c5dea5229cef0d202285790ac796683b847d5cee0432656c4765a0246590b0141f89e106987166b84958d46c73777278dd6c3bd48ce65a33691b5df7f811e1a2b8196eaa19b1e932826305d833bed08773e8f7fc5480cf60acc70282bcdfdf1ff406817cdb7b17486ff3ca201837615c16a704fdfe8a5a834723ab3911e18c9f682e84675e4864144a76161abbece2b5e44212431aef3a4b99c84d20a950198f548cfc0ce40cf3a0d707a4af4d4c197b8fe69c7b9f1b0b04233f9b714a2857b901aba00aaa9b848c888e3035589453cc0d8a444649e166c863c99d1a0ae23c586460860c837ffa3f3e70203dfc0fa1a94a334c940887027946f48c682e03e91c8583d164ba1c888d72e7da04d767cef89a30a25fa12cbc590ff1e742b2ccbb3ba5d2725e6e73699b4bdf712e7d16fa37e4dc96ff5bfe7f25fcbf13156fa0f6968b5b2ede968b5f923bcb74de92e75b21cff7bb52b739fd7fe1c53ace1875ab3551595eae55bdf39a68164b22690147dc9c56d729811cc2b829498f9844ac867b88e5835220cba31206f06abf0ba4af02bd4167d01dfa0b196cf89e96a5e1a7de600864ae7804b94135ac504dba7b5daf4b49ee9c0212cdb961d10263afbb8a81ae4c0e6b506db8dc762bd48f29da458d6c946dd8055fb00ce34c9ba234f26aaf0d8397feae29e122ea4cf23881b120c6c033c01c18bb4b2877fda31027293af885a23bd8f37a588870c264d5f0465c6c5cecf5943a701783ee864cc626e4128fbf154c9da3e58aaf873b2ee56aba18f10dfc40a17bd09a1cae574299cf68c9f3669b5b0db9b55c80bee2e4dad2ff4ef4ff7c2bbbf92eee1d1b6343a2099711b610abfbe70881e60c52f21e7df0ed057a1fc86a36c0b1a9e0da51bc0d77f1fb2a41e021c6199a530ecabebefe6d3576996b2eb57e58e06147f6d0365e725e07a9544634b7acccdc336e137f0d131592a46ea2d25dc470c16d5113d4ecef9c6bd7c3556644e1ae6d70e2d88f60af477401de32ae884a9b0eba9bed6cb720f527d17314cd99362c3c6284aeb2a0a9541d33edfad49adcb38a206d300cf198fb412b62e744326c6fc58c04f210fbbf5c13e1aa7cc67147705126181afcaeda08686155c624c79151ac8944eab821e30af98b22736e4ac39196b816c88dd2df401e5b34294de767954883f5dd1432423cb620abe5a6a19b297f0f6b9c44209f117a0a4870449fe85c73eb9afa43c1e6c462233dfa65baeaf3ad4aeb72d83ef147b4503b2de3ce2c4a8782cf5807c988e9800ec9382c0f05756ed49765137b957ce8e5eb7d517d1d37d821bc4278a950436b0ae8c7e156346a7837d162938daca6195e6ad6f06be4fa38e095680de19265eb119c68e845eb995e9173837c5f48de7bcccbd3d8b75913964bdbb6286c8bc2b628dc5751f82fb2e9363dd4ff28a49384e8945025545cd402fb0233b1e3927d0883ce134854ae319eaf1806c737bf4318ff357934e8628ccfa966fea520d8df7f00afb187656de83f7e00cf19654d6571dd41e215a30991682454b37044575e71aa5e603290095c5ce1ca8c3b5c90f2342e23f037ae12a85016b068a5e537734ef094806700eb2aa1eba3dd81c4c997158ea347d89e7b6c27af6630bb7c690ae14e14b6f236713216e10d36f34e199daa9eaa92e995dd19e58c14b799fe3163e14818553f3e5d2fc9b028c96e76b05c92abcbdbe5edf15edecadac8f2d7bfc154f74833dc0d2565f536e375365507c41dcb0e3345357efae445bcb8f8177fc5b9a7', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138955, 140, 20.0, 20.0, 'mg', NULL, 1, 'Adult', X'789c3332c84d57c8cf4b4e554849cccca954282e492c2ac9cc4b07722b158c8c1432d3149c8b9c73141e752e3534050061fc0fa6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138956, 140, 15.0, 15.0, 'mg', NULL, NULL, 'Adult', X'789c0bca2c4b2ccaaf484c4acc53303455c84dd74f49ac5428c8292d06007ede0949', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138957, 140, 15.0, 15.0, 'mg', NULL, 1, 'Adult', X'789c3334cd4d572829cf4c4e554849cccca954a850303204322b8b1532d3149c8b9c73141e752e353405000e360d9f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138958, 140, 20.0, 20.0, 'mg', NULL, 1, 'Adult', X'789c3332c84d57c8cf4b4e554849cccca954282e492c2ac9cc4b07722b158c8c1432d3149c8b9c73141e752e3534050061fc0fa6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138959, 140, 15.0, 15.0, 'mg', NULL, NULL, 'Adult', X'789c0bca2c4b2ccaaf484c4acc53303455c84dd74f49ac5428c8292d06007ede0949', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138960, 140, 15.0, 15.0, 'mg', NULL, 1, 'Adult', X'789c732e72ce513034d53535b00252b9e90a812ed60ace20411b43532b85c4b2fccc1485d2e25400d3c10b21', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138961, 28656, 1.0, 1.0, 'mcg/kg', NULL, NULL, 'Adult', X'789c33cc4d4ed7cf4e5748cacf292d5648cb2f52484c2e2d49552848cccc03008e0e0a10', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138962, 28656, 25.0, 5.0, 'mcg/kg', NULL, NULL, 'Adult', X'789c05c1410a80300c04c0afec510f5a29f4414b8935d4448cf93fceecb56d0dd64799a35c812535832978eb61ea2bce2760544f717a17d0790ff9943f1f3313cd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138963, 28656, 1.0, 1.0, 'mcg/kg', NULL, NULL, 'Pediatric', X'789c33cc4d4ed7cf4e5748cacf292d5648cb2f52484c2e2d49552848cccc03008e0e0a10', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138964, 28656, 25.0, 5.0, 'mcg/kg', NULL, NULL, 'Pediatric', X'789c05c1410a80300c04c0afec510f5a29f4414b8935d4448cf93fceecb56d0dd64799a35c812535832978eb61ea2bce2760544f717a17d0790ff9943f1f3313cd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138965, 10029, 1.0, 2.0, 'g', 'PO', 2, 'Adult', X'789c33d4354a5708f05770f27451f00f52303530d035343030c8050b8678bae829f826562a64e62517a52616a72a94e42b18e91ae999a68335a4e5172914a796a516a50255a4a5269764e6e71503008805184d', X'789ced586d73133710fe2b3bfe04337e370ed41f3a63925232d384d40eed07cc78649d7c277c271d922eb161f2dffb4897d83ec74030d342a7fde69357bbcfbeefea632d32453c552c13b501d5c6b9342c5b71a96a75aa1526f5878973b91db45ad77221b2a636b1ff255b555acb0dcb453465ce5fe9b6bb478d76a7d1695fb69f0ddadd41f7a766ff59bfd37e1a680577522b0bca8fb561944925ad33cc9f8523279681cbe52a178389ca18373a95919828a69c9c49ed249fa8136d592ce88536991d50b7dfae53bfdd9ea8912e9cb0a4e754653da08b57753afd63a28e7596694597864582cea13aee8ff455a98c08088bd936c81b1c39364b85ff7af3165fa9548bf0b141bb86f965d39dad496fde7adec3a848dd140a4915572cd0697463c0a6e7a727f46ae4f58349dbed2c1c5e9e9e34e98cad482a6e04b3829ca66ea3dbecc7e1c25c1bb2e24a18018af9ad3a1375a9973a4f99cd200e9f52516e44ec4d4bd73a130a16ef5847ce4818c60933a05e101731997a59d46b3ca1485e017e4491b6024cba2a6af54cb4b9143cd2e803e944e52b7fea12066fc0876b56c3f313c0ed81c216e99c45927d08049b7fe73092929c189711f5a175f99757ac47d7422c6c9d580a710a1e56315d4b975027a0b5ebe8f476dabe72a87f2b76fbb28fabe490b0e15431c897395d54c82b9cb60df7808cdda62e23ef42e01b5ee3fba2efe76e7b117b4766716bb18e4358b273d47cba3e8379276a5ccc78f0154b896b150b251d7eba6d230ca8ddec373aeb8bc199f7c2c3fbbd1fc27c97b01a254b7af2c910d8bebf15084b3ada7785ebc2208a438c7468259899a857481bf7794deee0ddd36013bf5b3876e157b2c0877625d6dff7a200e78850a85cf2153a7a76153ce1645b76607c6bbb268d442e98f379bc6d8a25759e65fad04cf931e2fb07cdb8712eb864e9f442e745ca367df04ec01ea3d72eca02cd57d3518880ca8563e644accd8a9ed769cce6bed8df55748eac79d3795bab3acda3f88d7117844f8db48b0abf13df31e50c4d34f2ac66beb538ca64bad8c367241474d9533b424b1b906a31c4fa5d9109df7bb8bc1439c0ecad41c7acf0303d92a4a42299e54c1a742ab7cbea33d15956bb6fb7e3ae6bfe9b863c58eb5df3fdbbd43e10edaed2ff14dc6f91f3f0ba1f441da34d1926558409e07e4d1ba6a930f1cacfa71c3dd4b6fcd27180946184b66cc57424187f58e51c0b237561777437f010f72d5d72e95675f44fd4e4b91f5ed0907fbf44daeb14ad3f68828139313a9b69be723ac73400171f271a185d305b693ee747e95f4f3fc59371e403ba6bea09eb74dcc4003d9f6f0ed091b54b84813fb0bba03461e290ea5d6150785ea75c6083413a09abf384c5a5b03f352ca17cd3beefc050ba70869fb69c1650c81a62296d981f5209330281f54bc39e742af7a38acd4ed5bbd2ac642534812018e69c1560d1bad299f47ceb60c98c4904c3b8328b70ead5f0a45f1bb8ff7bed215edb8df5efeeb6bf05c05796888b84196ce28884785541f292a5f3462ae762404ffc1ad26bf6137a74b73adf1afcf6d39b9bc5e2f1449d090883bf6d36a0db723a51bf2c41553e29bc107ee379044795b8957b5c27e3dbc401d8cf044f9882aca99e4f87fcde7bc8c82ff356ce109a33945aebeb29e20fab008d31e2cf0aac2afedd6386ea880c023034626db1d45b0f0aa36b0824df9553cd17fef504d49e036ab742e8e74e46217d7c688733d09507e6aee4d6713f91b3e0399f724e809f5d614b11d88c88a98882daef0b1fd25ca429c5465fbb04235477df08f590a8f2295131c5b976c47288bf2ac78cd7e3f2b9c3413e0a0521c0ead04c17714262c9bd6610479c417741997ff8f1c6337ef7a9ac7674ef3d04b87b87e01e0b311da6565770ef3cbe9c6dbf197ddf4789b3039faf6e6efe029c30f0db', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138966, 10029, 3.0, 3.0, 'g', 'PO', 1, 'Adult', X'789c332c2e512829cacc4d2d2e492db252304e5708f0574849cccca954c8cc5330d6355148c92ccb4c494d5148c92f4e2d06007bc20fe0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138967, 10029, 25.0, 50.0, 'mg', NULL, NULL, 'Adult', X'789c33ca4bd1372e4a512829cacc4d2d2e492d2ab6523032d53535c84d07007f9c08d6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138968, 10029, 2.0, 3.0, 'g', 'PO', 1, 'Adult', X'789c0bf0574849cccca95470f4735130d2354e07002e7e04df', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138969, 10029, 5.0, 5.0, 'mg', 'PO', 1, 'Adult', X'789c4b49cccca95470f4735148cbcfc9cccb4c56484cce4c5130cd4d5748014ba5e51729182b94a7a66617eb2824e694a416e5259664e6a52b946796642818a62b04f82b1417641625e6562667e6298478ba206b01001fe020a2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138970, 10029, 25.0, 25.0, 'mg/kg', 'PO', 2, 'Pediatric', X'789cb33332c84eb7523032cd4dd7cf4e5708f05770f27451c82f523034d333878b8578ba0000ea5b0b39', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138971, 10029, 0.5, 1.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c0b2e4d4acec9cccb4c4ecc5148cecf4b4fcdcb2c01324bf22bf20b72128b73f38b338bad140cf44c750d73d3f5b3d31502fc15521233732a016f471485', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138972, 10029, 50.0, 100.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c73f473513035d0353430c84dd7cf4e5708f0574849cccca904004c2a06de', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138973, 10029, 50.0, 100.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c6dcbd10d80200c05c055de001a2151f76948c50601d362c0ed5dc0fbbf81159d39d904ba1a6ba12625a24b3bb1b9d93b97e39222ec16a5fc062918d8ff4aa88f1a1b8eaaf07899f403b81f2003', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138974, 10029, 0.5, 0.5, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cf32f4b2d2a5148cecf4b4fcdcb2c49cc5128c9afc82fc8492ccecd2fce2cb65230d033cd4dd7cf4e5708f007006ac30f9b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138975, 10029, 50.0, 100.0, 'mg/kg', NULL, 1, 'Pediatric', X'789c4b49cccca95470f473513035d0353430c84dd7cf4e0700458b061f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138976, 10029, 5.0, 5.0, 'mg', 'PO', 1, 'Pediatric', X'789c1dcc4d0e82301006d0ab7c07f007a218b726aed57883493b94099d16da12c4d32b6cdfe2bd9eb0247ec1ed7147a30e6df412c4808c588c27fb87840b3486d2e51dc8174e818a0487594a87a6dad755a5eed83be44112e962246cddb024512e1da904de244fbe252bf45d618dcf9899fb7cc09b07a6021bf33a9b38a5cc191fd4578d3feb533889', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138977, 2069, 40.0, 40.0, 'mg', NULL, NULL, 'Adult', X'789c3331c84d070002a50139', X'789cbd56516fdb380cfe2b44807b6b1a276b0e3d037bc8da6dddddb6064db097b9306499b6b5ca9421c95b8da1fffd28a759e6ae43da62db9b257da4f889fc487f1de5b62d5312358e6218ad8d7558ab1c4707306aad0e7b95f78d8b27932fea0aeb4363cbf0a52603a893563498a7c2078b5934fb7b1c4dc7d3681d1dc7d1b3783e3d9cfe338f9e1df758945e19728cfc3a7a8d8456e8fedbe3756f7e1cb165f417183e804c19f159282d32a595ef4038304d631ce6e04d42456bcd268c843e4e2f7bff6df6fd1537bce545a631ac3e5ef24a2bbaea17bb2b776ef6137fb5c3de5c06ef8bbc56a49cb7225c3aa0b2ee1a8ce1ad314d42b96a2d7a25133a354e9408af8cad5d9cd085693d32ad02869e6278f3e10096e7099d98ba36046b2b7284f79c2b17c329d6bcba7e2ae36d34fbf99e6e915bb6adf6295350540eb81e4575394cc87398f11ee7e9b652e0394c03266b6bf4826e31f3deeea5af84b41d290942aa3ca1f9781645c0e6cb73ae047e0ac8b90cba4358abf03ec86e018b827943d6416eda8c5996fce1f04f57c1c177afb0e3b6dfc78b1d76e0e3ce5bec77b433487b834da696982be12d6fde93ad9528d077137e412585ec808c0774e18994ab307fdc13f6d7ad1a944ae874699a568b9dc4b7372e2d962488efbae053e29cc7f022a1b742fa1e0d56b9abb0f9860a41be5f82141422cb106cab59f32c15160c127786bc271573e420f24fadf335121f9e61c3eee4fdc74fad8cbbb13f4035a1ad6ec02e55947ef3304cf590fd7eb7dff069c0a79285501aab38f84dce4f0cb13a14371b794f0a165aa32dbb201da9857393d0fc135a506b957842ca17f967646da71728e48fb7dde370b442ab4c3bc47de0c4709572d158f042569d14962b37a1d5bfabc9fae5fb84cebdf1e65a491e00a361481bcea13b0e6bcde82e70e25aa9b8a37ae5eedaedade65f11e85df6bf25d2073b7d64729795b0b590469bb21b783f13ba186b55f0649b8d8fa032ad7509bde3569619ee1e358fb4e5d13ce29e7e2dc3e40893ac97ec93d5c7def64ba3476d54f00e65c57dd5d5a929d285fc612c87810cdb091883228fb640cb43f88bf2154fd8c97f93130dd2b096c835c67a709df3581f30b652990ab2068b2273c636bd7c797ab3191b29025f21ffa7486415324cab3a0bc76157878bf9fb0c493f724cdd5625a60bedcc80cd76403f32c93f71f0b09f81bedfdcdcfc0fc9607518', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138978, 2069, 20.0, 20.0, 'mg', NULL, NULL, 'Adult', X'789cb3553032c84d5728c92f2a4ecdcd4c4955b05530cc4d07004e6b0702', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138979, 2069, 50.0, 50.0, 'mg', NULL, NULL, 'Adult', X'789cb3553035c84d070004b90197', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138980, 2069, 5.0, 200.0, 'mg', 'PO', 1, 'Adult', X'789c33d535323050c84d5708f057c82f52f00c534849cccca9d45308c92c294a2c495528c957484d4b4b4d2e5148aa5448c92f4dcac9cc4b07328a53011afb1390', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138981, 1262, 250.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333235d035353050c84d5708f05728b4c80000223d043e', X'789ced5a6b6fdb3816fd2b1701164831b6133b7192bafbc571d247a6ee1871fa188c8b8096ae654e25524352693c83fef73d94fc4cdc2a5107d8596c3f24b11cdec3cb739fa4f8d74e68b2e85a8984773ab4d3e38908626d766ab49399d87f35752eb59dbdbdcff213270d6d22ff49eead8fb481112987d7c27981d67eeba8bedfac37f7aff68f3b874f3bed76e3e4b879d26ae6633970522b8b917fedbc60c546c4f967c7b7b9f8d52ce50eb5544851fe5f3f7aa4024ea722d636d546e2f14c5b11313dd726b11d0a446ab3986be4c4386657230d50b2994d59d95c7c3e7ee80cabc84d573298a9bd9f44356aefe3cfb339c2e2e90e4e879aad7612edb593d7b542aef878703cff76a42e75e6d8929e50374ca492d6152be8d0e09791eae924d18aae8c0899de807328d2634f638d2e85924b42b3f13a4f5ff055ae987ffaed239e62a93ee50f2bde36187a88fdd6877ff9e8e7e88659ecaec19554d1864db6e8b4f34a4d8ac7daf558048e8dbc63c85749c2a1148eeb866316963b2305d2eae09692087cd01f27d391ea8b5b1881a2bd50cc46eafcd6b10a395c93998f3fbfcc459aad426621b2b3c9cd976f7095aff11fa4f6c3ad9c6b3ec8d53232f81e0b5db736c49a3f51a2b1befdfaa1d776ef53ae9cd7389437120ba2e6497da13bdcffefe3fc6f53e4912c0e530efcf4039d66b15891b5506460385242053304a403cb2384eee948bd86def340ee43afcc327d9eca98696c606f376118c70fbe648594511868a4f280822fbcd124c2df33eb12566ea45e9e75e885bc610a3570c4048c6099229e5969476a80ff42c066691a7321b0343d5288e9c5f4efe67e87ce38f073cf51dafbffaa00fc9253ac2ad8a2b0a390275271b831fbdaf755f3d45d82cb53d599af50c5607b2dd5f512619eb67a5a21cb4a15ca608b41bb71cc269a91d314c4c2da3d5ff0c0a3c872738203141c637d86777035e7478e1432be0c641cfb6253d85426a990a6a00d330699412d71a490478d76fa162ca2c4f8ff0e59fe99191e4121ab4dc8c643047eb018dfd6a1820e7c7e0929d031e6b4344599d0e691debc5ae14ad7722e07abb1c05e61cc752e07580c5c548c1bcfddf5258be03ef5db92d210d1afb33b2652229dce6271ebbdf40a7426631dcc9cf60b139e4f9325752b834f8aada5180a91994fb8c6f69b95256045ff9c39b3c0e82a4efcdf1a4d39d1f1cc796f3ebf9dc002f0191f316c127c725e85a1e31bf843fd424f9545bd1ece5408a530c73083afc8453a832334105f9389a714f1b6b4ac37bd3066ca98b137d5309f4f1e98f177917937e5bb1934f762df1b6cf072b604a98d9412483ac5c71b9dc82237bd13119a8c5ce981c98c7499cd471861a7f987cc605e61fcd25f3fbf2254a79b794775ee435ea74862523c22a16fb55ab9dbac0fde70bcbbe62e87ba27f19d8ebc2ebde633e508eb8337500a677b0829f9b84dfdbfe27b0f58d0a6e4f55272037fe1980f48bb8b911bf2eb1efc6df98bc5c80df9b3ef9cbf08830718a718b721bb889b72e9778b911bf2cb687b00c072e806c222481f90a8172337e47d5c97cb5efa511b72cb34502efc7639b448f13f12f6c2ddef96b21f19fb47c6fe91b17f64ec7f5ac6fe6fe7a52a7b981f4ef63fe66483a940fdc50e5647b30d577b29e2493d9613eed041bbde3ea444aa67d4aa1f4c0d4945e797c3b391ea333c02a5dc261d1a08408bd817fa54cccb7c60b8386c798be2cd941a9960ee7846bb47fbf593f6bf2853c154a888c3271ecc7f06567eec1a1482afd4548ea5b314701cd367815f491620f7a74e864c76a6dc94adb4cf687e2415c850c4150e94baca61220dc5af87cb4304c9e53be19f7993b8e148d9cc065e41ccb6b7389160dacd6c06fd6758eaab91920adace8f2869f7c69b640c62d6458d5f9813ca41e21221bc78a45d6d4869473cc91b226007580cec5aa00f7f820a33c526c27819d067e9a66bfc89e54a911ade62e852c30970df5ebd22adbc89148aa09d59875219d0b2f702fe8726928fa6503824910fad91128512700b7066748dc699cb154490866bba61f4c13746af06aeadccebf4c2e82ca52e596738a5142e3b53517ee4a2cd4a334b61c6fe7ce8bc4113c100f259f0c3619519e73329ce9082cbda34e4bf5c436ffd17462434d005a15eec1713e54e5db418406d2c9653a3d31af56af462276fcf970757f9c822c097b05f411a2c14e40a18efa441ac80b67cb1d59540fca26ec07129da86f2a1590273ee2341073a0800b130dc16a0cbc7e2c82ca9a24f7f38ec5660a37fb955ac4ceb5eb75e5172e8d0d937e83c957e0f25c3ada4bd2a9bbe41bf334ac476aeca5478dd20b85fbe23f06ff91e62b53c40de7094effeec5dc0370d8a0088ce40f356a72e5b0f0012ec0bf2f4508d91be36e216c952508004074dbee28e65382f1b3e35c519ab3f2b8527b2983f58ae20f973cc632bfd126c95b09e4fbcb782a1f3e1e9eb9faa84e43da49f07bd4a40796c1725dea635ea26698f14477f1754aaab649c211bff5a783bcd0f1526b44401a3eaab6d2a9466aba18811825f3576b9fc5446d5a507463b46ba4da41163b93d50cafc6d817193c511daa02a8600847fbba802d069d3460504443d1e7217ad06d0f39d45e1553431ec77e0db62f73130a1f46f65b22a84acc36c5f4f59faea2248e05802ed4125cfe806e8f8ddb7752835abe52c9c6b21d864799f212a009d66e6d354c7a17f658d4e381581ac0233748caed1608f3c572a11b15bdb313f12ee575817fda7209e772efe3562b00da994ede746c0f96deebf2e8b85f1f295f2c9a9c9826f8441a9fc6b8ea4fe9e401a086c393293232419f8f53bba2a9abc149ce4c6c9fcce005bd1d9b6802c857927c7466a9f9d949cc8606b38de03e94b1bdc8bc9692c925998ab242a46557f86bd2f9275b2da9b6ceb2d4a712e65f0899db3f27b1499efb8b384c4cd037bedae12bef8de6ffcfc7e5fe964166c6d22cbbd365745a306a0f53722fa4a292aaf237c836294bb1ec7f85af9be767b4c9695b55eacb1b142130a7e96ef2aaaac6d1d68d7ef5a97684f2aa58accae594e7190e733536daf34e0d4e97cffe8163bafed510fb63ede3f74f97176f2ff7176f2d8cb5dccd7ddd8ea9dcd97954bea69b72fa47a52f5907a3b52d91ba3a5ccf55ca63840bde409a3da06774e0abbd3185c58ea81d0536c0167f09d38d068426af4890d98830b67b6068f0a2953638d86917c076db2b1540dbaa0f975ad06b5f6f79bcf9a074f775b4f3a07cde3fa41f369837e1b64e3bebf4ed73c3c393e3e3af83852ddc41f7f0a455708677438010d513bd9cd6a34ca5afbcde04586fc083e7c8e849ddc94e9953fc51631f58512517e99acb8f38aba6be9bdf77dff1622c3a859bd1bfc9149833997a74e1d3a9322424f26b190aeb56ced0262c8e85da59fdb2f70318d671111810ae09faea66c443aabe5da85d888d125dfe0c7a6d2001998cda74f0ff0fbf064b7fda4d33c6c9ed45b47abb59fb40e9e364f8efcd28d567a32a1179735cf361a4f47effbfeb3816b5f0c6bc48efcd9b4bf8346c8f2363030a78abc5f17f7c29e0b340a863bf33b747487ac39257e313dd4ef1026af511bfc70d8a081afe8188dca2e6a34e87668698b9e8e638ed8533298ce2cd2b650f699b7e9718d523a6a6279ed83c6489dea0834f36719fc49fd7c9ed7d8444474f66b7f61bf7b37dc96d7b57ce4ae7b75f1ea0891f9d62711ac71a9f39cebb9735171a5d3934d1739dd6d4ff7eec1934eabd584a7adc88693359b27271ffd95bb2485d5055d9c81610d4dfbbd1a0d83a918739c60cde7357a296620eef4ace18d9c5fb304011b579bad576b75e5ad2ef2fb7d705afff2004e643b24080db1bf3a0ebb102a33d8f181710e6e23ea7be2b196d6333a6c79f7386ab6ea47adfd95c6ade6f161ebb0fdd4ab3cbfe54ebde2bab8a5dfd20d27808993fc35d8c7069d0ba795d39f61e037171d7acfd6d5df0b03d28a77259cf92e3d86152f32500c1dda8db5299677882f8b3bc47495df45ffe6946fb4812bbd17d0acf09f2bbe11f7e73be3809331b65398f3b0f1d8c4fae5cb7f00c0541e39', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138982, 1262, 2.0, 2.0, 'g', NULL, NULL, 'Adult', X'789cf34dacb052305248d74f49ac040016d103a7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138983, 1262, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c33353050c84d57700d5208f057283434ca00002544045c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138984, 1262, 2.0, 2.0, 'g', NULL, NULL, 'Adult', X'789cf34dac50305248d74f49ac040013a0036d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138985, 1262, 20.0, 40.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3332d0353150c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5130b4d03534ca00009eae098f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138986, 1262, 1.0, 1.0, 'g', NULL, NULL, 'Pediatric', X'789cf34dacb052305448d74f49ac040016ca03a6', X'789ced5a6b6fdb3816fd2b1701164831b6133b7192bafbc571d247a6ee1871fa188c8b8096ae654e25524352693c83fef73d94fc4cdc2a5107d8596c3f24b11cdec3cb739fa4f8d74e68b2e85a8984773ab4d3e38908626d766ab49399d87f35752eb59dbdbdcff213270d6d22ff49eead8fb481112987d7c27981d67eeba8bedfac37f7aff68f3b874f3bed76e3e4b879d26ae6633970522b8b917fedbc60c546c4f967c7b7b9f8d52ce50eb5544851fe5f3f7aa4024ea722d636d546e2f14c5b11313dd726b11d0a446ab3986be4c4386657230d50b2994d59d95c7c3e7ee80cabc84d573298a9bd9f44356aefe3cfb339c2e2e90e4e879aad7612edb593d7b542aef878703cff76a42e75e6d8929e50374ca492d6152be8d0e09791eae924d18aae8c0899de807328d2634f638d2e85924b42b3f13a4f5ff055ae987ffaed239e62a93ee50f2bde36187a88fdd6877ff9e8e7e88659ecaec19554d1864db6e8b4f34a4d8ac7daf558048e8dbc63c85749c2a1148eeb866316963b2305d2eae09692087cd01f27d391ea8b5b1881a2bd50cc46eafcd6b10a395c93998f3fbfcc459aad426621b2b3c9cd976f7095aff11fa4f6c3ad9c6b3ec8d53232f81e0b5db736c49a3f51a2b1befdfaa1d776ef53ae9cd7389437120ba2e6497da13bdcffefe3fc6f53e4912c0e530efcf4039d66b15891b5506460385242053304a403cb2384eee948bd86def340ee43afcc327d9eca98696c606f376118c70fbe648594511868a4f280822fbcd124c2df33eb12566ea45e9e75e885bc610a3570c4048c6099229e5969476a80ff42c066691a7321b0343d5288e9c5f4efe67e87ce38f073cf51dafbffaa00fc9253ac2ad8a2b0a390275271b831fbdaf755f3d45d82cb53d599af50c5607b2dd5f512619eb67a5a21cb4a15ca608b41bb71cc269a91d314c4c2da3d5ff0c0a3c872738203141c637d86777035e7478e1432be0c641cfb6253d85426a990a6a00d330699412d71a490478d76fa162ca2c4f8ff0e59fe99191e4121ab4dc8c643047eb018dfd6a1820e7c7e0929d031e6b4344599d0e691debc5ae14ad7722e07abb1c05e61cc752e07580c5c548c1bcfddf5258be03ef5db92d210d1afb33b2652229dce6271ebbdf40a7426631dcc9cf60b139e4f9325752b834f8aada5180a91994fb8c6f69b95256045ff9c39b3c0e82a4efcdf1a4d39d1f1cc796f3ebf9dc002f0191f316c127c725e85a1e31bf843fd424f9545bd1ece5408a530c73083afc8453a832334105f9389a714f1b6b4ac37bd3066ca98b137d5309f4f1e98f177917937e5bb1934f762df1b6cf072b604a98d9412483ac5c71b9dc82237bd13119a8c5ce981c98c7499cd471861a7f987cc605e61fcd25f3fbf2254a79b794775ee435ea74862523c22a16fb55ab9dbac0fde70bcbbe62e87ba27f19d8ebc2ebde633e508eb8337500a677b0829f9b84dfdbfe27b0f58d0a6e4f55272037fe1980f48bb8b911bf2eb1efc6df98bc5c80df9b3ef9cbf08830718a718b721bb889b72e9778b911bf2cb687b00c072e806c222481f90a8172337e47d5c97cb5efa511b72cb34502efc7639b448f13f12f6c2ddef96b21f19fb47c6fe91b17f64ec7f5ac6fe6fe7a52a7b981f4ef63fe66483a940fdc50e5647b30d577b29e2493d9613eed041bbde3ea444aa67d4aa1f4c0d4945e797c3b391ea333c02a5dc261d1a08408bd817fa54cccb7c60b8386c798be2cd941a9960ee7846bb47fbf593f6bf2853c154a888c3271ecc7f06567eec1a1482afd4548ea5b314701cd367815f491620f7a74e864c76a6dc94adb4cf687e2415c850c4150e94baca61220dc5af87cb4304c9e53be19f7993b8e148d9cc065e41ccb6b7389160dacd6c06fd6758eaab91920adace8f2869f7c69b640c62d6458d5f9813ca41e21221bc78a45d6d4869473cc91b226007580cec5aa00f7f820a33c526c27819d067e9a66bfc89e54a911ade62e852c30970df5ebd22adbc89148aa09d59875219d0b2f702fe8726928fa6503824910fad91128512700b7066748dc699cb154490866bba61f4c13746af06aeadccebf4c2e82ca52e596738a5142e3b53517ee4a2cd4a334b61c6fe7ce8bc4113c100f259f0c3619519e73329ce9082cbda34e4bf5c436ffd17462434d005a15eec1713e54e5db418406d2c9653a3d31af56af462276fcf970757f9c822c097b05f411a2c14e40a18efa441ac80b67cb1d59540fca26ec07129da86f2a1590273ee2341073a0800b130dc16a0cbc7e2c82ca9a24f7f38ec5660a37fb955ac4ceb5eb75e5172e8d0d937e83c957e0f25c3ada4bd2a9bbe41bf334ac476aeca5478dd20b85fbe23f06ff91e62b53c40de7094effeec5dc0370d8a0088ce40f356a72e5b0f0012ec0bf2f4508d91be36e216c952508004074dbee28e65382f1b3e35c519ab3f2b8527b2983f58ae20f973cc632bfd126c95b09e4fbcb782a1f3e1e9eb9faa84e43da49f07bd4a40796c1725dea635ea26698f14477f1754aaab649c211bff5a783bcd0f1526b44401a3eaab6d2a9466aba18811825f3576b9fc5446d5a507463b46ba4da41163b93d50cafc6d817193c511daa02a8600847fbba802d069d3460504443d1e7217ad06d0f39d45e1553431ec77e0db62f73130a1f46f65b22a84acc36c5f4f59faea2248e05802ed4125cfe806e8f8ddb7752835abe52c9c6b21d864799f212a009d66e6d354c7a17f658d4e381581ac0233748caed1608f3c572a11b15bdb313f12ee575817fda7209e772efe3562b00da994ede746c0f96deebf2e8b85f1f295f2c9a9c9826f8441a9fc6b8ea4fe9e401a086c393293232419f8f53bba2a9abc149ce4c6c9fcce005bd1d9b6802c857927c7466a9f9d949cc8606b38de03e94b1bdc8bc9692c925998ab242a46557f86bd2f9275b2da9b6ceb2d4a712e65f0899db3f27b1499efb8b384c4cd037bedae12bef8de6ffcfc7e5fe964166c6d22cbbd365745a306a0f53722fa4a292aaf237c836294bb1ec7f85af9be767b4c9695b55eacb1b142130a7e96ef2aaaac6d1d68d7ef5a97684f2aa58accae594e7190e733536daf34e0d4e97cffe8163bafed510fb63ede3f74f97176f2ff7176f2d8cb5dccd7ddd8ea9dcd97954bea69b72fa47a52f5907a3b52d91ba3a5ccf55ca63840bde409a3da06774e0abbd3185c58ea81d0536c0167f09d38d068426af4890d98830b67b6068f0a2953638d86917c076db2b1540dbaa0f975ad06b5f6f79bcf9a074f775b4f3a07cde3fa41f369837e1b64e3bebf4ed73c3c393e3e3af83852ddc41f7f0a455708677438010d513bd9cd6a34ca5afbcde04586fc083e7c8e849ddc94e9953fc51631f58512517e99acb8f38aba6be9bdf77dff1622c3a859bd1bfc9149833997a74e1d3a9322424f26b190aeb56ced0262c8e85da59fdb2f70318d671111810ae09faea66c443aabe5da85d888d125dfe0c7a6d2001998cda74f0ff0fbf064b7fda4d33c6c9ed45b47abb59fb40e9e364f8efcd28d567a32a1179735cf361a4f47effbfeb3816b5f0c6bc48efcd9b4bf8346c8f2363030a78abc5f17f7c29e0b340a863bf33b747487ac39257e313dd4ef1026af511bfc70d8a081afe8188dca2e6a34e87668698b9e8e638ed8533298ce2cd2b650f699b7e9718d523a6a6279ed83c6489dea0834f36719fc49fd7c9ed7d8444474f66b7f61bf7b37dc96d7b57ce4ae7b75f1ea0891f9d62711ac71a9f39cebb9735171a5d3934d1739dd6d4ff7eec1934eabd584a7adc88693359b27271ffd95bb2485d5055d9c81610d4dfbbd1a0d83a918739c60cde7357a296620eef4ace18d9c5fb304011b579bad576b75e5ad2ef2fb7d705afff2004e643b24080db1bf3a0ebb102a33d8f181710e6e23ea7be2b196d6333a6c79f7386ab6ea47adfd95c6ade6f161ebb0fdd4ab3cbfe54ebde2bab8a5dfd20d27808993fc35d8c7069d0ba795d39f61e037171d7acfd6d5df0b03d28a77259cf92e3d86152f32500c1dda8db5299677882f8b3bc47495df45ffe6946fb4812bbd17d0acf09f2bbe11f7e73be3809331b65398f3b0f1d8c4fae5cb7f00c0541e39', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138987, 29956, 600.0, 600.0, 'mg', 'IV', NULL, 'Adult', X'789c333330c84d57f00c53283434ca50a830d535574849ac2c0600495b0688', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138988, 29956, 600.0, 600.0, 'mg', 'IV', NULL, 'Adult', X'789c333330c84d57f00c53283434ca50a830d53534514849ac2c06004f2006b6', X'789ced58db6edb3810fd95819f5a208e9d6b51f5c975d24d8136356ca7c0625d08b434b6d850a44a524e8422ffbe43ca37394aed04e9ee6291175b97b970ce1cce0cf5b311eb7c1a4a96622380461727966925b8c470a20c4bb968ec4123d7c2bd4daccd4cd06addf06b4cf7959eba2bde7a40c9449a651887cc3addc3f6e169b37dd03c680fdb6f829376d03edc7f7b7a7afcf6c4cb6264b99286247f36fe40899a097f6df1d6ab0f8b0c0338b1094cfd5b273d925dcc122694c994e6747b46cea7081f944e4d005c7e27ab6c2c700f327513a38689d2a031224796dbbcb431571a588d726a13523c6eb7d3696bc699d883d3e5f548f6556ed1809a40274eb9e4c696eb08e0e3575a8b4a532561a8598c70497892a5214e0421e323ccc7eb41ded123bf3677f7d737ba23f8aefdcd2ae84a78bbe4615dfcee9bf3d1897361438a91cb6905d09a35355c08b9e4b6083bd18f9c6b4a5e4f624e61715651f6a850d4f0e3e03081db93e61b8859611ad5a09cff2e0a910b6eb9f9b58183e3872cf451325117415777051cb59bc4a53265ded83bf0cf0f4e9a47f4fc68edf9f9a07fd6ba380be070f9b0c6dd056694d4a8cee1a502167fcf8d4d51da4dd55f24b404e219b0bd97af17709fccb24d2cff2748fcee303661fb5d713cc6eeeea5d59bee61cc99d5f5c6bbb9a63e6045015241b69084d84bfafe61136ec035cdfd27f81e6418512f097b2acb055bc1b870dfd338954c4605f4e9ad9c8e64f07e243f31ea6365a719b009da02aee4b55437d4bd7cbea10c64247db50fe019723d924b980238a368090f0b6cc6b870e1792496f098919ce76b732594abce3257159b979da776c54d8cb63746b7feb014362197e1d2c2bc497695a456ce65cca39a9c7484403d2dc02a880433a6e5920faf0c223061d4c61442202b639a1a29677c46f57e245f9308f3d306f0092434c96883d250b99aa1b33a46cb9ac2e5383515511a55083660d2f23157046f93dc2b2290c51822e50b1e101dadd2c5b3cc18f716ffc8a123bca7bf9842662ee6b0ef5f6c025c575706a8b9ca37122159961482dd7247b87518c9132c6c1382b41c2259ccf314623e99f0880b1cc935ec88855a27c8467270d53bef7fbcfc70de1d7efc72e9789c2a5110d444618929f5e69a99c64f7a95a59d2d0d5eb2dcb8ff3e33891b0adda899cdc7d5af2ae5e5aeee7c1aee416730041438734bf201a96b269c4fda2889c0b1ef67bbd7cd5aa0b627705d98acafac3c88f0769b9baacbc4573dd4266a07caadd4c2955ac5f22a77db82f77215dd452e77a82b0bc98a7ec980edda73b98aae63cd764d2f5545728d673b00b82e5db1b360e8761b4bc94dce2c48bc134b96c2659df84fedfabad3d1cbb67fd9f62fdbfeb9b7fd3fbdb39e3227bdd0e35fa3472f613a6534efaa695121c9051393a6e013a493cbfe295ca85c538ff84ce3f498866393067051c49a2abbe1864e3f7ff68edd89482a89ef20d3cacff19192349bbaf6e0e6fbd597cc913cbf8d3496a7ae2b9a6d915478ca341785f311254c920bff35302aa5de53b1a30616f1d87d39e432a1a9dd1a322a04dc30fa49f3486598591e239842da04cd6309396f931876e8e8b1d12717a70403af3ed369e6f553a95e6f695b455dea84731d4adedddddf688b7ec6', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138989, 29956, 400.0, 400.0, 'mg', NULL, NULL, 'Adult', X'789c732e72ce513036d03535b052303130c84d57283434cab0567006891b9aea1a03c58d91c45d83835cf43d5cac148ce08200389d10ea', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138990, 29956, 400.0, 400.0, 'mg', NULL, NULL, 'Adult', X'789c732e72ce513036d03535b052303130c84d57283434cab0567006891b9aea1a03c58d91c45d83835cf43d5cac148ce08200389d10ea', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138991, 5106, 10.0, 20.0, 'mg', 'PO', NULL, 'Adult', X'789c3334d0353250c84d5708f057c82f52f0f4552834530808f2030049840632', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138992, 8103, 50.0, 50.0, 'mcg', NULL, NULL, 'Adult', X'789c3354c82f4acc51c8cccb48cc492cc9cccf53d03035c84d4ed754283434ca00009bc809b0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138993, 8103, 50.0, 50.0, 'mcg', NULL, NULL, 'Pediatric', X'789cb333a9ccb7523054c82f4acc51c8cccb48cc492cc9cccf53d03035c84d4ed754283434ca0000d5230b64', X'789cc555db6edb300cfd15224f1b903417b4d9e6870159bba1039a216bf23617062333b61659ca24b9ab51e4df47d95d5bb70182062bf6665134cfe14587b79dd49659a2b1a04e049d39aa823c59a33a5de894560563eefdc645fdfe6fb9a6e2c8d82c7cc97edbd7098b1b4a13f4e197d16034ee0d86bde16031781f0d86d1f1f8e8ddf8dd78785cfb92f0d268c79eb79d495a482d9db7186cb5c9d34d1d65516d288af527f2d81b016626f8c5ba0b4b6bb4c84d2a157a63637d661c66045f8c2d1cff70694a4f0ecc0adac123f8aa7354f577ac4f4d51180d0b8b29c1372e808b6a72e5f231bf2d9b3c2e1585d38f2b3e29a9d7f5e181689be1fed235fec95fffed554099a4a5f209a72275d62ac3108c4505f29e3bbc391914227b0bbf86a3fc659c6ba419a512bd956217dac7e3ca44f0cf31e71b12125532339bb289e85ab0334b99462d2ab8e45b9dc5dcadd3585fa0f00dbe956e1dd72d5ca1f6f511046a6d3c2c096ca92805ee3b779f34334febcc22d00630fd593a5f90e6cb73da7038b1fbfad0f63fe5be7f00cec2a36b9c5d2275721fa1c3800f81dbd9ef0f7bef9f04ff44a0a7cc58c9e49b113b359a9f82d4a9143b5a30518a6c56813720143ad70fd27040ab27e9355947c925a1788eb22360674e569ab2ed37278e4280cee70502dda020bbac5977ef8c3d4b3c49dcf694d0e7b19eb114199db1e1fb822797a5e91a6b6d7a44b6a94278f82db069e944a98c5b93e2a7a960c3450ac382298a9c9ec6d83bebaf9bced3eabd7a3e0701bc549372b4050a4e39ab5a48e7a8563d255714c1c9d109d765ca804ba3a42b22b87bceb1fe7c232c351a3f35ceab0a562476966b1f9129891c59968bc4ac928978b6942eb827bd30d83a63e179acfb5d705e1641dd78f9f052d195025185a74471391a7e18711799251f53503c0eaa5e51c1830569329ddd3935cb8db5125c618ccfa1e05a2b96381e8f9b66491e20bf44c94439d34ae5f9dafa3fcb6fbbfd03e9a6dffa', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138994, 6615, 5.0, 5.0, 'mg/kg', NULL, 1, 'Adult', X'789c0ba92cc84c4eccc9a9543055c84dd7cf4e57d0c82f52303630c84dd7544849cccca90400c7940b12', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138995, 6615, 10.0, 15.0, 'mg/kg', NULL, 1, 'Pediatric', X'789c7bd4b9c4c440213bdd4ac1d040d7d05421375d3f3b5d21253133a752472137b12233b73457c1d8c000289e925f9c0a0075160f87', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138996, 6615, 5.0, 5.0, 'mg/kg', NULL, 1, 'Pediatric', X'789cb33331c84eb7523055c84dd7cf4e574849cccca954c84dac50303630000aa5e417a70200ba500af3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);